0001213900-22-071662.txt : 20221114 0001213900-22-071662.hdr.sgml : 20221114 20221114085533 ACCESSION NUMBER: 0001213900-22-071662 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 76 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221114 DATE AS OF CHANGE: 20221114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Innovative Payment Solutions, Inc. CENTRAL INDEX KEY: 0001591913 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-CATALOG & MAIL-ORDER HOUSES [5961] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55648 FILM NUMBER: 221380784 BUSINESS ADDRESS: STREET 1: 56B 5TH AVENUE, LOT 1 #AT CITY: CARMEL BY THE SEA STATE: CA ZIP: 93921 BUSINESS PHONE: (866) 477-4729 MAIL ADDRESS: STREET 1: 56B 5TH AVENUE, LOT 1 #AT CITY: CARMEL BY THE SEA STATE: CA ZIP: 93921 FORMER COMPANY: FORMER CONFORMED NAME: QPAGOS DATE OF NAME CHANGE: 20160615 FORMER COMPANY: FORMER CONFORMED NAME: Asiya Pearls, Inc. DATE OF NAME CHANGE: 20131113 10-Q 1 f10q0922_innovative.htm QUARTERLY REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2022

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to ____________

  

Commission file number 000-55648

 

INNOVATIVE PAYMENT SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)

 

Nevada   33-1230229
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

56B 5th AvenueLot 1 #ATCarmel By The SeaCA 93921
(Address of Principal Executive Offices, including zip code)

 

(866) 477-4729
(Registrant’s telephone number, including area code)

 

n/a
(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No 

 

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files.) Yes  No 

 

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer   Accelerated Filer
Non-accelerated Filer   Smaller Reporting Company
Emerging growth company      

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
         

 

As of November 14, 2022, there were 376,901,679 shares of the Company’s common stock issued and outstanding.

 

 

 

 

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

 

Form 10-Q

For the Quarter Ended September 30, 2022

 

Index

 

    Page No.
     
Cautionary Note Regarding Forward-Looking Statements ii
     
Part I. Financial Information 1
     
Item 1. Financial Statements (Unaudited) 1
     
  Condensed Consolidated Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021 1
     
  Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2022 and 2021 (Unaudited) 2
     
  Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and nine months ended September 30, 2022 and 2021 (Unaudited) 3
     
  Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2022 and 2021 (Unaudited) 4
     
  Notes to the Condensed Consolidated Financial Statements (Unaudited) 5
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 26
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 33
     
Item 4. Controls and Procedures 33
     
Part II. Other Information 34
     
Item 1. Legal Proceedings 34
     
Item 1A. Risk Factors 34
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 34
     
Item 3. Defaults Upon Senior Securities 34
     
Item 4. Mine Safety Disclosures 34
     
Item 5. Other Information 34
     
Item 6. Exhibits 35
     
Signatures 36

 

i

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (this “report”) contains “forward-looking statements” (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) that reflect our current expectations and views of future events. The forward-looking statements are contained principally in the section of this report entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Readers are cautioned that significant known and unknown risks, uncertainties and other important factors (including those over which we may have no control and others listed in report and in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2021 (the “2021 Form 10-K”)) may cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. You can identify some of these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events that we believe may affect our financial condition, results of operations, business strategy and financial needs. These forward-looking statements include statements relating to:

 

  our ability to implement our business plan, including scaling our IPSIPay® and Beyond Wallet product offerings by increasing app downloads and usage by customers;
     
  acceptance by the marketplace of our products and services, notably IPSIPay and Beyond Wallet;
     
  our ability to formulate, implement and modify as necessary effective sales, marketing, and strategic initiatives to drive revenue growth;
     
  the viability of our current intellectual property and intellectual property created in the future;
     
  our ability to comply with currently applicable laws and government regulations and those that may be applicable in the future;
     
  our ability to retain key employees;
     
  adverse changes in general market conditions for digital payment solutions such as IPSIPay, Beyond Wallet and other products and services we offer or may in future offer;
     
  our ability to generate revenue, positive cash flow and, ultimately, profitability and continue as a going concern;
     
  our future financing plans; and
     
  our ability to adapt to changes in market conditions which could impair our operations and financial performance.

 

These forward-looking statements involve numerous and significant risks and uncertainties. Although we believe that our expectations expressed in these forward-looking statements are reasonable, our expectations may later be found to be incorrect. Our actual results of operations or the results of other matters that we anticipate herein could be materially different from our expectations. Important risks and factors that could cause our actual results to be materially different from our expectations are generally set forth in the “Management’s Discussion and Analysis of Financial Condition and Results of Operation,” section contain in this report and in the “Business,” “Risk Factors” and other sections of the 2021 Form 10-K. You should thoroughly read this report and the documents that we refer to with the understanding that our actual future results may be materially different from, and worse than, what we expect. We qualify all of our forward-looking statements by these cautionary statements.

 

The forward-looking statements made in this report relate only to events or information as of the date of this report. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this report completely and with the understanding that our actual future results may be materially different from what we expect

 

ii

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Balance Sheets

 

   September 30,   December 31, 
   2022   2021 
   (Unaudited)     
Assets        
Current Assets        
Cash  $1,352,983   $5,449,751 
Other current assets   133,880    85,034 
Total Current Assets   1,486,863    5,534,785 
           
Non-current assets          
Plant and equipment   52,434    28,799 
Intangible assets   1,198,011    625,000 
Security deposit   47,592    34,800 
Investment   500,001    500,001 
Total Non-Current Assets   1,798,038    1,188,600 
Total Assets  $3,284,901   $6,723,385 
           
Liabilities and Equity (Deficit)          
           
Current Liabilities          
Accounts payable  $574,825   $465,205 
Convertible debt, net of unamortized discount of $0 and $263,200, respectively   2,210,802    1,961,354 
Derivative liability   710,389    407,161 
Total Current Liabilities   3,496,016    2,833,720 
           
Non-Current Liabilities          
Federal relief loans   162,560    158,353 
Total Non-Current Liabilities   162,560    158,353 
           
Total Liabilities   3,658,576    2,992,073 
           
Equity (Deficit)          
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of September 30, 2022 and December 31, 2021.   
-
    
-
 
Common stock, $0.0001 par value; 750,000,000 and 500,000,000 shares authorized, 376,901,679 and 367,901,679 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively.   37,690    36,790 
Additional paid-in-capital   47,863,546    45,771,012 
Accumulated deficit   (48,290,394)   (42,111,701)
Total equity (deficit) attributable to Innovative Payment Solutions, Inc. Stockholders   (389,158)   3,696,101 
Non-controlling interest   15,483    35,211 
Total Equity (deficit)   (373,675)   3,731,312 
Total Liabilities and Equity (Deficit)   $3,284,901   $6,723,385 

 

See accompanying notes to condensed consolidated financial statements.

 

1

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Operations

(Unaudited)

 

   Three months
ended
   Three months
ended
   Nine months
ended
   Nine months
ended
 
   September 30,   September 30,   September 30,   September 30, 
   2022   2021   2022   2021 
                 
Net Revenue  $
-
   $
-
   $
-
   $
-
 
                     
Cost of Goods Sold   
-
    
-
    
-
    
-
 
                     
Gross profit   
-
    
-
    
-
    
-
 
                     
General and administrative   2,721,451    2,747,693    4,386,375    9,457,134 
Depreciation and amortization   20,500    4,642    29,493    13,293 
Total Expense   2,741,951    2,752,335    4,415,868    9,470,427 
                     
Loss from Operations   (2,741,951)   (2,752,335)   (4,415,868)   (9,470,427)
                     
Loss on debt conversion   
-
    
-
    
-
    (5,184,447)
Penalty on convertible notes   (602,100)   
-
    (1,321,658)   
-
 
Interest expense   (51,340)   (53,903)   (142,302)   (174,587)
Amortization of debt discount   
-
    (515,200)   (263,200)   (3,138,452)
Derivative liability movements   84,895    1,578,361    (65,046)   4,714,451 
Loss before Income Taxes   (3,310,496)   (1,743,077)   (6,208,074)   (13,253,462)
                     
Income Taxes   
-
    
-
    
-
    
-
 
Net Loss   (3,310,496)   (1,743,077)   (6,208,074)   (13,253,462)
Net loss attributable to non-controlling interest   7,652    
-
    29,381    
-
 
Net loss attributable to Innovative Payment Solutions, Inc. stockholders  $(3,302,844)  $(1,743,077)  $(6,178,693)  $(13,253,462)
                     
Basic and diluted loss per share
  $(0.01)  $(0.00)  $(0.02)  $(0.04)
                     
Weighted Average Number of Shares Outstanding – Basic and diluted
   375,956,027    364,722,331    370,615,966    323,034,956 

 

See accompanying notes to condensed consolidated financial statements.

 

2

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(Unaudited)

 

For the Three and Nine Months Ended September 30, 2022

 

    Preferred
Stock
Shares
    Amount     Common
Stock
Shares*
    Amount     Additional
Paid-in
Capital
    Accumulated
Deficit
    Non-
controlling
shareholders
interest
    Total
Stockholders’
Equity
(Deficit)
 
                                                 
Balance at December 31, 2021          -     $      -       367,901,679     $ 36,790     $ 45,771,012     $ (42,111,701 )   $ 35,211     $ 3,731,312  
Stock based option expense     -       -       -       -       94,466       -       -       94,466  
Restricted stock awards     -       -       -       -       62,766       -       -       62,766  
Net loss     -       -       -       -       -       (1,801,494 )     (8,752 )     (1,810,246 )
Balance at March 31, 2022     -     $ -       367,901,679     $ 36,790     $ 45,928,244     $ (43,913,195 )   $ 26,459     $ 2,078,298  
Contribution by minority shareholders                                                     9,653       9,653  
Stock based option expense     -       -       -       -       94,462       -       -       94,462  
Restricted stock awards     -       -       -       -       62,766       -       -       62,766  
Net loss     -       -       -       -       -       (1,074,355 )     (12,977 )     (1,087,332 )
Balance at June 30, 2022     -     $ -       367,901,679     $ 36,790     $ 46,085,472     $ (44,987,550 )   $ 23,135     $ 1,157,847  
Fair value of warrants issued     -       -       -       -       322,918       -       -       322,918  
Shares issued for services     -       -       7,000,000       700       332,300       -       -       333,000  
Restricted stock awards     -       -       2,000,000       200       109,800       -       -       110,000  
Stock based option expense     -       -       -       -       1,013,056       -       -       1,013,056  
Net loss     -       -       -       -       -       (3,302,844 )     (7,652 )     (3,310,496 )
Balance at September 30, 2022     -     $ -       376,901,679     $ 37,690     $ 47,863,546     $ (48,290,394 )    $ 15,483     $ (373,675 )

 

 

 

    Preferred
Stock
Shares
    Amount     Common
Stock
Shares*
    Amount     Additional
Paid-in
Capital
    Accumulated
Deficit
    Non-
controlling
shareholders
interest
    Total
Stockholders’
Equity
(Deficit)
 
                                                 
Balance at December 31, 2020          -     $      -       193,637,747     $ 19,363     $ 23,179,399     $ (27,629,575 )   $      -     $ (4,430,813 )
Warrants exercised     -       -       44,074,284       4,407       2,199,307       -       -       2,203,714  
Share subscriptions     -       -       30,333,334       3,033       4,546,967       -       -       4,550,000  
Share issue expenses     -       -       -       -       (501,100 )     -       -       (501,100 )
Conversion of debt to equity     -       -       61,793,616       6,180       7,437,488       -       -       7,443,668  
Fair value of warrants issued as compensation     -       -       -       -       4,327,899       -       -       4,327,899  
Stock based compensation     -       -       2,500,000       250       213,499       -       -       213,749  
Net loss     -       -       -       -       -       (11,394,106 )     -       (11,394,106 )
Balance at March 31, 2021     -     $ -       332,338,981     $ 33,233     $ 41,403,459     $ (39,023,681 )   $ -     $ 2,413,011  
Warrants exercised     -       -       16,112,698       1,611       804,024       -       -       805,635  
Shares issued for services     -       -       8,000,000       800       775,200       -       -       776,000  
Stock based compensation     -       -       -       -       72,141       -       -       72,141  
Net loss     -       -                               (116,279 )     -       (116,279 )
Balance as of June 30, 2021     -     $ -       356,451,679     $ 35,644     $ 43,054,824     $ (39,139,960 )   $ -     $ 3,950,508  
Shares issued for services     -       -       5,650,000       565       442,485       -       -       443,050  
Stock based compensation     -       -       5,800,000       580       1,802,102       -       -       1,802,682  
Net loss     -       -       -       -       -       (1,743,077 )     -       (1,743,077 )
Balance as of September 30, 2021     -     $ -       367,901,679     $ 36,789     $ 45,299,411     $ (40,883,037 )     -     $ 4,453,163  

 

 

 

See accompanying notes to condensed consolidated financial statements.

 

3

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

   Nine months
ended
   Nine months
ended
 
   September 30,   September 30, 
   2022   2021 
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss  $(6,208,074)  $(13,253,462)
Adjustments to reconcile net loss to net cash used in operating activities:          
Derivative liability movements   65,046    (4,714,451)
Depreciation   29,493    13,293 
Amortization of debt discount   263,200    3,138,452 
Loss on conversion of debt to equity   
-
    5,184,447 
Penalty on convertible debt   1,321,658    
-
 
Deposit forfeited   
-
    4,000 
Shares issued for services   333,000    1,219,050 
Stock based compensation   1,437,516    6,416,471 
Fair value of warrants issued   322,918    
-
 
Amortization of right of use asset   
-
    17,857 
Changes in Assets and Liabilities          
Other current assets   (48,846)   (53,834)
Accounts payable and accrued expenses   109,621    17,545 
Operating lease liabilities   
-
    (17,857)
Interest accruals   54,042    144,773 
CASH USED IN OPERATING ACTIVITIES   (2,320,426)   (1,883,716)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Investment in intangibles   (585,640)   (250,000)
Investment in Frictionless Financial Technologies Inc.   
-
    (500,000)
Deposits paid   (12,792)   (4,800)
Plant and equipment purchased   (40,500)   (9,234)
NET CASH USED IN INVESTING ACTIVITIES   (638,932)   (764,034)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from minority shareholder contributions   9,653    
-
 
Proceeds from share issuances   
-
    4,550,000 
Share issue expenses   
-
    (501,100)
Pr0oceeds from warrants exercised   
-
    3,009,349 
Repayment of loans payable   
-
    (22,049)
Repayment of convertible notes   (1,147,063)   (521,000)
Proceeds from short term notes and convertible notes   
-
    2,569,000 
NET CASH PROVIDED BY FINANCING ACTIVITIES   (1,137,410)   9,084,200 
           
NET INCREASE (DECREASE) IN CASH   (4,096,768)   6,436,450 
CASH AT BEGINNING OF PERIOD   5,449,751    94,703 
CASH AT END OF PERIOD  $1,352,983   $6,531,153 
           
CASH PAID FOR INTEREST AND TAXES:          
Cash paid for income taxes  $
-
   $
-
 
Cash paid for interest  $88,260   $29,813 
NON CASH INVESTING AND FINANCING ACTIVITIES          
De-recognition of right of use lease on early termination  $
-
   $34,070 
Conversion of convertible debt to equity  $
-
   $2,259,221 
Debt discount on convertible debt  $
-
   $
-
 

 

See notes to the unaudited condensed financial statements.

 

4

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

1ORGANIZATION AND DESCRIPTION OF BUSINESS

 

a)Organizational History

 

On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”.

 

Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.

 

The Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.

 

Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. 

 

On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.

 

On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.

 

On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi” or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.

 

5

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

1ORGANIZATION AND DESCRIPTION OF BUSINESS (continued)

 

b)Description of current business

 

The Company is presently focused on operating and developing e-wallets that enable consumers to deposit cash, convert it into a digital form and remit the funds to Mexico and other countries quickly and securely. The Company’s first e-wallet, Beyond Wallet, is currently operational and is focused on business customers. The Company’s flagship e-wallet, IPSIPay, is also fully operational. IPSIPay, which is focused on individual customers, was first launched in December 2021 and its commercial launch has continued during 2022. Previously the Company intended to invest in physical kiosks, which required the user presence at the kiosk location. The Company still intends to use its existing kiosks in certain target markets within Southern California, but its principal focus will be on downloadable apps used via smartphones.

 

The Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”) on June 22, 2021. Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.

 

2ACCOUNTING POLICIES AND ESTIMATES

 

a)Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the nine months ended September 30, 2022 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2021, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2022.

 

All amounts referred to in the notes to the unaudited condensed financial statements are in United States Dollars ($) unless stated otherwise.

 

6

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2ACCOUNTING POLICIES AND ESTIMATES (continued)

 

b)Principles of Consolidation

 

The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

 

The entities included in the accompanying unaudited condensed consolidated financial statements are as follows:

 

Innovative Payment Solutions, Inc. - Parent Company

Beyond Fintech Inc., 51% owned. 

 

c)Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

d)Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.

 

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

7

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2ACCOUNTING POLICIES AND ESTIMATES (continued)

 

e)Fair Value of Financial Instruments

 

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

 

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

 

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

 

The carrying amounts reported in the balance sheets for the investment in Vivi Holdings was evaluated at fair value using Level 3 Inputs based on the Company’s estimate of the market value of the entities disposed to Vivi Holdings. Vivi Holdings does not have sufficient information available to assess the current market price of its equity.

 

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

 

f)Risks and Uncertainties

 

The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) COVID-19 and its variants, (ii) launching and scaling the Company’s e-wallet and related products and the use by customers of such products, (iii) developing and implementing successful marketing campaigns and other strategic initiatives; (iv) competition, (iv) compliance with applicable laws, rules and regulations (including those related to fund remittance); (v) the Company’s outstanding indebtedness, including the Company’s ability to repay or extend the maturity of such indebtedness (see Note 8); (vi) inflation and other economic factors and (vii) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.

 

The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.

 

g)Recent accounting pronouncements

 

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended September 30, 2022. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.

 

8

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2ACCOUNTING POLICIES AND ESTIMATES (continued)

 

h)Reporting by Segment

 

No segmental information is required as the Company has not generated any revenue for the nine months ended September 30, 2022 and 2021 and only has one operating segment.

 

i)Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At September 30, 2022 and 2021, respectively, the Company had no cash equivalents.

 

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At September 30, 2022 and December 31, 2021, the balance exceed the federally insured limit by $1,094,504 and $5,117,551, respectively.

 

j)Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended September 30, 2022 and December 31, 2021.

 

k)Investments

 

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

l)Plant and Equipment

 

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

 

Description   Estimated Useful Life
     
Kiosks (not used in the Company’s current business)   7 years
     
Computer equipment   3 years
     
Leasehold improvements   Lesser of estimated useful life or life of lease
     
Office equipment   10 years

 

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

 

9

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2ACCOUNTING POLICIES AND ESTIMATES (continued)

 

m)Long-Term Assets

 

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

n)Revenue Recognition

 

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue Recognition.

 

The Company’s revenues will be recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

 

  i. identify the contract with a customer;

 

  ii. identify the performance obligations in the contract;

 

  iii. determine the transaction price;

 

  iv. allocate the transaction price to performance obligations in the contract; and

 

  v. recognize revenue as the performance obligation is satisfied.

 

The Company had no revenues during the nine months ended September 30, 2022 and 2021.

 

o)Share-Based Payment Arrangements

 

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

 

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

 

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

 

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

 

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

 

10

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2ACCOUNTING POLICIES AND ESTIMATES (continued)

 

p)Derivative Liabilities

 

ASC Topic 815, Derivatives and hedging (“ASC 815”) generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

q)Income Taxes

 

The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of September 30, 2022 and December 31, 2021, there have been no interest or penalties incurred on income taxes.

 

r)Comprehensive income

 

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

 

s)Reclassification of prior year presentation

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

 

3LIQUIDITY MATTERS

  

The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For and as of the end of nine months ended September 30, 2022, the Company had a net loss of $6,208,074. In connection with preparing the unaudited condensed consolidated financial statements for the nine months ended September 30, 2022, management evaluated the risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements.

 

The Company had a cash balance of $1,352,983 available as of September 30, 2022. Based on its evaluation of the Company’s current business plan, and assuming the Company can extend the maturity date of its existing indebtedness (see Note 8), management believes the Company’s existing cash is sufficient to conduct planned operations for at least one year from the date of issuance of these financial statements.

 

However, given the Company’s losses, negative cash flows and existing indebtedness, the Company will be required to raise significant additional funds to progress its business as planned by issuing equity or equity-linked securities. Should this occur, the Company’s stockholders would experience dilution, perhaps significantly. Additional debt financing, if available, may involve covenants restricting the Company’s operations or its ability to incur additional debt. Any additional debt financing or additional equity that the Company raises may contain terms that are not favorable to the Company or its stockholders and require significant debt service payments, which diverts resources from other activities. Moreover, there is a risk that financing may be unavailable to support the Company’s operations on favorable terms, or at all.

 

There is also a significant risk that none of the Company’s plans to raise financing will be implemented in a manner necessary to sustain the Company for an extended period of time. If adequate funds are not available to the Company when needed, the Company may be required to continue with reduced operations or to obtain funds through arrangements that may require the Company to relinquish rights to technologies or potential markets, any of which could have a material adverse effect on the Company. In addition, the Company’s inability to secure additional funding when needed could cause the Company’s business to fail or become bankrupt or force the Company to wind down or discontinue operations.

 

11

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

  

4INTANGIBLES

 

On August 26, 2021, the Company formed a subsidiary, Beyond Fintech. to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owns 51% of Beyond Fintech with the other 49% owned by Frictionless.

 

During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, and during the nine months ended September 30, 2022, an additional $544,320 was spent by the Company to facilitate the functioning of the IPSIPay software in the cloud environment. Beyond Fintech spent an additional $41,320 on software to further enhance the Beyond Wallet product offering. 

 

   September 30,
2022
   December 31,
2021
 
Purchased Technology  $1,210,640   $625,000 
Accumulated amortization   (12,629)   
-
 
   $1,198,011   $625,000 

 

Amortization expense was $12,629 for the three and nine months ended September 30, 2022 and $0 for the three and the nine months ended September 30, 2021.

 

5INVESTMENTS

 

Investment in Frictionless Financial Technologies Inc.

 

On June 22, 2021, the Company entered into a Stock Purchase Agreement (the “SPA”) with Frictionless, to purchase 150 common shares for gross proceeds of $500,000, representing 10.0% of the outstanding common shares. In terms of the SPA, Frictionless agreed to deliver to the Company on or before August 30, 2021, a live fully compliant financial payment software as a service solution for use by the Company as a digital payment platform that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate to Company’s product offerings. The Company’s IPSIPay app is the digital payment platform developed by Frictionless for the Company, and currently Frictionless provides back-end technical services to the Company relating to IPSIPay.

 

The Company has undertaken to issue Frictionless a non-restricted, non-dilutable 5 year warrant to purchase 30,000,000 shares of Common Stock at an exercise price of $0.15 per share, upon delivery of the financial payment software. Frictionless has delivered the IPSIPay-related software and the warrants will be issued in accordance with the agreement.

 

The Company has the right to appoint, and has appointed, one member to the board of directors of Frictionless, which appointee will remain on the board as long as the Company is the holder of the Frictionless common stock.

 

The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

The shares in Frictionless are unlisted as of September 30, 2022.

 

Investment in Vivi Holdings, Inc.

 

Effective December 31, 2019, the Company sold 100% of the outstanding common stock of its subsidiary, Qpagos Corporation, together with its 99.9% ownership interest of Qpagos Corporation’s two Mexican entities: Qpagos S.A.P.I. de C.V. and Redpag Electrónicos S.A.P.I. de C.V, to Vivi.

 

As consideration for the disposal, Vivi issued an aggregate of 2,250,000 Vivi Shares as follows: 2,047,500  Vivi Shares to the Company; 56,250 Vivi Shares to the Company’s designee, Mr. Andrey Novikov; 33,750 Vivi Shares to the Company’s designee, the Joseph W. & Patricia G. Abrams Family Trust; and 112,500 Vivi Shares to the Company’s designee, Mr. Gaston Pereira.

 

Due to the lack of available information, the Vivi Shares were valued by a modified market method, whereby the value of the assets disposed of were determined by management using the enterprise value of the entire Company less the liabilities and assets retained by the Company.

 

12

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

5INVESTMENTS (continued)

 

As of September 30, 2022 and December 31, 2021, the Company maintained the impairment of the carrying value of the investment in Vivi Holdings based on no activity by Vivi’s management for its proposed initial public offering and fund raising activities. The total impairment as of September 30, 2022 and December 31, 2021 was $1,019,960.

 

The shares in Vivi Holdings are unlisted as of September 30, 2022.

 

   September 30,
2022
  

December 31,
2021

 
Investment in Frictionless Financial Technologies, Inc.  $500,000   $500,000 
Investment in Vivi Holdings, Inc.   1    1 
   $500,001   $500,001 

 

6LEASES

 

On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5th Avenue, Lot 1 #AT, Carmel by The Sea, California. The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month.

 

Total Lease Cost

 

Individual components of the total lease cost incurred by the Company is as follows:

 

  

Nine months
ended
September 30,
2022

   Nine months
ended
September 30,
2021
 
Operating lease expense  $43,200   $17,857 

 

Other lease information:

 

   

Nine
months ended
September 30,

2022

    Nine
months ended
September 30,
2021
 
Cash paid for amounts included in the measurement of lease liabilities            
Operating cash flows from operating leases   $ (45,200 )   $ (60,403 )
                 
Remaining lease term – operating lease     -       6 months  

 

Maturity of Operating Leases

 

The amount of future minimum lease payments under operating leases are as follows:

 

   Amount 
Undiscounted minimum future lease payments under leases with terms twelve months or less    
Total instalments due:    
2022  $
            -
 

 

13

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

7FEDERAL RELIEF LOANS

 

Small Business Administration Disaster Relief loan

 

On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company. The proceeds are to be used for working capital purposes to alleviate economic injury caused by the COVID-19 pandemic.

 

The Company has accrued interest of $12,560 on this loan as of September 30, 2022.

  

8CONVERTIBLE NOTES PAYABLE

 

Convertible notes payable consists of the following:

 

Description  Effective Interest
Rate
   Maturity date  Principal   Accrued
Interest
   Unamortized
debt discount
  

September 30,
2022
Amount, net

  

December 31,
2021
Amount, net

 
Cavalry Fund I LP   28.7%  November 16, 2022  $1,091,754   $13,647   $
       -
   $1,105,401   $548,872 
                                  
Mercer Street Global Opportunity Fund, LLC   28.7%  November 16, 2022   1,091,754    13,647    
-
    1,105,401    548,872 
                                  
Bellridge Capital LP.   10%  February 16, 2022   
-
    
-
    
-
    
-
    863,609 
                                  
Total convertible notes payable          $2,183,508   $27,294   $
-
   $2,210,802   $1,961,353 

 

Interest expense totaled $49,912 and $52,236 and amortization of debt discount totaled $0 and $515,200 for the three months ended September 30, 2022 and 2021, respectively, and interest expense totaled $138,085 and $169,695 and amortization of debt discount totaled $263,200 and $3,138,452 for the nine months ended September 30, 2022 and 2021, respectively.

 

Cavalry Fund I LP

 

  On February 16, 2021, the Company closed a transaction with Cavalry Fund I LP (“Cavalry”), pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Cavalry Note”). The Cavalry Note is convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of Common Stock at an initial exercise price of $0.24 per share.

 

On February 3, 2022, the Company extended the maturity date of its Cavalry Note from February 16, 2022 to August 16, 2022. The Cavalry Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Cavalry agreed to extend the maturity date of the Cavalry Note to August 16, 2022 in consideration of the principal amount outstanding under the Cavalry Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. On August 30, 2022, the Company further extended the maturity date of its Cavalry note from August 16, 2022 to November 16, 2022. In terms of the agreement entered into with Cavalry, the principal outstanding was increased by $181,959 and the interest outstanding as of August 31, 2022 of $43,553 was capitalized, resulting in a principal balance outstanding of $1,091,754. In addition, the Company granted Cavalry a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share, maturing on August 30, 2027 and valued at $119,091 on the date of grant. 

 

This change to the maturity dates of the Cavalry Note from February 16, 2022 to August 31, 2022 and subsequently to November 16, 2022, was assessed in terms of ASC 470-50 as a debt extinguishment, which resulted in a penalty expense of $181,959 and $260,708 for the three months and nine months ended September 30, 2022, respectively, in addition the value of the warrant issued on the debt extension from August 16, 2022 to November 16, 2022, resulted in an additional penalty expense of $119,091 for the three and nine months ended September 30, 2022.

 

The balance of the Cavalry Note plus accrued interest at September 30, 2022 was $1,105,401.

 

14

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

8CONVERTIBLE NOTES PAYABLE (continued)

 

Mercer Street Global Opportunity Fund, LLC

   

  On February 16, 2021, the Company closed a transaction with Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Mercer Note”). The Mercer Note is convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of Common Stock at an initial exercise price of $0.24 per share.

 

On February 3, 2022, the Company extended the maturity date of its Mercer Note from February 16, 2022 to August 16, 2022. The Mercer Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Mercer agreed to extend the maturity date of the Mercer Note to August 16, 2022 in consideration of the principal amount outstanding under the Mercer Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. On August 30, 2022, the Company further extended the maturity date of its Mercer note from August 16, 2022 to November 16, 2022. In terms of the agreement entered into with Mercer, the principal outstanding was increased by $181,959 and the interest outstanding as of August 31, 2022 of $43,553 was capitalized, resulting in a principal balance outstanding of $1,091,754. In addition, the Company granted Mercer a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share, maturing on August 30, 2027 and valued at the date of grant at $119,091.

 

This change to the maturity dates of the Mercer Note from February 16, 2022 to August 31, 2022 and subsequently to November 16, 2022, was assessed in terms of ASC 470-50 as a debt extinguishment, which resulted in a penalty expense of $181,959 and $260,708 for the three months and nine months ended September 30, 2022, respectively, in addition the value of the warrant issued on the debt extension from August 16, 2022 to November 16, 2022, resulted in an additional penalty expense of $119,091 for the three and nine months ended September 30, 2022.

 

The balance of the Mercer Note plus accrued interest at September 30, 2022 was $1,105,401.

  

Bellridge Capital LP.

  

  On February 16, 2021, the Company closed a transaction with Bellridge Capital LP., pursuant to which the Company received net proceeds of $787,500, after an original issue discount of $112,500 in exchange for the issuance of a $900,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Bellridge Note”). The Bellridge Note was convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 3,913,044 shares of Common Stock at an initial exercise price of $0.24 per share.

 

The Bellridge Note was repaid on February 4, 2022 for gross proceeds of $1,235,313, including interest thereon of $88,250, thereby extinguishing the Bellridge Note.

 

9DERIVATIVE LIABILITY

 

Certain of the short-term convertible notes disclosed in note 8 above and certain warrants disclosed in note 10 below have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.

 

On August 30, 2022, the company extended the maturity date of convertible notes issued to Cavalry and Mercer and agreed to grant each note holder a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share with a maturity date of August 30, 2027. The warrant has full ratchet anti-dilution clauses and have fundamental transaction clauses which may give rise to cash settlement which gives rise to a derivative financial liability, which was originally valued at the grant date using a Black--Scholes valuation model at $238,182.

 

15

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

9DERIVATIVE LIABILITY (continued)

 

The value of this derivative financial liability was re-assessed at September 30, 2022 at $710,389, and $84,895 was credited and $65,046 was charged to the statement of operations for the three and nine months ended September 30, 2022, respectively. The value of the derivative liability will be re-assessed at each financial reporting period, with any movement thereon recorded in the statement of operations in the period in which it is incurred.

 

The following assumptions were used in the Black-Scholes valuation model:

 

  

Nine months
ended

September 30,
2022

   Year ended
December 31,
2021
 
Conversion price    $ 0.05 to $0.15     $ 0.05 to $0.24  
Risk free interest rate    0.79 to 4.25 %   0.05 to 1.12 %
Expected life of derivative liability    1.5 to 59 months     1.6 to 49.6 months  
Expected volatility of underlying stock    120.49 to 258.3 %   161.19 to 215.33 %
Expected dividend rate    0%   0%

 

The movement in derivative liability is as follows:

 

   September 30,
2022
   December 31,
2021
 
Opening balance  $407,161   $2,966,416 
Derivative financial liability arising from convertible note and warrants   238,182    2,569,000 
Fair value adjustment to derivative liability   65,046    (5,128,255)
   $710,389   $407,161 

 

10STOCKHOLDERS’ EQUITY

 

  a. Common Stock

 

The Company has total authorized Common Stock of 750,000,000  shares with a par value of $0.0001 each. The Company had 376,901,679 and 367,901,679 shares of Common Stock issued and outstanding as of September 30, 2022 and December 31, 2021, respectively.

 

On July 8, 2022, the Company entered into a consulting agreement with a third-party contractor for a period of twelve months to (i) review the Company’s business plan; (ii) analyze and assess the Company’s revenues, costs, and cash flow; and (iii) introduce the Company to and interface on the Company’s behalf with potential and actual commercial partners. The Company issued 2,000,000 shares of Common Stock as compensation for the services rendered which were fully earned on the date of issue. These shares were valued at $84,000 at the date of grant. In addition, the contractor will receive a monthly fee of $3,000 for the term of the Agreement, commencing on August 1, 2022.

 

On July 8, 2022, the Company entered into a second consulting agreement with a separate third-party contractor for a period of twelve months to (i) review the Company’s business plan; (ii) analyze and assess the Company’s revenues, costs, and cash flow; and (iii) introduce the Company to and interface on the Company’s behalf with potential and actual commercial partners. The Company issued 2,000,000 shares of Common Stock as compensation for the services rendered which were fully earned on the date of issue. These shares were valued at $84,000 at the date of grant.

 

On July 11, 2022, the Board approved the issuance of  2,000,000 restricted shares of Common Stock to Richard Rosenblum, the Company’s President and Chief Financial Officer. These shares were valued at $110,000 at the date of grant.

 

On August 5, 2022, the Board approved the issuance of 3,000,000 shares of Common Stock to Samad Harake or his designees as compensation for the services rendered which were fully earned on the date of issue., Mr. Harake is the president and control person of Frictionless. These shares were valued at $165,000 at the date of grant.

 

16

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

10STOCKHOLDERS’ EQUITY (continued)

   

b.Restricted stock awards

 

A summary of restricted stock activity during the period January 1, 2021 to September 30, 2022 is as follows:

 

   Total
restricted
shares
   Weighted
average
fair market
value per
share
   Total
unvested
restricted
shares
   Weighted
average
fair market
value per
share
   Total vested
restricted
shares
   Weighted
average
fair market
value per share
 
Outstanding January 1, 2021   20,495,000   $0.049    15,371,250   $0.049    5,123,750   $0.049 
Granted and issued   2,500,000    0.050    2,500,000    0.050    
-
    
-
 
Forfeited/Cancelled   (1,500,000)   (0.050)   (1,500,000)   (0.050)   
-
    
-
 
Vested   
-
    
-
    (6,123,750)   (0.049)   6,123,750    0.049 
Outstanding December 31, 2021   21,495,000   $0.049    10,247,500   $0.049    11,247,500   $0.049 
Granted and issued   2,000,000    0.055    
-
    
-
    2,000,000    0.055 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (5,123,750)   (0.049)   5,123,750    0.049 
Outstanding September 30, 2022   23,495,000   $0.050    5,123,750   $0.049    18,371,250   $0.050 

 

The restricted stock granted, issued and exercisable at September 30, 2022 is as follows:

 

    Restricted Stock Granted   Restricted Stock Vested 
Grant date
Price
   Number
Granted
   Weighted
Average
Fair Value
per
Share
   Number
Vested
   Weighted
Average
Fair Value
per
Share
 
$0.049    20,495,000   $0.049    15,371,250   $0.049 
$0.050    1,000,000    0.050    1,000,000    0.050 
$0.055    2,000,000    0.055    2,000,000    0.055 
      23,495,000   $0.050    18,371,250   $0.050 

 

The Company has recorded an expense of $172,766 and $44,165 for the three months ended September 30, 2022 and 2021, respectively and $298,298 and $188,448 for the nine months ended September 30, 2022 and 2021, respectively. 

 

  c. Preferred Stock

 

The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of September 30, 2022 and December 31, 2021.

 

17

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

10STOCKHOLDERS’ EQUITY (continued)

 

  d. Warrants

  

Effective July 8, 2022 (the “Effective Date”), the Company entered into an Endorsement Agreement with Pez-Mar, Inc., a California corporation (“Pez-Mar”), to furnish the services of Mario Lopez (“Lopez”). Pursuant to the Endorsement Agreement, Lopez will act as a Company spokesperson in connection with the promotion, advertisement and endorsement of the Company’s physical and virtual payment processing and money remittance business and the Company’s related products and services.

 

The Endorsement Agreement has a term of two (2) years from the Effective Date (the “Term”), which is subject to earlier termination on customary terms and conditions. The parties have agreed to certain deliverables of Lopez during the term of the agreement, including with respect to social media posts, television commercials, interviews and photo shoots. The Endorsement Agreement also contains other customary terms, covenants and conditions, including representations and warranties, restrictions on endorsements of competitive products during the term of the agreement, confidentiality, indemnification, and Pez-Mar and Lopez’s independent contractor status.

 

As compensation for the services provided under the Endorsement Agreement, Lopez or their designees are entitled to the following payments: (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Fifteen Million (15,000,000) shares of the Common Stock at an exercise price of $0.0345 per share. The Warrants shall have a three-year term commencing from the Effective Date. The right to exercise the Warrants shall be subject to vesting during the Term but shall vest in full upon the consummation of a fundamental transaction involving the Company or upon certain termination events provided for in the Endorsement Agreement. The Exercise Price may be payable via “cashless exercise”, unless the underlying Shares are registered under an effective registration statement under the Securities Act of 1933, as amended. The Shares are subject to certain “piggyback” registration rights.

 

On August 30, 2022, the Company extended the maturity date of convertible notes issued to Cavalry and Mercer and agreed to grant each note holder a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share with an expiration date of August 30, 2027.

 

The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

 

   Nine months
ended
September 30,
2022
 
Exercise price  $ 0.0345 to 0.15  
Risk free interest rate   3.14 to 3.27 %
Expected life   3 to 5 years  
Expected volatility of underlying stock   189.1 to 199.2 %
Expected dividend rate   0%

 

18

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

10STOCKHOLDERS’ EQUITY (continued)

 

d.Warrants (continued)

    

A summary of warrant activity during the period January 1, 2021 to September 30, 2022 is as follows:

 

   Shares
Underlying
Warrants
   Exercise
price per
share
   Weighted
average
exercise
price
 
Outstanding January 1, 2021    51,188,572   $0.05   $0.05 
Granted    66,302,515         0.05 to 0.24    0.16 
Forfeited/Cancelled    (20,000,000)   0.24    0.24 
Exercised    (60,186,982)   0.05    0.05 
Outstanding December 31, 2021    37,304,105   $ 0.05 – 0.1875   $0.12 
Granted    21,000,000      0.03450.15    0.07 
Forfeited/Cancelled    
-
    -    
-
 
Exercised    
-
    -    
-
 
Outstanding September 30, 2022    58,304,105   $  0.05 – 0.1875   $0.11 

 

The warrants outstanding and exercisable at September 30, 2022 are as follows:

 

    Warrants Outstanding   Warrants Exercisable 
Exercise
Price
   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
$0.0345    15,000,000             2.77                         8,437,500                                2.77 
$0.05    10,823,813    3.03         10,823,813         3.03 
$0.15    30,053,625    3.73         30,053,625         3.73 
$0.1875    2,426,667    3.46         2,426,667         3.46 
      58,304,105    3.34   $0.11    51,741,605   $0.11    3.42 

 

The warrants outstanding have an intrinsic value of $0 as of September 30, 2022 and December 31, 2021.

 

  e. Stock options

 

On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.

 

The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the Plan is 800,000 shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.

 

19

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

10STOCKHOLDERS’ EQUITY (continued)

 

e.Stock options (continued)

 

On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.

 

The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the 2021 Plan is 53,000,000 shares of Common Stock.

 

Under the 2021 Plan the company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.

  

On July 11, 2022, the Board approved, granted and issued 15,000,000 ten-year incentive stock options, with immediate vesting, to the Company’s Chairman and Chief Executive Officer at an exercise price of $0.15 per share. This resulted in an immediate expense of $823,854 for the three and nine months ended September 30, 2022.

 

On September 13, 2022, the Company granted ten-year options exercisable for 200,000 shares of Common Stock, with immediate vesting, to each of its four non-executive directors, totaling options exercisable for 800,000 shares of Common Stock at an exercise price of $0.04 per share. This resulted in an immediate expense of $31,970 for the three and nine months ended September 30, 2022.

 

The fair value of the options granted and issued were determined by using a Black Scholes valuation model using the following assumptions:

 

   Nine months
ended
September 30,
2022
 
Exercise price    $ 0.04 to 0.15   
Risk free interest rate     2.99 to 3.42 %
Expected life     10.0 years   
Expected volatility of underlying stock     206.4 to 208.4 %
Expected dividend rate    0%

 

A summary of option activity during the period January 1, 2021 to September 30, 2022 is as follows:

 

   Shares
Underlying
options
   Exercise
price per
share
   Weighted
average
exercise
price
 
Outstanding January 1, 2021    100,000   $0.40   $0.40 
Granted    30,416,666      0.15 – 0.24    0.15 
Forfeited/Cancelled    
-
    -    
-
 
Exercised    
-
    -    
-
 
Outstanding December 31, 2021    30,516,666   $ 0.15 to 0.40   $0.15 
Granted    15,800,000      0.040.15    0.14 
Forfeited/Cancelled    
-
    -    
-
 
Exercised    
-
    -    
-
 
Outstanding September 30, 2022    46,316,666   $ 0.04 to 0.40   $0.15 

 

20

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

10STOCKHOLDERS’ EQUITY (continued)

 

e.Stock options (continued)

 

The options outstanding and exercisable at September 30, 2022 are as follows:

 

    Options Outstanding   Options Exercisable 
Exercise
Price
   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
 0.04    800,000             9.96                          800,000                               9.96 
 0.15    45,208,333    9.19         35,625,000         9.27 
 0.24    208,333    8.40         208,333         8.40 
 0.40    100,000    6.25         100,000         6.25 
      46,316,666    9.19   $0.15    36,733,333   $0.15    9.27 

 

The options outstanding have an intrinsic value of $0 as of September 30, 2022 and December 31, 2021, respectively.

 

The option expense was $950,290 and $1,196,566 for the three months ended September 30, 2022 and 2021, respectively and $1,139,220 and $1,288,174 for the nine months ended September 30, 2022 and 2021, respectively. 

 

11NET LOSS PER SHARE

 

Basic loss per share is based on the weighted-average number of common shares outstanding during each period. Diluted loss per share is based on basic shares as determined above plus Common Stock equivalents. The computation of diluted net loss per share does not assume the issuance of common shares that have an anti-dilutive effect on net loss per share. For the three and nine months ended September 30, 2022 and 2021 all warrants, options and convertible debt securities were excluded from the computation of diluted net loss per share.

 

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three and nine months ended September 30 2022 and 2021 are as follows:

 

   Three and nine
months ended
September 30,
2022
(Shares)
   Three and nine
months ended
September 30,
2021
(Shares)
 
Convertible debt   14,738,682    13,626,666 
Stock options   46,316,666    30,516,666 
Warrants to purchase shares of Common Stock   58,304,105    37,304,104 
    119,359,453    81,447,436 

 

21

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

12RELATED PARTY TRANSACTIONS

 

The following transactions were entered into with related parties:

 

James Fuller

 

On February 22, 2021, the Board awarded James Fuller ( a director of the Company until November 2, 2022 when he voluntarily retired as a member of the Board) options under the Company’s 2018 Stock Incentive Plan to purchase 208,333 shares of Common Stock. The options are exercisable for a period of ten years from the date of grant, vest in full on the date of grant and have an exercise price of $0.24 per share.

 

On July 22. 2021, the Company granted Mr. Fuller 2,000,000 shares of Common Stock, valued at $154,000

 

Additionally, the Board approved the repricing of the options exercisable for 208,333 shares of Common Stock granted to Mr. Fuller on February 22, 2021, from $0.24 per share to $0.15 per share.

 

On September 13, 2022, the Company granted Mr. Fuller ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share.

 

The option expense for Mr. Fuller for the three and the nine months ended September 30, 2022 was $7,993.

 

Andrey Novikov

 

On February 22, 2021, the Board awarded Andrey Novikov options under the Company’s 2018 Stock Incentive Plan to purchase 208,333 shares of Common Stock. The options are exercisable for a period of ten years from the date of grant, vest in full on the date of grant and have an exercise price of $0.24 per share. 

 

On May 31, 2021, Mr. Novikov notified the Board of his decision to resign as a member of the Board and as Secretary of the Company, effective as of June 1, 2021. Since August 2021, Mr. Novikov has been on suspension from service as the Company’s Chief Technology Officer. On November 11, 2022, with the recommendation of a special committee of disinterested members of the Board who had reviewed this matter, the Board approved the formal termination of Mr. Novikov’s employment with the Company for “cause.”

 

William Corbett

 

On February 22, 2021, the Board appointed William Corbett as the Company’s Chief Executive Officer and Interim Chief Financial Officer, as its Chairman of the Board and issued him a five-year warrant to purchase 20,000,000 shares of the Common Stock at an exercise price of $0.24 per share. The Board also agreed to increase Mr. Corbett’s monthly base salary to $30,000. The warrant expense for Mr. Corbett for the year ended December 31, 2021 was $4,327,899.

 

On August 16, 2021, the Company and Mr. Corbett entered into an Executive Employment Agreement that replaced and superseded the previous executive employment agreement (the “August 2021 Corbett Employment Agreement”). The purpose of the August 2021 Corbett Employment Agreement was to provide a replacement grant for warrants previously granted to Mr. Corbett under the terms of his previous employment agreement with the Company. Pursuant to the August 2021 Corbett Employment Agreement, Mr. Corbett would continue to serve as the Company’s Chief Executive Officer on a full time basis effective as of the date of the August 2021 Corbett Employment Agreement until the close of business on December 31, 2024. Mr. Corbett’s base salary will be $30,000 per month, which shall be paid in accordance with the Company’s standard payroll practice for its executives, managers and salaried employees. In addition, the August 2021 Corbett Employment Agreement provides that: (1) Mr. Corbett will be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from time to time; (2) the Company will grant to Mr. Corbett options to purchase 20,000,000 shares of Common Stock at a per share exercise price of $0.15; and (3) a car allowance for Mr. Corbett in the amount of $800 per month. Fifty percent (50%) of the shares subject to the options shall vest on the grant date and the other 50% of the shares subject to the option shall vest at the rate of 1/36 per month over a three-year period. The options will be exercisable for a period of ten years after the date of grant and the Company shall provide for cashless exercise of the option. The options are being granted pursuant to the Company’s 2021 Stock Incentive Plan which was approved by the Board in August 2021, subject to approval of the 2021 Plan by the shareholders, which approval was obtained at the annual general meeting held on October 22, 2021.

 

22

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

12RELATED PARTY TRANSACTIONS (continued)

 

William Corbett (continued)

 

In addition, the Company and Mr. Corbett entered into an Indemnification Agreement on August 16, 2021 (the “August 2021 Corbett Indemnification Agreement”), pursuant to which the Company agreed to indemnify Mr. Corbett to indemnify Indemnitee to the fullest extent permitted by or under the Nevada Corporation Law in respect of claims, including third-party claims and derivative claims and provides for advancement of expenses. The August 2021 Corbett Indemnification Agreement amends the indemnification agreement in effect prior to entering into the August 2021 Corbett Indemnification Agreement to provide that unless Company shall pay Mr. Corbett’s attorneys’ fees and costs, including the compensation and expenses of any arbitrator, unless the arbitrator or the court determines that (a) Company has no liability in such dispute, or (b) the action or claims by Executive are frivolous in nature. In any other case or matter, the Company and Mr. Corbett shall each bear its or his own attorney fees and costs.

 

On July 11, 2022, the Company granted Mr. Corbett ten-year options exercisable for 15,000,000 shares of Common Stock at an exercise price of $0.15 per share.

 

The option expense for Mr. Corbett for the three and the nine months ended September 30, 2022 was $890,442 and $1,023,614, respectively.

 

Clifford Henry

 

On May 1, 2021, the Company appointed Mr. Henry to the Board.

 

On July 22, 2021, the Company granted Mr. Henry 2,000,000 shares of Common Stock, valued at $154,000.

 

Mr. Henry has an oral consulting arrangement with the Company whereby he is paid $3,500 per month for financial and capital markets advice. This consulting agreement commenced in May, 2021 and was approved and ratified by the Board in March 2022. This consulting agreement and related payments were terminated in September 2022.

 

On September 13, 2022, the Company granted Mr. Henry, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.

 

The option expense for Mr. Henry for the three and the nine months ended September 30, 2022 was $7,993.

 

Madisson Corbett

 

On May 1, 2021, the Company appointed Ms. Corbett to the Board. Ms. Corbett is the daughter of Mr. William Corbett, the Company’s Chief Executive Officer and Chairman of the Board.

 

On July 22, 2021, the Company granted Ms. Corbett 2,000,000 shares of Common Stock, valued at $154,000.

 

On September 13, 2022, the Company granted Ms. Corbett, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.

  

The option expense for Ms. Corbett for the three and the nine months ended September 30, 2022 was $7,993.

  

David Rios

 

On July 22, 2021, the Company appointed David Rios to the Board.

 

On July 22, 2021, the Company granted Mr. Rios 1,000,000 shares of Common Stock, valued at $77,000

 

On September 13, 2022, the Company granted Mr. Rios, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.

 

The option expense for Mr. Rios for the three and the nine months ended September 30, 2022 was $7,993.

 

23

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

12RELATED PARTY TRANSACTIONS (continued)

  

Richard Rosenblum

 

On July 22, 2021, the Company appointed Richard Rosenblum as President and Chief Financial Officer of the Company. In addition, Mr. Rosenblum was elected to the Board to serve until the Company’s next annual meeting of shareholders and was subsequently appointed as the Company’s Secretary.

 

On July 27, 2021, the Company and Mr. Rosenblum entered into an Executive Employment Agreement (the “Employment Agreement”), pursuant to which Mr. Rosenblum will serve as the Company’s President and Chief Financial Officer on a full time basis effective as of July 1, 2021. The effectiveness of the Employment Agreement is subject to the approval of the Employment Agreement by the Board, unless earlier terminated as provided in the Employment Agreement. The term of the Employment Agreement is until December 31, 2024. Mr. Rosenblum’s base salary will be $18,000 per month. In addition, the Employment Agreement provides that: (1) Mr. Rosenblum will be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from time to time; and (2) the Company will grant to Mr. Rosenblum options to purchase 10,000,000 shares of Common Stock at a per share exercise price equal to the fair market value of the Common Stock, as reflected in the closing price of the Common Stock on the OTC exchange or, in the event the stock is up listed, on a national stock exchange, on the date of grant (the “Options”)”. Fifty percent (50%) of the shares subject to the Options shall vest on the grant date and the other 50% of the shares subject to the Option shall vest at the rate of 1/36 per month over a three-year period. The Options will be exercisable for a period of ten (10) years after the date of grant and the Company shall provide for cashless exercise of the Option by Executive. The options are being granted pursuant to the Company’s 2021 Stock Incentive Plan which was approved by the Board in August 2021, subject to approval of the 2021 Plan by the shareholders, which approval was obtained at the annual general meeting held on October 22, 2021. The Options are being granted pursuant to the Company’s 2021 Stock Incentive Plan. 

 

If Mr. Rosenblum’s employment with Company is terminated at any time during the term of the Employment Agreement other than for Cause (as defined in the Employment Agreement), or due to voluntary termination, retirement, death or disability, then Mr. Rosenblum shall be entitled to severance equal to fifty percent (50%) of his annual base salary rate in effect as of the date of termination. If Mr. Rosenblum’s employment with Company is terminated at any time during the term of the Employment Agreement other than for Cause (as defined in the Employment Agreement), or due to voluntary termination, retirement, death or disability, within 12 months following an Acquisition (as defined in the Employment Agreement), then Mr. Rosenblum shall be entitled to severance equal to 100% of his annual base salary rate in effect as of the date of termination. Severance payments shall be subject to execution and delivery of a general release in favor of the Company.

 

On August 16, 2021, the Company entered into an amendment to the Rosenblum Executive Employment Agreement (the “First Amendment”) with Mr. Rosenblum. Under the terms of the Executive Employment Agreement, the Company had agreed to grant to Mr. Rosenblum an option to purchase 10,000,000 (ten million) common shares of Company Stock at a per share exercise price equal to the fair market value of the Common Stock, as reflected in the closing price of the Common Stock on the OTC exchange or, in the event the stock is uplisted, on a national stock exchange, on the date of grant (the “Option”).” The First Amendment provided that the Option was granted on August 31, 2021 at an exercise price of $0.15 per share.

 

In addition, the Company and Mr. Rosenblum entered into an Indemnification Agreement, pursuant to which the Company agreed to indemnify Mr. Rosenblum to indemnify Indemnitee to the fullest extent permitted by or under the Nevada Corporation Law in respect of claims, including third-party claims and derivative claims and provides for advancement of expenses.

 

On July 11, 2022, the Company granted Mr. Rosenblum 2,000,000 restricted shares of Common Stock valued at $110,000, all of which are vested.

 

The option expense for Mr. Rosenblum for the three months and nine months ended September 30, 2022 was $27,879 and $83,636, respectively.

 

24

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

13COMMITMENTS AND CONTINGENCIES

 

The Company has convertible notes, disclosed under note 8 above, which mature on November 16, 2022. Should these notes not be converted to Common Stock prior to that date, the Company may need to repay the principal and interest outstanding on these notes.

 

14SUBSEQUENT EVENTS

 

On November 2, 2022, the Company conducted its 2022 annual meeting of stockholders.

 

At the Annual Meeting, the Company’s stockholders (i) elected each of William D. Corbett, Richard Rosenblum, Madisson Corbett, Clifford Henry and David Rios as directors’ of the Company until the next annual meeting or until their successors shall be elected and qualified, (ii) ratified the appointment of RBSM LLP as the Company’s independent registered public accounting firm for fiscal year ended December 31, 2022, (iii) approved an amendment to the Company’s Articles of Incorporation to effect a reverse stock split of the issued and outstanding shares of common stock at a ratio (to be determined in the discretion of the Company’s Board during a two year period ending on November 2, 2024) within a range of one (1) share of Common Stock for every two (2) to thirty (30) shares of Common Stock, and (iv) approved a potential adjournment of the annual meeting,

 

The Company’s stockholders did not approve the proposed amendment to the Company’s Articles of Incorporation to provide the board of directors with the authority to, at its discretion, fix by resolution or resolutions, the designations, rights and privileges of the Company’s authorized preferred stock.

 

Other than the above, the Company has evaluated subsequent events through the date the financial statements were issued, and did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

 

25

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

All references to “we,” “us,” “our” and the “Company” refer to Innovative Payment Solutions, Inc., a Delaware corporation and its consolidated subsidiaries unless the context requires otherwise.

 

Overview

 

We are a provider of digital payment solutions and services to businesses and consumers. We are focused on operating and developing “e-wallets” that enable consumers to deposit cash, convert it into a digital form, and remit the funds to Mexico and other countries quickly and securely. Our first e-wallet, the Beyond Wallet, is focused on the business market and is currently operational. Our flagship e-wallet, IPSIPay, is focused on the consumer market and was fully launched in July 2022 after a soft launch in December 2021.

 

Our platform (which can be used both business-to-business and business-to-consumer) facilitates the transfer of funds in digital form to other countries, initially Mexico but also, India and the Philippines, primarily from hand-held devices as well as on desktop or laptop computers.

 

During the third quarter of 2022, we completed the key integration of our IPSIPay mobile application and back-end payment processing infrastructure through our commercial partners. Additionally, in July 2022 we entered into an endorsement agreement with Mexican-American actor and television personality, Mario Lopez, which we believe will be a significant part of our commercial launch efforts in our target markets as described below.

 

In October 2022, we announced that since the commencement of our new IPSIPay marketing campaign featuring Mr. Lopez in August 2022, we achieved 10,000 downloads of IPSIPay, and of the 10,000 downloads, 1,200 have been converted to active users with wallets, meaning the users have initiated at least one transaction via IPSIPay.

 

Our launch plan for IPSIPay and Beyond Wallet is to target lower income, migrant communities in California (notably in the agriculture industry), and expanding to other states with large migrant populations such as Texas and Florida. We not only believe the addressable market for our products and services is large and growing, but that servicing this market is socially responsible. We believe our digital payment facilitation platform and related apps will empower and enable the unbanked and under-served and payment providers who service these users, acting as a bridge to provide access to comprehensive and easy to use payment solutions. Given the large size of our addressable market, our ability to capture even a very small share of the market represents a significant revenue opportunity for our company.

 

Previously, we intended to invest in physical kiosks which required the user presence at digital payment kiosk locations, and we still intend to use our existing kiosks in certain target markets within Southern California.

 

We acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”), on June 22, 2021. Frictionless agreed to deliver to us, a live fully compliant financial payment software as a service solution for use by us as a digital payment platform that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate our anticipated product offerings. . IPSIPay is the digital payment solution provided to us by Frictionless, and Frictionless continues to provide back-end technical services to our company. We have an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

On August 26, 2021, we formed a new majority owned subsidiary, Beyond Fintech Inc. (“Beyond Fintech”), in which we own a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to our Beyond Wallet offering to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.

 

26

 

 

Known Trends, Demands, Commitments, Events or Uncertainties Impacting Our Business

 

Launch and Scaling of E-Wallets

 

Having achieved full commercial integration and launch of the IPSIPay app during the third quarter of 2022, the key for our business for the foreseeable future is to scale the number of IPSIPay and, to a lesser extent, Beyond Wallet downloads achieved and revenue generated from transactions process by customers via IPSIPay and Beyond Wallet. Presently, our ability to generate meaningful revenue from customer use of IPSIPay or Beyond Wallet is limited, given the relatively recent commencement of launch activities, the relatively limited app downloads and active users achieved to date and our launch promotional activities. While we see great potential for our product offerings in our initial target markets as described above, both the near- and long-term viability of our business is dependent in large part on our ability to scale our IPSIPay and Beyond Wallet business and add complimentary offerings (such as our telemedicine collaboration with MeMD (also known as Walmart Health Virtual Care), which we announced in October 2022), all with the goal of increasing app downloads and active users who would generate transaction processing and other fees for our company.

 

We expect to generate some initial IPSIPay-related revenue during the fourth quarter of 2022, with the goal of increasing revenues during 2023. However, our ability to scale our business and generate revenue is unproven at this time, so we remain faced with all of the risks associated with launching and seeking to scale a new business. If we are unable to grow our IPSIPay and Beyond Wallet business, our business would be severely harmed.

 

Outstanding Indebtedness

 

At September 30, 2022, we had outstanding convertible notes (described in note 8 to the accompanying condensed consolidated financial statements) in the principal amount of approximately $2.2 million. The notes mature on November 16, 2022 and are convertible into shares of our Common Stock at a conversion price of $0.15 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). We may be unable to repay these notes on maturity, and our inability to extent, repay or refinancing this indebtedness would have a material adverse effect on our ability to operate our company.

 

COVID-19

 

The novel coronavirus (“COVID-19”) pandemic has resulted in government authorities and businesses throughout the world implementing numerous measures intended to contain and limit the spread of COVID-19, including travel restrictions, border closures, quarantines, shelter-in-place and lock-down orders, mask and social distancing requirements, and business limitations and shutdowns. The spread of COVID-19 and increased variants has caused, and may continue to cause us to make significant modifications to our business practices, including enabling most of our workforce to work from home, establishing strict health and safety protocols for our offices, restricting physical participation in meetings, events, and conferences, and imposing restrictions on employee travel. We will continue to actively monitor the situation and may take further actions that alter our business practices as may be required by federal, state, or local authorities or that we determine are in the best interests of our employees, customers, or business partners.

 

The rapidly changing global market and economic conditions as a result of the COVID-19 pandemic have impacted, and are expected to continue to impact, our operations and business. For example, COVID-19 related issues has caused a delay in our ability to launch our products and services. The broader implications of the COVID-19 pandemic and related global economic unpredictability on our business, financial condition, and results of operations remain uncertain.

 

27

 

 

Russia’s Invasion of Ukraine

 

In February 2022, Russia invaded Ukraine, with Belarus complicit in the invasion. As of the date of this report, the conflict between these two countries is ongoing. We do not have any direct or indirect exposure to Ukraine, Belarus or Russia, through our operations, employee base or any investments in any of these countries. In addition, our securities are not traded on any stock exchanges in these three countries. We do not believe that the sanction levied against Russia or Belarus or individuals and entities associated with these two countries will have a material impact on our operations or business, if any. Further, we do not believe that we have any direct or indirect reliance on goods sourced from Russia, Ukraine or Belarus or countries that are supportive of Russia.

 

We have commercially launched our e-wallet platforms which provide online money transfer and payment services to our customers which may expose us to cybersecurity risks. We employ the latest encryption techniques and firewall practices and constantly monitor the usage of our software, however, this may not be sufficient to prevent the heightened risk of cybersecurity attacks emanating from Russia, Ukraine, Belarus, or any other country.

 

The impact of the invasion by Russia of Ukraine has increased volatility in stock trading prices and commodities throughout the world. To date, we have not seen a material impact on our operations; however, a prolonged conflict may impact on consumer spending, in general, which could have an adverse impact on the payment services industry as a whole and our business.

 

Inflation

 

Macro-economic conditions could affect consumer spending adversely and consequently our future operations when we fully launch our e-wallet products commercially. The U.S. has entered a period of significant inflation, and this may impact consumer’s desire to adopt our products and services and may increase our costs overall. However, as of the date of this report, we do not expect there to be any material impact on our liquidity as forecast in our business plan due to recent inflationary concerns in the U.S.

 

Foreign Exchange Risks

 

We intend to operate in several foreign countries, including Mexico. Changes and fluctuations in the foreign exchange rate between the US Dollar and other foreign currencies, including the Mexican Peso, may in future have an effect our results of operations.

 

Critical Accounting Estimates

 

Preparation of our consolidated financial statements in accordance with U.S. generally accepted accounting principles ("GAAP") requires us to make estimates and assumptions that affect the reported amounts of certain assets, liabilities, revenues and expenses, as well as related disclosure of contingent assets and liabilities. Significant accounting policies are fundamental to understanding our financial condition and results as they require the use of estimates and assumptions which affect the financial statements and accompanying notes. See Note 2 - Summary of Significant Accounting Policies of the Notes to the condensed Consolidated Financial Statements included in Part I, Item I of this Form 10-Q for further information.

 

The critical accounting policies that involved significant estimation included the following:

 

Derivative liabilities

 

We have certain short-term convertible notes and certain warrants which have fundamental transaction clauses which might result in cash settlement. The conversion feature of these convertible notes and warrants are recorded as derivative liabilities which are valued at each reporting date.

 

The derivative liability is valued using the following inputs:

 

  Conversion prices;

 

  Current market prices of our equity

  

  Risk free interest rates;

 

28

 

 

  Expected remaining life of the derivative liability;

 

  Expected volatility of the underlying stock; and expected dividend rates

 

Any change in the above factors such as a change in risk free interest rates, a significant increase or decrease in our current stock prices and a change in the volatility of our Common Stock may result in a significant increase or decrease in the derivative liability.

 

Impairment of Investments and Intangible assets

 

We carried investments of $500,001 and Intangible assets of $964,310 as more fully described in Notes 4 and 5 to the accompanying condensed consolidated financial statements. The Company tests its investments and intangible assets with an indefinite useful life annually for impairment or more frequently if indicators for impairment exist. The value of our Investments and intangibles is based upon our mutual goal of providing payment services to an underserved market. Currently our investments or our intangible assets have not produced any revenues on which to assess whether the income generated from these assets can support the carrying value of these assets. For impairment testing of investments and intangibles we determine the fair value of the underlying assets using an income-based approach which estimates the fair value using a discounted cash flow model. Key assumptions in estimating fair values include projected revenue growth and the weighted average cost of capital. In addition, management recently reviewed the future revenue and profit projections of our e-wallet services based on management forecasts of the size of the market and expected customer growth and retention, we determined that no impairment charges were necessary, however if we are unable to achieve our forecasts once operations begin, we may need to re-evaluate our forecasts which could result in an impairment charge. Since performing this analysis we have no reason to believe that further impairment is necessary as of September 30, 2022.

 

Results of Operations

 

Results of Operations for the Three Months Ended September 30, 2022 and 2021

 

Net revenue

 

We did not have revenues during the three months ended September 30, 2022 and 2021. We anticipate that we will commence generating revenue during the fourth quarter as we have fully launched our IPSIPay e-wallet.

 

Cost of goods sold

 

As we did not have revenues during the three months ended September 30, 2022 and 2021, we anticipate that we will begin to recognize cost of goods sold during the fourth quarter as we have launched our IPSIPay e-wallet.

 

General and administrative expenses

 

General and administrative expenses were $2,721,451 and $2,747,693 for the three months ended September 30, 2022 and 2021, respectively, a decrease of $26,242 or 1.0%. The decrease is primarily due to the following:

 

  (i) Consulting fees were $193,000 and $470,250 for the three months ended September 30, 2022 and 2021, respectively, a decrease of $277,250. In the prior year 5,650,000 shares valued at $443,050 were issued to various consultants for services rendered in connection with developing the IPSIPay platform, in the current year, we issued a further 4,000,000 shares of our Common Stock to two consultants for marketing efforts related to our platform, valued at $168,000.
     
  (ii) Payroll expenses were $1,290,681 and $1,437,751 for the three months ended September 30, 2022 and 2021, respectively, a decrease of $147,070 or 10.2%. The decrease is primarily due to the reduction is stock based compensation of $140,620 over the prior period based on the amortization of option and restricted stock expense and shares of Common Stock issued for salaries.
     
  (iii) Professional fees were $454,613 and $104,756 for the three months ended September 30, 2022 and 2021, respectively, an increase of $349,857 or 334.0%. The increase is primarily due to; (i) professional fees paid to Frictionless in managing and providing customer support for the IPSIPay platform, including expenses incurred on setting up Mexican operations; and (ii) social media expenses incurred to promote the IPSIPay platform to our target market.
     
  (iv) Selling and marketing expenses were $412,567 and $2,333 for the three months ended September 30, 2022 and 2021, respectively, an increase of $410,234. The increase is primarily attributable to Mario Lopez related endorsement expenses of $357,370 and marketing expenses of $33,553 incurred during the current period to promote the launch of the IPSIPay wallet and platform.
     
  (v) Legal fees were $213,760 and $39,025 for the three months ended September 30, 2022 and 2021, respectively, an increase of $174,735.The increase is primarily due to legal expenses incurred on labor disputes filed by several employees who were severed in the prior year.
     
  (vi) Directors fees were $30,000 and $583,006 for the three months ended September 30, 2022 and 2021, respectively, a decrease of $553,006, primarily due to the prior year issuance of 7,000,000 shares of Common Stock to directors valued at $538,300.
     
  (vii) The balance of the general and administrative expenses increased by approximately $16,258, which is made up of several individually insignificant expenses.

 

29

 

 

Depreciation and amortization

 

Depreciation was $20,500 and $4,642 for the three months ended September 30, 2022 and 2021, respectively, an increase of $15,858 or 341.6%, the increase is primarily due to the amortization of the IPSIPay intangible which was brought into use during the current period.

 

Penalty on convertible notes

 

Penalty on convertible notes was $602,100 and $0 for the three months ended September 30, 2022 and 2021, an increase of $602,100 or 100.0%. The increase is due to the modification of the maturity date of two convertible notes, resulting in the negotiation of a 20% repayment penalty on the convertible notes and the value of the warrants to purchase 6,000,0000 shares of our Common Stock that were issued to the note holders as additional compensation for extending the maturity date to November 16, 2022.

 

Interest expense, net

 

Interest expense was $51,340 and $53,903 for the three months ended September 30, 2022 and 2021, respectively, a decrease of $2,563 or 4.8%. The decrease is due to the repayment of our convertible note with Bellridge, offset by an increase in the principal due on the two remaining convertible notes.

 

Amortization of debt discount

 

Amortization of debt discount was $0 and $515,200 for the three months ended September 30, 2022 and 2021, respectively, a decrease of $515,200 or 100.0%. The decrease is due to the full amortization of the debt discount on convertible notes in the first quarter of the current year, in the prior year, debt discount was amortized on the three remaining convertible notes.

 

Derivative liability movements

 

Derivative liability movements were $84,895 and $1,578,361 for the three months ended September 30, 2022 and 2021, respectively, a decrease of $1,493,466 or 94.6%. The derivative liability arose due to the issuance of convertible securities and warrants with a fundamental transaction clause allowing for a cash settlement of the convertible note at the option of the holder. The charge during the current period represents the increase in the mark-to-market value of the derivative liability due to an increase in the share price over the prior quarter.

 

Net loss

 

Net loss was $3,310,496 and $1,743,077 for the three months ended September 30, 2022 and 2021, respectively, an increase in loss of $1,567,419 or 89.9%. The increase is primarily due to the increase in penalty on convertible notes and the reduction in the derivative liability movement, offset by the reduction in amortization of debt discount, as discussed above.

 

Results of Operations for the Nine Months Ended September 30, 2022 and September 30, 2021

 

Net revenue

 

We did not have revenues during the nine months ended September 30, 2022 and 2021. We anticipate that we will commence generating revenue during the fourth quarter as we have fully launched our IPSIPay e-wallet.

 

Cost of goods sold

 

As we did not have revenues during the nine months ended September 30, 2022 and 2021, we anticipate that we will begin to recognize cost of goods sold during the fourth quarter as we have launched our IPSIPay e-wallet.

 

30

 

 

General and administrative expenses

 

General and administrative expenses were $4,386,375 and $9,457,134 for the nine months ended September 30, 2022 and 2021, respectively, a decrease of $5,070,759 or 53.6%. The decrease is primarily due to the following:

 

  (i) Consulting fees were $247,900 and $1,313,134 for the nine months ended September 30, 2022 and 2021, respectively, a decrease of $1,065,234. In the prior year 10,000,000 shares valued at $938,000 were issued to 4 advisory board members and a third party as compensation for their services and consulting fees of $60,000 were paid to our previous CTO.
     
  (ii) Payroll expenses were $1,998,232 and $6,656,270 for the nine months ended September 30, 2022 and 2021, respectively, a decrease of $4,658,038 or  70.0%. The decrease is primarily due to the issue of warrants exercisable for 20,000,000 shares of Common Stock to our CEO in the prior period with a fair value of $4,327,899 and restricted Common Stock of 1,000,000 shares with a fair value of $50,000 issued to one of our previous employees and the creation of a severance provision of $294,000 representing six months of pay for five former employees in the prior year, offset by an increase in base salaries over the prior period due to an improvement in the caliber of employees, including the hiring of our current CFO.
     
  (iii) Professional fees were $734,300 and $226,866 for the nine months ended September 30, 2022 and 2021, respectively, an increase of $507,434, or 223.7%. The increase is primarily due to; (i) professional fees paid to Frictionless in managing and providing customer support for the IPSIPay platform, including expenses incurred on setting up Mexican operations; and (ii) social media expenses incurred to promote the IPSIPay platform to our target market.
     
  (iv) Selling and marketing expenses were $498,494 and $119,514 for the nine months ended September 30, 2022 and 2021, respectively, an increase of $378,980. The increase is primarily attributable to Mario Lopez related endorsement expenses of $357,370 and an increase in marketing expenses of $40,363 incurred during the current period to promote the launch of the IPSIPay wallet and platform.
     
  (v) Legal fees were $335,846 and $171,866 for the nine months ended September 30, 2022 and 2021, respectively, an increase of $163,980.The increase is primarily due to legal expenses incurred on labor disputes filed by several employees who were severed in the prior year.
     
  (vi) Directors fees were $90,000 and $681,614 for the nine months ended September 30, 2022 and 2021, respectively, a decrease of $591,614, primarily due to the prior year issuance of 7,000,000 shares of Common Stock to directors valued at $538,300.
     
  (iv) The balance of the general and administrative expenses decreased by $193,733, which is made up of several individually insignificant expenses.

  

Depreciation

 

Depreciation was $29,493 and $13,293 for the nine months ended September 30, 2022 and 2021, respectively, an increase of $16,200 or 121.9%, primarily due to the amortization of the IPSIPay platform which commenced during the third quarter.

 

Penalty on convertible notes

 

Penalty on convertible notes was $1,321,658 and $0 for the nine months ended September 30, 2022 and 2021, an increase of $1,321,658, or 100.0%. The increase is due to the repayment of one convertible note and the modification of the maturity date of two convertible notes during the first and the third quarters, respectively, resulting in the triggering of the repayment penalty per the convertible note agreements as well as additional penalties for the extension of the maturity date.

  

Loss on debt conversion

 

Loss on debt conversion was $0 and $5,184,447 for the nine months ended September 30, 2022 and 2021, respectively, a decrease of $5,184,447. The loss on debt conversion during the prior year represented a loss realized on the conversion of convertible notes, into equity at fixed conversion prices which ranged from $0.035 to $0.05 per share, when the stock price ranged from $0.05 per share to $0.22 per share, resulting in a significant loss. A total of $2,259,221 was converted from convertible debt to equity during the nine months ended September 30, 2021.

 

31

 

 

Interest expense, net

 

Interest expense was $142,302 and $174,587 for the nine months ended September 30, 2022 and 2021, respectively, a decrease of $32,285 or 18.5%. The decrease is due to the repayment of our convertible note with Bellridge, offset by an increase in the principal due on the two remaining convertible notes.

 

Amortization of debt discount

 

Amortization of debt discount was $263,200 and $3,138,452 for the nine months ended September 30, 2022 and 2021, respectively, a decrease of $2,875,252 or 91.6%. The decrease is primarily due to the accelerated amortization of debt discount related to notes converted to equity during the first quarter of the prior year.

 

 Derivative liability movements

 

Derivative liability movements were $(65,046) and $4,714,451 for the nine months ended September 30, 2022 and 2021, respectively. The derivative liability arose due to the issuance of convertible securities and warrants with a fundamental transaction clause allowing for a cash settlement of the convertible note at the option of the holder. The charge during the current period represents the increase in the mark-to-market value of the derivative liability due to an increase in the share price over the prior period.

  

Net loss

 

Net loss was $6,208,074 and $13,253,462 for the nine months ended September 30, 2022 and 2021, respectively, a decrease in loss of $7,045,388, or 53.2%. The decrease is due to the decrease in general and administrative expenses, the loss realized on the conversion of convertible debt in the prior year and the decrease in amortization of debt discount, offset by the movement in derivative liabilities, discussed in detail above.

  

Liquidity and Capital Resources

 

To date, our primary sources of cash have been funds raised primarily from the sale of our debt and equity securities.

 

We have an accumulated deficit of approximately $48.3 million through September 30, 2022 and incurred negative cash flow from operations of $2.3 million for the nine months ended September 30, 2022. Our primary focus is on operating e-wallets that enable consumers to deposit cash, convert it into a digital form and remit the funds to Mexico and other countries quickly and securely, which will require us to spend, substantial amounts in connection with implementing our business strategy.

 

At September 30, 2022, we had cash of approximately $1.35 million and a working capital deficit of $2.0 million including a derivative liability of approximately $0.7 million, after eliminating the derivative liability our working capital is $1.3 million.

 

We utilized cash of approximately $2.3 million and $1.9 million in operations for each of the nine months ended September 30, 2022 and 2021, respectively.

 

We invested approximately $0.6 million during the first nine months of 2022 in our e-wallet platforms to enhance our product offering.

 

We utilized cash of $1.1 million during the current period to repay a convertible note together with a prepayment penalty. Cash provided by financing activities for the nine months ended September 30, 2021 was primarily comprised of gross proceeds of approximately $4.6 million from the private placement on March 17, 2021, approximately $3.0 million from warrants exercised and approximately $2.6 million from convertible debt issued, we utilized $0.5 million for share issue expenses and repaid convertible debt of approximately $0.5million during the prior period.

 

32

 

 

At September 30, 2022, we had outstanding notes in the principal amount of approximately $2.2 million. The notes were issued on February 16, 2021, and the maturity date was extended from February 16, 2022 to August 16, 2022 and again to November 16, 2022. The notes contain certain covenants, such as restrictions on: (i) distributions on capital stock, (ii) stock repurchases, and (iii) sales and the transfer of assets. The notes bear interest at a rate of 10% per annum. and are convertible into shares of our Common Stock at a conversion price of $0.15 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). Upon the occurrence of an event of default under the notes, the respective holder has the right to be prepaid at 140% of the outstanding principal balance and accrued interest, and interest accrues at 18% per annum (or the maximum amount permitted by law). In addition, if an event of default under a note has occurred, regardless of whether it has been cured or remains ongoing, such Note will thereafter be convertible at 65% of the lowest closing price of our Common Stock for the last 10 consecutive trading days. Should the investors choose not to convert these convertible notes, we may need to repay these notes together with interest thereon which will impact on our liquidity.

 

We expect to invest an additional $250,000 to enhance our e-wallet products, other capital expenditure is expected to be less than $100,000 during the next twelve-month period. Accordingly, we expect to meet our cash requirements for the next twelve months, and beyond twelve months, we expect to raise either debt or equity funding and generate revenue from operations to meet cash requirements. We will also incur costs and expenses on sales and marketing initiatives and for our general working capital.

 

However, given our losses and negative cash flows, we will be required to raise significant additional funds to progress our business as planned by issuing equity or equity-linked securities. Should this occur, our stockholders would experience dilution, perhaps significantly. Additional debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any additional debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders and require significant debt service payments, which diverts resources from other activities. Moreover, there is a risk that financing may be unavailable to support our operations on favorable terms, or at all.

 

There is also a significant risk that none of our plans to raise financing will be implemented in a manner necessary to sustain us for an extended period of time. If adequate funds are not available to us when needed, we may be required to continue with reduced operations or to obtain funds through arrangements that may require us to relinquish rights to technologies or potential markets, any of which could have a material adverse effect on our company. In addition, our inability to secure additional funding when needed could cause our business to fail or become bankrupt or force us to wind down or discontinue operations.

 

We do not have any off-balance sheet financing arrangements as of the date of this report.

  

Item 3. Quantitative and Qualitative Disclosures About Market Risks

 

Not required for smaller reporting companies.

 

Item 4. Controls and Procedures

 

(a) Evaluation of disclosure controls and procedures

 

Pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934 (“Exchange Act”), our management carried out an evaluation, with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our CEO and CFO concluded that our disclosure controls and procedures as of September 30, 2022 are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act, was recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, to allow timely decisions regarding required disclosure.

 

(b) Changes in Internal Control over Financial Reporting

 

There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during our fiscal quarter ended September 30, 2022.

 

33

 

 

Part II. Other Information

 

Item 1. Legal Proceedings.

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Below is a description of our outstanding pending litigation matters. Litigation is subject to inherent uncertainties and an adverse result in the below described or other matters may arise from time to time that may harm our business.

 

Voloshin v. Innovative Payment Solutions, Inc.

 

On October 20, 2021, a complaint was filed against our company and certain of its officers and directors with the Occupational Safety and Health Administration of the United Stated Department of Labor (“OSHA”), captioned Naum Voloshin, Yulia Rey, Alexander Voloshin, Andrey Novikov, and Frank Perez v. Innovative Payment Solutions, Inc., William Corbett, Richard Rosenblum, Madisson Corbett, Jim Fuller, Cliff Henry and David Rios. The complaint generally alleges that complainants, four former employees of our company and one employee who is on suspension, did not receive compensation to which they claim they were entitled and that they were wrongfully terminated for engaging in protected activities in violation of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1514A. The complaint seeks reinstatement of complainants’ employment, monetary damages including back pay, raises, bonuses, benefits, overtime, emotional distress and loss of reputation, orders of abatement and injunctive relief, and costs of litigation.

 

In early 2022, OSHA dismissed the claims of Ms. Rey and Mr. Perez; they appealed that decision. We moved to dismiss the remaining claims and as of this writing OSHA took no action with respect to that motion. On October 26, 2022, OSHA scheduled a hearing on Ms. Rey’s and Mr. Perez’s appeal for April 5, 2023. On November 8, 2022, the claimants’ counsel informed us that all five claimants intended to exercise their right to file a lawsuit in federal court and asked if we would to stipulate to dismissal of Rey’s and Perez’s OSHA claims without prejudice. We agreed and a stipulation of dismissal without prejudice was filed on November 10, 2022. No other formal activity has taken place in the proceedings. We may engage in alternative dispute resolution with the plaintiffs but there can be no assurance that these efforts will be successful. While the outcome of the anticipated civil action is uncertain at this point, we intend to vigorously defend against the action.

 

Minkovich v. Corbett, et al.

 

On May 26, 2022, Mr. Jan Minkovich (“Minkovich”) filed a lawsuit in California Superior Court in Los Angeles County (Minkovich v. Corbett, et al., CASE NO. 22CHCV00377) against our company and our Chairman and Chief Executive Officer William Corbett. The complaint asserts six causes of action for: (I) breach of contract; (II) nonpayment of wages; (III) waiting time penalties; (IV) failure to indemnify for alleged employee business expenses; (V) violation of Section 17200 of the California Business and Professional Code; and (VI) wrongful termination of employment in violation of public policy. Minkovich seeks $570,000 in damages, penalties, and attorneys’ fees plus shares equal to five percent (5%) ownership of our company.

 

We are vigorously defending these claims, which are premised upon a putative three-year employment agreement that is not signed by our company or Mr. Corbett, and which Minkovich admits in his complaint that we expressly refused to sign.

 

We and Mr. Corbett filed a motion to compel arbitration. The motion was denied on October 4, 2022. We and Mr. Corbett have appealed that decision to the California Court of Appeal. As a result of the appeal, the court case is stayed until the appeal is decided, which we expect to take at least six months. As a result of the stay, the demurrer (the equivalent of a motion to dismiss) we and Mr. Corbett filed has yet to be decided and will not be decided unless the court’s decision is sustained on appeal. Otherwise, the case shall proceed to arbitration.

 

Other than as set forth above, we are not presently a party to any legal proceedings that, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition or cash flows.

 

Item 1A. Risk Factors.

 

Not applicable to smaller reporting companies.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 3. Defaults upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

On November 11, 2022, with the recommendation of a special committee of disinterested members of the Board who had reviewed this matter, the Board approved the formal termination of Andrei Novikov’s employment with the Company as Chief Technology Officer for “cause.” Since August 2021, Mr. Novikov had been on suspension from service as an employee of the Company.

 

34

 

 

Item 6. Exhibits

 

Exhibit No.   Exhibit Description
31.1*   Certification of William Corbett, Chief Executive Officer, pursuant to Rule 13a-14(a) or Rule 15d-14(a)
31.2*   Certification of Richard Rosenblum, Chief Financial Officer, pursuant to Rule 13a-14(a) or Rule15d-14(a)
32.1*   Certification of William Corbett, Chief Executive Officer pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002
32.2*   Certification of Richard Rosenblum, Chief Financial Officer pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002
101.INS   Inline XBRL Instance Document.*
101.SCH   Inline XBRL Taxonomy Extension Schema Document.*
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.*
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.*
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.*
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.*
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).*

 

* Filed herewith

 

35

 

 

SIGNATURES

 

Pursuant to the requirements of the Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  INNOVATIVE PAYMENT SOLUTIONS, INC.
   
Date: November 14, 2022 By: /s/ William D. Corbett
    William D. Corbett
    Chief Executive Officer
    (Principal Executive Officer)

 

Date: November 14, 2022 By: /s/ Richard Rosenblum
    Richard Rosenblum
    President & Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

 

36

 

 

0.00 0.01 0.02 0.04 323034956 364722331 370615966 375956027 P10Y false --12-31 Q3 0001591913 NONE N/A N/A 0001591913 2022-01-01 2022-09-30 0001591913 2022-11-14 0001591913 2022-09-30 0001591913 2021-12-31 0001591913 2022-07-01 2022-09-30 0001591913 2021-07-01 2021-09-30 0001591913 2021-01-01 2021-09-30 0001591913 us-gaap:PreferredStockMember 2021-12-31 0001591913 us-gaap:CommonStockMember 2021-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001591913 us-gaap:RetainedEarningsMember 2021-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2021-12-31 0001591913 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001591913 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001591913 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001591913 2022-01-01 2022-03-31 0001591913 us-gaap:PreferredStockMember 2022-03-31 0001591913 us-gaap:CommonStockMember 2022-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001591913 us-gaap:RetainedEarningsMember 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-03-31 0001591913 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0001591913 2022-04-01 2022-06-30 0001591913 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001591913 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001591913 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001591913 us-gaap:PreferredStockMember 2022-06-30 0001591913 us-gaap:CommonStockMember 2022-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001591913 us-gaap:RetainedEarningsMember 2022-06-30 0001591913 us-gaap:NoncontrollingInterestMember 2022-06-30 0001591913 2022-06-30 0001591913 us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001591913 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001591913 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001591913 us-gaap:NoncontrollingInterestMember 2022-07-01 2022-09-30 0001591913 us-gaap:PreferredStockMember 2022-09-30 0001591913 us-gaap:CommonStockMember 2022-09-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001591913 us-gaap:RetainedEarningsMember 2022-09-30 0001591913 us-gaap:NoncontrollingInterestMember 2022-09-30 0001591913 us-gaap:PreferredStockMember 2020-12-31 0001591913 us-gaap:CommonStockMember 2020-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001591913 us-gaap:RetainedEarningsMember 2020-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2020-12-31 0001591913 2020-12-31 0001591913 us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0001591913 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001591913 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001591913 2021-01-01 2021-03-31 0001591913 us-gaap:PreferredStockMember 2021-03-31 0001591913 us-gaap:CommonStockMember 2021-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001591913 us-gaap:RetainedEarningsMember 2021-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2021-03-31 0001591913 2021-03-31 0001591913 us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0001591913 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001591913 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001591913 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0001591913 2021-04-01 2021-06-30 0001591913 us-gaap:PreferredStockMember 2021-06-30 0001591913 us-gaap:CommonStockMember 2021-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001591913 us-gaap:RetainedEarningsMember 2021-06-30 0001591913 us-gaap:NoncontrollingInterestMember 2021-06-30 0001591913 2021-06-30 0001591913 us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0001591913 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001591913 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001591913 us-gaap:NoncontrollingInterestMember 2021-07-01 2021-09-30 0001591913 us-gaap:PreferredStockMember 2021-09-30 0001591913 us-gaap:CommonStockMember 2021-09-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001591913 us-gaap:RetainedEarningsMember 2021-09-30 0001591913 us-gaap:NoncontrollingInterestMember 2021-09-30 0001591913 2021-09-30 0001591913 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001591913 2019-10-25 2019-11-01 0001591913 2019-12-01 2019-12-31 0001591913 qpag:FrictionlessMember 2022-09-30 0001591913 qpag:FrictionlessMember 2022-06-22 0001591913 qpag:FrictionlessMember 2022-01-01 2022-09-30 0001591913 qpag:FrictionlessFinancialTechnologiesIncMember 2022-09-30 0001591913 qpag:BeyondFintechMember 2021-08-01 2021-08-26 0001591913 2021-08-01 2021-08-26 0001591913 qpag:KiosksMember 2022-01-01 2022-09-30 0001591913 us-gaap:ComputerEquipmentMember 2022-01-01 2022-09-30 0001591913 us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-09-30 0001591913 us-gaap:OfficeEquipmentMember 2022-01-01 2022-09-30 0001591913 2021-01-01 2021-12-31 0001591913 qpag:StockPurchaseAgreementMember qpag:FrictionlessTechnologiesIncMember 2021-06-01 2021-06-22 0001591913 qpag:StockPurchaseAgreementMember qpag:FrictionlessTechnologiesIncMember 2021-06-22 0001591913 qpag:FrictionlessTechnologiesIncMember 2021-06-22 0001591913 qpag:FrictionlessTechnologiesIncMember 2021-06-01 2021-06-22 0001591913 2019-01-01 2019-12-31 0001591913 qpag:ViviHoldingsIncMember 2022-01-01 2022-09-30 0001591913 qpag:MrAndreyNovikovMember 2022-01-01 2022-09-30 0001591913 qpag:JosephWPatriciaGAbramsFamilyTrustMember 2022-01-01 2022-09-30 0001591913 qpag:MrGastonPereiraMember 2022-01-01 2022-09-30 0001591913 qpag:FrictionlessTechnologiesIncMember 2022-09-30 0001591913 qpag:FrictionlessTechnologiesIncMember 2021-12-31 0001591913 qpag:ViviHoldingsIncMember 2022-09-30 0001591913 qpag:ViviHoldingsIncMember 2021-12-31 0001591913 2020-07-01 2020-07-07 0001591913 qpag:CavalryFundILPMember 2021-02-01 2021-02-16 0001591913 qpag:CavalryFundILPMember 2021-02-16 0001591913 qpag:CavalryFundILPMember 2022-02-01 2022-02-03 0001591913 qpag:CavalryFundILPMember 2022-07-01 2022-09-30 0001591913 qpag:CavalryFundILPMember 2022-01-01 2022-09-30 0001591913 qpag:CavalryFundILPMember 2022-09-30 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-02-01 2022-02-03 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2021-02-01 2021-02-16 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2021-02-16 0001591913 2021-02-16 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-01-01 2022-09-30 0001591913 qpag:BellridgeCapitalLPMember 2021-02-01 2021-02-16 0001591913 qpag:BellridgeCapitalLPMember 2021-02-16 0001591913 qpag:BellridgeCapitalLPMember 2022-02-04 0001591913 qpag:CavalryFundILPMember 2022-09-30 0001591913 qpag:CavalryFundILPMember 2022-01-01 2022-09-30 0001591913 qpag:CavalryFundILPMember 2021-12-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-09-30 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-01-01 2022-09-30 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2021-12-31 0001591913 qpag:BellridgeCapitalLPMember 2022-09-30 0001591913 qpag:BellridgeCapitalLPMember 2022-01-01 2022-09-30 0001591913 qpag:BellridgeCapitalLPMember 2021-12-31 0001591913 us-gaap:ConvertibleNotesPayableMember 2022-09-30 0001591913 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-09-30 0001591913 us-gaap:ConvertibleNotesPayableMember 2021-12-31 0001591913 2022-08-01 2022-08-30 0001591913 2022-08-30 0001591913 srt:MinimumMember 2022-09-30 0001591913 srt:MaximumMember 2022-09-30 0001591913 srt:MinimumMember 2021-12-31 0001591913 srt:MaximumMember 2021-12-31 0001591913 srt:MinimumMember 2022-01-01 2022-09-30 0001591913 srt:MaximumMember 2022-01-01 2022-09-30 0001591913 srt:MinimumMember 2021-01-01 2021-12-31 0001591913 srt:MaximumMember 2021-01-01 2021-12-31 0001591913 2022-07-08 0001591913 2022-07-01 2022-07-08 0001591913 us-gaap:CommonStockMember 2022-07-08 0001591913 qpag:RichardRosenblumMember 2022-07-01 2022-07-11 0001591913 2022-07-11 0001591913 qpag:SamadHarakeMember 2022-08-05 0001591913 2022-07-01 2022-07-11 0001591913 qpag:TwoThousandEighteenStockIncentivePlanMember 2022-01-01 2022-09-30 0001591913 qpag:TwoThousandEighteenStockIncentivePlanMember srt:MaximumMember 2022-09-30 0001591913 srt:MaximumMember us-gaap:CommonStockMember 2022-09-30 0001591913 qpag:TwoThousandTwentyOnePlanMember 2022-01-01 2022-09-30 0001591913 qpag:TwoThousandTwentyOnePlanMember srt:MaximumMember 2022-09-30 0001591913 srt:ChiefExecutiveOfficerMember 2022-07-11 0001591913 srt:ChiefExecutiveOfficerMember 2022-07-01 2022-07-11 0001591913 srt:ChiefExecutiveOfficerMember 2022-07-01 2022-09-30 0001591913 srt:ChiefExecutiveOfficerMember 2022-01-01 2022-09-30 0001591913 2022-09-01 2022-09-13 0001591913 qpag:TotalRestrictedSharesMember 2020-12-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2020-12-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2020-12-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2020-12-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2020-12-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2020-12-31 0001591913 qpag:TotalRestrictedSharesMember 2021-01-01 2021-12-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2021-01-01 2021-12-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2021-01-01 2021-12-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-01-01 2021-12-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2021-01-01 2021-12-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-01-01 2021-12-31 0001591913 qpag:TotalRestrictedSharesMember 2021-12-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2021-12-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2021-12-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 qpag:TotalRestrictedSharesMember 2022-01-01 2022-09-30 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-09-30 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2022-01-01 2022-09-30 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-09-30 0001591913 qpag:TotalVestedRestrictedSharesMember 2022-01-01 2022-09-30 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-09-30 0001591913 qpag:TotalRestrictedSharesMember 2022-09-30 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2022-09-30 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2022-09-30 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-09-30 0001591913 qpag:TotalVestedRestrictedSharesMember 2022-09-30 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-09-30 0001591913 qpag:ExercisePrice0049Member 2022-01-01 2022-09-30 0001591913 qpag:ExercisePriceRange5Member 2022-01-01 2022-09-30 0001591913 qpag:ExercisePrice0055Member 2022-01-01 2022-09-30 0001591913 srt:MinimumMember qpag:WarrantsMember 2022-09-30 0001591913 srt:MaximumMember qpag:WarrantsMember 2022-09-30 0001591913 srt:MinimumMember qpag:WarrantsMember 2022-01-01 2022-09-30 0001591913 srt:MaximumMember qpag:WarrantsMember 2022-01-01 2022-09-30 0001591913 qpag:WarrantsMember 2022-01-01 2022-09-30 0001591913 srt:MinimumMember qpag:StockOptionsMember 2022-09-30 0001591913 srt:MaximumMember qpag:StockOptionsMember 2022-09-30 0001591913 srt:MinimumMember qpag:StockOptionsMember 2022-01-01 2022-09-30 0001591913 srt:MaximumMember qpag:StockOptionsMember 2022-01-01 2022-09-30 0001591913 qpag:StockOptionsMember 2022-01-01 2022-09-30 0001591913 us-gaap:WarrantMember 2020-12-31 0001591913 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001591913 us-gaap:WarrantMember 2021-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2021-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2021-12-31 0001591913 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-01-01 2022-09-30 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-01-01 2022-09-30 0001591913 us-gaap:WarrantMember 2022-09-30 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-09-30 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-09-30 0001591913 qpag:ExercisePrice00345Member 2022-09-30 0001591913 qpag:ExercisePrice00345Member 2022-01-01 2022-09-30 0001591913 qpag:ExercisePriceRange5Member 2022-09-30 0001591913 qpag:ExercisePrice015Member 2022-09-30 0001591913 qpag:ExercisePrice015Member 2022-01-01 2022-09-30 0001591913 qpag:ExercisePrice0187Member 2022-09-30 0001591913 qpag:ExercisePrice0187Member 2022-01-01 2022-09-30 0001591913 us-gaap:StockOptionMember 2020-12-31 0001591913 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001591913 us-gaap:StockOptionMember 2021-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2021-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2021-12-31 0001591913 us-gaap:StockOptionMember 2022-01-01 2022-09-30 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2022-01-01 2022-09-30 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2022-01-01 2022-09-30 0001591913 us-gaap:StockOptionMember 2022-09-30 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2022-09-30 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2022-09-30 0001591913 qpag:ExercisePrice004Member 2022-09-30 0001591913 qpag:ExercisePrice004Member 2022-01-01 2022-09-30 0001591913 qpag:ExercisePrice024Member 2022-09-30 0001591913 qpag:ExercisePrice024Member 2022-01-01 2022-09-30 0001591913 qpag:ExercisePrice040Member 2022-09-30 0001591913 qpag:ExercisePrice040Member 2022-01-01 2022-09-30 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2022-07-01 2022-09-30 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-09-30 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2021-07-01 2021-09-30 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2021-01-01 2021-09-30 0001591913 qpag:StockOptionsMember 2022-07-01 2022-09-30 0001591913 qpag:StockOptionsMember 2022-01-01 2022-09-30 0001591913 qpag:StockOptionsMember 2021-07-01 2021-09-30 0001591913 qpag:StockOptionsMember 2021-01-01 2021-09-30 0001591913 us-gaap:WarrantMember 2022-07-01 2022-09-30 0001591913 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001591913 us-gaap:WarrantMember 2021-07-01 2021-09-30 0001591913 us-gaap:WarrantMember 2021-01-01 2021-09-30 0001591913 2021-02-01 2021-02-22 0001591913 qpag:JamesFullerMember 2021-02-01 2021-02-22 0001591913 qpag:JamesFullerMember 2021-07-01 2021-07-22 0001591913 qpag:JamesFullerMember 2021-07-22 0001591913 srt:MaximumMember qpag:JamesFullerMember 2021-02-22 0001591913 srt:MinimumMember qpag:JamesFullerMember 2021-02-22 0001591913 qpag:JamesFullerMember 2022-09-01 2022-09-13 0001591913 qpag:JamesFullerMember 2022-07-01 2022-09-30 0001591913 qpag:JamesFullerMember 2022-01-01 2022-09-30 0001591913 qpag:MrAndreyNovikovMember 2021-02-01 2021-02-22 0001591913 qpag:WilliamCorbettMember 2021-02-01 2021-02-22 0001591913 qpag:WilliamCorbettMember 2021-01-01 2021-12-31 0001591913 qpag:WilliamCorbettMember 2021-08-01 2021-08-16 0001591913 qpag:WilliamCorbettMember 2022-07-01 2022-07-11 0001591913 qpag:WilliamCorbettMember 2022-07-01 2022-09-30 0001591913 qpag:WilliamCorbettMember 2022-01-01 2022-09-30 0001591913 qpag:CliffordHenryMember 2021-07-01 2021-07-22 0001591913 qpag:CliffordHenryMember 2021-07-22 0001591913 qpag:CliffordHenryMember 2022-01-01 2022-09-30 0001591913 qpag:CliffordHenryMember 2022-09-01 2022-09-13 0001591913 qpag:CliffordHenryMember 2022-09-13 0001591913 qpag:CliffordHenryMember 2022-07-01 2022-09-30 0001591913 qpag:MadissonCorbettMember 2021-07-01 2021-07-22 0001591913 qpag:MadissonCorbettMember 2021-07-22 0001591913 qpag:MadissonCorbettMember 2022-09-01 2022-09-13 0001591913 qpag:MadissonCorbettMember 2022-09-13 0001591913 qpag:MadissonCorbettMember 2022-07-01 2022-09-30 0001591913 qpag:MadissonCorbettMember 2022-01-01 2022-09-30 0001591913 qpag:DavidRiosMember 2021-07-01 2021-07-22 0001591913 qpag:DavidRiosMember 2021-07-22 0001591913 qpag:DavidRiosMember 2022-09-01 2022-09-13 0001591913 qpag:DavidRiosMember 2022-09-13 0001591913 qpag:DavidRiosMember 2022-07-01 2022-09-30 0001591913 qpag:DavidRiosMember 2022-01-01 2022-09-30 0001591913 qpag:RichardRosenblumMember 2021-07-01 2021-07-27 0001591913 qpag:RichardRosenblumMember 2022-01-01 2022-09-30 0001591913 qpag:RichardRosenblumMember 2021-08-01 2021-08-16 0001591913 qpag:RichardRosenblumMember 2021-08-01 2021-08-31 0001591913 qpag:RichardRosenblumMember 2022-07-11 0001591913 qpag:RichardRosenblumMember 2022-07-01 2022-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure
EX-31.1 2 f10q0922ex31-1_innovative.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO RULE 13a-14(a) AND RULE 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 

 

I, William Corbett, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Innovative Payment Solutions, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

  

Date: November 14, 2022 By: /s/ William D. Corbett
    William D. Corbett
    Chief Executive Officer
    (Principal Executive Officer)

EX-31.2 3 f10q0922ex31-2_innovative.htm CERTIFICATION

Exhibit 31.2

 

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER

PURSUANT TO RULE 13a-14(a) AND RULE 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 

 

I, Richard Rosenblum, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Innovative Payment Solutions, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2022 By: /s/ Richard Rosenblum
    Richard Rosenblum
    Chief Financial Officer
    (Principal Financial Officer)

 

EX-32.1 4 f10q0922ex32-1_innovative.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION OF THE

PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 

 

In connection with the Quarterly Report on Form 10-Q of Innovative Payment Solutions, Inc. (the “Company”) for the quarter ended September 30, 2022, as filed with the Securities and Exchange Commission (the “Report”), I, William Corbett, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

1.the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

 

Date: November 14, 2022 By: /s/ William D. Corbett
    William D. Corbett
    Chief Executive Officer
    (Principal Executive Officer)

EX-32.2 5 f10q0922ex32-2_innovative.htm CERTIFICATION

Exhibit 32.2

 

CERTIFICATION OF THE

PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 

 

In connection with the Quarterly Report on Form 10-Q of Innovative Payment Solutions, Inc. (the “Company”) for the quarter ended September 30, 2022, as filed with the Securities and Exchange Commission (the “Report”), I, Richard Rosenblum, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

1.the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

 

Date: November 14, 2022 By: /s/ Richard Rosenblum
    Richard Rosenblum
    Chief Financial Officer
    (Principal Financial Officer)

 

EX-101.SCH 6 qpag-20220930.xsd XBRL SCHEMA FILE 001 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - LIQUIDITY MATTERS link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - INTANGIBLES link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - INVESTMENTS link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - LEASES link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - FEDERAL RELIEF LOANS link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - CONVERTIBLE NOTES PAYABLE link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - DERIVATIVE LIABILITY link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - NET LOSS PER SHARE link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES (Tables) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - INTANGIBLES (Tables) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - INVESTMENTS (Tables) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - LEASES (Tables) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - CONVERTIBLE NOTES PAYABLE (Tables) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - DERIVATIVE LIABILITY (Tables) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - STOCKHOLDERS’ EQUITY (Tables) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - NET LOSS PER SHARE (Tables) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES (Details) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES (Details) - Schedule of estimated useful lives of the assets link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - LIQUIDITY MATTERS (Details) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - INTANGIBLES (Details) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - INTANGIBLES (Details) - Schedule of facilitate the functioning of the IPSIPay software link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - INVESTMENTS (Details) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - INVESTMENTS (Details) - Schedule of investment link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - LEASES (Details) link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - LEASES (Details) - Schedule of total lease cost link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - LEASES (Details) - Schedule of other lease information link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - LEASES (Details) - Schedule of maturity of operating leases link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - FEDERAL RELIEF LOANS (Details) link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details) link:presentationLink link:definitionLink link:calculationLink 044 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details) - Schedule of convertible notes payable link:presentationLink link:definitionLink link:calculationLink 045 - Disclosure - DERIVATIVE LIABILITY (Details) link:presentationLink link:definitionLink link:calculationLink 046 - Disclosure - DERIVATIVE LIABILITY (Details) - Schedule of assumptions were used in the Black-Scholes valuation model link:presentationLink link:definitionLink link:calculationLink 047 - Disclosure - DERIVATIVE LIABILITY (Details) - Schedule of movement in derivative liability link:presentationLink link:definitionLink link:calculationLink 048 - Disclosure - STOCKHOLDERS’ EQUITY (Details) link:presentationLink link:definitionLink link:calculationLink 049 - Disclosure - STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock activity link:presentationLink link:definitionLink link:calculationLink 050 - Disclosure - STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock granted and exercisable link:presentationLink link:definitionLink link:calculationLink 051 - Disclosure - STOCKHOLDERS’ EQUITY (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model link:presentationLink link:definitionLink link:calculationLink 052 - Disclosure - STOCKHOLDERS’ EQUITY (Details) - Schedule of warrant activity link:presentationLink link:definitionLink link:calculationLink 053 - Disclosure - STOCKHOLDERS’ EQUITY (Details) - Schedule of warrants outstanding and exercisable link:presentationLink link:definitionLink link:calculationLink 054 - Disclosure - STOCKHOLDERS’ EQUITY (Details) - Schedule of option activity link:presentationLink link:definitionLink link:calculationLink 055 - Disclosure - STOCKHOLDERS’ EQUITY (Details) - Schedule of options outstanding and exercisable link:presentationLink link:definitionLink link:calculationLink 056 - Disclosure - NET LOSS PER SHARE (Details) - Schedule of dilutive shares link:presentationLink link:definitionLink link:calculationLink 057 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:definitionLink link:calculationLink 058 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 qpag-20220930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 qpag-20220930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 qpag-20220930_lab.xml XBRL LABEL FILE EX-101.PRE 10 qpag-20220930_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2022
Nov. 14, 2022
Document Information Line Items    
Entity Registrant Name INNOVATIVE PAYMENT SOLUTIONS, INC.  
Trading Symbol N/A  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   376,901,679
Amendment Flag false  
Entity Central Index Key 0001591913  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Sep. 30, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 000-55648  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 33-1230229  
Entity Address, Address Line One 56B 5th Avenue  
Entity Address, Address Line Two Lot 1 #AT  
Entity Address, City or Town Carmel By The Sea  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 93921  
City Area Code (866)  
Local Phone Number 477-4729  
Entity Interactive Data Current Yes  
Security Exchange Name NONE  
Title of 12(b) Security N/A  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current Assets    
Cash $ 1,352,983 $ 5,449,751
Other current assets 133,880 85,034
Total Current Assets 1,486,863 5,534,785
Non-current assets    
Plant and equipment 52,434 28,799
Intangible assets 1,198,011 625,000
Security deposit 47,592 34,800
Investment 500,001 500,001
Total Non-Current Assets 1,798,038 1,188,600
Total Assets 3,284,901 6,723,385
Current Liabilities    
Accounts payable 574,825 465,205
Convertible debt, net of unamortized discount of $0 and $263,200, respectively 2,210,802 1,961,354
Derivative liability 710,389 407,161
Total Current Liabilities 3,496,016 2,833,720
Non-Current Liabilities    
Federal relief loans 162,560 158,353
Total Non-Current Liabilities 162,560 158,353
Total Liabilities 3,658,576 2,992,073
Equity (Deficit)    
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of September 30, 2022 and December 31, 2021.
Common stock, $0.0001 par value; 750,000,000 and 500,000,000 shares authorized, 376,901,679 and 367,901,679 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively. 37,690 36,790
Additional paid-in-capital 47,863,546 45,771,012
Accumulated deficit (48,290,394) (42,111,701)
Total equity (deficit) attributable to Innovative Payment Solutions, Inc. Stockholders (389,158) 3,696,101
Non-controlling interest 15,483 35,211
Total Equity (deficit) (373,675) 3,731,312
Total Liabilities and Equity (Deficit) $ 3,284,901 $ 6,723,385
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Convertible debt, net of unamortized discount (in Dollars) $ 0 $ 263,200
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, authorized 25,000,000 25,000,000
Preferred stock, issued 0 0
Preferred stock, outstanding 0 0
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, authorized 750,000,000 500,000,000
Common stock, issued 376,901,679 367,901,679
Common stock, outstanding 376,901,679 367,901,679
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Net Revenue
Cost of Goods Sold
Gross profit
General and administrative 2,721,451 2,747,693 4,386,375 9,457,134
Depreciation and amortization 20,500 4,642 29,493 13,293
Total Expense 2,741,951 2,752,335 4,415,868 9,470,427
Loss from Operations (2,741,951) (2,752,335) (4,415,868) (9,470,427)
Loss on debt conversion (5,184,447)
Penalty on convertible notes (602,100) (1,321,658)
Interest expense (51,340) (53,903) (142,302) (174,587)
Amortization of debt discount (515,200) (263,200) (3,138,452)
Derivative liability movements 84,895 1,578,361 (65,046) 4,714,451
Loss before Income Taxes (3,310,496) (1,743,077) (6,208,074) (13,253,462)
Income Taxes
Net Loss (3,310,496) (1,743,077) (6,208,074) (13,253,462)
Net loss attributable to non-controlling interest 7,652 29,381
Net loss attributable to Innovative Payment Solutions, Inc. stockholders $ (3,302,844) $ (1,743,077) $ (6,178,693) $ (13,253,462)
Basic and diluted loss per share (in Dollars per share) $ (0.01) $ 0 $ (0.02) $ (0.04)
Weighted Average Number of Shares Outstanding – Basic and diluted (in Shares) 375,956,027 364,722,331 370,615,966 323,034,956
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Basic and diluted loss per share $ (0.01) $ 0.00 $ (0.02) $ (0.04)
Weighted Average Number of Shares Outstanding – Basic and diluted 375,956,027 364,722,331 370,615,966 323,034,956
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Non-controlling shareholders interest
Total
Balance at Dec. 31, 2020 $ 19,363 $ 23,179,399 $ (27,629,575) $ (4,430,813)
Balance (in Shares) at Dec. 31, 2020 193,637,747        
Fair value of warrants issued as compensation 4,327,899 4,327,899
Warrants exercised $ 4,407 2,199,307 2,203,714
Warrants exercised (in Shares) 44,074,284        
Share subscriptions $ 3,033 4,546,967 4,550,000
Share subscriptions (in Shares) 30,333,334        
Share issue expenses (501,100) (501,100)
Conversion of debt to equity $ 6,180 7,437,488 7,443,668
Conversion of debt to equity (in Shares) 61,793,616        
Stock based compensation $ 250 213,499 213,749
Stock based compensation (in Shares) 2,500,000        
Net loss (11,394,106) (11,394,106)
Balance at Mar. 31, 2021 $ 33,233 41,403,459 (39,023,681) 2,413,011
Balance (in Shares) at Mar. 31, 2021 332,338,981        
Balance at Dec. 31, 2020 $ 19,363 23,179,399 (27,629,575) (4,430,813)
Balance (in Shares) at Dec. 31, 2020 193,637,747        
Net loss           (13,253,462)
Balance at Sep. 30, 2021 $ 36,789 45,299,411 (40,883,037) 4,453,163
Balance (in Shares) at Sep. 30, 2021 367,901,679        
Balance at Mar. 31, 2021 $ 33,233 41,403,459 (39,023,681) 2,413,011
Balance (in Shares) at Mar. 31, 2021 332,338,981        
Shares issued for services $ 800 775,200 776,000
Shares issued for services (in Shares) 8,000,000        
Warrants exercised $ 1,611 804,024 805,635
Warrants exercised (in Shares) 16,112,698        
Stock based compensation 72,141 72,141
Net loss     (116,279) (116,279)
Balance at Jun. 30, 2021 $ 35,644 43,054,824 (39,139,960) 3,950,508
Balance (in Shares) at Jun. 30, 2021 356,451,679        
Shares issued for services $ 565 442,485 443,050
Shares issued for services (in Shares) 5,650,000        
Stock based compensation $ 580 1,802,102 1,802,682
Stock based compensation (in Shares) 5,800,000        
Net loss (1,743,077) (1,743,077)
Balance at Sep. 30, 2021 $ 36,789 45,299,411 (40,883,037) 4,453,163
Balance (in Shares) at Sep. 30, 2021 367,901,679        
Balance at Dec. 31, 2021 $ 36,790 45,771,012 (42,111,701) 35,211 3,731,312
Balance (in Shares) at Dec. 31, 2021 367,901,679        
Stock based option expense 94,466 94,466
Restricted stock awards 62,766 62,766
Net loss (1,801,494) (8,752) (1,810,246)
Balance at Mar. 31, 2022 $ 36,790 45,928,244 (43,913,195) 26,459 2,078,298
Balance (in Shares) at Mar. 31, 2022 367,901,679        
Balance at Dec. 31, 2021 $ 36,790 45,771,012 (42,111,701) 35,211 3,731,312
Balance (in Shares) at Dec. 31, 2021 367,901,679        
Net loss           (6,208,074)
Balance at Sep. 30, 2022 $ 37,690 47,863,546 (48,290,394) 15,483 (373,675)
Balance (in Shares) at Sep. 30, 2022 376,901,679        
Balance at Mar. 31, 2022 $ 36,790 45,928,244 (43,913,195) 26,459 2,078,298
Balance (in Shares) at Mar. 31, 2022 367,901,679        
Contribution by minority shareholders         9,653 9,653
Stock based option expense 94,462 94,462
Restricted stock awards 62,766 62,766
Net loss (1,074,355) (12,977) (1,087,332)
Balance at Jun. 30, 2022 $ 36,790 46,085,472 (44,987,550) 23,135 1,157,847
Balance (in Shares) at Jun. 30, 2022 367,901,679        
Fair value of warrants issued as compensation 322,918 322,918
Shares issued for services $ 700 332,300 333,000
Shares issued for services (in Shares) 7,000,000        
Stock based option expense 1,013,056 1,013,056
Restricted stock awards $ 200 109,800 110,000
Restricted stock awards (in Shares) 2,000,000        
Net loss (3,302,844) (7,652) (3,310,496)
Balance at Sep. 30, 2022 $ 37,690 $ 47,863,546 $ (48,290,394) $ 15,483 $ (373,675)
Balance (in Shares) at Sep. 30, 2022 376,901,679        
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (6,208,074) $ (13,253,462)
Adjustments to reconcile net loss to net cash used in operating activities:    
Derivative liability movements 65,046 (4,714,451)
Depreciation 29,493 13,293
Amortization of debt discount 263,200 3,138,452
Loss on conversion of debt to equity 5,184,447
Penalty on convertible debt 1,321,658
Deposit forfeited 4,000
Shares issued for services 333,000 1,219,050
Stock based compensation 1,437,516 6,416,471
Fair value of warrants issued 322,918
Amortization of right of use asset 17,857
Changes in Assets and Liabilities    
Other current assets (48,846) (53,834)
Accounts payable and accrued expenses 109,621 17,545
Operating lease liabilities (17,857)
Interest accruals 54,042 144,773
CASH USED IN OPERATING ACTIVITIES (2,320,426) (1,883,716)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Investment in intangibles (585,640) (250,000)
Investment in Frictionless Financial Technologies Inc. (500,000)
Deposits paid (12,792) (4,800)
Plant and equipment purchased (40,500) (9,234)
NET CASH USED IN INVESTING ACTIVITIES (638,932) (764,034)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from minority shareholder contributions 9,653
Proceeds from share issuances 4,550,000
Share issue expenses (501,100)
Pr0oceeds from warrants exercised 3,009,349
Repayment of loans payable (22,049)
Repayment of convertible notes (1,147,063) (521,000)
Proceeds from short term notes and convertible notes 2,569,000
NET CASH PROVIDED BY FINANCING ACTIVITIES (1,137,410) 9,084,200
NET INCREASE (DECREASE) IN CASH (4,096,768) 6,436,450
CASH AT BEGINNING OF PERIOD 5,449,751 94,703
CASH AT END OF PERIOD 1,352,983 6,531,153
CASH PAID FOR INTEREST AND TAXES:    
Cash paid for income taxes
Cash paid for interest 88,260 29,813
NON CASH INVESTING AND FINANCING ACTIVITIES    
De-recognition of right of use lease on early termination 34,070
Conversion of convertible debt to equity 2,259,221
Debt discount on convertible debt
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
ORGANIZATION AND DESCRIPTION OF BUSINESS
9 Months Ended
Sep. 30, 2022
ORGANIZATION AND DESCRIPTION OF BUSINESS [Abstract]  
ORGANIZATION AND DESCRIPTION OF BUSINESS
1ORGANIZATION AND DESCRIPTION OF BUSINESS

 

a)Organizational History

 

On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”.

 

Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.

 

The Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.

 

Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. 

 

On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.

 

On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.

 

On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi” or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.

 

b)Description of current business

 

The Company is presently focused on operating and developing e-wallets that enable consumers to deposit cash, convert it into a digital form and remit the funds to Mexico and other countries quickly and securely. The Company’s first e-wallet, Beyond Wallet, is currently operational and is focused on business customers. The Company’s flagship e-wallet, IPSIPay, is also fully operational. IPSIPay, which is focused on individual customers, was first launched in December 2021 and its commercial launch has continued during 2022. Previously the Company intended to invest in physical kiosks, which required the user presence at the kiosk location. The Company still intends to use its existing kiosks in certain target markets within Southern California, but its principal focus will be on downloadable apps used via smartphones.

 

The Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”) on June 22, 2021. Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
ACCOUNTING POLICIES AND ESTIMATES
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
ACCOUNTING POLICIES AND ESTIMATES
2ACCOUNTING POLICIES AND ESTIMATES

 

a)Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the nine months ended September 30, 2022 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2021, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2022.

 

All amounts referred to in the notes to the unaudited condensed financial statements are in United States Dollars ($) unless stated otherwise.

 

b)Principles of Consolidation

 

The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

 

The entities included in the accompanying unaudited condensed consolidated financial statements are as follows:

 

Innovative Payment Solutions, Inc. - Parent Company

Beyond Fintech Inc., 51% owned. 

 

c)Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

d)Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.

 

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

e)Fair Value of Financial Instruments

 

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

 

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

 

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

 

The carrying amounts reported in the balance sheets for the investment in Vivi Holdings was evaluated at fair value using Level 3 Inputs based on the Company’s estimate of the market value of the entities disposed to Vivi Holdings. Vivi Holdings does not have sufficient information available to assess the current market price of its equity.

 

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

 

f)Risks and Uncertainties

 

The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) COVID-19 and its variants, (ii) launching and scaling the Company’s e-wallet and related products and the use by customers of such products, (iii) developing and implementing successful marketing campaigns and other strategic initiatives; (iv) competition, (iv) compliance with applicable laws, rules and regulations (including those related to fund remittance); (v) the Company’s outstanding indebtedness, including the Company’s ability to repay or extend the maturity of such indebtedness (see Note 8); (vi) inflation and other economic factors and (vii) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.

 

The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.

 

g)Recent accounting pronouncements

 

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended September 30, 2022. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.

 

h)Reporting by Segment

 

No segmental information is required as the Company has not generated any revenue for the nine months ended September 30, 2022 and 2021 and only has one operating segment.

 

i)Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At September 30, 2022 and 2021, respectively, the Company had no cash equivalents.

 

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At September 30, 2022 and December 31, 2021, the balance exceed the federally insured limit by $1,094,504 and $5,117,551, respectively.

 

j)Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended September 30, 2022 and December 31, 2021.

 

k)Investments

 

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

l)Plant and Equipment

 

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

 

Description   Estimated Useful Life
     
Kiosks (not used in the Company’s current business)   7 years
     
Computer equipment   3 years
     
Leasehold improvements   Lesser of estimated useful life or life of lease
     
Office equipment   10 years

 

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

 

m)Long-Term Assets

 

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

n)Revenue Recognition

 

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue Recognition.

 

The Company’s revenues will be recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

 

  i. identify the contract with a customer;

 

  ii. identify the performance obligations in the contract;

 

  iii. determine the transaction price;

 

  iv. allocate the transaction price to performance obligations in the contract; and

 

  v. recognize revenue as the performance obligation is satisfied.

 

The Company had no revenues during the nine months ended September 30, 2022 and 2021.

 

o)Share-Based Payment Arrangements

 

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

 

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

 

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

 

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

 

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

 

p)Derivative Liabilities

 

ASC Topic 815, Derivatives and hedging (“ASC 815”) generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

q)Income Taxes

 

The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of September 30, 2022 and December 31, 2021, there have been no interest or penalties incurred on income taxes.

 

r)Comprehensive income

 

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

 

s)Reclassification of prior year presentation

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
LIQUIDITY MATTERS
9 Months Ended
Sep. 30, 2022
Liquidity Matters [Abstract]  
LIQUIDITY MATTERS
3LIQUIDITY MATTERS

  

The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For and as of the end of nine months ended September 30, 2022, the Company had a net loss of $6,208,074. In connection with preparing the unaudited condensed consolidated financial statements for the nine months ended September 30, 2022, management evaluated the risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements.

 

The Company had a cash balance of $1,352,983 available as of September 30, 2022. Based on its evaluation of the Company’s current business plan, and assuming the Company can extend the maturity date of its existing indebtedness (see Note 8), management believes the Company’s existing cash is sufficient to conduct planned operations for at least one year from the date of issuance of these financial statements.

 

However, given the Company’s losses, negative cash flows and existing indebtedness, the Company will be required to raise significant additional funds to progress its business as planned by issuing equity or equity-linked securities. Should this occur, the Company’s stockholders would experience dilution, perhaps significantly. Additional debt financing, if available, may involve covenants restricting the Company’s operations or its ability to incur additional debt. Any additional debt financing or additional equity that the Company raises may contain terms that are not favorable to the Company or its stockholders and require significant debt service payments, which diverts resources from other activities. Moreover, there is a risk that financing may be unavailable to support the Company’s operations on favorable terms, or at all.

 

There is also a significant risk that none of the Company’s plans to raise financing will be implemented in a manner necessary to sustain the Company for an extended period of time. If adequate funds are not available to the Company when needed, the Company may be required to continue with reduced operations or to obtain funds through arrangements that may require the Company to relinquish rights to technologies or potential markets, any of which could have a material adverse effect on the Company. In addition, the Company’s inability to secure additional funding when needed could cause the Company’s business to fail or become bankrupt or force the Company to wind down or discontinue operations.

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTANGIBLES
9 Months Ended
Sep. 30, 2022
Intangibles [Abstract]  
INTANGIBLES
4INTANGIBLES

 

On August 26, 2021, the Company formed a subsidiary, Beyond Fintech. to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owns 51% of Beyond Fintech with the other 49% owned by Frictionless.

 

During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, and during the nine months ended September 30, 2022, an additional $544,320 was spent by the Company to facilitate the functioning of the IPSIPay software in the cloud environment. Beyond Fintech spent an additional $41,320 on software to further enhance the Beyond Wallet product offering. 

 

   September 30,
2022
   December 31,
2021
 
Purchased Technology  $1,210,640   $625,000 
Accumulated amortization   (12,629)   
-
 
   $1,198,011   $625,000 

 

Amortization expense was $12,629 for the three and nine months ended September 30, 2022 and $0 for the three and the nine months ended September 30, 2021.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
INVESTMENTS
9 Months Ended
Sep. 30, 2022
Investments, All Other Investments [Abstract]  
INVESTMENTS
5INVESTMENTS

 

Investment in Frictionless Financial Technologies Inc.

 

On June 22, 2021, the Company entered into a Stock Purchase Agreement (the “SPA”) with Frictionless, to purchase 150 common shares for gross proceeds of $500,000, representing 10.0% of the outstanding common shares. In terms of the SPA, Frictionless agreed to deliver to the Company on or before August 30, 2021, a live fully compliant financial payment software as a service solution for use by the Company as a digital payment platform that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate to Company’s product offerings. The Company’s IPSIPay app is the digital payment platform developed by Frictionless for the Company, and currently Frictionless provides back-end technical services to the Company relating to IPSIPay.

 

The Company has undertaken to issue Frictionless a non-restricted, non-dilutable 5 year warrant to purchase 30,000,000 shares of Common Stock at an exercise price of $0.15 per share, upon delivery of the financial payment software. Frictionless has delivered the IPSIPay-related software and the warrants will be issued in accordance with the agreement.

 

The Company has the right to appoint, and has appointed, one member to the board of directors of Frictionless, which appointee will remain on the board as long as the Company is the holder of the Frictionless common stock.

 

The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

The shares in Frictionless are unlisted as of September 30, 2022.

 

Investment in Vivi Holdings, Inc.

 

Effective December 31, 2019, the Company sold 100% of the outstanding common stock of its subsidiary, Qpagos Corporation, together with its 99.9% ownership interest of Qpagos Corporation’s two Mexican entities: Qpagos S.A.P.I. de C.V. and Redpag Electrónicos S.A.P.I. de C.V, to Vivi.

 

As consideration for the disposal, Vivi issued an aggregate of 2,250,000 Vivi Shares as follows: 2,047,500  Vivi Shares to the Company; 56,250 Vivi Shares to the Company’s designee, Mr. Andrey Novikov; 33,750 Vivi Shares to the Company’s designee, the Joseph W. & Patricia G. Abrams Family Trust; and 112,500 Vivi Shares to the Company’s designee, Mr. Gaston Pereira.

 

Due to the lack of available information, the Vivi Shares were valued by a modified market method, whereby the value of the assets disposed of were determined by management using the enterprise value of the entire Company less the liabilities and assets retained by the Company.

 

As of September 30, 2022 and December 31, 2021, the Company maintained the impairment of the carrying value of the investment in Vivi Holdings based on no activity by Vivi’s management for its proposed initial public offering and fund raising activities. The total impairment as of September 30, 2022 and December 31, 2021 was $1,019,960.

 

The shares in Vivi Holdings are unlisted as of September 30, 2022.

 

   September 30,
2022
  

December 31,
2021

 
Investment in Frictionless Financial Technologies, Inc.  $500,000   $500,000 
Investment in Vivi Holdings, Inc.   1    1 
   $500,001   $500,001 
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
LEASES
9 Months Ended
Sep. 30, 2022
Leases [Abstract]  
LEASES
6LEASES

 

On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5th Avenue, Lot 1 #AT, Carmel by The Sea, California. The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month.

 

Total Lease Cost

 

Individual components of the total lease cost incurred by the Company is as follows:

 

  

Nine months
ended
September 30,
2022

   Nine months
ended
September 30,
2021
 
Operating lease expense  $43,200   $17,857 

 

Other lease information:

 

   

Nine
months ended
September 30,

2022

    Nine
months ended
September 30,
2021
 
Cash paid for amounts included in the measurement of lease liabilities            
Operating cash flows from operating leases   $ (45,200 )   $ (60,403 )
                 
Remaining lease term – operating lease     -       6 months  

 

Maturity of Operating Leases

 

The amount of future minimum lease payments under operating leases are as follows:

 

   Amount 
Undiscounted minimum future lease payments under leases with terms twelve months or less    
Total instalments due:    
2022  $
            -
 
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
FEDERAL RELIEF LOANS
9 Months Ended
Sep. 30, 2022
Federal Relief Loans [Abstract]  
FEDERAL RELIEF LOANS
7FEDERAL RELIEF LOANS

 

Small Business Administration Disaster Relief loan

 

On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company. The proceeds are to be used for working capital purposes to alleviate economic injury caused by the COVID-19 pandemic.

 

The Company has accrued interest of $12,560 on this loan as of September 30, 2022.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONVERTIBLE NOTES PAYABLE
9 Months Ended
Sep. 30, 2022
Convertible Notes Payable [Abstract]  
CONVERTIBLE NOTES PAYABLE
8CONVERTIBLE NOTES PAYABLE

 

Convertible notes payable consists of the following:

 

Description  Effective Interest
Rate
   Maturity date  Principal   Accrued
Interest
   Unamortized
debt discount
  

September 30,
2022
Amount, net

  

December 31,
2021
Amount, net

 
Cavalry Fund I LP   28.7%  November 16, 2022  $1,091,754   $13,647   $
       -
   $1,105,401   $548,872 
                                  
Mercer Street Global Opportunity Fund, LLC   28.7%  November 16, 2022   1,091,754    13,647    
-
    1,105,401    548,872 
                                  
Bellridge Capital LP.   10%  February 16, 2022   
-
    
-
    
-
    
-
    863,609 
                                  
Total convertible notes payable          $2,183,508   $27,294   $
-
   $2,210,802   $1,961,353 

 

Interest expense totaled $49,912 and $52,236 and amortization of debt discount totaled $0 and $515,200 for the three months ended September 30, 2022 and 2021, respectively, and interest expense totaled $138,085 and $169,695 and amortization of debt discount totaled $263,200 and $3,138,452 for the nine months ended September 30, 2022 and 2021, respectively.

 

Cavalry Fund I LP

 

  On February 16, 2021, the Company closed a transaction with Cavalry Fund I LP (“Cavalry”), pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Cavalry Note”). The Cavalry Note is convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of Common Stock at an initial exercise price of $0.24 per share.

 

On February 3, 2022, the Company extended the maturity date of its Cavalry Note from February 16, 2022 to August 16, 2022. The Cavalry Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Cavalry agreed to extend the maturity date of the Cavalry Note to August 16, 2022 in consideration of the principal amount outstanding under the Cavalry Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. On August 30, 2022, the Company further extended the maturity date of its Cavalry note from August 16, 2022 to November 16, 2022. In terms of the agreement entered into with Cavalry, the principal outstanding was increased by $181,959 and the interest outstanding as of August 31, 2022 of $43,553 was capitalized, resulting in a principal balance outstanding of $1,091,754. In addition, the Company granted Cavalry a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share, maturing on August 30, 2027 and valued at $119,091 on the date of grant. 

 

This change to the maturity dates of the Cavalry Note from February 16, 2022 to August 31, 2022 and subsequently to November 16, 2022, was assessed in terms of ASC 470-50 as a debt extinguishment, which resulted in a penalty expense of $181,959 and $260,708 for the three months and nine months ended September 30, 2022, respectively, in addition the value of the warrant issued on the debt extension from August 16, 2022 to November 16, 2022, resulted in an additional penalty expense of $119,091 for the three and nine months ended September 30, 2022.

 

The balance of the Cavalry Note plus accrued interest at September 30, 2022 was $1,105,401.

 

Mercer Street Global Opportunity Fund, LLC

   

  On February 16, 2021, the Company closed a transaction with Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Mercer Note”). The Mercer Note is convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of Common Stock at an initial exercise price of $0.24 per share.

 

On February 3, 2022, the Company extended the maturity date of its Mercer Note from February 16, 2022 to August 16, 2022. The Mercer Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Mercer agreed to extend the maturity date of the Mercer Note to August 16, 2022 in consideration of the principal amount outstanding under the Mercer Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. On August 30, 2022, the Company further extended the maturity date of its Mercer note from August 16, 2022 to November 16, 2022. In terms of the agreement entered into with Mercer, the principal outstanding was increased by $181,959 and the interest outstanding as of August 31, 2022 of $43,553 was capitalized, resulting in a principal balance outstanding of $1,091,754. In addition, the Company granted Mercer a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share, maturing on August 30, 2027 and valued at the date of grant at $119,091.

 

This change to the maturity dates of the Mercer Note from February 16, 2022 to August 31, 2022 and subsequently to November 16, 2022, was assessed in terms of ASC 470-50 as a debt extinguishment, which resulted in a penalty expense of $181,959 and $260,708 for the three months and nine months ended September 30, 2022, respectively, in addition the value of the warrant issued on the debt extension from August 16, 2022 to November 16, 2022, resulted in an additional penalty expense of $119,091 for the three and nine months ended September 30, 2022.

 

The balance of the Mercer Note plus accrued interest at September 30, 2022 was $1,105,401.

  

Bellridge Capital LP.

  

  On February 16, 2021, the Company closed a transaction with Bellridge Capital LP., pursuant to which the Company received net proceeds of $787,500, after an original issue discount of $112,500 in exchange for the issuance of a $900,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Bellridge Note”). The Bellridge Note was convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 3,913,044 shares of Common Stock at an initial exercise price of $0.24 per share.

 

The Bellridge Note was repaid on February 4, 2022 for gross proceeds of $1,235,313, including interest thereon of $88,250, thereby extinguishing the Bellridge Note.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
DERIVATIVE LIABILITY
9 Months Ended
Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE LIABILITY
9DERIVATIVE LIABILITY

 

Certain of the short-term convertible notes disclosed in note 8 above and certain warrants disclosed in note 10 below have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.

 

On August 30, 2022, the company extended the maturity date of convertible notes issued to Cavalry and Mercer and agreed to grant each note holder a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share with a maturity date of August 30, 2027. The warrant has full ratchet anti-dilution clauses and have fundamental transaction clauses which may give rise to cash settlement which gives rise to a derivative financial liability, which was originally valued at the grant date using a Black--Scholes valuation model at $238,182.

 

The value of this derivative financial liability was re-assessed at September 30, 2022 at $710,389, and $84,895 was credited and $65,046 was charged to the statement of operations for the three and nine months ended September 30, 2022, respectively. The value of the derivative liability will be re-assessed at each financial reporting period, with any movement thereon recorded in the statement of operations in the period in which it is incurred.

 

The following assumptions were used in the Black-Scholes valuation model:

 

  

Nine months
ended

September 30,
2022

   Year ended
December 31,
2021
 
Conversion price    $ 0.05 to $0.15     $ 0.05 to $0.24  
Risk free interest rate    0.79 to 4.25 %   0.05 to 1.12 %
Expected life of derivative liability    1.5 to 59 months     1.6 to 49.6 months  
Expected volatility of underlying stock    120.49 to 258.3 %   161.19 to 215.33 %
Expected dividend rate    0%   0%

 

The movement in derivative liability is as follows:

 

   September 30,
2022
   December 31,
2021
 
Opening balance  $407,161   $2,966,416 
Derivative financial liability arising from convertible note and warrants   238,182    2,569,000 
Fair value adjustment to derivative liability   65,046    (5,128,255)
   $710,389   $407,161 
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS’ EQUITY
9 Months Ended
Sep. 30, 2022
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS’ EQUITY
10STOCKHOLDERS’ EQUITY

 

  a. Common Stock

 

The Company has total authorized Common Stock of 750,000,000  shares with a par value of $0.0001 each. The Company had 376,901,679 and 367,901,679 shares of Common Stock issued and outstanding as of September 30, 2022 and December 31, 2021, respectively.

 

On July 8, 2022, the Company entered into a consulting agreement with a third-party contractor for a period of twelve months to (i) review the Company’s business plan; (ii) analyze and assess the Company’s revenues, costs, and cash flow; and (iii) introduce the Company to and interface on the Company’s behalf with potential and actual commercial partners. The Company issued 2,000,000 shares of Common Stock as compensation for the services rendered which were fully earned on the date of issue. These shares were valued at $84,000 at the date of grant. In addition, the contractor will receive a monthly fee of $3,000 for the term of the Agreement, commencing on August 1, 2022.

 

On July 8, 2022, the Company entered into a second consulting agreement with a separate third-party contractor for a period of twelve months to (i) review the Company’s business plan; (ii) analyze and assess the Company’s revenues, costs, and cash flow; and (iii) introduce the Company to and interface on the Company’s behalf with potential and actual commercial partners. The Company issued 2,000,000 shares of Common Stock as compensation for the services rendered which were fully earned on the date of issue. These shares were valued at $84,000 at the date of grant.

 

On July 11, 2022, the Board approved the issuance of  2,000,000 restricted shares of Common Stock to Richard Rosenblum, the Company’s President and Chief Financial Officer. These shares were valued at $110,000 at the date of grant.

 

On August 5, 2022, the Board approved the issuance of 3,000,000 shares of Common Stock to Samad Harake or his designees as compensation for the services rendered which were fully earned on the date of issue., Mr. Harake is the president and control person of Frictionless. These shares were valued at $165,000 at the date of grant.

 

b.Restricted stock awards

 

A summary of restricted stock activity during the period January 1, 2021 to September 30, 2022 is as follows:

 

   Total
restricted
shares
   Weighted
average
fair market
value per
share
   Total
unvested
restricted
shares
   Weighted
average
fair market
value per
share
   Total vested
restricted
shares
   Weighted
average
fair market
value per share
 
Outstanding January 1, 2021   20,495,000   $0.049    15,371,250   $0.049    5,123,750   $0.049 
Granted and issued   2,500,000    0.050    2,500,000    0.050    
-
    
-
 
Forfeited/Cancelled   (1,500,000)   (0.050)   (1,500,000)   (0.050)   
-
    
-
 
Vested   
-
    
-
    (6,123,750)   (0.049)   6,123,750    0.049 
Outstanding December 31, 2021   21,495,000   $0.049    10,247,500   $0.049    11,247,500   $0.049 
Granted and issued   2,000,000    0.055    
-
    
-
    2,000,000    0.055 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (5,123,750)   (0.049)   5,123,750    0.049 
Outstanding September 30, 2022   23,495,000   $0.050    5,123,750   $0.049    18,371,250   $0.050 

 

The restricted stock granted, issued and exercisable at September 30, 2022 is as follows:

 

    Restricted Stock Granted   Restricted Stock Vested 
Grant date
Price
   Number
Granted
   Weighted
Average
Fair Value
per
Share
   Number
Vested
   Weighted
Average
Fair Value
per
Share
 
$0.049    20,495,000   $0.049    15,371,250   $0.049 
$0.050    1,000,000    0.050    1,000,000    0.050 
$0.055    2,000,000    0.055    2,000,000    0.055 
      23,495,000   $0.050    18,371,250   $0.050 

 

The Company has recorded an expense of $172,766 and $44,165 for the three months ended September 30, 2022 and 2021, respectively and $298,298 and $188,448 for the nine months ended September 30, 2022 and 2021, respectively. 

 

  c. Preferred Stock

 

The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of September 30, 2022 and December 31, 2021.

 

  d. Warrants

  

Effective July 8, 2022 (the “Effective Date”), the Company entered into an Endorsement Agreement with Pez-Mar, Inc., a California corporation (“Pez-Mar”), to furnish the services of Mario Lopez (“Lopez”). Pursuant to the Endorsement Agreement, Lopez will act as a Company spokesperson in connection with the promotion, advertisement and endorsement of the Company’s physical and virtual payment processing and money remittance business and the Company’s related products and services.

 

The Endorsement Agreement has a term of two (2) years from the Effective Date (the “Term”), which is subject to earlier termination on customary terms and conditions. The parties have agreed to certain deliverables of Lopez during the term of the agreement, including with respect to social media posts, television commercials, interviews and photo shoots. The Endorsement Agreement also contains other customary terms, covenants and conditions, including representations and warranties, restrictions on endorsements of competitive products during the term of the agreement, confidentiality, indemnification, and Pez-Mar and Lopez’s independent contractor status.

 

As compensation for the services provided under the Endorsement Agreement, Lopez or their designees are entitled to the following payments: (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Fifteen Million (15,000,000) shares of the Common Stock at an exercise price of $0.0345 per share. The Warrants shall have a three-year term commencing from the Effective Date. The right to exercise the Warrants shall be subject to vesting during the Term but shall vest in full upon the consummation of a fundamental transaction involving the Company or upon certain termination events provided for in the Endorsement Agreement. The Exercise Price may be payable via “cashless exercise”, unless the underlying Shares are registered under an effective registration statement under the Securities Act of 1933, as amended. The Shares are subject to certain “piggyback” registration rights.

 

On August 30, 2022, the Company extended the maturity date of convertible notes issued to Cavalry and Mercer and agreed to grant each note holder a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share with an expiration date of August 30, 2027.

 

The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

   Nine months
ended
September 30,
2022
 
Exercise price  $ 0.0345 to 0.15  
Risk free interest rate   3.14 to 3.27 %
Expected life   3 to 5 years  
Expected volatility of underlying stock   189.1 to 199.2 %
Expected dividend rate   0%

 

A summary of warrant activity during the period January 1, 2021 to September 30, 2022 is as follows:

 

   Shares
Underlying
Warrants
   Exercise
price per
share
   Weighted
average
exercise
price
 
Outstanding January 1, 2021    51,188,572   $0.05   $0.05 
Granted    66,302,515         0.05 to 0.24    0.16 
Forfeited/Cancelled    (20,000,000)   0.24    0.24 
Exercised    (60,186,982)   0.05    0.05 
Outstanding December 31, 2021    37,304,105   $ 0.05 – 0.1875   $0.12 
Granted    21,000,000      0.0345 – 0.15    0.07 
Forfeited/Cancelled    
-
    -    
-
 
Exercised    
-
    -    
-
 
Outstanding September 30, 2022    58,304,105   $  0.05 – 0.1875   $0.11 

 

The warrants outstanding and exercisable at September 30, 2022 are as follows:

 

    Warrants Outstanding   Warrants Exercisable 
Exercise
Price
   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
$0.0345    15,000,000             2.77                         8,437,500                                2.77 
$0.05    10,823,813    3.03         10,823,813         3.03 
$0.15    30,053,625    3.73         30,053,625         3.73 
$0.1875    2,426,667    3.46         2,426,667         3.46 
      58,304,105    3.34   $0.11    51,741,605   $0.11    3.42 

 

The warrants outstanding have an intrinsic value of $0 as of September 30, 2022 and December 31, 2021.

 

  e. Stock options

 

On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.

 

The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the Plan is 800,000 shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.

 

On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.

 

The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the 2021 Plan is 53,000,000 shares of Common Stock.

 

Under the 2021 Plan the company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.

  

On July 11, 2022, the Board approved, granted and issued 15,000,000 ten-year incentive stock options, with immediate vesting, to the Company’s Chairman and Chief Executive Officer at an exercise price of $0.15 per share. This resulted in an immediate expense of $823,854 for the three and nine months ended September 30, 2022.

 

On September 13, 2022, the Company granted ten-year options exercisable for 200,000 shares of Common Stock, with immediate vesting, to each of its four non-executive directors, totaling options exercisable for 800,000 shares of Common Stock at an exercise price of $0.04 per share. This resulted in an immediate expense of $31,970 for the three and nine months ended September 30, 2022.

 

The fair value of the options granted and issued were determined by using a Black Scholes valuation model using the following assumptions:

 

   Nine months
ended
September 30,
2022
 
Exercise price    $ 0.04 to 0.15   
Risk free interest rate     2.99 to 3.42 %
Expected life     10.0 years   
Expected volatility of underlying stock     206.4 to 208.4 %
Expected dividend rate    0%

 

A summary of option activity during the period January 1, 2021 to September 30, 2022 is as follows:

 

   Shares
Underlying
options
   Exercise
price per
share
   Weighted
average
exercise
price
 
Outstanding January 1, 2021    100,000   $0.40   $0.40 
Granted    30,416,666      0.15 – 0.24    0.15 
Forfeited/Cancelled    
-
    -    
-
 
Exercised    
-
    -    
-
 
Outstanding December 31, 2021    30,516,666   $ 0.15 to 0.40   $0.15 
Granted    15,800,000      0.04 – 0.15    0.14 
Forfeited/Cancelled    
-
    -    
-
 
Exercised    
-
    -    
-
 
Outstanding September 30, 2022    46,316,666   $ 0.04 to 0.40   $0.15 

 

The options outstanding and exercisable at September 30, 2022 are as follows:

 

    Options Outstanding   Options Exercisable 
Exercise
Price
   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
 0.04    800,000             9.96                          800,000                               9.96 
 0.15    45,208,333    9.19         35,625,000         9.27 
 0.24    208,333    8.40         208,333         8.40 
 0.40    100,000    6.25         100,000         6.25 
      46,316,666    9.19   $0.15    36,733,333   $0.15    9.27 

 

The options outstanding have an intrinsic value of $0 as of September 30, 2022 and December 31, 2021, respectively.

 

The option expense was $950,290 and $1,196,566 for the three months ended September 30, 2022 and 2021, respectively and $1,139,220 and $1,288,174 for the nine months ended September 30, 2022 and 2021, respectively. 

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
NET LOSS PER SHARE
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
NET LOSS PER SHARE
11NET LOSS PER SHARE

 

Basic loss per share is based on the weighted-average number of common shares outstanding during each period. Diluted loss per share is based on basic shares as determined above plus Common Stock equivalents. The computation of diluted net loss per share does not assume the issuance of common shares that have an anti-dilutive effect on net loss per share. For the three and nine months ended September 30, 2022 and 2021 all warrants, options and convertible debt securities were excluded from the computation of diluted net loss per share.

 

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three and nine months ended September 30 2022 and 2021 are as follows:

 

   Three and nine
months ended
September 30,
2022
(Shares)
   Three and nine
months ended
September 30,
2021
(Shares)
 
Convertible debt   14,738,682    13,626,666 
Stock options   46,316,666    30,516,666 
Warrants to purchase shares of Common Stock   58,304,105    37,304,104 
    119,359,453    81,447,436 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
RELATED PARTY TRANSACTIONS
9 Months Ended
Sep. 30, 2022
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS
12RELATED PARTY TRANSACTIONS

 

The following transactions were entered into with related parties:

 

James Fuller

 

On February 22, 2021, the Board awarded James Fuller ( a director of the Company until November 2, 2022 when he voluntarily retired as a member of the Board) options under the Company’s 2018 Stock Incentive Plan to purchase 208,333 shares of Common Stock. The options are exercisable for a period of ten years from the date of grant, vest in full on the date of grant and have an exercise price of $0.24 per share.

 

On July 22. 2021, the Company granted Mr. Fuller 2,000,000 shares of Common Stock, valued at $154,000. 

 

Additionally, the Board approved the repricing of the options exercisable for 208,333 shares of Common Stock granted to Mr. Fuller on February 22, 2021, from $0.24 per share to $0.15 per share.

 

On September 13, 2022, the Company granted Mr. Fuller ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share.

 

The option expense for Mr. Fuller for the three and the nine months ended September 30, 2022 was $7,993.

 

Andrey Novikov

 

On February 22, 2021, the Board awarded Andrey Novikov options under the Company’s 2018 Stock Incentive Plan to purchase 208,333 shares of Common Stock. The options are exercisable for a period of ten years from the date of grant, vest in full on the date of grant and have an exercise price of $0.24 per share. 

 

On May 31, 2021, Mr. Novikov notified the Board of his decision to resign as a member of the Board and as Secretary of the Company, effective as of June 1, 2021. Since August 2021, Mr. Novikov has been on suspension from service as the Company’s Chief Technology Officer. On November 11, 2022, with the recommendation of a special committee of disinterested members of the Board who had reviewed this matter, the Board approved the formal termination of Mr. Novikov’s employment with the Company for “cause.”

 

William Corbett

 

On February 22, 2021, the Board appointed William Corbett as the Company’s Chief Executive Officer and Interim Chief Financial Officer, as its Chairman of the Board and issued him a five-year warrant to purchase 20,000,000 shares of the Common Stock at an exercise price of $0.24 per share. The Board also agreed to increase Mr. Corbett’s monthly base salary to $30,000. The warrant expense for Mr. Corbett for the year ended December 31, 2021 was $4,327,899.

 

On August 16, 2021, the Company and Mr. Corbett entered into an Executive Employment Agreement that replaced and superseded the previous executive employment agreement (the “August 2021 Corbett Employment Agreement”). The purpose of the August 2021 Corbett Employment Agreement was to provide a replacement grant for warrants previously granted to Mr. Corbett under the terms of his previous employment agreement with the Company. Pursuant to the August 2021 Corbett Employment Agreement, Mr. Corbett would continue to serve as the Company’s Chief Executive Officer on a full time basis effective as of the date of the August 2021 Corbett Employment Agreement until the close of business on December 31, 2024. Mr. Corbett’s base salary will be $30,000 per month, which shall be paid in accordance with the Company’s standard payroll practice for its executives, managers and salaried employees. In addition, the August 2021 Corbett Employment Agreement provides that: (1) Mr. Corbett will be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from time to time; (2) the Company will grant to Mr. Corbett options to purchase 20,000,000 shares of Common Stock at a per share exercise price of $0.15; and (3) a car allowance for Mr. Corbett in the amount of $800 per month. Fifty percent (50%) of the shares subject to the options shall vest on the grant date and the other 50% of the shares subject to the option shall vest at the rate of 1/36 per month over a three-year period. The options will be exercisable for a period of ten years after the date of grant and the Company shall provide for cashless exercise of the option. The options are being granted pursuant to the Company’s 2021 Stock Incentive Plan which was approved by the Board in August 2021, subject to approval of the 2021 Plan by the shareholders, which approval was obtained at the annual general meeting held on October 22, 2021.

 

In addition, the Company and Mr. Corbett entered into an Indemnification Agreement on August 16, 2021 (the “August 2021 Corbett Indemnification Agreement”), pursuant to which the Company agreed to indemnify Mr. Corbett to indemnify Indemnitee to the fullest extent permitted by or under the Nevada Corporation Law in respect of claims, including third-party claims and derivative claims and provides for advancement of expenses. The August 2021 Corbett Indemnification Agreement amends the indemnification agreement in effect prior to entering into the August 2021 Corbett Indemnification Agreement to provide that unless Company shall pay Mr. Corbett’s attorneys’ fees and costs, including the compensation and expenses of any arbitrator, unless the arbitrator or the court determines that (a) Company has no liability in such dispute, or (b) the action or claims by Executive are frivolous in nature. In any other case or matter, the Company and Mr. Corbett shall each bear its or his own attorney fees and costs.

 

On July 11, 2022, the Company granted Mr. Corbett ten-year options exercisable for 15,000,000 shares of Common Stock at an exercise price of $0.15 per share.

 

The option expense for Mr. Corbett for the three and the nine months ended September 30, 2022 was $890,442 and $1,023,614, respectively.

 

Clifford Henry

 

On May 1, 2021, the Company appointed Mr. Henry to the Board.

 

On July 22, 2021, the Company granted Mr. Henry 2,000,000 shares of Common Stock, valued at $154,000.

 

Mr. Henry has an oral consulting arrangement with the Company whereby he is paid $3,500 per month for financial and capital markets advice. This consulting agreement commenced in May, 2021 and was approved and ratified by the Board in March 2022. This consulting agreement and related payments were terminated in September 2022.

 

On September 13, 2022, the Company granted Mr. Henry, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.

 

The option expense for Mr. Henry for the three and the nine months ended September 30, 2022 was $7,993.

 

Madisson Corbett

 

On May 1, 2021, the Company appointed Ms. Corbett to the Board. Ms. Corbett is the daughter of Mr. William Corbett, the Company’s Chief Executive Officer and Chairman of the Board.

 

On July 22, 2021, the Company granted Ms. Corbett 2,000,000 shares of Common Stock, valued at $154,000.

 

On September 13, 2022, the Company granted Ms. Corbett, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.

  

The option expense for Ms. Corbett for the three and the nine months ended September 30, 2022 was $7,993.

  

David Rios

 

On July 22, 2021, the Company appointed David Rios to the Board.

 

On July 22, 2021, the Company granted Mr. Rios 1,000,000 shares of Common Stock, valued at $77,000. 

 

On September 13, 2022, the Company granted Mr. Rios, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.

 

The option expense for Mr. Rios for the three and the nine months ended September 30, 2022 was $7,993.

 

Richard Rosenblum

 

On July 22, 2021, the Company appointed Richard Rosenblum as President and Chief Financial Officer of the Company. In addition, Mr. Rosenblum was elected to the Board to serve until the Company’s next annual meeting of shareholders and was subsequently appointed as the Company’s Secretary.

 

On July 27, 2021, the Company and Mr. Rosenblum entered into an Executive Employment Agreement (the “Employment Agreement”), pursuant to which Mr. Rosenblum will serve as the Company’s President and Chief Financial Officer on a full time basis effective as of July 1, 2021. The effectiveness of the Employment Agreement is subject to the approval of the Employment Agreement by the Board, unless earlier terminated as provided in the Employment Agreement. The term of the Employment Agreement is until December 31, 2024. Mr. Rosenblum’s base salary will be $18,000 per month. In addition, the Employment Agreement provides that: (1) Mr. Rosenblum will be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from time to time; and (2) the Company will grant to Mr. Rosenblum options to purchase 10,000,000 shares of Common Stock at a per share exercise price equal to the fair market value of the Common Stock, as reflected in the closing price of the Common Stock on the OTC exchange or, in the event the stock is up listed, on a national stock exchange, on the date of grant (the “Options”)”. Fifty percent (50%) of the shares subject to the Options shall vest on the grant date and the other 50% of the shares subject to the Option shall vest at the rate of 1/36 per month over a three-year period. The Options will be exercisable for a period of ten (10) years after the date of grant and the Company shall provide for cashless exercise of the Option by Executive. The options are being granted pursuant to the Company’s 2021 Stock Incentive Plan which was approved by the Board in August 2021, subject to approval of the 2021 Plan by the shareholders, which approval was obtained at the annual general meeting held on October 22, 2021. The Options are being granted pursuant to the Company’s 2021 Stock Incentive Plan. 

 

If Mr. Rosenblum’s employment with Company is terminated at any time during the term of the Employment Agreement other than for Cause (as defined in the Employment Agreement), or due to voluntary termination, retirement, death or disability, then Mr. Rosenblum shall be entitled to severance equal to fifty percent (50%) of his annual base salary rate in effect as of the date of termination. If Mr. Rosenblum’s employment with Company is terminated at any time during the term of the Employment Agreement other than for Cause (as defined in the Employment Agreement), or due to voluntary termination, retirement, death or disability, within 12 months following an Acquisition (as defined in the Employment Agreement), then Mr. Rosenblum shall be entitled to severance equal to 100% of his annual base salary rate in effect as of the date of termination. Severance payments shall be subject to execution and delivery of a general release in favor of the Company.

 

On August 16, 2021, the Company entered into an amendment to the Rosenblum Executive Employment Agreement (the “First Amendment”) with Mr. Rosenblum. Under the terms of the Executive Employment Agreement, the Company had agreed to grant to Mr. Rosenblum an option to purchase 10,000,000 (ten million) common shares of Company Stock at a per share exercise price equal to the fair market value of the Common Stock, as reflected in the closing price of the Common Stock on the OTC exchange or, in the event the stock is uplisted, on a national stock exchange, on the date of grant (the “Option”).” The First Amendment provided that the Option was granted on August 31, 2021 at an exercise price of $0.15 per share.

 

In addition, the Company and Mr. Rosenblum entered into an Indemnification Agreement, pursuant to which the Company agreed to indemnify Mr. Rosenblum to indemnify Indemnitee to the fullest extent permitted by or under the Nevada Corporation Law in respect of claims, including third-party claims and derivative claims and provides for advancement of expenses.

 

On July 11, 2022, the Company granted Mr. Rosenblum 2,000,000 restricted shares of Common Stock valued at $110,000, all of which are vested.

 

The option expense for Mr. Rosenblum for the three months and nine months ended September 30, 2022 was $27,879 and $83,636, respectively.

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES
13COMMITMENTS AND CONTINGENCIES

 

The Company has convertible notes, disclosed under note 8 above, which mature on November 16, 2022. Should these notes not be converted to Common Stock prior to that date, the Company may need to repay the principal and interest outstanding on these notes.

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUBSEQUENT EVENTS
9 Months Ended
Sep. 30, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
14SUBSEQUENT EVENTS

 

On November 2, 2022, the Company conducted its 2022 annual meeting of stockholders.

 

At the Annual Meeting, the Company’s stockholders (i) elected each of William D. Corbett, Richard Rosenblum, Madisson Corbett, Clifford Henry and David Rios as directors’ of the Company until the next annual meeting or until their successors shall be elected and qualified, (ii) ratified the appointment of RBSM LLP as the Company’s independent registered public accounting firm for fiscal year ended December 31, 2022, (iii) approved an amendment to the Company’s Articles of Incorporation to effect a reverse stock split of the issued and outstanding shares of common stock at a ratio (to be determined in the discretion of the Company’s Board during a two year period ending on November 2, 2024) within a range of one (1) share of Common Stock for every two (2) to thirty (30) shares of Common Stock, and (iv) approved a potential adjournment of the annual meeting,

 

The Company’s stockholders did not approve the proposed amendment to the Company’s Articles of Incorporation to provide the board of directors with the authority to, at its discretion, fix by resolution or resolutions, the designations, rights and privileges of the Company’s authorized preferred stock.

 

Other than the above, the Company has evaluated subsequent events through the date the financial statements were issued, and did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accounting Policies, by Policy (Policies)
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Basis of Presentation
a)Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the nine months ended September 30, 2022 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2021, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2022.

 

All amounts referred to in the notes to the unaudited condensed financial statements are in United States Dollars ($) unless stated otherwise.

 

Principles of Consolidation
b)Principles of Consolidation

 

The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

 

The entities included in the accompanying unaudited condensed consolidated financial statements are as follows:

 

Innovative Payment Solutions, Inc. - Parent Company

Beyond Fintech Inc., 51% owned. 

 

Use of Estimates
c)Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

Contingencies
d)Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.

 

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

Fair Value of Financial Instruments
e)Fair Value of Financial Instruments

 

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

 

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

 

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

 

The carrying amounts reported in the balance sheets for the investment in Vivi Holdings was evaluated at fair value using Level 3 Inputs based on the Company’s estimate of the market value of the entities disposed to Vivi Holdings. Vivi Holdings does not have sufficient information available to assess the current market price of its equity.

 

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

 

Risks and Uncertainties
f)Risks and Uncertainties

 

The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) COVID-19 and its variants, (ii) launching and scaling the Company’s e-wallet and related products and the use by customers of such products, (iii) developing and implementing successful marketing campaigns and other strategic initiatives; (iv) competition, (iv) compliance with applicable laws, rules and regulations (including those related to fund remittance); (v) the Company’s outstanding indebtedness, including the Company’s ability to repay or extend the maturity of such indebtedness (see Note 8); (vi) inflation and other economic factors and (vii) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.

 

The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.

 

Recent accounting pronouncements
g)Recent accounting pronouncements

 

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended September 30, 2022. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.

 

Reporting by Segment
h)Reporting by Segment

 

No segmental information is required as the Company has not generated any revenue for the nine months ended September 30, 2022 and 2021 and only has one operating segment.

 

Cash and Cash Equivalents
i)Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At September 30, 2022 and 2021, respectively, the Company had no cash equivalents.

 

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At September 30, 2022 and December 31, 2021, the balance exceed the federally insured limit by $1,094,504 and $5,117,551, respectively.

 

Accounts Receivable and Allowance for Doubtful Accounts
j)Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended September 30, 2022 and December 31, 2021.

 

Investments
k)Investments

 

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

Plant and Equipment
l)Plant and Equipment

 

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

 

Description   Estimated Useful Life
     
Kiosks (not used in the Company’s current business)   7 years
     
Computer equipment   3 years
     
Leasehold improvements   Lesser of estimated useful life or life of lease
     
Office equipment   10 years

 

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

 

Long-Term Assets
m)Long-Term Assets

 

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

Revenue Recognition
n)Revenue Recognition

 

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue Recognition.

 

The Company’s revenues will be recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

 

  i. identify the contract with a customer;

 

  ii. identify the performance obligations in the contract;

 

  iii. determine the transaction price;

 

  iv. allocate the transaction price to performance obligations in the contract; and

 

  v. recognize revenue as the performance obligation is satisfied.

 

The Company had no revenues during the nine months ended September 30, 2022 and 2021.

 

Share-Based Payment Arrangements
o)Share-Based Payment Arrangements

 

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

 

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

 

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

 

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

 

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

 

Derivative Liabilities
p)Derivative Liabilities

 

ASC Topic 815, Derivatives and hedging (“ASC 815”) generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

Income Taxes
q)Income Taxes

 

The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of September 30, 2022 and December 31, 2021, there have been no interest or penalties incurred on income taxes.

 

Comprehensive income
r)Comprehensive income

 

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

 

Reclassification of prior year presentation
s)Reclassification of prior year presentation

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
ACCOUNTING POLICIES AND ESTIMATES (Tables)
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Schedule of estimated useful lives of the assets
Description   Estimated Useful Life
     
Kiosks (not used in the Company’s current business)   7 years
     
Computer equipment   3 years
     
Leasehold improvements   Lesser of estimated useful life or life of lease
     
Office equipment   10 years

 

XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTANGIBLES (Tables)
9 Months Ended
Sep. 30, 2022
Intangibles Table [Abstract]  
Schedule of facilitate the functioning of the IPSIPay software
   September 30,
2022
   December 31,
2021
 
Purchased Technology  $1,210,640   $625,000 
Accumulated amortization   (12,629)   
-
 
   $1,198,011   $625,000 

 

XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
INVESTMENTS (Tables)
9 Months Ended
Sep. 30, 2022
Investments, All Other Investments [Abstract]  
Schedule of investment
   September 30,
2022
  

December 31,
2021

 
Investment in Frictionless Financial Technologies, Inc.  $500,000   $500,000 
Investment in Vivi Holdings, Inc.   1    1 
   $500,001   $500,001 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
LEASES (Tables)
9 Months Ended
Sep. 30, 2022
Leases [Abstract]  
Schedule of total lease cost
  

Nine months
ended
September 30,
2022

   Nine months
ended
September 30,
2021
 
Operating lease expense  $43,200   $17,857 

 

Schedule of other lease information
   

Nine
months ended
September 30,

2022

    Nine
months ended
September 30,
2021
 
Cash paid for amounts included in the measurement of lease liabilities            
Operating cash flows from operating leases   $ (45,200 )   $ (60,403 )
                 
Remaining lease term – operating lease     -       6 months  

 

Schedule of maturity of operating leases
   Amount 
Undiscounted minimum future lease payments under leases with terms twelve months or less    
Total instalments due:    
2022  $
            -
 
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONVERTIBLE NOTES PAYABLE (Tables)
9 Months Ended
Sep. 30, 2022
Convertible Notes Payable [Abstract]  
Schedule of convertible notes payable
Description  Effective Interest
Rate
   Maturity date  Principal   Accrued
Interest
   Unamortized
debt discount
  

September 30,
2022
Amount, net

  

December 31,
2021
Amount, net

 
Cavalry Fund I LP   28.7%  November 16, 2022  $1,091,754   $13,647   $
       -
   $1,105,401   $548,872 
                                  
Mercer Street Global Opportunity Fund, LLC   28.7%  November 16, 2022   1,091,754    13,647    
-
    1,105,401    548,872 
                                  
Bellridge Capital LP.   10%  February 16, 2022   
-
    
-
    
-
    
-
    863,609 
                                  
Total convertible notes payable          $2,183,508   $27,294   $
-
   $2,210,802   $1,961,353 

 

XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
DERIVATIVE LIABILITY (Tables)
9 Months Ended
Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of assumptions were used in the Black-Scholes valuation model
  

Nine months
ended

September 30,
2022

   Year ended
December 31,
2021
 
Conversion price    $ 0.05 to $0.15     $ 0.05 to $0.24  
Risk free interest rate    0.79 to 4.25 %   0.05 to 1.12 %
Expected life of derivative liability    1.5 to 59 months     1.6 to 49.6 months  
Expected volatility of underlying stock    120.49 to 258.3 %   161.19 to 215.33 %
Expected dividend rate    0%   0%

 

Schedule of movement in derivative liability
   September 30,
2022
   December 31,
2021
 
Opening balance  $407,161   $2,966,416 
Derivative financial liability arising from convertible note and warrants   238,182    2,569,000 
Fair value adjustment to derivative liability   65,046    (5,128,255)
   $710,389   $407,161 
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS’ EQUITY (Tables)
9 Months Ended
Sep. 30, 2022
Stockholders' Equity Note [Abstract]  
Schedule of restricted stock activity
   Total
restricted
shares
   Weighted
average
fair market
value per
share
   Total
unvested
restricted
shares
   Weighted
average
fair market
value per
share
   Total vested
restricted
shares
   Weighted
average
fair market
value per share
 
Outstanding January 1, 2021   20,495,000   $0.049    15,371,250   $0.049    5,123,750   $0.049 
Granted and issued   2,500,000    0.050    2,500,000    0.050    
-
    
-
 
Forfeited/Cancelled   (1,500,000)   (0.050)   (1,500,000)   (0.050)   
-
    
-
 
Vested   
-
    
-
    (6,123,750)   (0.049)   6,123,750    0.049 
Outstanding December 31, 2021   21,495,000   $0.049    10,247,500   $0.049    11,247,500   $0.049 
Granted and issued   2,000,000    0.055    
-
    
-
    2,000,000    0.055 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (5,123,750)   (0.049)   5,123,750    0.049 
Outstanding September 30, 2022   23,495,000   $0.050    5,123,750   $0.049    18,371,250   $0.050 

 

Schedule of restricted stock granted and exercisable
    Restricted Stock Granted   Restricted Stock Vested 
Grant date
Price
   Number
Granted
   Weighted
Average
Fair Value
per
Share
   Number
Vested
   Weighted
Average
Fair Value
per
Share
 
$0.049    20,495,000   $0.049    15,371,250   $0.049 
$0.050    1,000,000    0.050    1,000,000    0.050 
$0.055    2,000,000    0.055    2,000,000    0.055 
      23,495,000   $0.050    18,371,250   $0.050 

 

Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model
   Nine months
ended
September 30,
2022
 
Exercise price  $ 0.0345 to 0.15  
Risk free interest rate   3.14 to 3.27 %
Expected life   3 to 5 years  
Expected volatility of underlying stock   189.1 to 199.2 %
Expected dividend rate   0%

 

   Nine months
ended
September 30,
2022
 
Exercise price    $ 0.04 to 0.15   
Risk free interest rate     2.99 to 3.42 %
Expected life     10.0 years   
Expected volatility of underlying stock     206.4 to 208.4 %
Expected dividend rate    0%

 

Schedule of warrant activity
   Shares
Underlying
Warrants
   Exercise
price per
share
   Weighted
average
exercise
price
 
Outstanding January 1, 2021    51,188,572   $0.05   $0.05 
Granted    66,302,515         0.05 to 0.24    0.16 
Forfeited/Cancelled    (20,000,000)   0.24    0.24 
Exercised    (60,186,982)   0.05    0.05 
Outstanding December 31, 2021    37,304,105   $ 0.05 – 0.1875   $0.12 
Granted    21,000,000      0.0345 – 0.15    0.07 
Forfeited/Cancelled    
-
    -    
-
 
Exercised    
-
    -    
-
 
Outstanding September 30, 2022    58,304,105   $  0.05 – 0.1875   $0.11 

 

Schedule of warrants outstanding and exercisable
    Warrants Outstanding   Warrants Exercisable 
Exercise
Price
   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
$0.0345    15,000,000             2.77                         8,437,500                                2.77 
$0.05    10,823,813    3.03         10,823,813         3.03 
$0.15    30,053,625    3.73         30,053,625         3.73 
$0.1875    2,426,667    3.46         2,426,667         3.46 
      58,304,105    3.34   $0.11    51,741,605   $0.11    3.42 

 

Schedule of option activity
   Shares
Underlying
options
   Exercise
price per
share
   Weighted
average
exercise
price
 
Outstanding January 1, 2021    100,000   $0.40   $0.40 
Granted    30,416,666      0.15 – 0.24    0.15 
Forfeited/Cancelled    
-
    -    
-
 
Exercised    
-
    -    
-
 
Outstanding December 31, 2021    30,516,666   $ 0.15 to 0.40   $0.15 
Granted    15,800,000      0.04 – 0.15    0.14 
Forfeited/Cancelled    
-
    -    
-
 
Exercised    
-
    -    
-
 
Outstanding September 30, 2022    46,316,666   $ 0.04 to 0.40   $0.15 

 

Schedule of options outstanding and exercisable
    Options Outstanding   Options Exercisable 
Exercise
Price
   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
 0.04    800,000             9.96                          800,000                               9.96 
 0.15    45,208,333    9.19         35,625,000         9.27 
 0.24    208,333    8.40         208,333         8.40 
 0.40    100,000    6.25         100,000         6.25 
      46,316,666    9.19   $0.15    36,733,333   $0.15    9.27 

 

XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
NET LOSS PER SHARE (Tables)
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Schedule of dilutive shares
   Three and nine
months ended
September 30,
2022
(Shares)
   Three and nine
months ended
September 30,
2021
(Shares)
 
Convertible debt   14,738,682    13,626,666 
Stock options   46,316,666    30,516,666 
Warrants to purchase shares of Common Stock   58,304,105    37,304,104 
    119,359,453    81,447,436 
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
ORGANIZATION AND DESCRIPTION OF BUSINESS (Details) - USD ($)
1 Months Ended 9 Months Ended
Nov. 01, 2019
Aug. 26, 2021
Dec. 31, 2019
Sep. 30, 2022
Jun. 22, 2022
Organization and Description of Business (Textual)          
Reverse stock split, description On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.         
Stock purchase agreement, description     On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi” or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%).    
Percentage of remaining shares owned   49.00%      
Common Stock [Member]          
Organization and Description of Business (Textual)          
Merger agreement, description       to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.  
Frictionless Financial Technologies, Inc. [Member]          
Organization and Description of Business (Textual)          
Acquired percentage       1.00%  
Beyond Fintech [Member]          
Organization and Description of Business (Textual)          
Stake owned percentage   51.00%      
Frictionless [Member]          
Organization and Description of Business (Textual)          
Strategic interest       10.00%  
Common stock outstanding percentage         41.00%
Purchase price (in Dollars)       $ 300,000  
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
ACCOUNTING POLICIES AND ESTIMATES (Details) - USD ($)
9 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Accounting Policies and Estimates (Textual)    
Beyond fintech inc owned percentage 51.00%  
Federally insured limit $ 1,094,504 $ 5,117,551
Ownership percentage 20.00%  
Plant and equipment costs $ 1,000  
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
ACCOUNTING POLICIES AND ESTIMATES (Details) - Schedule of estimated useful lives of the assets
9 Months Ended
Sep. 30, 2022
Kiosks [Member]  
Estimated useful lives 7 years
Computer equipment [Member]  
Estimated useful lives 3 years
Leasehold improvements [Member]  
Estimated useful lives of property Lesser of estimated useful life or life of lease
Office equipment [Member]  
Estimated useful lives 10 years
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
LIQUIDITY MATTERS (Details)
9 Months Ended
Sep. 30, 2022
USD ($)
Liquidity Matters (Textual)  
Net loss $ 6,208,074
Cash balance $ 1,352,983
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTANGIBLES (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Aug. 26, 2021
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]            
Gross proceeds $ 250,000         $ 375,000
Beyond fintech percentage 51.00%          
Owned frictionless percentage 49.00%          
Additional amount   $ 544,320   $ 544,320    
Additional amount of software       41,320    
Amortization expense   $ 12,629 $ 0 $ 12,629 $ 0  
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTANGIBLES (Details) - Schedule of facilitate the functioning of the IPSIPay software - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Schedule of Facilitate The Functioning of The Ipsipay Software [Abstract]    
Purchased Technology $ 1,210,640 $ 625,000
Accumulated amortization (12,629)
Total $ 1,198,011 $ 625,000
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
INVESTMENTS (Details) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Jun. 22, 2021
Sep. 30, 2022
Dec. 31, 2021
Dec. 31, 2019
Aug. 30, 2022
Feb. 16, 2021
Investment (Textual)            
Exercise price (in Dollars per share)         $ 0.15 $ 0.24
Investment, description       Effective December 31, 2019, the Company sold 100% of the outstanding common stock of its subsidiary, Qpagos Corporation, together with its 99.9% ownership interest of Qpagos Corporation’s two Mexican entities: Qpagos S.A.P.I. de C.V. and Redpag Electrónicos S.A.P.I. de C.V, to Vivi.     
Number of common stock issued   2,047,500        
Impairment charges (in Dollars)   $ 1,019,960 $ 1,019,960      
Vivi Holdings, Inc. [Member]            
Investment (Textual)            
Number of common stock issued   2,250,000        
Mr. Andrey Novikov [Member]            
Investment (Textual)            
Number of common stock issued   56,250        
Joseph W [Member]            
Investment (Textual)            
Number of common stock issued   33,750        
Mr. Gaston Pereira [Member]            
Investment (Textual)            
Number of common stock issued   112,500        
Frictionless Technologies, Inc. [Member]            
Investment (Textual)            
Warrants term 5 years          
Warrant purchase 30,000,000          
Exercise price (in Dollars per share) $ 0.15          
Right to acquire 41.00%          
Purchase price to acquire outstanding common stock for 1% acquired (in Dollars) $ 300,000          
Frictionless Technologies, Inc. [Member] | Stock Purchase Agreement [Member]            
Investment (Textual)            
Purchase of common shares 150          
Gross proceed (in Dollars) $ 500,000          
Common shares outstanding percentage 10.00%          
Right to acquire 1.00%          
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
INVESTMENTS (Details) - Schedule of investment - USD ($)
Sep. 30, 2022
Dec. 31, 2021
INVESTMENTS (Details) - Schedule of investment [Line Items]    
Investment $ 500,001 $ 500,001
Frictionless Financial Technologies, Inc. [Member]    
INVESTMENTS (Details) - Schedule of investment [Line Items]    
Investment 500,000 500,000
Vivi Holdings, Inc. [Member]    
INVESTMENTS (Details) - Schedule of investment [Line Items]    
Investment $ 1 $ 1
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
LEASES (Details)
9 Months Ended
Sep. 30, 2022
USD ($)
Leases (Textual)  
Lease amount $ 4,800
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
LEASES (Details) - Schedule of total lease cost - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Schedule Of Total Lease Cost Abstract    
Operating lease expense $ 43,200 $ 17,857
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
LEASES (Details) - Schedule of other lease information - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash paid for amounts included in the measurement of lease liabilities    
Operating cash flows from operating leases $ (45,200) $ (60,403)
Remaining lease term – operating lease 6 months
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
LEASES (Details) - Schedule of maturity of operating leases
Sep. 30, 2022
USD ($)
Total instalments due:  
2022
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
FEDERAL RELIEF LOANS (Details) - USD ($)
9 Months Ended
Jul. 07, 2020
Sep. 30, 2022
Federal Relief Loans [Abstract]    
Disaster loan amount $ 150,000  
Bearing interest, percentage 3.75%  
Repayable installments $ 731  
Accrued interest   $ 12,560
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONVERTIBLE NOTES PAYABLE (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 03, 2022
Feb. 16, 2021
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Aug. 30, 2022
Jul. 08, 2022
Feb. 04, 2022
Convertible Notes Payable (Textual)                  
Interest expense     $ 49,912 $ 52,236 $ 138,085 $ 169,695      
Amortization of debt discount     0 $ 515,200 263,200 $ 3,138,452      
Warrant exercisable (in Shares)   2,486,957              
Exercise price per share (in Dollars per share)   $ 0.24         $ 0.15    
Common stock shares (in Shares)               2,000,000  
Cavalry Fund I LP [Member]                  
Convertible Notes Payable (Textual)                  
Net proceeds   $ 500,500              
Senior secured convertible note   71,500              
Original issue discount   $ 572,000              
Original issue discount rate   10.00%              
initial conversion price per share (in Dollars per share)   $ 0.23              
Warrant exercisable (in Shares)   2,486,957              
Exercise price per share (in Dollars per share)   $ 0.24              
Description of conversion terms On February 3, 2022, the Company extended the maturity date of its Cavalry Note from February 16, 2022 to August 16, 2022. The Cavalry Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Cavalry agreed to extend the maturity date of the Cavalry Note to August 16, 2022 in consideration of the principal amount outstanding under the Cavalry Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. On August 30, 2022, the Company further extended the maturity date of its Cavalry note from August 16, 2022 to November 16, 2022. In terms of the agreement entered into with Cavalry, the principal outstanding was increased by $181,959 and the interest outstanding as of August 31, 2022 of $43,553 was capitalized, resulting in a principal balance outstanding of $1,091,754. In addition, the Company granted Cavalry a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share, maturing on August 30, 2027 and valued at $119,091 on the date of grant.                
Penalty expense     181,959   260,708        
Additional penalty expense     $ 119,091   $ 119,091        
Conversion price (in Dollars per share)     $ 1,105,401   $ 1,105,401        
Mercer Street Global Opportunity Fund, LLC [Member]                  
Convertible Notes Payable (Textual)                  
Net proceeds   $ 500,500              
Senior secured convertible note   572,000              
Original issue discount   $ 71,500              
Description of conversion terms On February 16, 2021, the Company closed a transaction with Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Mercer Note”). The Mercer Note is convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of Common Stock at an initial exercise price of $0.24 per share.On February 3, 2022, the Company extended the maturity date of its Mercer Note from February 16, 2022 to August 16, 2022. The Mercer Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Mercer agreed to extend the maturity date of the Mercer Note to August 16, 2022 in consideration of the principal amount outstanding under the Mercer Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. On August 30, 2022, the Company further extended the maturity date of its Mercer note from August 16, 2022 to November 16, 2022. In terms of the agreement entered into with Mercer, the principal outstanding was increased by $181,959 and the interest outstanding as of August 31, 2022 of $43,553 was capitalized, resulting in a principal balance outstanding of $1,091,754. In addition, the Company granted Mercer a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share, maturing on August 30, 2027 and valued at the date of grant at $119,091. This change to the maturity dates of the Mercer Note from February 16, 2022 to August 31, 2022 and subsequently to November 16, 2022, was assessed in terms of ASC 470-50 as a debt extinguishment, which resulted in a penalty expense of $181,959 and $260,708 for the three months and nine months ended September 30, 2022, respectively, in addition the value of the warrant issued on the debt extension from August 16, 2022 to November 16, 2022, resulted in an additional penalty expense of $119,091 for the three and nine months ended September 30, 2022.                 
Conversion price (in Dollars per share)   $ 0.23              
Interest rate   10.00%              
Accrued interest and penalty interest         $ 1,105,401        
Bellridge Capital LP. [Member]                  
Convertible Notes Payable (Textual)                  
Net proceeds   $ 787,500              
Senior secured convertible note   900,000              
Original issue discount   $ 112,500              
Warrant exercisable (in Shares)   3,913,044              
Exercise price per share (in Dollars per share)   $ 0.24              
Conversion price (in Dollars per share)   $ 0.23              
Interest rate   10.00%              
Aggregate principal amount                 $ 1,235,313
Common stock shares (in Shares)                 88,250
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONVERTIBLE NOTES PAYABLE (Details) - Schedule of convertible notes payable - USD ($)
9 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Accrued Interest $ 12,560  
Unamortized debt discount $ 0 $ (263,200)
Cavalry Fund I LP [Member]    
Interest Rate 28.70%  
Maturity date November 16, 2022  
Principal $ 1,091,754  
Accrued Interest 13,647  
Unamortized debt discount  
Convertible notes payable $ 1,105,401 548,872
Mercer Street Global Opportunity Fund, LLC [Member]    
Interest Rate 28.70%  
Maturity date November 16, 2022  
Principal $ 1,091,754  
Accrued Interest 13,647  
Unamortized debt discount  
Convertible notes payable $ 1,105,401 548,872
Bellridge Capital LP., [Member]    
Interest Rate 10.00%  
Maturity date February 16, 2022  
Principal  
Accrued Interest  
Unamortized debt discount  
Convertible notes payable 863,609
Total Convertible Notes Payable [Member]    
Principal 2,183,508  
Accrued Interest 27,294  
Unamortized debt discount  
Convertible notes payable $ 2,210,802 $ 1,961,353
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
DERIVATIVE LIABILITY (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 30, 2022
Sep. 30, 2022
Sep. 30, 2022
Derivative Liability (Textual)      
Shares of common stock (in Shares) 3,000,000    
Exercise price (in Dollars per share) $ 0.15    
Derivative financial liability $ 238,182 $ 710,389 $ 710,389
Derivative liability credited   $ 84,895 $ 65,046
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.22.2.2
DERIVATIVE LIABILITY (Details) - Schedule of assumptions were used in the Black-Scholes valuation model - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Expected dividend rate 0.00% 0.00%
Minimum [Member]    
Conversion price (in Dollars per share) $ 0.05 $ 0.05
Risk free interest rate 0.79% 0.05%
Expected life of derivative liability 1 year 6 months 1 year 7 months 6 days
Expected volatility of underlying stock 120.49% 161.19%
Maximum [Member]    
Conversion price (in Dollars per share) $ 0.15 $ 0.24
Risk free interest rate 4.25% 1.12%
Expected life of derivative liability 59 months 49 months 18 days
Expected volatility of underlying stock 258.30% 215.33%
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.22.2.2
DERIVATIVE LIABILITY (Details) - Schedule of movement in derivative liability - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Opening balance $ 407,161 $ 2,966,416
Derivative financial liability arising from convertible note and warrants 238,182 2,569,000
Fair value adjustment to derivative liability 65,046 (5,128,255)
Closing balance $ 710,389 $ 407,161
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS’ EQUITY (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 13, 2022
Jul. 11, 2022
Jul. 08, 2022
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Aug. 30, 2022
Aug. 05, 2022
Dec. 31, 2021
Feb. 16, 2021
Stockholders' Equity (Textual)                      
Common stock, authorized (in Shares)       750,000,000   750,000,000       500,000,000  
Common stock, par value (in Dollars per share)       $ 0.0001   $ 0.0001       $ 0.0001  
Common stock, shares issued (in Shares)       376,901,679   376,901,679       367,901,679  
Common stock, shares outsatnding (in Shares)       376,901,679   376,901,679       367,901,679  
Issued shares (in Shares)     2,000,000                
Value of grant date   $ 110,000 $ 84,000                
Agreement fee     $ 3,000                
Grant value   $ 165,000                  
Expense       $ 172,766 $ 44,165 $ 298,298 $ 188,448        
Preferred stock, authorized (in Shares)       25,000,000   25,000,000       25,000,000  
Preferred stock, par value (in Dollars per share)       $ 0.0001   $ 0.0001       $ 0.0001  
Description of compensation service           As compensation for the services provided under the Endorsement Agreement, Lopez or their designees are entitled to the following payments: (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Fifteen Million (15,000,000) shares of the Common Stock at an exercise price of $0.0345 per share.          
Warrant exercisable (in Shares)               3,000,000      
Exercise price per share (in Dollars per share)               $ 0.15     $ 0.24
Warrants outstanding an intrinsic value       $ 0   $ 0       $ 0  
Incentive stock options (in Shares)       58,304,105   58,304,105          
Amount of immediate expense       $ 31,970   $ 31,970          
Description of granted options exercisable On September 13, 2022, the Company granted ten-year options exercisable for 200,000 shares of Common Stock, with immediate vesting, to each of its four non-executive directors, totaling options exercisable for 800,000 shares of Common Stock at an exercise price of $0.04 per share.                    
Intrinsic value outstanding options       0   0       $ 0  
Option expense       $ 950,290 $ 1,196,566 $ 1,139,220 $ 1,288,174        
Common Stock [Member]                      
Stockholders' Equity (Textual)                      
Issued shares (in Shares)     2,000,000                
Value of grant date     $ 84,000                
Maximum [Member] | Common Stock [Member]                      
Stockholders' Equity (Textual)                      
Shares of Common Stock (in Shares)       100,000   100,000          
Chief Executive Officer [Member]                      
Stockholders' Equity (Textual)                      
Incentive stock options (in Shares)   15,000,000                  
Stock option exercise price (in Dollars per share)   $ 0.15                  
Amount of immediate expense       $ 823,854   $ 823,854          
2021 Stock Incentive Plan [Member] | Maximum [Member]                      
Stockholders' Equity (Textual)                      
Shares of Common Stock (in Shares)       53,000,000   53,000,000          
2018 Stock Incentive Plan [Member]                      
Stockholders' Equity (Textual)                      
Terminates period           10 years          
2018 Stock Incentive Plan [Member] | Maximum [Member]                      
Stockholders' Equity (Textual)                      
Shares of Common Stock (in Shares)       800,000   800,000          
2021 Stock Incentive Plan [Member]                      
Stockholders' Equity (Textual)                      
Terminates period           10 years          
Richard Rosenblum [Member]                      
Stockholders' Equity (Textual)                      
Restricted shares (in Shares)   2,000,000                  
Option expense       $ 27,879   $ 83,636          
Samad Harake [Member]                      
Stockholders' Equity (Textual)                      
Issued shares (in Shares)                 3,000,000    
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock activity - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Total restricted shares [Member]    
STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock activity [Line Items]    
Total restricted shares, Outstanding at beginning (in Shares) 21,495,000 20,495,000
Total restricted shares, Outstanding at ending (in Shares) 23,495,000 21,495,000
Total restricted shares, Granted and issued (in Shares) 2,000,000 2,500,000
Total restricted shares, Forfeited/Cancelled (in Shares) (1,500,000)
Total restricted shares, Vested (in Shares)
Weighted average fair market value per share [Member]    
STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock activity [Line Items]    
Weighted average fair market value per share, Outstanding at beginning $ 0.049 $ 0.049
Weighted average fair market value per share, Outstanding at ending 0.05 0.049
Weighted average fair market value per share, Granted and issued 0.055 0.05
Weighted average fair market value per share, Forfeited/Cancelled (0.05)
Weighted average fair market value per share, Vested
Total unvested restricted shares [Member]    
STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock activity [Line Items]    
Total unvested restricted shares, Outstanding at beginning (in Shares) 10,247,500 15,371,250
Total unvested restricted shares, Outstanding at ending (in Shares) 5,123,750 10,247,500
Total unvested restricted shares, Granted and issued (in Shares) 2,500,000
Total unvested restricted shares, Forfeited/Cancelled (in Shares) (1,500,000)
Total unvested restricted shares, Vested (in Shares) (5,123,750) (6,123,750)
Unvested restricted Weighted average fair market value per share [Member]    
STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock activity [Line Items]    
Weighted average fair market value per share, Outstanding at beginning $ 0.049 $ 0.049
Weighted average fair market value per share, Outstanding at ending 0.049 0.049
Weighted average fair market value per share, Granted and issued 0.05
Weighted average fair market value per share, Forfeited/Cancelled (0.05)
Weighted average fair market value per share, Vested (0.049) (0.049)
Total vested restricted shares [Member]    
STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock activity [Line Items]    
Total vested restricted shares, Outstanding at beginning 11,247,500 5,123,750
Total vested restricted shares, Outstanding at ending 18,371,250 11,247,500
Total vested restricted shares, Granted and issued 2,000,000
Total vested restricted shares, Forfeited/Cancelled
Total vested restricted shares, Vested 5,123,750 6,123,750
Vested restricted Weighted average fair market value per share [Member]    
STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock activity [Line Items]    
Weighted average fair market value per share, Outstanding at beginning 0.049 0.049
Weighted average fair market value per share, Outstanding at ending 0.05 0.049
Weighted average fair market value per share, Granted and issued 0.055
Weighted average fair market value per share, Forfeited/Cancelled
Weighted average fair market value per share, Vested $ 0.049 $ 0.049
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS’ EQUITY (Details) - Schedule of restricted stock granted and exercisable
9 Months Ended
Sep. 30, 2022
$ / shares
shares
Restricted stock granted, number granted (in Shares) | shares 23,495,000
Restricted stock granted, weighted average fair value per share $ 0.05
Restricted stock vested, number vested (in Shares) | shares 18,371,250
Restricted stock vested, weighted average fair value per share $ 0.05
Grant date Price 0.049 [Member]  
Restricted stock granted, grant date price $ 0.049
Restricted stock granted, number granted (in Shares) | shares 20,495,000
Restricted stock granted, weighted average fair value per share $ 0.049
Restricted stock vested, number vested (in Shares) | shares 15,371,250
Restricted stock vested, weighted average fair value per share $ 0.049
Grant date Price 0.050 [Member]  
Restricted stock granted, grant date price $ 0.05
Restricted stock granted, number granted (in Shares) | shares 1,000,000
Restricted stock granted, weighted average fair value per share $ 0.05
Restricted stock vested, number vested (in Shares) | shares 1,000,000
Restricted stock vested, weighted average fair value per share $ 0.05
Grant date Price 0.055 [Member]  
Restricted stock granted, grant date price $ 0.055
Restricted stock granted, number granted (in Shares) | shares 2,000,000
Restricted stock granted, weighted average fair value per share $ 0.055
Restricted stock vested, number vested (in Shares) | shares 2,000,000
Restricted stock vested, weighted average fair value per share $ 0.055
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS’ EQUITY (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model
9 Months Ended
Sep. 30, 2022
$ / shares
Warrants [Member]  
STOCKHOLDERS’ EQUITY (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model [Line Items]  
Expected dividend rate 0.00%
Warrants [Member] | Minimum [Member]  
STOCKHOLDERS’ EQUITY (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model [Line Items]  
Exercise price (in Dollars per share) $ 0.0345
Risk free interest rate 3.14%
Expected life 3 years
Expected volatility of underlying stock 189.10%
Warrants [Member] | Maximum [Member]  
STOCKHOLDERS’ EQUITY (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model [Line Items]  
Exercise price (in Dollars per share) $ 0.15
Risk free interest rate 3.27%
Expected life 5 years
Expected volatility of underlying stock 199.20%
Options [Member]  
STOCKHOLDERS’ EQUITY (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model [Line Items]  
Expected life 10 years
Expected dividend rate 0.00%
Options [Member] | Minimum [Member]  
STOCKHOLDERS’ EQUITY (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model [Line Items]  
Exercise price (in Dollars per share) $ 0.04
Risk free interest rate 2.99%
Expected volatility of underlying stock 206.40%
Options [Member] | Maximum [Member]  
STOCKHOLDERS’ EQUITY (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model [Line Items]  
Exercise price (in Dollars per share) $ 0.15
Risk free interest rate 3.42%
Expected volatility of underlying stock 208.40%
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS’ EQUITY (Details) - Schedule of warrant activity - Warrant [Member] - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Shares Underlying Warrants, Outstanding at beginning (in Shares) 37,304,105 51,188,572
Exercise price per share, Outstanding at beginning   $ 0.05
Weighted average exercise price, Outstanding at beginning $ 0.12 $ 0.05
Shares Underlying Warrants, Outstanding at ending (in Shares) 58,304,105 37,304,105
Weighted average exercise price, Outstanding at ending $ 0.11 $ 0.12
Shares Underlying Warrants, Granted (in Shares) 21,000,000 66,302,515
Exercise price per share, Granted  
Weighted average exercise price, Granted $ 0.07 $ 0.16
Shares Underlying Warrants, Forfeited/Cancelled (in Shares) (20,000,000)
Exercise price per share, Forfeited/Cancelled $ 0.24
Weighted average exercise price, Forfeited/Cancelled $ 0.24
Shares Underlying Warrants, Exercised (in Shares) (60,186,982)
Exercise price per share, Exercised $ 0.05
Weighted average exercise price, Exercised 0.05
Minimum [Member]    
Exercise price per share, Outstanding at beginning 0.05  
Exercise price per share, Outstanding at ending 0.05 0.05
Exercise price per share, Granted 0.0345 0.05
Maximum [Member]    
Exercise price per share, Outstanding at beginning 0.1875  
Exercise price per share, Outstanding at ending 0.1875 0.1875
Exercise price per share, Granted $ 0.15 $ 0.24
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS’ EQUITY (Details) - Schedule of warrants outstanding and exercisable
9 Months Ended
Sep. 30, 2022
$ / shares
shares
Warrants Outstanding, Number Outstanding 58,304,105
Warrants Outstanding, Weighted Average Remaining Contractual life in years 3 years 4 months 2 days
Warrants Outstanding, Weighted Average Exercise Price | $ / shares $ 0.11
Warrants Exercisable, Number Exercisable 51,741,605
Warrants Exercisable ,Weighted Average Exercise Price | $ / shares $ 0.11
Warrants Exercisable, Weighted Average Remaining Contractual life in years 3 years 5 months 1 day
Exercise Price 0.0345 [Member]  
Warrants Outstanding, Exercise Price | $ / shares $ 0.0345
Warrants Outstanding, Number Outstanding 15,000,000
Warrants Outstanding, Weighted Average Remaining Contractual life in years 2 years 9 months 7 days
Warrants Exercisable, Number Exercisable 8,437,500
Warrants Exercisable, Weighted Average Remaining Contractual life in years 2 years 9 months 7 days
Exercise Price 0.05 [Member]  
Warrants Outstanding, Exercise Price | $ / shares $ 0.05
Warrants Outstanding, Number Outstanding 10,823,813
Warrants Outstanding, Weighted Average Remaining Contractual life in years 3 years 10 days
Warrants Exercisable, Number Exercisable 10,823,813
Warrants Exercisable, Weighted Average Remaining Contractual life in years 3 years 10 days
Exercise Price 0.15 [Member]  
Warrants Outstanding, Exercise Price | $ / shares $ 0.15
Warrants Outstanding, Number Outstanding 30,053,625
Warrants Outstanding, Weighted Average Remaining Contractual life in years 3 years 8 months 23 days
Warrants Exercisable, Number Exercisable 30,053,625
Warrants Exercisable, Weighted Average Remaining Contractual life in years 3 years 8 months 23 days
Exercise Price 0.1875 [Member]  
Warrants Outstanding, Exercise Price | $ / shares $ 0.1875
Warrants Outstanding, Number Outstanding 2,426,667
Warrants Outstanding, Weighted Average Remaining Contractual life in years 3 years 5 months 15 days
Warrants Exercisable, Number Exercisable 2,426,667
Warrants Exercisable, Weighted Average Remaining Contractual life in years 3 years 5 months 15 days
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS’ EQUITY (Details) - Schedule of option activity - Stock Options [Member] - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Shares Underlying options, Outstanding at beginning (in Shares) 30,516,666 100,000
Exercise price per share, Outstanding at beginning   $ 0.4
Weighted average exercise price, Outstanding at beginning $ 0.15 $ 0.4
Shares Underlying options, Outstanding at ending (in Shares) 46,316,666 30,516,666
Weighted average exercise price, Outstanding at ending $ 0.15 $ 0.15
Shares Underlying options, Granted (in Shares) 15,800,000 30,416,666
Exercise price per share, Granted  
Weighted average exercise price, Granted $ 0.14 $ 0.15
Shares Underlying options, Forfeited/Cancelled (in Shares)
Exercise price per share, Forfeited/Cancelled
Weighted average exercise price, Forfeited/Cancelled
Shares Underlying options, Exercised (in Shares)
Exercise price per share, Exercised
Weighted average exercise price, Exercised
Minimum [Member]    
Exercise price per share, Outstanding at beginning 0.15  
Exercise price per share, Outstanding at ending 0.04 0.15
Exercise price per share, Granted 0.04 0.15
Maximum [Member]    
Exercise price per share, Outstanding at beginning 0.4  
Exercise price per share, Outstanding at ending 0.4 0.4
Exercise price per share, Granted $ 0.15 $ 0.24
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS’ EQUITY (Details) - Schedule of options outstanding and exercisable
9 Months Ended
Sep. 30, 2022
$ / shares
shares
Options Outstanding, Number Outstanding 46,316,666
Options Outstanding, Weighted Average Remaining Contractual life in years 9 years 2 months 8 days
Options Outstanding, Weighted Average Exercise Price | $ / shares $ 0.15
Options Exercisable, Number Exercisable 36,733,333
Options Exercisable ,Weighted Average Exercise Price | $ / shares $ 0.15
Options Exercisable, Weighted Average Remaining Contractual life in years 9 years 3 months 7 days
Exercise Price 0.04 [Member]  
Options Outstanding, Exercise Price | $ / shares $ 0.04
Options Outstanding, Number Outstanding 800,000
Options Outstanding, Weighted Average Remaining Contractual life in years 9 years 11 months 15 days
Options Exercisable, Number Exercisable 800,000
Options Exercisable, Weighted Average Remaining Contractual life in years 9 years 11 months 15 days
Exercise Price 0.15 [Member]  
Options Outstanding, Exercise Price | $ / shares $ 0.15
Options Outstanding, Number Outstanding 45,208,333
Options Outstanding, Weighted Average Remaining Contractual life in years 9 years 2 months 8 days
Options Exercisable, Number Exercisable 35,625,000
Options Exercisable, Weighted Average Remaining Contractual life in years 9 years 3 months 7 days
Exercise Price 0.24 [Member]  
Options Outstanding, Exercise Price | $ / shares $ 0.24
Options Outstanding, Number Outstanding 208,333
Options Outstanding, Weighted Average Remaining Contractual life in years 8 years 4 months 24 days
Options Exercisable, Number Exercisable 208,333
Options Exercisable, Weighted Average Remaining Contractual life in years 8 years 4 months 24 days
Exercise Price 0.40 [Member]  
Options Outstanding, Exercise Price | $ / shares $ 0.4
Options Outstanding, Number Outstanding 100,000
Options Outstanding, Weighted Average Remaining Contractual life in years 6 years 3 months
Options Exercisable, Number Exercisable 100,000
Options Exercisable, Weighted Average Remaining Contractual life in years 6 years 3 months
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.22.2.2
NET LOSS PER SHARE (Details) - Schedule of dilutive shares - shares
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Anti-dilutive shares 119,359,453 81,447,436 119,359,453 81,447,436
Convertible debt [Member]        
Anti-dilutive shares 14,738,682 13,626,666 14,738,682 13,626,666
Stock options [Member]        
Anti-dilutive shares 46,316,666 30,516,666 46,316,666 30,516,666
Warrants to purchase shares of common stock [Member]        
Anti-dilutive shares 58,304,105 37,304,104 58,304,105 37,304,104
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.22.2.2
RELATED PARTY TRANSACTIONS (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 13, 2022
Jul. 11, 2022
Aug. 31, 2021
Aug. 16, 2021
Jul. 27, 2021
Jul. 22, 2021
Feb. 22, 2021
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Related Party Transactions (Textual)                        
Shares of common stock (in Shares)             208,333          
Option expense               $ 950,290 $ 1,196,566 $ 1,139,220 $ 1,288,174  
Exercise price (in Dollars per share)             $ 0.24          
Salary rate                   100.00%    
James Fuller [Member]                        
Related Party Transactions (Textual)                        
Shares of common stock (in Shares) 200,000         2,000,000 208,333          
Exercise price (in Dollars per share) $ 0.04           $ 0.24          
Common stock, value           $ 154,000            
Option expense               7,993   $ 7,993    
James Fuller [Member] | Maximum [Member]                        
Related Party Transactions (Textual)                        
Common stock, per share (in Dollars per share)             0.24          
James Fuller [Member] | Minimum [Member]                        
Related Party Transactions (Textual)                        
Common stock, per share (in Dollars per share)             $ 0.15          
Andrey Novikov [Member]                        
Related Party Transactions (Textual)                        
Shares of common stock (in Shares)             208,333          
William Corbett [Member]                        
Related Party Transactions (Textual)                        
Shares of common stock (in Shares)   15,000,000         20,000,000          
Exercise price (in Dollars per share)   $ 0.15         $ 0.24          
Option expense               890,442   1,023,614    
Salary amount       $ 30,000     $ 30,000          
Warrant expense                       $4,327,899
Related party transactions, description       the August 2021 Corbett Employment Agreement provides that: (1) Mr. Corbett will be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from time to time; (2) the Company will grant to Mr. Corbett options to purchase 20,000,000 shares of Common Stock at a per share exercise price of $0.15; and (3) a car allowance for Mr. Corbett in the amount of $800 per month. Fifty percent (50%) of the shares subject to the options shall vest on the grant date and the other 50% of the shares subject to the option shall vest at the rate of 1/36 per month over a three-year period. The options will be exercisable for a period of ten years after the date of grant and the Company shall provide for cashless exercise of the option. The options are being granted pursuant to the Company’s 2021 Stock Incentive Plan which was approved by the Board in August 2021, subject to approval of the 2021 Plan by the shareholders, which approval was obtained at the annual general meeting held on October 22, 2021.                
Clifford Henry [Member]                        
Related Party Transactions (Textual)                        
Shares of common stock (in Shares) 200,000         2,000,000            
Exercise price (in Dollars per share) $ 0.04                      
Common stock, value $ 7,993         $ 154,000            
Option expense               7,993   7,993    
Financial and capital markets advice                   3,500    
Madisson Corbett [Member]                        
Related Party Transactions (Textual)                        
Shares of common stock (in Shares) 200,000         2,000,000            
Exercise price (in Dollars per share) $ 0.04                      
Common stock, value $ 7,993         $ 154,000            
Option expense               7,993   7,993    
David Rios [Member]                        
Related Party Transactions (Textual)                        
Shares of common stock (in Shares) 200,000         1,000,000            
Exercise price (in Dollars per share) $ 0.04                      
Common stock, value $ 7,993         $ 77,000            
Option expense               7,993   7,993    
Vesting term 10 years                      
Mr. Rosenblum [Member]                        
Related Party Transactions (Textual)                        
Shares of common stock (in Shares)   2,000,000   10,000,000                
Exercise price (in Dollars per share)     $ 0.15                  
Common stock, value   $ 110,000                    
Option expense               $ 27,879   $ 83,636    
Employment agreement, description         The term of the Employment Agreement is until December 31, 2024. Mr. Rosenblum’s base salary will be $18,000 per month. In addition, the Employment Agreement provides that: (1) Mr. Rosenblum will be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from time to time; and (2) the Company will grant to Mr. Rosenblum options to purchase 10,000,000 shares of Common Stock at a per share exercise price equal to the fair market value of the Common Stock, as reflected in the closing price of the Common Stock on the OTC exchange or, in the event the stock is up listed, on a national stock exchange, on the date of grant (the “Options”)”. Fifty percent (50%) of the shares subject to the Options shall vest on the grant date and the other 50% of the shares subject to the Option shall vest at the rate of 1/36 per month over a three-year period. The Options will be exercisable for a period of ten (10) years after the date of grant and the Company shall provide for cashless exercise of the Option by Executive.              
Salary rate                   50.00%    
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUBSEQUENT EVENTS (Details)
9 Months Ended
Sep. 30, 2022
Subsequent Events [Abstract]  
Annual meeting of stockholders description At the Annual Meeting, the Company’s stockholders (i) elected each of William D. Corbett, Richard Rosenblum, Madisson Corbett, Clifford Henry and David Rios as directors’ of the Company until the next annual meeting or until their successors shall be elected and qualified, (ii) ratified the appointment of RBSM LLP as the Company’s independent registered public accounting firm for fiscal year ended December 31, 2022, (iii) approved an amendment to the Company’s Articles of Incorporation to effect a reverse stock split of the issued and outstanding shares of common stock at a ratio (to be determined in the discretion of the Company’s Board during a two year period ending on November 2, 2024) within a range of one (1) share of Common Stock for every two (2) to thirty (30) shares of Common Stock, and (iv) approved a potential adjournment of the annual meeting, 
XML 70 f10q0922_innovative_htm.xml IDEA: XBRL DOCUMENT 0001591913 2022-01-01 2022-09-30 0001591913 2022-11-14 0001591913 2022-09-30 0001591913 2021-12-31 0001591913 2022-07-01 2022-09-30 0001591913 2021-07-01 2021-09-30 0001591913 2021-01-01 2021-09-30 0001591913 us-gaap:PreferredStockMember 2021-12-31 0001591913 us-gaap:CommonStockMember 2021-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001591913 us-gaap:RetainedEarningsMember 2021-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2021-12-31 0001591913 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001591913 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001591913 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001591913 2022-01-01 2022-03-31 0001591913 us-gaap:PreferredStockMember 2022-03-31 0001591913 us-gaap:CommonStockMember 2022-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001591913 us-gaap:RetainedEarningsMember 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-03-31 0001591913 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0001591913 2022-04-01 2022-06-30 0001591913 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001591913 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001591913 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001591913 us-gaap:PreferredStockMember 2022-06-30 0001591913 us-gaap:CommonStockMember 2022-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001591913 us-gaap:RetainedEarningsMember 2022-06-30 0001591913 us-gaap:NoncontrollingInterestMember 2022-06-30 0001591913 2022-06-30 0001591913 us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001591913 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001591913 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001591913 us-gaap:NoncontrollingInterestMember 2022-07-01 2022-09-30 0001591913 us-gaap:PreferredStockMember 2022-09-30 0001591913 us-gaap:CommonStockMember 2022-09-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001591913 us-gaap:RetainedEarningsMember 2022-09-30 0001591913 us-gaap:NoncontrollingInterestMember 2022-09-30 0001591913 us-gaap:PreferredStockMember 2020-12-31 0001591913 us-gaap:CommonStockMember 2020-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001591913 us-gaap:RetainedEarningsMember 2020-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2020-12-31 0001591913 2020-12-31 0001591913 us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0001591913 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001591913 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001591913 2021-01-01 2021-03-31 0001591913 us-gaap:PreferredStockMember 2021-03-31 0001591913 us-gaap:CommonStockMember 2021-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001591913 us-gaap:RetainedEarningsMember 2021-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2021-03-31 0001591913 2021-03-31 0001591913 us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0001591913 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001591913 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001591913 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0001591913 2021-04-01 2021-06-30 0001591913 us-gaap:PreferredStockMember 2021-06-30 0001591913 us-gaap:CommonStockMember 2021-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001591913 us-gaap:RetainedEarningsMember 2021-06-30 0001591913 us-gaap:NoncontrollingInterestMember 2021-06-30 0001591913 2021-06-30 0001591913 us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0001591913 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001591913 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001591913 us-gaap:NoncontrollingInterestMember 2021-07-01 2021-09-30 0001591913 us-gaap:PreferredStockMember 2021-09-30 0001591913 us-gaap:CommonStockMember 2021-09-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001591913 us-gaap:RetainedEarningsMember 2021-09-30 0001591913 us-gaap:NoncontrollingInterestMember 2021-09-30 0001591913 2021-09-30 0001591913 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001591913 2019-10-25 2019-11-01 0001591913 2019-12-01 2019-12-31 0001591913 qpag:FrictionlessMember 2022-09-30 0001591913 qpag:FrictionlessMember 2022-06-22 0001591913 qpag:FrictionlessMember 2022-01-01 2022-09-30 0001591913 qpag:FrictionlessFinancialTechnologiesIncMember 2022-09-30 0001591913 qpag:BeyondFintechMember 2021-08-01 2021-08-26 0001591913 2021-08-01 2021-08-26 0001591913 qpag:KiosksMember 2022-01-01 2022-09-30 0001591913 us-gaap:ComputerEquipmentMember 2022-01-01 2022-09-30 0001591913 us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-09-30 0001591913 us-gaap:OfficeEquipmentMember 2022-01-01 2022-09-30 0001591913 2021-01-01 2021-12-31 0001591913 qpag:FrictionlessTechnologiesIncMember qpag:StockPurchaseAgreementMember 2021-06-01 2021-06-22 0001591913 qpag:FrictionlessTechnologiesIncMember qpag:StockPurchaseAgreementMember 2021-06-22 0001591913 qpag:FrictionlessTechnologiesIncMember 2021-06-22 0001591913 qpag:FrictionlessTechnologiesIncMember 2021-06-01 2021-06-22 0001591913 2019-01-01 2019-12-31 0001591913 qpag:ViviHoldingsIncMember 2022-01-01 2022-09-30 0001591913 qpag:MrAndreyNovikovMember 2022-01-01 2022-09-30 0001591913 qpag:JosephWPatriciaGAbramsFamilyTrustMember 2022-01-01 2022-09-30 0001591913 qpag:MrGastonPereiraMember 2022-01-01 2022-09-30 0001591913 qpag:FrictionlessTechnologiesIncMember 2022-09-30 0001591913 qpag:FrictionlessTechnologiesIncMember 2021-12-31 0001591913 qpag:ViviHoldingsIncMember 2022-09-30 0001591913 qpag:ViviHoldingsIncMember 2021-12-31 0001591913 2020-07-01 2020-07-07 0001591913 qpag:CavalryFundILPMember 2021-02-01 2021-02-16 0001591913 qpag:CavalryFundILPMember 2021-02-16 0001591913 qpag:CavalryFundILPMember 2022-02-01 2022-02-03 0001591913 qpag:CavalryFundILPMember 2022-07-01 2022-09-30 0001591913 qpag:CavalryFundILPMember 2022-01-01 2022-09-30 0001591913 qpag:CavalryFundILPMember 2022-09-30 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-02-01 2022-02-03 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2021-02-01 2021-02-16 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2021-02-16 0001591913 2021-02-16 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-01-01 2022-09-30 0001591913 qpag:BellridgeCapitalLPMember 2021-02-01 2021-02-16 0001591913 qpag:BellridgeCapitalLPMember 2021-02-16 0001591913 qpag:BellridgeCapitalLPMember 2022-02-04 0001591913 qpag:CavalryFundILPMember 2022-09-30 0001591913 qpag:CavalryFundILPMember 2022-01-01 2022-09-30 0001591913 qpag:CavalryFundILPMember 2021-12-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-09-30 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-01-01 2022-09-30 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2021-12-31 0001591913 qpag:BellridgeCapitalLPMember 2022-09-30 0001591913 qpag:BellridgeCapitalLPMember 2022-01-01 2022-09-30 0001591913 qpag:BellridgeCapitalLPMember 2021-12-31 0001591913 us-gaap:ConvertibleNotesPayableMember 2022-09-30 0001591913 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-09-30 0001591913 us-gaap:ConvertibleNotesPayableMember 2021-12-31 0001591913 2022-08-01 2022-08-30 0001591913 2022-08-30 0001591913 srt:MinimumMember 2022-09-30 0001591913 srt:MaximumMember 2022-09-30 0001591913 srt:MinimumMember 2021-12-31 0001591913 srt:MaximumMember 2021-12-31 0001591913 srt:MinimumMember 2022-01-01 2022-09-30 0001591913 srt:MaximumMember 2022-01-01 2022-09-30 0001591913 srt:MinimumMember 2021-01-01 2021-12-31 0001591913 srt:MaximumMember 2021-01-01 2021-12-31 0001591913 2022-07-08 0001591913 2022-07-01 2022-07-08 0001591913 us-gaap:CommonStockMember 2022-07-08 0001591913 qpag:RichardRosenblumMember 2022-07-01 2022-07-11 0001591913 2022-07-11 0001591913 qpag:SamadHarakeMember 2022-08-05 0001591913 2022-07-01 2022-07-11 0001591913 qpag:TwoThousandEighteenStockIncentivePlanMember 2022-01-01 2022-09-30 0001591913 qpag:TwoThousandEighteenStockIncentivePlanMember srt:MaximumMember 2022-09-30 0001591913 srt:MaximumMember us-gaap:CommonStockMember 2022-09-30 0001591913 qpag:TwoThousandTwentyOnePlanMember 2022-01-01 2022-09-30 0001591913 qpag:TwoThousandTwentyOnePlanMember srt:MaximumMember 2022-09-30 0001591913 srt:ChiefExecutiveOfficerMember 2022-07-11 0001591913 srt:ChiefExecutiveOfficerMember 2022-07-01 2022-07-11 0001591913 srt:ChiefExecutiveOfficerMember 2022-07-01 2022-09-30 0001591913 srt:ChiefExecutiveOfficerMember 2022-01-01 2022-09-30 0001591913 2022-09-01 2022-09-13 0001591913 qpag:TotalRestrictedSharesMember 2020-12-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2020-12-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2020-12-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2020-12-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2020-12-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2020-12-31 0001591913 qpag:TotalRestrictedSharesMember 2021-01-01 2021-12-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2021-01-01 2021-12-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2021-01-01 2021-12-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-01-01 2021-12-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2021-01-01 2021-12-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-01-01 2021-12-31 0001591913 qpag:TotalRestrictedSharesMember 2021-12-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2021-12-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2021-12-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 qpag:TotalRestrictedSharesMember 2022-01-01 2022-09-30 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-09-30 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2022-01-01 2022-09-30 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-09-30 0001591913 qpag:TotalVestedRestrictedSharesMember 2022-01-01 2022-09-30 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-09-30 0001591913 qpag:TotalRestrictedSharesMember 2022-09-30 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2022-09-30 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2022-09-30 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-09-30 0001591913 qpag:TotalVestedRestrictedSharesMember 2022-09-30 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-09-30 0001591913 qpag:ExercisePrice0049Member 2022-01-01 2022-09-30 0001591913 qpag:ExercisePriceRange5Member 2022-01-01 2022-09-30 0001591913 qpag:ExercisePrice0055Member 2022-01-01 2022-09-30 0001591913 srt:MinimumMember qpag:WarrantsMember 2022-09-30 0001591913 srt:MaximumMember qpag:WarrantsMember 2022-09-30 0001591913 srt:MinimumMember qpag:WarrantsMember 2022-01-01 2022-09-30 0001591913 srt:MaximumMember qpag:WarrantsMember 2022-01-01 2022-09-30 0001591913 qpag:WarrantsMember 2022-01-01 2022-09-30 0001591913 srt:MinimumMember qpag:StockOptionsMember 2022-09-30 0001591913 srt:MaximumMember qpag:StockOptionsMember 2022-09-30 0001591913 srt:MinimumMember qpag:StockOptionsMember 2022-01-01 2022-09-30 0001591913 srt:MaximumMember qpag:StockOptionsMember 2022-01-01 2022-09-30 0001591913 qpag:StockOptionsMember 2022-01-01 2022-09-30 0001591913 us-gaap:WarrantMember 2020-12-31 0001591913 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001591913 us-gaap:WarrantMember 2021-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2021-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2021-12-31 0001591913 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-01-01 2022-09-30 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-01-01 2022-09-30 0001591913 us-gaap:WarrantMember 2022-09-30 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-09-30 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-09-30 0001591913 qpag:ExercisePrice00345Member 2022-09-30 0001591913 qpag:ExercisePrice00345Member 2022-01-01 2022-09-30 0001591913 qpag:ExercisePriceRange5Member 2022-09-30 0001591913 qpag:ExercisePrice015Member 2022-09-30 0001591913 qpag:ExercisePrice015Member 2022-01-01 2022-09-30 0001591913 qpag:ExercisePrice0187Member 2022-09-30 0001591913 qpag:ExercisePrice0187Member 2022-01-01 2022-09-30 0001591913 us-gaap:StockOptionMember 2020-12-31 0001591913 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001591913 us-gaap:StockOptionMember 2021-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2021-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2021-12-31 0001591913 us-gaap:StockOptionMember 2022-01-01 2022-09-30 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2022-01-01 2022-09-30 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2022-01-01 2022-09-30 0001591913 us-gaap:StockOptionMember 2022-09-30 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2022-09-30 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2022-09-30 0001591913 qpag:ExercisePrice004Member 2022-09-30 0001591913 qpag:ExercisePrice004Member 2022-01-01 2022-09-30 0001591913 qpag:ExercisePrice024Member 2022-09-30 0001591913 qpag:ExercisePrice024Member 2022-01-01 2022-09-30 0001591913 qpag:ExercisePrice040Member 2022-09-30 0001591913 qpag:ExercisePrice040Member 2022-01-01 2022-09-30 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2022-07-01 2022-09-30 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-09-30 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2021-07-01 2021-09-30 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2021-01-01 2021-09-30 0001591913 qpag:StockOptionsMember 2022-07-01 2022-09-30 0001591913 qpag:StockOptionsMember 2022-01-01 2022-09-30 0001591913 qpag:StockOptionsMember 2021-07-01 2021-09-30 0001591913 qpag:StockOptionsMember 2021-01-01 2021-09-30 0001591913 us-gaap:WarrantMember 2022-07-01 2022-09-30 0001591913 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001591913 us-gaap:WarrantMember 2021-07-01 2021-09-30 0001591913 us-gaap:WarrantMember 2021-01-01 2021-09-30 0001591913 2021-02-01 2021-02-22 0001591913 qpag:JamesFullerMember 2021-02-01 2021-02-22 0001591913 qpag:JamesFullerMember 2021-07-01 2021-07-22 0001591913 qpag:JamesFullerMember 2021-07-22 0001591913 srt:MaximumMember qpag:JamesFullerMember 2021-02-22 0001591913 srt:MinimumMember qpag:JamesFullerMember 2021-02-22 0001591913 qpag:JamesFullerMember 2022-09-01 2022-09-13 0001591913 qpag:JamesFullerMember 2022-07-01 2022-09-30 0001591913 qpag:JamesFullerMember 2022-01-01 2022-09-30 0001591913 qpag:MrAndreyNovikovMember 2021-02-01 2021-02-22 0001591913 qpag:WilliamCorbettMember 2021-02-01 2021-02-22 0001591913 qpag:WilliamCorbettMember 2021-01-01 2021-12-31 0001591913 qpag:WilliamCorbettMember 2021-08-01 2021-08-16 0001591913 qpag:WilliamCorbettMember 2022-07-01 2022-07-11 0001591913 qpag:WilliamCorbettMember 2022-07-01 2022-09-30 0001591913 qpag:WilliamCorbettMember 2022-01-01 2022-09-30 0001591913 qpag:CliffordHenryMember 2021-07-01 2021-07-22 0001591913 qpag:CliffordHenryMember 2021-07-22 0001591913 qpag:CliffordHenryMember 2022-01-01 2022-09-30 0001591913 qpag:CliffordHenryMember 2022-09-01 2022-09-13 0001591913 qpag:CliffordHenryMember 2022-09-13 0001591913 qpag:CliffordHenryMember 2022-07-01 2022-09-30 0001591913 qpag:MadissonCorbettMember 2021-07-01 2021-07-22 0001591913 qpag:MadissonCorbettMember 2021-07-22 0001591913 qpag:MadissonCorbettMember 2022-09-01 2022-09-13 0001591913 qpag:MadissonCorbettMember 2022-09-13 0001591913 qpag:MadissonCorbettMember 2022-07-01 2022-09-30 0001591913 qpag:MadissonCorbettMember 2022-01-01 2022-09-30 0001591913 qpag:DavidRiosMember 2021-07-01 2021-07-22 0001591913 qpag:DavidRiosMember 2021-07-22 0001591913 qpag:DavidRiosMember 2022-09-01 2022-09-13 0001591913 qpag:DavidRiosMember 2022-09-13 0001591913 qpag:DavidRiosMember 2022-07-01 2022-09-30 0001591913 qpag:DavidRiosMember 2022-01-01 2022-09-30 0001591913 qpag:RichardRosenblumMember 2021-07-01 2021-07-27 0001591913 qpag:RichardRosenblumMember 2022-01-01 2022-09-30 0001591913 qpag:RichardRosenblumMember 2021-08-01 2021-08-16 0001591913 qpag:RichardRosenblumMember 2021-08-01 2021-08-31 0001591913 qpag:RichardRosenblumMember 2022-07-11 0001591913 qpag:RichardRosenblumMember 2022-07-01 2022-09-30 shares iso4217:USD iso4217:USD shares pure 10-Q true 2022-09-30 2022 false 000-55648 INNOVATIVE PAYMENT SOLUTIONS, INC. NV 33-1230229 56B 5th Avenue Lot 1 #AT Carmel By The Sea CA 93921 (866) 477-4729 Yes Yes Non-accelerated Filer true false false 376901679 1352983 5449751 133880 85034 1486863 5534785 52434 28799 1198011 625000 47592 34800 500001 500001 1798038 1188600 3284901 6723385 574825 465205 0 263200 2210802 1961354 710389 407161 3496016 2833720 162560 158353 162560 158353 3658576 2992073 0.0001 0.0001 25000000 25000000 0 0 0 0 0.0001 0.0001 750000000 500000000 376901679 376901679 367901679 367901679 37690 36790 47863546 45771012 -48290394 -42111701 -389158 3696101 15483 35211 -373675 3731312 3284901 6723385 2721451 2747693 4386375 9457134 20500 4642 29493 13293 2741951 2752335 4415868 9470427 -2741951 -2752335 -4415868 -9470427 -5184447 -602100 -1321658 51340 53903 142302 174587 -515200 -263200 -3138452 -84895 -1578361 65046 -4714451 -3310496 -1743077 -6208074 -13253462 -3310496 -1743077 -6208074 -13253462 -7652 -29381 -3302844 -1743077 -6178693 -13253462 -0.01 0 -0.02 -0.04 375956027 364722331 370615966 323034956 367901679 36790 45771012 -42111701 35211 3731312 94466 94466 62766 62766 -1801494 -8752 -1810246 367901679 36790 45928244 -43913195 26459 2078298 9653 9653 94462 94462 62766 62766 -1074355 -12977 -1087332 367901679 36790 46085472 -44987550 23135 1157847 322918 322918 7000000 700 332300 333000 2000000 200 109800 110000 1013056 1013056 -3302844 -7652 -3310496 376901679 37690 47863546 -48290394 15483 -373675 193637747 19363 23179399 -27629575 -4430813 44074284 4407 2199307 2203714 30333334 3033 4546967 4550000 -501100 -501100 61793616 6180 7437488 7443668 4327899 4327899 2500000 250 213499 213749 -11394106 -11394106 332338981 33233 41403459 -39023681 2413011 16112698 1611 804024 805635 8000000 800 775200 776000 72141 72141 -116279 -116279 356451679 35644 43054824 -39139960 3950508 5650000 565 442485 443050 5800000 580 1802102 1802682 -1743077 -1743077 367901679 36789 45299411 -40883037 4453163 -6208074 -13253462 65046 -4714451 29493 13293 263200 3138452 5184447 1321658 4000 333000 1219050 1437516 6416471 322918 17857 48846 53834 109621 17545 -17857 54042 144773 -2320426 -1883716 585640 250000 500000 12792 4800 40500 9234 -638932 -764034 9653 4550000 501100 3009349 22049 1147063 521000 2569000 -1137410 9084200 -4096768 6436450 5449751 94703 1352983 6531153 88260 29813 34070 2259221 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>1</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>ORGANIZATION AND DESCRIPTION OF BUSINESS</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>a)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Organizational History</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi” or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>b)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Description of current business</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company is presently focused on operating and developing e-wallets that enable consumers to deposit cash, convert it into a digital form and remit the funds to Mexico and other countries quickly and securely. The Company’s first e-wallet, Beyond Wallet, is currently operational and is focused on business customers. The Company’s flagship e-wallet, IPSIPay, is also fully operational. IPSIPay, which is focused on individual customers, was first launched in December 2021 and its commercial launch has continued during 2022. Previously the Company intended to invest in physical kiosks, which required the user presence at the kiosk location. The Company still intends to use its existing kiosks in certain target markets within Southern California, but its principal focus will be on downloadable apps used via smartphones.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”) on June 22, 2021. Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.</span></p> to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock. On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.  On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi” or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). 0.10 0.41 300000 0.01 0.51 0.49 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>2</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>ACCOUNTING POLICIES AND ESTIMATES</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>a)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Basis of Presentation</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the nine months ended September 30, 2022 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2021, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>All amounts referred to in the notes to the unaudited condensed financial statements are in United States Dollars ($) unless stated otherwise.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>b)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Principles of Consolidation</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The entities included in the accompanying unaudited condensed consolidated financial statements are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Innovative Payment Solutions, Inc. - Parent Company</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span>Beyond Fintech Inc., 51% owned. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>c)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Use of Estimates</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>d)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Contingencies</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>e)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Fair Value of Financial Instruments</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The carrying amounts reported in the balance sheets for the investment in Vivi Holdings was evaluated at fair value using Level 3 Inputs based on the Company’s estimate of the market value of the entities disposed to Vivi Holdings. Vivi Holdings does not have sufficient information available to assess the current market price of its equity.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>ASC 825-10 “<i>Financial Instruments</i>” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>f)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Risks and Uncertainties</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) COVID-19 and its variants, (ii) launching and scaling the Company’s e-wallet and related products and the use by customers of such products, (iii) developing and implementing successful marketing campaigns and other strategic initiatives; (iv) competition, (iv) compliance with applicable laws, rules and regulations (including those related to fund remittance); (v) the Company’s outstanding indebtedness, including the Company’s ability to repay or extend the maturity of such indebtedness (see Note 8); (vi) inflation and other economic factors and (vii) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>g)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Recent accounting pronouncements</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended September 30, 2022. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>h)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Reporting by Segment</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>No segmental information is required as the Company has not generated any revenue for the nine months ended September 30, 2022 and 2021 and only has one operating segment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>i)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Cash and Cash Equivalents</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At September 30, 2022 and 2021, respectively, the Company had no cash equivalents.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At September 30, 2022 and December 31, 2021, the balance exceed the federally insured limit by $1,094,504 and $5,117,551, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>j)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Accounts Receivable and Allowance for Doubtful Accounts</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended September 30, 2022 and December 31, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>k)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Investments</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>l)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Plant and Equipment</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 50%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Description</b></span></td> <td style="width: 1%"> </td> <td style="width: 49%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Estimated Useful Life</b></span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Kiosks (not used in the Company’s current business)</span></td> <td> </td> <td><span style="font-size: 10pt">7 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Computer equipment</span></td> <td> </td> <td><span style="font-size: 10pt">3 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Leasehold improvements</span></td> <td> </td> <td><span style="font-size: 10pt">Lesser of estimated useful life or life of lease</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Office equipment</span></td> <td> </td> <td><span style="font-size: 10pt">10 years</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>m)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Long-Term Assets</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>n)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Revenue Recognition</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, <i>Revenue Recognition</i>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s revenues will be recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">i.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">identify the contract with a customer;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">ii.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">identify the performance obligations in the contract;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">iii.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">determine the transaction price;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">iv.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">allocate the transaction price to performance obligations in the contract; and</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">v.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">recognize revenue as the performance obligation is satisfied.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company had no revenues during the nine months ended September 30, 2022 and 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>o)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Share-Based Payment Arrangements</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><b> </b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>p)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Derivative Liabilities</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>ASC Topic 815, <i>Derivatives and hedging </i>(“ASC 815”) generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>q)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Income Taxes</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of September 30, 2022 and December 31, 2021, there have been no interest or penalties incurred on income taxes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>r)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Comprehensive income</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>s)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Reclassification of prior year presentation</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>a)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Basis of Presentation</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the nine months ended September 30, 2022 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2021, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>All amounts referred to in the notes to the unaudited condensed financial statements are in United States Dollars ($) unless stated otherwise.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>b)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Principles of Consolidation</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The entities included in the accompanying unaudited condensed consolidated financial statements are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Innovative Payment Solutions, Inc. - Parent Company</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span>Beyond Fintech Inc., 51% owned. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> 0.51 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>c)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Use of Estimates</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>d)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Contingencies</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>e)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Fair Value of Financial Instruments</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The carrying amounts reported in the balance sheets for the investment in Vivi Holdings was evaluated at fair value using Level 3 Inputs based on the Company’s estimate of the market value of the entities disposed to Vivi Holdings. Vivi Holdings does not have sufficient information available to assess the current market price of its equity.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>ASC 825-10 “<i>Financial Instruments</i>” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>f)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Risks and Uncertainties</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) COVID-19 and its variants, (ii) launching and scaling the Company’s e-wallet and related products and the use by customers of such products, (iii) developing and implementing successful marketing campaigns and other strategic initiatives; (iv) competition, (iv) compliance with applicable laws, rules and regulations (including those related to fund remittance); (v) the Company’s outstanding indebtedness, including the Company’s ability to repay or extend the maturity of such indebtedness (see Note 8); (vi) inflation and other economic factors and (vii) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>g)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Recent accounting pronouncements</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended September 30, 2022. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>h)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Reporting by Segment</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>No segmental information is required as the Company has not generated any revenue for the nine months ended September 30, 2022 and 2021 and only has one operating segment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>i)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Cash and Cash Equivalents</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At September 30, 2022 and 2021, respectively, the Company had no cash equivalents.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At September 30, 2022 and December 31, 2021, the balance exceed the federally insured limit by $1,094,504 and $5,117,551, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> 1094504 5117551 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>j)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Accounts Receivable and Allowance for Doubtful Accounts</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended September 30, 2022 and December 31, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>k)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Investments</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> 0.20 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>l)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Plant and Equipment</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 50%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Description</b></span></td> <td style="width: 1%"> </td> <td style="width: 49%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Estimated Useful Life</b></span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Kiosks (not used in the Company’s current business)</span></td> <td> </td> <td><span style="font-size: 10pt">7 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Computer equipment</span></td> <td> </td> <td><span style="font-size: 10pt">3 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Leasehold improvements</span></td> <td> </td> <td><span style="font-size: 10pt">Lesser of estimated useful life or life of lease</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Office equipment</span></td> <td> </td> <td><span style="font-size: 10pt">10 years</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> 1000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 50%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Description</b></span></td> <td style="width: 1%"> </td> <td style="width: 49%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Estimated Useful Life</b></span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Kiosks (not used in the Company’s current business)</span></td> <td> </td> <td><span style="font-size: 10pt">7 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Computer equipment</span></td> <td> </td> <td><span style="font-size: 10pt">3 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Leasehold improvements</span></td> <td> </td> <td><span style="font-size: 10pt">Lesser of estimated useful life or life of lease</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Office equipment</span></td> <td> </td> <td><span style="font-size: 10pt">10 years</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> P7Y P3Y Lesser of estimated useful life or life of lease P10Y <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>m)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Long-Term Assets</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>n)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Revenue Recognition</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, <i>Revenue Recognition</i>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company’s revenues will be recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">i.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">identify the contract with a customer;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">ii.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">identify the performance obligations in the contract;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">iii.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">determine the transaction price;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">iv.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">allocate the transaction price to performance obligations in the contract; and</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">v.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">recognize revenue as the performance obligation is satisfied.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company had no revenues during the nine months ended September 30, 2022 and 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>o)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Share-Based Payment Arrangements</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>p)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Derivative Liabilities</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>ASC Topic 815, <i>Derivatives and hedging </i>(“ASC 815”) generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>q)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Income Taxes</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of September 30, 2022 and December 31, 2021, there have been no interest or penalties incurred on income taxes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>r)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Comprehensive income</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>s)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Reclassification of prior year presentation</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>3</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>LIQUIDITY MATTERS</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>  </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For and as of the end of nine months ended September 30, 2022, the Company had a net loss of $6,208,074. In connection with preparing the unaudited condensed consolidated financial statements for the nine months ended September 30, 2022, management evaluated the risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The Company had a cash balance of $1,352,983 available as of September 30, 2022. Based on its evaluation of the Compa</span>ny’s current business plan, and assuming the Company can extend the maturity date of its existing indebtedness (see Note 8), management believes the Company’s existing cash is sufficient to conduct planned operations for at least one year from the date of issuance of these financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>However, given the Company’s losses, negative cash flows and existing indebtedness, the Company will be required to raise significant additional funds to progress its business as planned by issuing equity or equity-linked securities. Should this occur, the Company’s stockholders would experience dilution, perhaps significantly. Additional debt financing, if available, may involve covenants restricting the Company’s operations or its ability to incur additional debt. Any additional debt financing or additional equity that the Company raises may contain terms that are not favorable to the Company or its stockholders and require significant debt service payments, which diverts resources from other activities. Moreover, there is a risk that financing may be unavailable to support the Company’s operations on favorable terms, or at all.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>There is also a significant risk that none of the Company’s plans to raise financing will be implemented in a manner necessary to sustain the Company for an extended period of time. If adequate funds are not available to the Company when needed, the Company may be required to continue with reduced operations or to obtain funds through arrangements that may require the Company to relinquish rights to technologies or potential markets, any of which could have a material adverse effect on the Company. In addition, the Company’s inability to secure additional funding when needed could cause the Company’s business to fail or become bankrupt or force the Company to wind down or discontinue operations.</span></p> 6208074 1352983 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>4</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>INTANGIBLES</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On August 26, 2021, the Company formed a subsidiary, Beyond Fintech. to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owns 51% of Beyond Fintech with the other 49% owned by Frictionless.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, and during the nine months ended September 30, 2022, an additional $544,320 was spent by the Company to facilitate the functioning of the IPSIPay software in the cloud environment. Beyond Fintech spent an additional $41,320 on software to further enhance the Beyond Wallet product offering. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">September 30,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Purchased Technology</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,210,640</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">625,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Accumulated amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,629</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-168">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,198,011</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">625,000</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Amortization expense was $12,629 for the three and nine months ended September 30, 2022 and $0 for the three and the nine months ended September 30, 2021.</p> 250000 0.51 0.49 375000 544320 41320 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">September 30,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Purchased Technology</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,210,640</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">625,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Accumulated amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,629</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-168">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,198,011</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">625,000</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> 1210640 625000 12629 1198011 625000 12629 12629 0 0 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>5</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>INVESTMENTS</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>Investment in Frictionless Financial Technologies Inc.</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On June 22, 2021, the Company entered into a Stock Purchase Agreement (the “SPA”) with Frictionless, to purchase 150 common shares for gross proceeds of $500,000, representing 10.0% of the outstanding common shares. In terms of the SPA, Frictionless agreed to deliver to the Company on or before August 30, 2021, a live fully compliant financial payment software as a service solution for use by the Company as a digital payment platform that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate to Company’s product offerings. The Company’s IPSIPay app is the digital payment platform developed by Frictionless for the Company, and currently Frictionless provides back-end technical services to the Company relating to IPSIPay.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The Company has undertaken to issue Frictionless a non-restricted, non-dilutable 5 year warrant to purchase 30,000,000 shares of Common Stock at an exercise price of $0.15 per share, upon delivery of the financial payment software. Frictionless has delivered the IPSIPay-related software and the warrants will be issued in accordance with the agreement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The Company has the right to appoint, and has appointed, one member to the board of directors of Frictionless, which appointee will remain on the board as long as the Company is the holder of the Frictionless common stock.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The shares in Frictionless are unlisted as of September 30, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>Investment in Vivi Holdings, Inc.</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Effective December 31, 2019, the Company sold 100% of the outstanding common stock of its subsidiary, Qpagos Corporation, together with its 99.9% ownership interest of Qpagos Corporation’s two Mexican entities: Qpagos S.A.P.I. de C.V. and Redpag Electrónicos S.A.P.I. de C.V, to Vivi.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>As consideration for the disposal, Vivi issued an aggregate of 2,250,000 Vivi Shares as follows: 2,047,500  Vivi Shares to the Company; 56,250 Vivi Shares to the Company’s designee, Mr. Andrey Novikov; 33,750 Vivi Shares to the Company’s designee, the Joseph W. &amp; Patricia G. Abrams Family Trust; and 112,500 Vivi Shares to the Company’s designee, Mr. Gaston Pereira.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Due to the lack of available information, the Vivi Shares were valued by a modified market method, whereby the value of the assets disposed of were determined by management using the enterprise value of the entire Company less the liabilities and assets retained by the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>As of September 30, 2022 and December 31, 2021, the Company maintained the impairment of the carrying value of the investment in Vivi Holdings based on no activity by Vivi’s management for its proposed initial public offering and fund raising activities. The total impairment as of September 30, 2022 and December 31, 2021 was $1,019,960.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The shares in Vivi Holdings are unlisted as of September 30, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">September 30,<br/> 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,<br/> 2021</b></p></td><td style="white-space: nowrap; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Investment in Frictionless Financial Technologies, Inc.</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">500,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">500,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Investment in Vivi Holdings, Inc.</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">500,001</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">500,001</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 150 500000 0.10 P5Y 30000000 0.15 0.41 300000 0.01 Effective December 31, 2019, the Company sold 100% of the outstanding common stock of its subsidiary, Qpagos Corporation, together with its 99.9% ownership interest of Qpagos Corporation’s two Mexican entities: Qpagos S.A.P.I. de C.V. and Redpag Electrónicos S.A.P.I. de C.V, to Vivi.  2250000 2047500 56250 33750 112500 1019960 1019960 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">September 30,<br/> 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,<br/> 2021</b></p></td><td style="white-space: nowrap; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Investment in Frictionless Financial Technologies, Inc.</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">500,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">500,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Investment in Vivi Holdings, Inc.</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">500,001</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">500,001</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 500000 500000 1 1 500001 500001 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>6</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>LEASES</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5<sup>th</sup> Avenue, Lot 1 #AT, Carmel by The Sea, California. The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>Total Lease Cost</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Individual components of the total lease cost incurred by the Company is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Nine months<br/> ended<br/> September 30,<br/> 2022</b></p></td><td style="white-space: nowrap; padding-bottom: 1.5pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nine months<br/> ended<br/> September 30,<br/> 2021</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-weight: bold; text-align: left">Operating lease expense</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">43,200</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">17,857</td><td style="width: 1%; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>Other lease information:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Nine <br/> months ended<br/> September 30,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2022</b></p></td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Nine <br/> months ended<br/> September 30,<br/> 2021</b></span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 10pt"><b>Cash paid for amounts included in the measurement of lease liabilities</b></span></td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 78%"><span style="font-size: 10pt">Operating cash flows from operating leases</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 8%; text-align: right"><span style="font-size: 10pt">(45,200</span></td> <td style="width: 1%"><span style="font-size: 10pt">)</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 8%; text-align: right"><span style="font-size: 10pt">(60,403</span></td> <td style="width: 1%"><span style="font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">Remaining lease term – operating lease</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-169; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">6 months</span></td> <td> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>Maturity of Operating Leases</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The amount of future minimum lease payments under operating leases are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; font-weight: bold">Undiscounted minimum future lease payments under leases with terms twelve months or less</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">Total instalments due:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left; padding-bottom: 1.5pt">2022</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-170">            -</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 4800 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Nine months<br/> ended<br/> September 30,<br/> 2022</b></p></td><td style="white-space: nowrap; padding-bottom: 1.5pt"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nine months<br/> ended<br/> September 30,<br/> 2021</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-weight: bold; text-align: left">Operating lease expense</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">43,200</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">17,857</td><td style="width: 1%; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b> </b></p> 43200 17857 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Nine <br/> months ended<br/> September 30,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2022</b></p></td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Nine <br/> months ended<br/> September 30,<br/> 2021</b></span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 10pt"><b>Cash paid for amounts included in the measurement of lease liabilities</b></span></td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 78%"><span style="font-size: 10pt">Operating cash flows from operating leases</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 8%; text-align: right"><span style="font-size: 10pt">(45,200</span></td> <td style="width: 1%"><span style="font-size: 10pt">)</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 8%; text-align: right"><span style="font-size: 10pt">(60,403</span></td> <td style="width: 1%"><span style="font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">Remaining lease term – operating lease</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-169; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">6 months</span></td> <td> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> -45200 -60403 P6M <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; font-weight: bold">Undiscounted minimum future lease payments under leases with terms twelve months or less</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">Total instalments due:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left; padding-bottom: 1.5pt">2022</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-170">            -</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>7</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>FEDERAL RELIEF LOANS</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>Small Business Administration Disaster Relief loan</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company. The proceeds are to be used for working capital purposes to alleviate economic injury caused by the COVID-19 pandemic.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The Company has accrued interest of $12,560 on this loan as of September 30, 2022.</span></p> 150000 0.0375 731 12560 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>8</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>CONVERTIBLE NOTES PAYABLE</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Convertible notes payable consists of the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; padding: 0pt 0pt 0pt 0.125in; font-weight: bold; text-indent: -0.125in">Description</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0pt">Effective Interest<br/> Rate</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td style="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0pt">Maturity date</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0pt">Principal</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0pt">Accrued<br/> Interest</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0pt">Unamortized<br/> debt discount</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td colspan="2" style="padding: 0pt; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>September 30,<br/> 2022<br/> Amount, net</b></p></td><td style="padding: 0pt; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td colspan="2" style="padding: 0pt; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,<br/> 2021<br/> Amount, net</b></p></td><td style="padding: 0pt; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 0.125in; text-align: left; text-indent: -0.125in">Cavalry Fund I LP</td><td style="padding: 0pt; width: 1%; text-indent: 0pt"> </td> <td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; width: 9%; text-align: right; text-indent: 0pt">28.7</td><td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">%</td><td style="padding: 0pt; width: 1%; text-indent: 0pt"> </td> <td style="padding: 0pt; width: 15%; text-align: center; text-indent: 0pt">November 16, 2022</td><td style="padding: 0pt; width: 1%; text-indent: 0pt"> </td> <td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; width: 9%; text-align: right; text-indent: 0pt">1,091,754</td><td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; width: 1%; text-indent: 0pt"> </td> <td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; width: 9%; text-align: right; text-indent: 0pt">13,647</td><td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; width: 1%; text-indent: 0pt"> </td> <td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; width: 9%; text-align: right; text-indent: 0pt"><div style="-sec-ix-hidden: hidden-fact-171">       -</div></td><td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; width: 1%; text-indent: 0pt"> </td> <td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; width: 9%; text-align: right; text-indent: 0pt">1,105,401</td><td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; width: 1%; text-indent: 0pt"> </td> <td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; width: 9%; text-align: right; text-indent: 0pt">548,872</td><td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding: 0pt 0pt 0pt 0.125in; text-indent: -0.125in"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: center; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 0.125in; text-align: left; text-indent: -0.125in">Mercer Street Global Opportunity Fund, LLC</td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt">28.7</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">%</td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: center; text-indent: 0pt">November 16, 2022</td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt">1,091,754</td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt">13,647</td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><div style="-sec-ix-hidden: hidden-fact-172">-</div></td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt">1,105,401</td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt">548,872</td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding: 0pt 0pt 0pt 0.125in; text-indent: -0.125in"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: center; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 0.125in; text-align: left; text-indent: -0.125in">Bellridge Capital LP.</td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt">10</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">%</td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: center; text-indent: 0pt">February 16, 2022</td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0pt"><div style="-sec-ix-hidden: hidden-fact-173">-</div></td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0pt"><div style="-sec-ix-hidden: hidden-fact-174">-</div></td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0pt"><div style="-sec-ix-hidden: hidden-fact-175">-</div></td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0pt"><div style="-sec-ix-hidden: hidden-fact-176">-</div></td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0pt">863,609</td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding: 0pt 0pt 0pt 0.125in; text-indent: -0.125in"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: center; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 0.125in; font-weight: bold; text-align: left; text-indent: -0.125in">Total convertible notes payable</td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: center; text-indent: 0pt"> </td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: right; text-indent: 0pt">2,183,508</td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: right; text-indent: 0pt">27,294</td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: right; text-indent: 0pt"><div style="-sec-ix-hidden: hidden-fact-177">-</div></td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: right; text-indent: 0pt">2,210,802</td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: right; text-indent: 0pt">1,961,353</td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Interest expense totaled $49,912 and $52,236 and amortization of debt discount totaled $0 and $515,200 for the three months ended September 30, 2022 and 2021, respectively, and interest expense totaled $138,085 and $169,695 and amortization of debt discount totaled $263,200 and $3,138,452 for the nine months ended September 30, 2022 and 2021, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b><i>Cavalry Fund I LP</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">On February 16, 2021, the Company closed a transaction with Cavalry Fund I LP (“Cavalry”), pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Cavalry Note”). The Cavalry Note is convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of Common Stock at an initial exercise price of $0.24 per share.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On February 3, 2022, the Company extended the maturity date of its Cavalry Note from February 16, 2022 to August 16, 2022. The Cavalry Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Cavalry agreed to extend the maturity date of the Cavalry Note to August 16, 2022 in consideration of the principal amount outstanding under the Cavalry Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. On August 30, 2022, the Company further extended the maturity date of its Cavalry note from August 16, 2022 to November 16, 2022. In terms of the agreement entered into with Cavalry, the principal outstanding was increased by $181,959 and the interest outstanding as of August 31, 2022 of $43,553 was capitalized, resulting in a principal balance outstanding of $1,091,754. In addition, the Company granted Cavalry a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share, maturing on August 30, 2027 and valued at $119,091 on the date of grant.</span> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">This change to the maturity dates of the Cavalry Note from February 16, 2022 to August 31, 2022 and subsequently to November 16, 2022, was assessed in terms of ASC 470-50 as a debt extinguishment, which resulted in a penalty expense of $181,959 and $260,708 for the three months and nine months ended September 30, 2022, respectively, in addition the value of the warrant issued on the debt extension from August 16, 2022 to November 16, 2022, resulted in an additional penalty expense of $119,091 for the three and nine months ended September 30, 2022.</p><p style="margin-top: 0pt; margin-left: 0.5in; text-align: justify; margin-bottom: 0pt"> </p><p style="margin-top: 0pt; margin-left: 0.5in; text-align: justify; margin-bottom: 0pt"><span>The balance of the Cavalry Note plus accrued interest at September 30, 2022 was $1,105,401.</span></p><p style="margin-top: 0pt; margin-left: 0.5in; text-align: justify; margin-bottom: 0pt"><span> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b><i>Mercer Street Global Opportunity Fund, LLC</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>   </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">On February 16, 2021, the Company closed a transaction with Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Mercer Note”). The Mercer Note is convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of Common Stock at an initial exercise price of $0.24 per share.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On February 3, 2022, the Company extended the maturity date of its Mercer Note from February 16, 2022 to August 16, 2022. The Mercer Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Mercer agreed to extend the maturity date of the Mercer Note to August 16, 2022 in consideration of the principal amount outstanding under the Mercer Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. On August 30, 2022, the Company further extended the maturity date of its Mercer note from August 16, 2022 to November 16, 2022. In terms of the agreement entered into with Mercer, the principal outstanding was increased by $181,959 and the interest outstanding as of August 31, 2022 of $43,553 was capitalized, resulting in a principal balance outstanding of $1,091,754. In addition, the Company granted Mercer a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share, maturing on August 30, 2027 and valued at the date of grant at $119,091.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">This change to the maturity dates of the Mercer Note from February 16, 2022 to August 31, 2022 and subsequently to November 16, 2022, was assessed in terms of ASC 470-50 as a debt extinguishment, which resulted in a penalty expense of $181,959 and $260,708 for the three months and nine months ended September 30, 2022, respectively, in addition the value of the warrant issued on the debt extension from August 16, 2022 to November 16, 2022, resulted in an additional penalty expense of $119,091 for the three and nine months ended September 30, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The balance of the Mercer Note plus accrued interest at September 30, 2022 was $1,105,401.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span> </span> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b><i>Bellridge Capital LP.</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>  </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">On February 16, 2021, the Company closed a transaction with Bellridge Capital LP., pursuant to which the Company received net proceeds of $787,500, after an original issue discount of $112,500 in exchange for the issuance of a $900,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Bellridge Note”). The Bellridge Note was convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 3,913,044 shares of Common Stock at an initial exercise price of $0.24 per share.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Bellridge Note was repaid on February 4, 2022 for gross proceeds of $1,235,313, including interest thereon of $88,250, thereby extinguishing the Bellridge Note.</span></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; padding: 0pt 0pt 0pt 0.125in; font-weight: bold; text-indent: -0.125in">Description</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0pt">Effective Interest<br/> Rate</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td style="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0pt">Maturity date</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0pt">Principal</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0pt">Accrued<br/> Interest</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0pt">Unamortized<br/> debt discount</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td colspan="2" style="padding: 0pt; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>September 30,<br/> 2022<br/> Amount, net</b></p></td><td style="padding: 0pt; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td colspan="2" style="padding: 0pt; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,<br/> 2021<br/> Amount, net</b></p></td><td style="padding: 0pt; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 0.125in; text-align: left; text-indent: -0.125in">Cavalry Fund I LP</td><td style="padding: 0pt; width: 1%; text-indent: 0pt"> </td> <td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; width: 9%; text-align: right; text-indent: 0pt">28.7</td><td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">%</td><td style="padding: 0pt; width: 1%; text-indent: 0pt"> </td> <td style="padding: 0pt; width: 15%; text-align: center; text-indent: 0pt">November 16, 2022</td><td style="padding: 0pt; width: 1%; text-indent: 0pt"> </td> <td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; width: 9%; text-align: right; text-indent: 0pt">1,091,754</td><td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; width: 1%; text-indent: 0pt"> </td> <td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; width: 9%; text-align: right; text-indent: 0pt">13,647</td><td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; width: 1%; text-indent: 0pt"> </td> <td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; width: 9%; text-align: right; text-indent: 0pt"><div style="-sec-ix-hidden: hidden-fact-171">       -</div></td><td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; width: 1%; text-indent: 0pt"> </td> <td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; width: 9%; text-align: right; text-indent: 0pt">1,105,401</td><td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; width: 1%; text-indent: 0pt"> </td> <td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; width: 9%; text-align: right; text-indent: 0pt">548,872</td><td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding: 0pt 0pt 0pt 0.125in; text-indent: -0.125in"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: center; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 0.125in; text-align: left; text-indent: -0.125in">Mercer Street Global Opportunity Fund, LLC</td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt">28.7</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">%</td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: center; text-indent: 0pt">November 16, 2022</td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt">1,091,754</td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt">13,647</td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"><div style="-sec-ix-hidden: hidden-fact-172">-</div></td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt">1,105,401</td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt">548,872</td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding: 0pt 0pt 0pt 0.125in; text-indent: -0.125in"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: center; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 0.125in; text-align: left; text-indent: -0.125in">Bellridge Capital LP.</td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt">10</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">%</td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: center; text-indent: 0pt">February 16, 2022</td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0pt"><div style="-sec-ix-hidden: hidden-fact-173">-</div></td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0pt"><div style="-sec-ix-hidden: hidden-fact-174">-</div></td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0pt"><div style="-sec-ix-hidden: hidden-fact-175">-</div></td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0pt"><div style="-sec-ix-hidden: hidden-fact-176">-</div></td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0pt">863,609</td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding: 0pt 0pt 0pt 0.125in; text-indent: -0.125in"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: center; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 0.125in; font-weight: bold; text-align: left; text-indent: -0.125in">Total convertible notes payable</td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: center; text-indent: 0pt"> </td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: right; text-indent: 0pt">2,183,508</td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: right; text-indent: 0pt">27,294</td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: right; text-indent: 0pt"><div style="-sec-ix-hidden: hidden-fact-177">-</div></td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: right; text-indent: 0pt">2,210,802</td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: right; text-indent: 0pt">1,961,353</td><td style="padding: 0pt; font-weight: bold; text-align: left; text-indent: 0pt"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.287 November 16, 2022 1091754 13647 1105401 548872 0.287 November 16, 2022 1091754 13647 1105401 548872 0.10 February 16, 2022 863609 2183508 27294 2210802 1961353 49912 52236 0 515200 138085 169695 263200 3138452 500500 71500 572000 0.10 0.23 2486957 0.24 On February 3, 2022, the Company extended the maturity date of its Cavalry Note from February 16, 2022 to August 16, 2022. The Cavalry Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Cavalry agreed to extend the maturity date of the Cavalry Note to August 16, 2022 in consideration of the principal amount outstanding under the Cavalry Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. On August 30, 2022, the Company further extended the maturity date of its Cavalry note from August 16, 2022 to November 16, 2022. In terms of the agreement entered into with Cavalry, the principal outstanding was increased by $181,959 and the interest outstanding as of August 31, 2022 of $43,553 was capitalized, resulting in a principal balance outstanding of $1,091,754. In addition, the Company granted Cavalry a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share, maturing on August 30, 2027 and valued at $119,091 on the date of grant. 181959 260708 119091 119091 1105401 On February 16, 2021, the Company closed a transaction with Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022 (the “Mercer Note”). The Mercer Note is convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of Common Stock at an initial exercise price of $0.24 per share.On February 3, 2022, the Company extended the maturity date of its Mercer Note from February 16, 2022 to August 16, 2022. The Mercer Note was due to mature on February 16, 2022 and would have resulted in the accrual of a $157,499 prepayment penalty on the principal of $572,000 and interest of $57,994 outstanding, totaling $787,493. Mercer agreed to extend the maturity date of the Mercer Note to August 16, 2022 in consideration of the principal amount outstanding under the Mercer Note being increased by an additional $78,749, thereby increasing the total principal outstanding to $866,242. On August 30, 2022, the Company further extended the maturity date of its Mercer note from August 16, 2022 to November 16, 2022. In terms of the agreement entered into with Mercer, the principal outstanding was increased by $181,959 and the interest outstanding as of August 31, 2022 of $43,553 was capitalized, resulting in a principal balance outstanding of $1,091,754. In addition, the Company granted Mercer a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share, maturing on August 30, 2027 and valued at the date of grant at $119,091. This change to the maturity dates of the Mercer Note from February 16, 2022 to August 31, 2022 and subsequently to November 16, 2022, was assessed in terms of ASC 470-50 as a debt extinguishment, which resulted in a penalty expense of $181,959 and $260,708 for the three months and nine months ended September 30, 2022, respectively, in addition the value of the warrant issued on the debt extension from August 16, 2022 to November 16, 2022, resulted in an additional penalty expense of $119,091 for the three and nine months ended September 30, 2022.  500500 71500 572000 0.10 0.23 2486957 0.24 1105401 787500 112500 900000 0.10 0.23 3913044 0.24 1235313 88250 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>9</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>DERIVATIVE LIABILITY</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Certain of the short-term convertible notes disclosed in note 8 above and certain warrants disclosed in note 10 below have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On August 30, 2022, the company extended the maturity date of convertible notes issued to Cavalry and Mercer and agreed to grant each note holder a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share with a maturity date of August 30, 2027. The warrant has full ratchet anti-dilution clauses and have fundamental transaction clauses which may give rise to cash settlement which gives rise to a derivative financial liability, which was originally valued at the grant date using a Black--Scholes valuation model at $238,182.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The value of this derivative financial liability was re-assessed at September 30, 2022 at $710,389, and $84,895 was credited and $65,046 was charged to the statement of operations for the three and nine months ended September 30, 2022, respectively. The value of the derivative liability will be re-assessed at each financial reporting period, with any movement thereon recorded in the statement of operations in the period in which it is incurred.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The following assumptions were used in the Black-Scholes valuation model:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">Nine months<br/> ended<br/> </p> <p style="margin-top: 0; margin-bottom: 0">September 30,<br/> 2022</p></td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year ended<br/> December 31,<br/> 2021</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Conversion price </td><td> </td> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$ 0.05 to $0.15 </span></td><td style="text-align: left"> </td><td> </td> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$ 0.05 to $0.24 </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Risk free interest rate </td><td> </td> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.79 to 4.25 </span></td><td style="text-align: left">%</td><td> </td> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.05 to 1.12 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected life of derivative liability </td><td> </td> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5 to 59 months </span></td><td style="text-align: left"> </td><td> </td> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6 to 49.6 months </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected volatility of underlying stock </td><td> </td> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120.49 to 258.3 </span></td><td style="text-align: left">%</td><td> </td> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">161.19 to 215.33 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Expected dividend rate </td><td style="width: 1%"> </td> <td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="white-space: nowrap; width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="white-space: nowrap; width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The movement in derivative liability is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">September 30,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -9pt; padding-left: 9pt">Opening balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">407,161</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,966,416</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Derivative financial liability arising from convertible note and warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">238,182</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,569,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Fair value adjustment to derivative liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">65,046</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,128,255</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">710,389</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">407,161</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 3000000 0.15 238182 710389 84895 65046 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">Nine months<br/> ended<br/> </p> <p style="margin-top: 0; margin-bottom: 0">September 30,<br/> 2022</p></td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year ended<br/> December 31,<br/> 2021</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Conversion price </td><td> </td> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$ 0.05 to $0.15 </span></td><td style="text-align: left"> </td><td> </td> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$ 0.05 to $0.24 </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Risk free interest rate </td><td> </td> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.79 to 4.25 </span></td><td style="text-align: left">%</td><td> </td> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.05 to 1.12 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected life of derivative liability </td><td> </td> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5 to 59 months </span></td><td style="text-align: left"> </td><td> </td> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6 to 49.6 months </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected volatility of underlying stock </td><td> </td> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120.49 to 258.3 </span></td><td style="text-align: left">%</td><td> </td> <td style="white-space: nowrap; text-align: left"> </td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">161.19 to 215.33 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Expected dividend rate </td><td style="width: 1%"> </td> <td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="white-space: nowrap; width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="white-space: nowrap; width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.05 0.15 0.05 0.24 0.0079 0.0425 0.0005 0.0112 P1Y6M P59M P1Y7M6D P49M18D 1.2049 2.583 1.6119 2.1533 0 0 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">September 30,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -9pt; padding-left: 9pt">Opening balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">407,161</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,966,416</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Derivative financial liability arising from convertible note and warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">238,182</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,569,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Fair value adjustment to derivative liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">65,046</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,128,255</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">710,389</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">407,161</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 407161 2966416 238182 2569000 65046 -5128255 710389 407161 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>10</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>STOCKHOLDERS’ EQUITY</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>a.</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Common Stock</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company has total authorized Common Stock of 750,000,000  shares with a par value of $0.0001 each. The Company had 376,901,679 and 367,901,679 shares of Common Stock issued and outstanding as of September 30, 2022 and December 31, 2021, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On July 8, 2022, the Company entered into a consulting agreement with a third-party contractor for a period of twelve months to (i) review the Company’s business plan; (ii) analyze and assess the Company’s revenues, costs, and cash flow; and (iii) introduce the Company to and interface on the Company’s behalf with potential and actual commercial partners. The Company issued 2,000,000 shares of Common Stock as compensation for the services rendered which were fully earned on the date of issue. These shares were valued at $84,000 at the date of grant. In addition, the contractor will receive a monthly fee of $3,000 for the term of the Agreement, commencing on August 1, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On July 8, 2022, the Company entered into a second consulting agreement with a separate third-party contractor for a period of twelve months to (i) review the Company’s business plan; (ii) analyze and assess the Company’s revenues, costs, and cash flow; and (iii) introduce the Company to and interface on the Company’s behalf with potential and actual commercial partners. The Company issued 2,000,000 shares of Common Stock as compensation for the services rendered which were fully earned on the date of issue. These shares were valued at $84,000 at the date of grant.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On July 11, 2022, the Board approved the issuance of  2,000,000 restricted shares of Common Stock to Richard Rosenblum, the Company’s President and Chief Financial Officer. These shares were valued at $110,000 at the date of grant.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On August 5, 2022, the Board approved the issuance of 3,000,000 shares of Common Stock to Samad Harake or his designees as compensation for the services rendered which were fully earned on the date of issue., Mr. Harake is the president and control person of Frictionless. These shares were valued at $165,000 at the date of grant.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>b.</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Restricted stock awards</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>A summary of restricted stock activity during the period January 1, 2021 to September 30, 2022 is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> restricted<br/> shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> average<br/> fair market<br/> value per<br/> share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> unvested<br/> restricted<br/> shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> average<br/> fair market<br/> value per<br/> share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total vested<br/> restricted<br/> shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> average<br/> fair market<br/> value per share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; font-weight: bold; text-indent: -9pt; padding-left: 9pt">Outstanding January 1, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">20,495,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">15,371,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">5,123,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 9pt">Granted and issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-178">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-179">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt">Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,500,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.050</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,500,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.050</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-180">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-181">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Vested</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-182">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-183">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,123,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.049</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,123,750</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.049</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-indent: -9pt; padding-left: 9pt">Outstanding December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,495,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.049</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,247,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.049</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,247,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.049</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 9pt">Granted and issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.055</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-184">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-185">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.055</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt">Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-186">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-187">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-188">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-189">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-190">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-191">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Vested</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-192">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-193">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,123,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.049</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,123,750</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.049</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Outstanding September 30, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">23,495,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.050</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">5,123,750</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.049</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">18,371,250</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.050</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The restricted stock granted, issued and exercisable at September 30, 2022 is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Restricted Stock Granted</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Restricted Stock Vested</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Grant date <br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Granted</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Fair Value<br/> per<br/> Share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Vested</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Fair Value<br/> per<br/> Share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 17%; text-align: right">20,495,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 17%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 17%; text-align: right">15,371,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 17%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">$</td><td style="text-align: right">0.050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.050</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.055</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,000,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.055</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,000,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.055</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">23,495,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.050</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">18,371,250</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.050</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company has recorded an expense of $172,766 and $44,165 for the three months ended September 30, 2022 and 2021, respectively and $298,298 and $188,448 for the nine months ended September 30, 2022 and 2021, respectively. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>c.</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Preferred Stock</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of September 30, 2022 and December 31, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>d.</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Warrants</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>  </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Effective July 8, 2022 (the “Effective Date”), the Company entered into an Endorsement Agreement with Pez-Mar, Inc., a California corporation (“Pez-Mar”), to furnish the services of Mario Lopez (“Lopez”). Pursuant to the Endorsement Agreement, Lopez will act as a Company spokesperson in connection with the promotion, advertisement and endorsement of the Company’s physical and virtual payment processing and money remittance business and the Company’s related products and services.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Endorsement Agreement has a term of two (2) years from the Effective Date (the “Term”), which is subject to earlier termination on customary terms and conditions. The parties have agreed to certain deliverables of Lopez during the term of the agreement, including with respect to social media posts, television commercials, interviews and photo shoots. The Endorsement Agreement also contains other customary terms, covenants and conditions, including representations and warranties, restrictions on endorsements of competitive products during the term of the agreement, confidentiality, indemnification, and Pez-Mar and Lopez’s independent contractor status.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>As compensation for the services provided under the Endorsement Agreement, Lopez or their designees are entitled to the following payments: (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90<sup>th</sup> day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Fifteen Million (15,000,000) shares of the Common Stock at an exercise price of $0.0345 per share. The Warrants shall have a three-year term commencing from the Effective Date. The right to exercise the Warrants shall be subject to vesting during the Term but shall vest in full upon the consummation of a fundamental transaction involving the Company or upon certain termination events provided for in the Endorsement Agreement. The Exercise Price may be payable via “cashless exercise”, unless the underlying Shares are registered under an effective registration statement under the Securities Act of 1933, as amended. The Shares are subject to certain “piggyback” registration rights.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On August 30, 2022, the Company extended the maturity date of convertible notes issued to Cavalry and Mercer and agreed to grant each note holder a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share with an expiration date of August 30, 2027. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nine months<br/> ended<br/> September 30,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 90%">Exercise price</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.0345 to 0.15 </span> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.14 to 3.27</span> </td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected life</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 to 5 years </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected volatility of underlying stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">189.1 to 199.2 </span> </td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected dividend rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>A summary of warrant activity during the period January 1, 2021 to September 30, 2022 is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Shares<br/> Underlying<br/> Warrants</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Exercise<br/> price per<br/> share</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted<br/> average<br/> exercise<br/> price</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-weight: bold">Outstanding January 1, 2021 </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">51,188,572</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.05</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.05</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Granted </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">66,302,515</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">     0.05 to 0.24</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.16</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited/Cancelled </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(20,000,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.24</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.24</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Exercised </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(60,186,982</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.05</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.05</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Outstanding December 31, 2021 </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">37,304,105</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.05 – 0.1875</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.12</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Granted </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  0.0345 – 0.15</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.07</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited/Cancelled </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-194">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-195">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-196">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Exercised </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-197">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-198">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-199">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; font-weight: bold">Outstanding September 30, 2022 </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">58,304,105</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  0.05 – 0.1875</span></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.11</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The warrants outstanding and exercisable at September 30, 2022 are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">0.0345</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">15,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">         2.77</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">                 </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">8,437,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">                </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">        2.77</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">$</td><td style="text-align: right">0.05</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,823,813</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.03</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,823,813</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.03</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td style="text-align: right">0.15</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,053,625</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.73</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,053,625</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.73</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.1875</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,426,667</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3.46</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,426,667</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3.46</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">58,304,105</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">3.34</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.11</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">51,741,605</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.11</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">3.42</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The warrants outstanding have an intrinsic value of $0 as of September 30, 2022 and December 31, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>e.</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Stock options</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The maximum number of securities available under the Plan is 800,000 shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The maximum number of securities available under the 2021 Plan is 53,000,000 shares of Common Stock.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; "><span>Under the 2021 Plan the company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span> <b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On July 11, 2022, the Board approved, granted and issued 15,000,000 ten-year incentive stock options, with immediate vesting, to the Company’s Chairman and Chief Executive Officer at an exercise price of $0.15 per share. This resulted in an immediate expense of $823,854 for the three and nine months ended September 30, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On September 13, 2022, the Company granted ten-year options exercisable for 200,000 shares of Common Stock, with immediate vesting, to each of its four non-executive directors, totaling options exercisable for 800,000 shares of Common Stock at an exercise price of $0.04 per share. This resulted in an immediate expense of $31,970 for the three and nine months ended September 30, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The fair value of the options granted and issued were determined by using a Black Scholes valuation model using the following assumptions:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Nine months<br/> ended<br/> September 30,<br/> 2022</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercise price </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$ 0.04 to 0.15  </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Risk free interest rate </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2.99 to 3.42 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected life </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 10.0 years  </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected volatility of underlying stock </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 206.4 to 208.4 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Expected dividend rate </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>A summary of option activity during the period January 1, 2021 to September 30, 2022 is as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Shares<br/> Underlying<br/> options</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Exercise<br/> price per<br/> share</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted<br/> average<br/> exercise<br/> price</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-weight: bold">Outstanding January 1, 2021 </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">100,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.40</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Granted </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,416,666</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  0.15 – 0.24</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.15</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited/Cancelled </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-200">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-201">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-202">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Exercised </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-203">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-204">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-205">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Outstanding December 31, 2021 </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,516,666</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.15 to 0.40</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.15</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Granted </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,800,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  0.04 – 0.15</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.14</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited/Cancelled </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-206">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-207">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-208">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Exercised </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-209">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-210">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-211">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; font-weight: bold">Outstanding September 30, 2022 </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">46,316,666</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.04 to 0.40</span></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.15</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The options outstanding and exercisable at September 30, 2022 are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Options Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">0.04</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">800,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">         9.96</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">                  </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">800,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">               </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">        9.96</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"> </td><td style="text-align: right">0.15</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">45,208,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9.19</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">35,625,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9.27</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: right">0.24</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">208,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">208,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8.40</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right">0.40</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">100,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">6.25</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">100,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">6.25</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">46,316,666</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">9.19</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.15</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">36,733,333</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.15</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">9.27</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The options outstanding have an intrinsic value of $0 as of September 30, 2022 and December 31, 2021, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The option expense was $950,290 and $1,196,566 for the three months ended September 30, 2022 and 2021, respectively and $1,139,220 and $1,288,174 for the nine months ended September 30, 2022 and 2021, respectively.</span> </p> 750000000 0.0001 376901679 376901679 367901679 367901679 2000000 84000 3000 2000000 84000 2000000 110000 3000000 165000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> restricted<br/> shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> average<br/> fair market<br/> value per<br/> share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> unvested<br/> restricted<br/> shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> average<br/> fair market<br/> value per<br/> share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total vested<br/> restricted<br/> shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> average<br/> fair market<br/> value per share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; font-weight: bold; text-indent: -9pt; padding-left: 9pt">Outstanding January 1, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">20,495,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">15,371,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">5,123,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 9pt">Granted and issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-178">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-179">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt">Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,500,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.050</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,500,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.050</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-180">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-181">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Vested</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-182">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-183">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,123,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.049</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,123,750</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.049</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-indent: -9pt; padding-left: 9pt">Outstanding December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,495,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.049</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,247,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.049</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,247,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.049</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 9pt">Granted and issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.055</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-184">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-185">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.055</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt">Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-186">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-187">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-188">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-189">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-190">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-191">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Vested</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-192">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-193">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,123,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.049</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,123,750</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.049</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Outstanding September 30, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">23,495,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.050</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">5,123,750</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.049</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">18,371,250</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.050</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> 20495000 0.049 15371250 0.049 5123750 0.049 2500000 0.05 2500000 0.05 1500000 0.05 1500000 0.05 -6123750 -0.049 6123750 0.049 21495000 0.049 10247500 0.049 11247500 0.049 2000000 0.055 2000000 0.055 -5123750 -0.049 5123750 0.049 23495000 0.05 5123750 0.049 18371250 0.05 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Restricted Stock Granted</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Restricted Stock Vested</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Grant date <br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Granted</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Fair Value<br/> per<br/> Share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Vested</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Fair Value<br/> per<br/> Share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 17%; text-align: right">20,495,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 17%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 17%; text-align: right">15,371,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 17%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">$</td><td style="text-align: right">0.050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.050</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.055</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,000,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.055</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,000,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.055</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">23,495,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.050</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">18,371,250</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.050</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 0.049 20495000 0.049 15371250 0.049 0.05 1000000 0.05 1000000 0.05 0.055 2000000 0.055 2000000 0.055 23495000 0.05 18371250 0.05 172766 44165 298298 188448 25000000 0.0001 As compensation for the services provided under the Endorsement Agreement, Lopez or their designees are entitled to the following payments: (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Fifteen Million (15,000,000) shares of the Common Stock at an exercise price of $0.0345 per share. 3000000 0.15 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nine months<br/> ended<br/> September 30,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 90%">Exercise price</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.0345 to 0.15 </span> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.14 to 3.27</span> </td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected life</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 to 5 years </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected volatility of underlying stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">189.1 to 199.2 </span> </td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected dividend rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Nine months<br/> ended<br/> September 30,<br/> 2022</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercise price </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$ 0.04 to 0.15  </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Risk free interest rate </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2.99 to 3.42 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected life </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 10.0 years  </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected volatility of underlying stock </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 206.4 to 208.4 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Expected dividend rate </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.0345 0.15 0.0314 0.0327 P3Y P5Y 1.891 1.992 0 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Shares<br/> Underlying<br/> Warrants</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Exercise<br/> price per<br/> share</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted<br/> average<br/> exercise<br/> price</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-weight: bold">Outstanding January 1, 2021 </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">51,188,572</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.05</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.05</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Granted </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">66,302,515</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">     0.05 to 0.24</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.16</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited/Cancelled </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(20,000,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.24</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.24</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Exercised </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(60,186,982</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.05</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.05</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Outstanding December 31, 2021 </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">37,304,105</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.05 – 0.1875</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.12</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Granted </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  0.0345 – 0.15</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.07</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited/Cancelled </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-194">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-195">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-196">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Exercised </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-197">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-198">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-199">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; font-weight: bold">Outstanding September 30, 2022 </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">58,304,105</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  0.05 – 0.1875</span></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.11</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 51188572 0.05 0.05 66302515 0.05 0.24 0.16 -20000000 0.24 0.24 -60186982 0.05 0.05 37304105 0.05 0.1875 0.12 21000000 0.0345 0.15 0.07 58304105 0.05 0.1875 0.11 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">0.0345</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">15,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">         2.77</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">                 </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">8,437,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">                </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">        2.77</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">$</td><td style="text-align: right">0.05</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,823,813</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.03</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,823,813</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.03</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td style="text-align: right">0.15</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,053,625</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.73</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,053,625</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.73</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.1875</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,426,667</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3.46</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,426,667</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3.46</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">58,304,105</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">3.34</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.11</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">51,741,605</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.11</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">3.42</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> 0.0345 15000000 P2Y9M7D 8437500 P2Y9M7D 0.05 10823813 P3Y10D 10823813 P3Y10D 0.15 30053625 P3Y8M23D 30053625 P3Y8M23D 0.1875 2426667 P3Y5M15D 2426667 P3Y5M15D 58304105 P3Y4M2D 0.11 51741605 0.11 P3Y5M1D 0 0 P10Y 800000 100000 P10Y 53000000 15000000 0.15 823854 823854 On September 13, 2022, the Company granted ten-year options exercisable for 200,000 shares of Common Stock, with immediate vesting, to each of its four non-executive directors, totaling options exercisable for 800,000 shares of Common Stock at an exercise price of $0.04 per share. 31970 31970 0.04 0.15 0.0299 0.0342 P10Y 2.064 2.084 0 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Shares<br/> Underlying<br/> options</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Exercise<br/> price per<br/> share</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted<br/> average<br/> exercise<br/> price</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-weight: bold">Outstanding January 1, 2021 </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">100,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.40</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Granted </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,416,666</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  0.15 – 0.24</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.15</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited/Cancelled </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-200">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-201">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-202">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Exercised </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-203">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-204">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-205">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Outstanding December 31, 2021 </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,516,666</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.15 to 0.40</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.15</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Granted </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,800,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  0.04 – 0.15</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.14</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited/Cancelled </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-206">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-207">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-208">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Exercised </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-209">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-210">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-211">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; font-weight: bold">Outstanding September 30, 2022 </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">46,316,666</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.04 to 0.40</span></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.15</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 100000 0.4 0.4 30416666 0.15 0.24 0.15 30516666 0.15 0.4 0.15 15800000 0.04 0.15 0.14 46316666 0.04 0.4 0.15 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Options Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">0.04</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">800,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">         9.96</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">                  </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">800,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">               </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">        9.96</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"> </td><td style="text-align: right">0.15</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">45,208,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9.19</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">35,625,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9.27</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: right">0.24</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">208,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">208,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8.40</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right">0.40</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">100,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">6.25</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">100,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">6.25</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">46,316,666</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">9.19</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.15</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">36,733,333</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.15</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">9.27</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.04 800000 P9Y11M15D 800000 P9Y11M15D 0.15 45208333 P9Y2M8D 35625000 P9Y3M7D 0.24 208333 P8Y4M24D 208333 P8Y4M24D 0.4 100000 P6Y3M 100000 P6Y3M 46316666 P9Y2M8D 0.15 36733333 0.15 P9Y3M7D 0 0 950290 1196566 1139220 1288174 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>11</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>NET LOSS PER SHARE</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Basic loss per share is based on the weighted-average number of common shares outstanding during each period. Diluted loss per share is based on basic shares as determined above plus Common Stock equivalents. The computation of diluted net loss per share does not assume the issuance of common shares that have an anti-dilutive effect on net loss per share. For the three and nine months ended September 30, 2022 and 2021 all warrants, options and convertible debt securities were excluded from the computation of diluted net loss per share.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three and nine months ended September 30 2022 and 2021 are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three and nine<br/> months ended<br/> September 30,<br/> 2022<br/> (Shares)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three and nine<br/> months ended<br/> September 30,<br/> 2021<br/> (Shares)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Convertible debt</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">14,738,682</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">13,626,666</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Stock options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,316,666</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,516,666</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants to purchase shares of Common Stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">58,304,105</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">37,304,104</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">119,359,453</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">81,447,436</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three and nine<br/> months ended<br/> September 30,<br/> 2022<br/> (Shares)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three and nine<br/> months ended<br/> September 30,<br/> 2021<br/> (Shares)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Convertible debt</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">14,738,682</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">13,626,666</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Stock options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,316,666</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,516,666</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants to purchase shares of Common Stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">58,304,105</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">37,304,104</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">119,359,453</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">81,447,436</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 14738682 14738682 13626666 13626666 46316666 46316666 30516666 30516666 58304105 58304105 37304104 37304104 119359453 119359453 81447436 81447436 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>12</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>RELATED PARTY TRANSACTIONS</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The following transactions were entered into with related parties:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>James Fuller</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On February 22, 2021, the Board awarded James Fuller ( a director of the Company until November 2, 2022 when he voluntarily retired as a member of the Board) options under the Company’s 2018 Stock Incentive Plan to purchase 208,333 shares of Common Stock. The options are exercisable for a period of ten years from the date of grant, vest in full on the date of grant and have an exercise price of $0.24 per share.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On July 22. 2021, the Company granted Mr. Fuller 2,000,000 shares of Common Stock, valued at $154,000. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Additionally, the Board approved the repricing of the options exercisable for 208,333 shares of Common Stock granted to Mr. Fuller on February 22, 2021, from $0.24 per share to $0.15 per share.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On September 13, 2022, the Company granted Mr. Fuller ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The option expense for Mr. Fuller for the three and the nine months ended September 30, 2022 was $7,993.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>Andrey Novikov</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On February 22, 2021, the Board awarded Andrey Novikov options under the Company’s 2018 Stock Incentive Plan to purchase 208,333 shares of Common Stock. The options are exercisable for a period of ten years from the date of grant, vest in full on the date of grant and have an exercise price of $0.24 per share. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On May 31, 2021, Mr. Novikov notified the Board of his decision to resign as a member of the Board and as Secretary of the Company, effective as of June 1, 2021. Since August 2021, Mr. Novikov has been on suspension from service as the Company’s Chief Technology Officer. On November 11, 2022, with the recommendation of a special committee of disinterested members of the Board who had reviewed this matter, the Board approved the formal termination of Mr. Novikov’s employment with the Company for “cause.”</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>William Corbett</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On February 22, 2021, the Board appointed William Corbett as the Company’s Chief Executive Officer and Interim Chief Financial Officer, as its Chairman of the Board and issued him a five-year warrant to purchase 20,000,000 shares of the Common Stock at an exercise price of $0.24 per share. The Board also agreed to increase Mr. Corbett’s monthly base salary to $30,000. The warrant expense for Mr. Corbett for the year ended December 31, 2021 was $4,327,899.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On August 16, 2021, the Company and Mr. Corbett entered into an Executive Employment Agreement that replaced and superseded the previous executive employment agreement (the “August 2021 Corbett Employment Agreement”). The purpose of the August 2021 Corbett Employment Agreement was to provide a replacement grant for warrants previously granted to Mr. Corbett under the terms of his previous employment agreement with the Company. Pursuant to the August 2021 Corbett Employment Agreement, Mr. Corbett would continue to serve as the Company’s Chief Executive Officer on a full time basis effective as of the date of the August 2021 Corbett Employment Agreement until the close of business on December 31, 2024. Mr. Corbett’s base salary will be $30,000 per month, which shall be paid in accordance with the Company’s standard payroll practice for its executives, managers and salaried employees. In addition, the August 2021 Corbett Employment Agreement provides that: (1) Mr. Corbett will be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from time to time; (2) the Company will grant to Mr. Corbett options to purchase 20,000,000 shares of Common Stock at a per share exercise price of $0.15; and (3) a car allowance for Mr. Corbett in the amount of $800 per month. Fifty percent (50%) of the shares subject to the options shall vest on the grant date and the other 50% of the shares subject to the option shall vest at the rate of 1/36 per month over a three-year period. The options will be exercisable for a period of ten years after the date of grant and the Company shall provide for cashless exercise of the option. The options are being granted pursuant to the Company’s 2021 Stock Incentive Plan which was approved by the Board in August 2021, subject to approval of the 2021 Plan by the shareholders, which approval was obtained at the annual general meeting held on October 22, 2021. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>In addition, the Company and Mr. Corbett entered into an Indemnification Agreement on August 16, 2021 (the “August 2021 Corbett Indemnification Agreement”), pursuant to which the Company agreed to indemnify Mr. Corbett to indemnify Indemnitee to the fullest extent permitted by or under the Nevada Corporation Law in respect of claims, including third-party claims and derivative claims and provides for advancement of expenses. The August 2021 Corbett Indemnification Agreement amends the indemnification agreement in effect prior to entering into the August 2021 Corbett Indemnification Agreement to provide that unless Company shall pay Mr. Corbett’s attorneys’ fees and costs, including the compensation and expenses of any arbitrator, unless the arbitrator or the court determines that (a) Company has no liability in such dispute, or (b) the action or claims by Executive are frivolous in nature. In any other case or matter, the Company and Mr. Corbett shall each bear its or his own attorney fees and costs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On July 11, 2022, the Company granted Mr. Corbett ten-year options exercisable for 15,000,000 shares of Common Stock at an exercise price of $0.15 per share.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The option expense for Mr. Corbett for the three and the nine months ended September 30, 2022 was $890,442 and $1,023,614, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>Clifford Henry</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On May 1, 2021, the Company appointed Mr. Henry to the Board.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On July 22, 2021, the Company granted Mr. Henry 2,000,000 shares of Common Stock, valued at $154,000.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Mr. Henry has an oral consulting arrangement with the Company whereby he is paid $3,500 per month for financial and capital markets advice. This consulting agreement commenced in May, 2021 and was approved and ratified by the Board in March 2022. This consulting agreement and related payments were terminated in September 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On September 13, 2022, the Company granted Mr. Henry, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The option expense for Mr. Henry for the three and the nine months ended September 30, 2022 was $7,993.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>Madisson Corbett</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On May 1, 2021, the Company appointed Ms. Corbett to the Board. Ms. Corbett is the daughter of Mr. William Corbett, the Company’s Chief Executive Officer and Chairman of the Board.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On July 22, 2021, the Company granted Ms. Corbett 2,000,000 shares of Common Stock, valued at $154,000.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On September 13, 2022, the Company granted Ms. Corbett, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>  </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The option expense for Ms. Corbett for the three and the nine months ended September 30, 2022 was $7,993.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>  </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>David Rios</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On July 22, 2021, the Company appointed David Rios to the Board.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On July 22, 2021, the Company granted Mr. Rios 1,000,000 shares of Common Stock, valued at $77,000. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On September 13, 2022, the Company granted Mr. Rios, immediately vesting, <span style="-sec-ix-hidden: hidden-fact-212">ten</span>-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The option expense for Mr. Rios for the three and the nine months ended September 30, 2022 was $7,993.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span><b>Richard Rosenblum</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On July 22, 2021, the Company appointed Richard Rosenblum as President and Chief Financial Officer of the Company. In addition, Mr. Rosenblum was elected to the Board to serve until the Company’s next annual meeting of shareholders and was subsequently appointed as the Company’s Secretary.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On July 27, 2021, the Company and Mr. Rosenblum entered into an Executive Employment Agreement (the “Employment Agreement”), pursuant to which Mr. Rosenblum will serve as the Company’s President and Chief Financial Officer on a full time basis effective as of July 1, 2021. The effectiveness of the Employment Agreement is subject to the approval of the Employment Agreement by the Board, unless earlier terminated as provided in the Employment Agreement. The term of the Employment Agreement is until December 31, 2024. Mr. Rosenblum’s base salary will be $18,000 per month. In addition, the Employment Agreement provides that: (1) Mr. Rosenblum will be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from time to time; and (2) the Company will grant to Mr. Rosenblum options to purchase 10,000,000 shares of Common Stock at a per share exercise price equal to the fair market value of the Common Stock, as reflected in the closing price of the Common Stock on the OTC exchange or, in the event the stock is up listed, on a national stock exchange, on the date of grant (the “Options”)”. Fifty percent (50%) of the shares subject to the Options shall vest on the grant date and the other 50% of the shares subject to the Option shall vest at the rate of 1/36 per month over a three-year period. The Options will be exercisable for a period of ten (10) years after the date of grant and the Company shall provide for cashless exercise of the Option by Executive. The options are being granted pursuant to the Company’s 2021 Stock Incentive Plan which was approved by the Board in August 2021, subject to approval of the 2021 Plan by the shareholders, which approval was obtained at the annual general meeting held on October 22, 2021. The Options are being granted pursuant to the Company’s 2021 Stock Incentive Plan. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>If Mr. Rosenblum’s employment with Company is terminated at any time during the term of the Employment Agreement other than for Cause (as defined in the Employment Agreement), or due to voluntary termination, retirement, death or disability, then Mr. Rosenblum shall be entitled to severance equal to fifty percent (50%) of his annual base salary rate in effect as of the date of termination. If Mr. Rosenblum’s employment with Company is terminated at any time during the term of the Employment Agreement other than for Cause (as defined in the Employment Agreement), or due to voluntary termination, retirement, death or disability, within 12 months following an Acquisition (as defined in the Employment Agreement), then Mr. Rosenblum shall be entitled to severance equal to 100% of his annual base salary rate in effect as of the date of termination. Severance payments shall be subject to execution and delivery of a general release in favor of the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On August 16, 2021, the Company entered into an amendment to the Rosenblum Executive Employment Agreement (the “First Amendment”) with Mr. Rosenblum. Under the terms of the Executive Employment Agreement, the Company had agreed to grant to Mr. Rosenblum an option to purchase 10,000,000 (ten million) common shares of Company Stock at a per share exercise price equal to the fair market value of the Common Stock, as reflected in the closing price of the Common Stock on the OTC exchange or, in the event the stock is uplisted, on a national stock exchange, on the date of grant (the “Option”).” The First Amendment provided that the Option was granted on August 31, 2021 at an exercise price of $0.15 per share.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>In addition, the Company and Mr. Rosenblum entered into an Indemnification Agreement, pursuant to which the Company agreed to indemnify Mr. Rosenblum to indemnify Indemnitee to the fullest extent permitted by or under the Nevada Corporation Law in respect of claims, including third-party claims and derivative claims and provides for advancement of expenses.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>On July 11, 2022, the Company granted Mr. Rosenblum 2,000,000 restricted shares of Common Stock valued at $110,000, all of which are vested.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The option expense for Mr. Rosenblum for the three months and nine months ended September 30, 2022 was $27,879 and $83,636, respectively.</span></p> 208333 0.24 2000000 154000 208333 0.24 0.15 200000 0.04 7993 7993 208333 0.24 20000000 0.24 30000 $4,327,899 30000 the August 2021 Corbett Employment Agreement provides that: (1) Mr. Corbett will be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from time to time; (2) the Company will grant to Mr. Corbett options to purchase 20,000,000 shares of Common Stock at a per share exercise price of $0.15; and (3) a car allowance for Mr. Corbett in the amount of $800 per month. Fifty percent (50%) of the shares subject to the options shall vest on the grant date and the other 50% of the shares subject to the option shall vest at the rate of 1/36 per month over a three-year period. The options will be exercisable for a period of ten years after the date of grant and the Company shall provide for cashless exercise of the option. The options are being granted pursuant to the Company’s 2021 Stock Incentive Plan which was approved by the Board in August 2021, subject to approval of the 2021 Plan by the shareholders, which approval was obtained at the annual general meeting held on October 22, 2021. 15000000 0.15 890442 1023614 2000000 154000 3500 200000 0.04 7993 7993 7993 2000000 154000 200000 0.04 7993 7993 7993 1000000 77000 200000 0.04 7993 7993 7993 The term of the Employment Agreement is until December 31, 2024. Mr. Rosenblum’s base salary will be $18,000 per month. In addition, the Employment Agreement provides that: (1) Mr. Rosenblum will be eligible for a cash bonus as determined by the Board to the extent the Company achieves (or exceeds) annual revenue or other financial performance objectives established by the Board, in its sole discretion, from time to time; and (2) the Company will grant to Mr. Rosenblum options to purchase 10,000,000 shares of Common Stock at a per share exercise price equal to the fair market value of the Common Stock, as reflected in the closing price of the Common Stock on the OTC exchange or, in the event the stock is up listed, on a national stock exchange, on the date of grant (the “Options”)”. Fifty percent (50%) of the shares subject to the Options shall vest on the grant date and the other 50% of the shares subject to the Option shall vest at the rate of 1/36 per month over a three-year period. The Options will be exercisable for a period of ten (10) years after the date of grant and the Company shall provide for cashless exercise of the Option by Executive. 0.50 1 10000000 0.15 2000000 110000 27879 83636 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>13</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>COMMITMENTS AND CONTINGENCIES</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>The Company has convertible notes, disclosed under note 8 above, which mature on November 16, 2022. Should these notes not be converted to Common Stock prior to that date, the Company may need to repay the principal and interest outstanding on these notes.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>14</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>SUBSEQUENT EVENTS</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On November 2, 2022, the Company conducted its 2022 annual meeting of stockholders.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">At the Annual Meeting, the Company’s stockholders (i) elected each of William D. Corbett, Richard Rosenblum, Madisson Corbett, Clifford Henry and David Rios as directors’ of the Company until the next annual meeting or until their successors shall be elected and qualified, (ii) ratified the appointment of RBSM LLP as the Company’s independent registered public accounting firm for fiscal year ended December 31, 2022, (iii) approved an amendment to the Company’s Articles of Incorporation to effect a reverse stock split of the issued and outstanding shares of common stock at a ratio (to be determined in the discretion of the Company’s Board during a two year period ending on November 2, 2024) within a range of one (1) share of Common Stock for every two (2) to thirty (30) shares of Common Stock, and (iv) approved a potential adjournment of the annual meeting,</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company’s stockholders did not approve the proposed amendment to the Company’s Articles of Incorporation to provide the board of directors with the authority to, at its discretion, fix by resolution or resolutions, the designations, rights and privileges of the Company’s authorized preferred stock.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span>Other than the above, the Company has evaluated subsequent events through the date the financial statements were issued, and did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.</span></p> At the Annual Meeting, the Company’s stockholders (i) elected each of William D. Corbett, Richard Rosenblum, Madisson Corbett, Clifford Henry and David Rios as directors’ of the Company until the next annual meeting or until their successors shall be elected and qualified, (ii) ratified the appointment of RBSM LLP as the Company’s independent registered public accounting firm for fiscal year ended December 31, 2022, (iii) approved an amendment to the Company’s Articles of Incorporation to effect a reverse stock split of the issued and outstanding shares of common stock at a ratio (to be determined in the discretion of the Company’s Board during a two year period ending on November 2, 2024) within a range of one (1) share of Common Stock for every two (2) to thirty (30) shares of Common Stock, and (iv) approved a potential adjournment of the annual meeting,  0.00 -0.01 -0.02 -0.04 323034956 364722331 370615966 375956027 P10Y false --12-31 Q3 0001591913 NONE N/A N/A EXCEL 71 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

Q4AL].?XQNGAD MJXPMG_B9WO:^'#>DG+M;!='KKF#&HC>O+$CJ*A?SA&HYC[N; A2F_V[(2YC- M]_87SRS-^%'O33['S(+Q_"+?FV3YK.\Z(5$,49=3O'39S6K4/U$:J>I2(F@>JPZ$RT _Z-*%/V(5J'E3S49J8BZJ; M3)5WDPF'=__]4!S*_J\V'M".,:AF0#4*U4RH9D$U&ZHY4,V%:AY4\U&:F-FJ M1TW==!W@;J"G0MO3H)H!U2A4,Z&:!=5LJ.9 -1>J>5#-1VEB>*N6'E7>TM/J M;A!RJW5NHJ&5"-0C43JEE0S89J#E1SH9H'U7R4)L:XZBU21^@S M5&A;$50SH!J%:B94LZ":#=4JR_]G_F5%6. MM@TP5#.@&BVU_1-?I>XS^]"J5L.J-K2J ]52O1PSQD M4T)W33L?I]-PS!+I :^<;!TY:'\.5*-0S81J%E2SH9H#U5RHYD$U'Z6)\:WZ MJ>5#-1VEB>/?^'IF\-^@'/PDC M5ULG^/C^0TKM_8<,:%T*U4RH9D$U&ZHY4,V%:AY4\U&:F,ZJ0TF3=R@][F7R ML/6\^:>MY45:AW6CR3^9:T!K4JAF0C4+JME0S8%J+E3SH)J/TL2@5FU)VIG; M*[7[6)M<:YU(:$\25*.E)ER<5;5A3S^<,()V&S6L:D.K.E#-A6H>5/-1FIBV MJH](D_<1Y7^,MYR9K8Y?/RV":/_:Z>'EU-H<0GN,H)H!U2A4,Z&:!=5LJ.9 M-1>J>5#-1VEBIJM&)&V GD6"]B1!-0.J4:AF0C4+JME0S8%J+E3SH)J/TL3P M5JU+FKQUZ0'-AM!-0.J4:AF0C4+JME0S8%J+E3SH)J/TL3P5HU+NKQQ*;]5 M>Q@%&2NNP(3QI#:OT$XEJ&9 -0K53*AFG=F22I?D=ZBJNY&,#5T0!ZJY4,V# M:CY*$\-9M27I\ML&G3\T;CA)+*_3.L#0;B6H1J&:"=4LJ&9#-0>JN5#-@VH^ M2A,S774KZ1KZ:!G:J 35#*A&H9H)U2RH9D,U!ZJY4,V#:CY*$\-;-3/I9YJ9 M?FB26(ZV#C!2,Z :+;7]R=IAW10QM*K5L*H-K>I -1>J>5#-1VEBZ*K&)%W> MF'2^5:(V=-#^)*AF0#4*U4RH9D$U&ZHY4,V%:AY4\U&:&."JUTGOHP]YH4U- M4,V :A2JF5#-@FHV5'.@F@O5/*CFHS0QO%53DRZ_NU*S"6)H'Q-4,Z :A6HF M5+/.;$GI!#&T:0FJN5#-@VH^2A/#634MZ?*FI<_AF)]V3LCG.&71T^+<+#"T M60FJ&5"-0C43JEE0S89J#E1SH9H'U7R4)@:W:GK2T7=8TJ$-3U#-@&H4JIE0 MS8)J-E1SH)H+U3RHYJ,T(;R]JN&I)[_#TF>69DDXSAK?!UCNMJ>5#-1VEB+*M6IMZ9/^=V]F_$R('6.83V,4$U M6FK[GQY5!\/!Z. Z#+2H55-TJ/6U@S\W8T.+.E#-A6H>5/-1FABOJAFI)V]& M>@R6P83801)\8]+33+G3.F709B.H1J&:"=4LJ&9#-0>JN5#-@VH^2A,S6S4; M]=#-1CUHLQ%4,Z :A6HF5+.@F@W5'*CF0C4/JODH30QOU6S4DS<;M?I3,W*K M=6ZA/490C4(U$ZI94,V&:@Y4RD<\8R(\B"^[LE M2V;L@2T6*1GG-T+*WU3W?DH2-N6156[?JY>=HY]3Y=94:GYN*;=V\?-.Q=_? MK8(9^Q DLS!*R8)->:GNVP%?DTDXF^^^R>+5NTM^Q/\49UF\++Z&PO=V]R:W-H965T*3=M"].!)M-U^^U$/$4V;ID1''I(7B20?[_@[ M*[S_B>JMH_@YF1-"P<_ #Y.^,:=T<6::R7A. C]*(E];V0W,8@60:!&_\Z)WZT[AO0>+EP MY\WF-+U@#GH+=T9&A#XL;F-V9I9>)EY PL2+0A"3:=_X L^&MIT.R"P>/;). M-HY!BO(41<_IR=6D;UCIC(A/QC1UX;(_*S(DOI]Z8O/XMW!JE#'3@9O'+]Y_ MS^ 9S).;D&'D?_._"3[#=:%K66 \3*A M45 ,9C,(O##_Z_XL$K$Q@/F1#T#% +0]H+5G "X&X PTGUF&=>%2=]"+HS6( M4VOF+3W(F'Z-(QJS3STVC@Y&]S?#/[_>?+NXO!N]?]=!L/T97/[U M<'7_-_AP0:CK^V-*)H!-;_R_<7L?@,F M2.8N,^F9E$TO#6*.BZFZ;2!==12.<)N PG9"(9/U2/ATCAP&1Y*9.# M7I)SCI0>1V1Q"K#U"2 +(=F$U,,OR)@-A]EPJ)@.+K\KG/FS]_B[CZCK"^G/ M,@U^7)/@B<3_R%*N])BN$6?)PAV3OL$6@83$*V(,WK^#+>NS#+ MR,P+P_3D@Q>"46;T49:9/)R3A4M+Q&J H-UU+,OJF:M-:HFAM64H$+5*HE8C M1"0_JL!I[QG"T5B MYXAV DFG).D<1L+*[91X[(HY=,,Q*]C5*,I(\G\9(/O7Z^R@GD 5:[=D[1[& M^L@N5>,IG6O@O=Z/0 \M+AHL)?_W3!VE=^>*Q$SM@:GKQ4R6Q,],>*Y<53DJJ#*-#^GI'8BJX&(-UU-@R7.5E7*_54OO67I$;\B9F@HLYV'E#M>P MO:?(7$/>Q,QQ:0CK:,/]]]#AO5<1>%/.0@O9;6='XLLL'=R&3.C+5PO$I1]2 M2S]MO'J-6!%U<\8.1+CM;*-)#'>2(*)Q_8:4*J<&FGY3I@ZIL2@6CFJW;8B+ M+Z067]78!W1PZI@ZW$BSAT-KD<-1,SM[%76D?% MN8S":AGU>+S>2AU9>]4]QL,OS)47[KZA>G6 (E-DKB%OXMLM7+S938HWG>IE M2U2:3,U5VXEH7,S9:C%WI-ZJB%JU!?9B5A>+:S.[R4W+>A6M"%FY!::>FOXR M;G-=93>YGUFSO*EC:I2W!AR)>=EX/:W)#=']Q:X(4_DDI-HN!S$WW@T-2#S+ M7IE-P#A:AC1_3;2\6KZ6^R5[&=7DYOD[O==NS):9!/ADRH9:IVU6:./\-=G\ MA$:+[$W3IXC2*,@.Y\2=D#@U8)]/HXB^G*0!RI>5!_\!4$L#!!0 ( .U& M;E4.);%PP0, ",2 9 >&PO=V]R:W-H965TS4=66PQ(3)$YYA MJI_,N4B8TD.Q<&4FD(4V*(E=ZGD]-V%1ZDQ&=NY:3$9\I>(HQ6L!HOF?70H_<,DL8)9C*B*<@<#YVWI'3,]HU M 7;%GQ%NY-8]F%9FG-^:P<=P['@&$<88*)."Z7-],7SP:4]-_"Y=?O'[_]#2\O4+$H MEJ_@#4SUUQ"N8@0^U^]"*A$%"D/0\();6 B6FA%+0\ [%$$DV2S&D:LT0%/& M#0HP9SD8N@/,$*YXJI82+M,0PX?QKFZL[([>=W=&&Q-.,3N!CO<:J$]YWLA=UP#MED"[!P+=V"_7O+\U"JU$F+-(P)K%*X1,=V"QUD'- M"PZVH'HGGE\/TR]A^NU@KO7$%IWY<&\V_4=LDD&G3ZB_@\U>";-W&,R#R>RU M(+-?HNPWHOS#O&((F4*XUF@1=,KN$/ZY0L/EOW4P&A,:BSB5&0MP[&@/D"C6 MZ$Q>/",][VV#E@8EW,&!G^BB:B0SC=0ASW,3\I#![K">PF&):?BT^AX^UK?7 MI&_B5;_DWE,KO*BX+ZEDRW7(4\J\J/9 YWZ3S@FMD-(G5GI1<&]2*RLBS5Y4 M)W??:Y1[<\8#]4XJ3R*'FM(^BB=M#(A4#D1:6M"QDB1!I:4+'ZWW0AM'*F$BS,]6JW6]6>V/& ]5. M*X.BAQK4/FJG]5[D[R"25EY$6WK1L7JGC]V(-GVCG;16 M;D1;[HR.4SRMV1@UDEJ9$&UI0DY?O^:GE^?'+%Q")*)<0XUZ'>25\3)?(3B7R@>&9/ 69<*9[8VR6R$(59 MH)_/.5?W U.@/!>:_ )02P,$% @ [49N51(Q>!UC! +A@ !D !X M;"]W;W)K&ULW5EM;]LV$/XKA#H4+;!9(F7'5FH; M:%Z&!FN0+&Y7#,4^,-+9)D*)&DG;"; ?/^HEDI-(]$MG8,B76*1T#Y\[W=U# M,<.5D'=J#J#1?<=N3%EB3,>YG/7@X*%TJ+N#0V#&*6%+_TO@S$F@'I MM1B0TH#DO(N%N-OYDK-RPY'Y2<"1[ M/R/B$8)^0BY2 MS^]3TT^,"Q%;L@B,2Y)J:&)9X 0Y3M8;EV-OZ"X;ECZJEC[:+870/^B2)2Q> MQ-:LLJ+N&:Y^Q;G_6K*J?X P#:HP#39D%,P:XV\P M>[4N>=L5&F?3QI4WV/OH 4S\+"\'KVDDWH[+4G"34ISIARPW%T9V)']@R0P9 MG0[O&EGBEP'"G4& 6^)#:DYD]VY [S=V SOLGGF.:QG$_FMI"/@0F4"*]Z JDWT*BED!LU\#-7<%NW]O<%6II MPU9)^*&NT&_J"D% 6N)3ZPBV"\E560S6#F"%V#>O:VW!P:OI %:9W#-2I)9 M\H,2N,$>>QNSG=0:2+;4P(T;WQ)HBYTOJ=6.V-7N>5YON?6UH^[[ FNQ(Z]& M[,@AQ([48D<.)':D2>R\EMTGJ<6._&=B1YK%C@1!"XE:[,B68K>[P)3(3TB1 MCG?4%IA:](A=])H*<8M=IQUUW_2J99$,7DTA'D*=2:W.Q/[IMW\A!COL.OU: M WV[ANU0B"72BUUGMV57Y=?:YQ_L^\]O^/XSA3AX7HCNVA%N#'*6'U0K%(I% MHHO3W&JV.@S_6!P!UX\7)^F75,Z824T.4V/J=?JF0K!DV105:?8+6P]W MQ_OQCO)?'&T9_RE6 !(]1V$LQM9*RO6%;0M_!1$59VP-L;JS8#RB4IWRI2W6 M'.@\=8I"FSB.:T>S4*3?:)O;.A;R-T*R*'=6&41! MG/W2YWPB]AQ4'+T#R1W(H8-;X]#+'7HI:)99BG5))9V,.-LBGEBK:,E!.C>I MMZ()XJ2,,\G5W4#YRWOO$('GY"5W_QS"H0R!=U^R&_]//VZ=-*)1?>*CH!3'*'-_K2I*-.$A'3!;_TZ0W[#E][ Q&]M,^ MZK'A &//&PQ)85B!ZA=0?2/4U3-P/Q" UCSPU3?PK('JD708QC&2A^*%6%,? MQI9ZZ@G@3V!-WK[!KO-)5]4LF+>'ZISMS4<%:(/@%73TH$ M%>YVM --@I@<%$QG5$?A%A3NJ3H0LJ.&]G./N\K3MM^QX5&?5HB&!='PI'7) ML'0H0UU1\ &&UJAF!7D%@M>Y*+\FOXJNH0S>T>P2[*2?@_R/#5VWYY !KBG# M><%PWO$ID!/HLC:&U"]ZI%OO'>+H'AX5<.R4?\7._^M PPSDH0\6^="I? Y[ M4.N$77T!\9ZDP)W;4&FO!00*PI[2V%?JK;DES:.UJ&X>:+]G/Q+GH+NKS*1D M)AW;5D.LI33&;T-)-$4E_1K 4G%@L^1H;,[71;'A/WJ\GT M^H=9[PQ?F76I6(A9L5S3Y\9%90[1=E&=*EH5N)0KI*M<:;.H\D$.ZH:]X5'= M.HB;9MI2NQ"S=CG!LLI'> 5JLV&5HE0FI.O^B&EIZ;8P\%'2.JLC+67O;3-& MP)?I[JM /MO$,MMQ+*X6.[R?TWU-NS3/MH>O*5=])5 ("^7JG V5%N#9CFMV M(MDZW;1\9%*R*#U< 56:+#%0]Q>,R=U),D"Q[SWY#U!+ P04 " #M1FY5 MZGJ"&W\$ !\& &0 'AL+W=O8@^>>^Y5X?GA,Q@S?@7L0"0Z"F)4S&T%E(NSVU;3!>04''*EI"J M)S/&$RK5)9_;8LF!AMF@)+:)X_3MA$:I-1ID]V[Y:,!6,HY2N.5(K)*$\N=+ MB-EZ:&%K<^,NFB^DOF&/!DLZAPG(S\M;KJ[L,DH8)9"*B*6(PVQH7>#S2Y?H M =D;?T:P%EOG2)?RP-@7??$Q'%J.1@0Q3*4.0=7A$:X@CG4DA>/?(JA5YM0# MM\\WT7_)BE?%/% !5RR^CT*Y&%J!A4*8T54L[]CZ Q0%>3K>E,4B^XW6Q;N. MA:8K(5E2#%8(DBC-C_2I:,36 %5H]0!2#,@:8>>),I3OJ:2C 6=KQ/7;*IH^ MR4K-1BMP4:J_RD1R]312X^1H\NGFZM1H \Q#&RI MP.D4]K0 =KR!_5B!J5=BZG7 =)^1$T)T\0A<339T!WK&Z@]WI;K.U=Q8T1C% MT0Q0E*)GH%Q4H:[/[>8#40\E^:OM&\>1=#5KL&$=P.DRV ]E1Y/"_HH,NO\-%$MPB]/<.PYV0_>V 1 XM\1]UM2$X*ZIYMJ.LW"2\V'H=;FEP' M0<.[+A?T7-_;VV[C MI!7]"BO99WK8N!YN:7M=E,+?50HG(&Z W3VPC,7AEAYW'*5H9W+8::2LL3=< M[V\O4HBS _M,C(V1EC9V%(EH2-Z^S\0X'ZEWOAUIP/724!^NHS00XXBDBR,> M* U%CF_^RMPC#<28&CG>RHWLFIKK.)[;)_M@&5UT4P=CV.]$B_W_>K4;G&XMPN*[77HF]#\MWU MLM=$7]=XG=MRE==!+]S=55Y]OXVEN2TM[2ART9#\D'[;6QO""?!YMNTMT)2M M4IGO#9=WRZWUBWQ#V;R>[\M?4SZ/4H%BF*FASJFO^LKSK>[\0K)EMKW\P*1D M27:Z !H"UR^HYS/&Y.9")RC_X3#Z'U!+ P04 " #M1FY53]EV27<$ "N M%P &0 'AL+W=O@["RF75ZXK_ 5$5%RP)<3JR8SQB$HUY'-7+#G0 M:>(4A2[QO+8;T2!V!KWDWCT?]-A*AD$,]QR)5111_G(-(=OT'>R\WG@(Y@NI M;[B#WI+.80SR<7G/U?)_V'4]'!"'X4D-0];.&(82A1E)Q_)>!.OFD9E0 4,6 M_@RF#X+1?*--IFMYR!_)22+,F<5013$Z2]] MSA*QY:!PS XDBDT0 MZS*.)5=/ ^4G!^,?=\/?O]W]<7/[,'[_KDMPYS.Z_?/Q^X^_T8<;D#0(Q4?T M*QJK]IFN0D!LAMBR*$ @7_13R?PG=)?<%^B?$403X/^J![\@%XD%Y2!ZKE31 MZCE=/XOL.HV,'(CL$HU8+!<"W<93F!K\AW9_3"P KDI3GBORFJMK8D41#'>O AB%'J]]%4D73"5C*AW@#6@X;7PFWUZ;GK;:;[AMC3 MG]RLQ*B9,VI:&=T^ _<# 6C) U]] T^[YS A$PGK''I;O!)+ZD/?4?N> +X& M9_#^'6Y[GTTE3<'P-E/OHFFFVR6"$N_CV*93=4OQ MX=9.N5I'L&CG+-IG:C](KRIZK[W74LUVP]1[^X9[35HBU,D)=LH$<=>\5?LG=: E@QDT#OMU-PIFMGJ0-/A+0V!Z[:= MTEHS"%30[I#&OE)KU2UHG^R(:IX!J)P04B2$U&QB0SZ,.;#B'Y.#TX'*.2C4 M";;+D\IN?FLJK-,19,#*WHA[#_'2@,O-"*F&[5JI<"_8$6,&/2<#I0.4$%-(*V[75*(B# M:!7E[X9&FE:(8X7[N=#*A LAANU*[#RO,MDDF-BEI#V6NEP+Q8;K2K8W*^9L MAAVBWIY^,9H=$C"D4%[$KKQJBRB:T2?*Y>4'>+8)74N MM#+A0E21NJ+JF"653:*W0N.[<$:UAFRJIEIH)V+73F=84=D,53PKK,KQ%X*' MU#W(L:VGYEM>FXU69#=B=^M$- (^3PZ*!?+9*I;IX6A^-S^,_I(7J2 M/:)&ULQ5EM;^(X$/XK5O:TNI-Z)'8@0!>0^L)I5W>]]LKN MK4ZG^^"2 :)-8LXVT$K[X]=.0DP7,"$MVGQH7LC,/#,9/X_M]E:,?Q$S (D> MDS@5?66\@X2N&.([%($LJ?+B%FJ[Z#G?6#^V@ZD_J!.^C-Z11&(#_-[[BZ ML['0>%,*&+ M6-ZSU7LH$FII?V,6B^PO6A7O>@X:+X1D26&L$"11FI_I8U&(#0.5Z&X#4AAD MA7#S0!G*:RKIH,?9"G']MO*F+[)4,VL%+DKU5QE)KGZ-E)T7OW^_O:/ MZ^']Z.V;#L'M=VCXUZ?8#N>#0&]'7CD^]*)@_9V?@"7@.W=E<_*($&E8 .S4 H&V)H'QS! M5D/X0=O7QVY([1)2^UA(Z.REM6L?4;M.";1S?.U>JW/MH=>=ZZ\[MWVH<[ME M4EVKY^_JZC6\)OKW!G1#_+<+I]6;UN=S,:=CZ#M*@ 7P)3B#MV]PX+VS8,6> M40+O^'%V9&L4(9[WAM?/O9@(@83^7%<>R#VNF4Q M7O5S5IM(VRXFK*=A!\.Q*Y5;:-NV"YO6R2AG-M( MPNZN+DL8C.) [.,G$L0H(+$KX!9+ M$/M4PNZN)DL0(XZDAC@>R1)%B.V8DS:^VJ*O!#?[VHLY:9*-;?C7=.@DW'(A=IQ[O"'UD,0!'3UF:LXD60L(3FBL)IHU^95,)+VRN![ CMV,$8R MDB4ACW+R,9IHACP0I!!RR8#%SQ9FD*:22!SC5\6IU2XE\'"\9_^@8A>Q+#&# M&4D?DHC'$VVHH0A6>)/R>[*[A2H>5_*%)&7J&^U*6T\8AQO&25:!Q0FR)"]_ M\5.5AP. X&D&6!7 .@4XSP#L"F!W]>!4 *>K![<"J-#U,G:5.!]S/!U3LD-4 M6@LV.5#95VB1KR27.EEP*G83@>/3S\%7].G+8H'FP3U:W%[?!^B-#QPG*7N+ M+M!"Z#+:I(#("D5)NI%512S&%)C8+0=CG8N#2#H]K)S>E$ZM9YS:Z([D/&8H MR".(&O!^.W[4@M=% NHL6/LLW%BMA LH+I%MO$.685D-YYEUAYM-X?R?]^"? MO1\EPZXE82L^YQF^ZYPG%R?%;JIQR>(J%GD=;:>F.;+=D>/:8WU[F+USRZ'I M. /']HX-_;(4FH]@R=&/.\B60'\V9:"52M[P M5ZS (4PT<84SH%O0IJ]?F9[QODEB?9+Y?9(%/9$=U<.MZ^'V(D;W7#G.P!YZ M0^M$BPV&MF=YXG.BQ:Z,00?&H]"].G2O-?0%)^$C(H7\0V6M.FSE>:D.^R3S M^R0+>B([*L:@+L:@%QT.SL3@>+9Y+J_9N:%MN V&?E?&H /C4>C#.O1A:^@/ MF%*<V!,G1.5-J5,>C 6(:N'S2U&="U>DTP(;=- MSLMFIEZM'RS7JD\_6;\QKV9FP[HO'CCE>^0O??DZNL-TG8@[-X65<&5<#L1Q M:?GB*"><%*JE7A(N&G0UC,4C#:@T$/LK0OA^(AW4S[[I'U!+ P04 " #M M1FY57^^"4/$1 "+ZP &0 'AL+W=O,TFN52&EBP';LW6RD7'A_N5WMICU557\@]B2FB\$'.,E* M_>,[ ]AX'#PV>]^IH7_(W+F^ME^$2_T>(?RR\9 M>W6Y46;1@B9YE"8DHX^?3FZ5#\%PS N4W_AG1%_RK=\)7Y6'-/W.7SBS3R=] MOD0TIM."$R'[\4SO:!QSB2W''S5ZLJF3%]S^?:V;Y:F^.[@Z(=-57J2+NC!;@D645#_# MU[HAM@HH@ST%U+J >FP!K2Z@[188[BDPJ L,=@J,^WL*#.L"PV,+C.H"HV/7 MX:HN<'5L@7%=8'SL2D_J I-C:U#ZZRW7/[8.9;.QC][:RGIS*V^V]VA?D?4& M5\HM?EGMB^6.K(=%>'.=I2\DX]]G'O^EC(:R/-M_HX0'[KXM8QQ=6]Q6UY<9,^2(L[1VPXK;^WY=WCB[?5[OVYVOT_ M5WL@+Z[3Z;[=1@@";=/M:*6G[>MV:!P6=$:^A%GQ@]QG89*'Y9$\)Z?W]+58 MA7%;9_-KI0[:57Z2\R%?AE/ZZ82=Q>0T>Z8G-W_[BS+J?VP+-"2F(S$#B9E( MS$)B-A)SD)B+Q#PDYB.Q (0)7':V,_U. M3J.$5!^U=@!2LVL'@,1T)&8@,1.)64C,KK!AB?%+S.<;M3_6-.WZ\GD[M)%U MNDC,0V(^$@M F!#:PTUH#Z6A_7E97I33UR6[PJ=M82PMWS6,D9B.Q PD9B(Q M"XG92,RIL-%6GS 9]M5)7^P3W+=?4Y3):#@:B=_SVKZG351UQ_-;OJ>.Q\K5 M0/Q> %I7(:Y&F[@:2>/*>*79-,HI66;1E):'2CV-XS#+R9)F).>'S=:CII3M M&FY(3$=B!A(SD9B%Q.P*&V_MJOT+=6<_=9 UNDC,0V(^$@M F!#;5YO8OI*? M#H;F)^\RR#V!-D%(#$=B1E(S$1B%A*SD9B# MQ%PDYB$Q'XD%($SH I1^<_^\_P[#V#4JCGSR_\3SHSMYY5W#&ZH94,V$:M;> M]MUI8+OUBRU#T-#%"[K:/J.7D.XU7K M^)A=JM8YND_^1('R-%JN%=,!;3G<.8FC.%E0SH)H)U2RH9D,U M!ZJY4,V#:CY4"U":V"DT25[*\%V&OQ5H\A=4TZ&: =5,J&9!-1NJ.5#-A6H> M5/.A6H#2Q ZAR4Y3Y.EIXJ7Z9GRMRZ@;-%$-JNE0S8!J)E2SH)I=:XIZ8'@. MFK &U3RHYD.U *6),=]DK2GRM+6]5P91HR 2F.ZBF0S4#JIE0S8)J-E1S MH)H+U3RHYD.U *6)'4*3S*?*D_E^+EE>CG;N#J"Y?5#-@&HF5+.@FEUK!_/N MH;6Z4,V#:CY4"U":&.A-;I\JS^W[/8KC*%R0NS1[H$4A/_V'9OE!-1VJ&5#- MA&H65+.AF@/57*CF034?J@4H3>P$FJQ!=? ^I__(+*D[J*9#-0.JF5#-@FHV M5'.@F@O5/*CF0[4 I8D=0I,QJ,J?"_>3I__0?,%:VS[Q5(9M?QJJ0^LUH)H) MU2RH9K>TM7?X3^_D0.=0 MA>;F034#JIE0S8)J-E1S:FW[,#^>] <#=>>/[Z"U>BVU*GU5&RD[/9,/K39 M:6*\-@EUJOSI7VMM32Q-:J075[.-6 MP8%6ZD(U#ZKY4"U :6*L-KENJCS7[?J>5#-AVK!@=C\97"NJ5?GX\E$$NI:D^.FR7/\9B&:<_%I3U MI+=/&:7E;\LL?8Y8RY)B'A8?R*ER1H+L8G.7\26*8_) "8VCI^@AIN0QS4A( MIF$^)P]ILLI)F+,-4]!LP99B1A[81F/5_YJ&V8P4:?F"OA:\)O[K7;I8ALF/ M7CB=1_29U7K*./HZI726GY$P259A3#+V2;*BA'V4LD(9>8R2,)E&[*,ES7JZRZ3S,:;6QU/XY.^G@ M_ZK7^69TMD[7_E:.SH8%:\+-N$Z/BH,_[-N_\%&7CZP]9N14.RO;F[5Z'*GM]X+JH6LHZ3T^+X?TSPGF^U6KVRU M(.)"\93\!QHE3Q7/>[95EJ_JG6IK=_O;7\:J#TWX$7; MR0>T5[2@F@W5'*CF0C4/JOE0+4!IXME(DVVKR9]U>1='CRSD9\2F2?9#FG(C MESJ??4 3;*&: =5,J&9!-1NJ.5#-A6H>5/.A6H#2Q#Z@2;#5U'=)N=&@*;90 M38=J!E0SH9H%U6RHYD U%ZIY4,V':@%*$SN$K7F6Y8FX/Y=RH[U]K&+KX^GE ME7<.=.P5/.A6H#2Q$AO$F0U>8+LD0^[ MU]Y.5OOV"<1W\KHZQS4T&Q:JF5#-:FG=UH?80VMUH)H+U3RHYD.U *6)$=OD MPFKR7-C#F71RH/.E-?29EE#-@&HF5+.@F@W5G%H[\!![:)W>477ZT#H#E":& M:I/TJLF37LW-C5E^VVP:+J."WPL*L^^TR$DX>V8GUZT!#$V%A6HZ5#.@F@G5 M+*AF0S4'JKE0S=/>)LQJP]US&1]:9X#2Q$!OLF4U>;9L$,ZB/&='Y6/^^EQN M=8YN:.8L5#.@F@G5+*AF0S4'JKE0S8-J/E0+4)K8"S1YN-K[S,ZL09-SH9H. MU0RH9D(U"ZK94,V!:BY4\Z":#]4"E"9T"(,F6W?P'C,U#XZ>== AVH& M5#.AFK6W?7>'VZ#5.E#-A6H>5/.A6H#2Q!ANJN5#-@VH^5 M0FABQ3:K9X,_.YRP'NEY:0S4=JAE0 MS81J%E2SH9HS.&H^9VB=WE%U^M Z Y0FAFJ343:0YK')+@-Y ENQXZ-OWW.8-O8.#1E M#:H94,V$:E9;ZUZU')JAN6A0S85J'E3SH5J TL2 ;7+1!O+GSATQ- [-.H-J M.E0SH)H)U2RH9D,UI]8.#8U#L\F.JM.'UAF@-"%4ATV6V%">)?9/FI?/!N,/ M"6P+U /%E7[UR+:VJ)07[1J54,V :B94LZ":#=4JN5#-@VH^5 M0FM@A M-/EKP_=X5)H<[=P='/E@,!U:K=%2K=(Z99\)K=>":C94:?*I# UJG"=4LJ&9#-0>JN5#-@VH^5 M0 MFACI31+;$/*P-+G2.:Y;'@ZFM!V?H=EH4,V$:A94LZ&: ]5C6^FNS<+X-6ZK54 M.M9&VFCGAAFTT@"EB<':I)T-#Z2=-1-UA>N)N@Y.?R8W.\=Q8W\Y"QN M/>@L;D2 '6[/8915C\2 ML3JC7N])V^!YCVV C#[&K"WH;#VAVS1./O/P^2) M-_CY&N";H-IDU< ;WT^7A#4QJ^2<%PY)$O+U9XM;?J.W5L[7M#@[VBE_B^_$ M:O]C=4J1EZ^4CV?USR/FF=N=#N[SFWGF>@?FF2,'IYC[+)MBCG288JYWO[6$ MQTXQ=ZKTSXZ;9XYTF&>N5Z]QO6XL1(Q7.EWQX&F;7LV"]I,V5'.@F@O5/*CF M0[4 I8EG)DV:[/"H6=-Y$+6>@T"?_ C5=*AF0#43JEE0S89J#E1SH9I7:Q-A M2'BX>Z$!3:)%:54X7[)3)UKH81'>7"]H]D3O:!SG9,JGA>65;+W+3S98N"L? M;M63RS?OZ\H'6VEYWU$^N&WO>\H'OWS_LJGVYGH9/M$@S)XB=N2,Z2-;A/[% MU?"$9-'3?/.B2)>?3I03=AI:%.FB_'5.PQG-^!?8YX]I6JQ?\ I>TNQ[N9HW M_P=02P,$% @ [49N5156O*KL P 3 @ !D !X;"]W;W)K&UL?591;^(X$'[G5XRRT@HDU$!@=WM=0 +*:5?:KGKENOMP MN@<33XBOCIW:#I1_?V,G34&BO(38F?GF^V;&8R9[;9YLCNC@I9#*3J/G0L;)8/ Y+IA0T6P2]N[-;*(K)X7" M>P.V*@IF#@N4>C^-AM'KQH/8YLYOQ+-)R;:X1O=8WAM:Q2T*%P4J*[0"@]DT MF@]O%F-O'PQ^"=S;HW?P2C9:/_G%=SZ-!IX02DR=1V#TL\,E2NF!B,9S@QFU M(;WC\?LK^I]!.VG9,(M++7\+[O)I=!T!QXQ5TCWH_3=L]'SR>*F6-CQA7]N. M1Q&DE76Z:)R)02%4_FCP<.5P/WG%(&H1$XH7Y2U,_15D)^;K1\7Z]5?CZN??\/J%SW7T+U%QX2TO4GL*( WB],& M;%&#)>^ _0%W6KGK'3TM_#/?6&>H-_X])[=&&Y]'\^?EQI8LQ6E$!\*BV6$T M^_AA^'GP]0+7<J8A(*JJQ06] 94#.D3[F6'(VESK.I$:5O[7/, M+V*?9SYWX'*$)NY=';O#@TAS9C@\:(MJ(ZNB#W>,"VOI<+9&2RDR&C4W.!66(>&D,IJ(T5*TRG5GAEQS(0I@') +S8E[@=D!KPCI0)3+#9H M8#2LST3@1<2(B]$[Y!U&@XX8\<#*Z;-,YL:)5*+UA?JN4FU*[851&<@!LXST M R...ZHNUET'MI3"RPR 5+.JR1#->>OHQ1.G%)J VDEU41!<[9(VFF8$890 9':(#48.)S6LR6]T+YW>&5\) 9NK^O$E&B$YCX_H;X*?E(> M0HZ2?H=2-.[11'4YQ?$DU!9] *T0NL->S=AO+&O"ZT#8Y]Z+/X0HW:17)U(8 M=X#N:-![$WKBUP\)Z8K=6SDH9JD=E4(PV6'\/UT9U?1+W4(GW=E_?W;$1Q.^ M0+,-]YB%T#/UL&]WVZMR7M\0;^;U/7O'S%8H"Q(SS3>@+YGFB0U"Q^@_0,Q^Q]02P,$% @ [49N59J;X5IF M P E1< T !X;"]S='EL97,N>&ULW5C1;MHP%/V5*%VG5IH:0M:4K("T M(56:M$V5VH>]588X8,EQ,L=TL*^?KQU"H+Z(]6$C"RJQ[\DY]]B^3D*'E5IS M^K"@5'FKG(MJY"^4*C\$035;T)Q45T5)A4:R0N9$Z:Z/9\]N[LK/=T>;L?OS# I1\X1:^/$+WJZ0-5-B@F'Q\G?T@2$_I M+:A3A1"I?EDXM#W8G;5.SD0A36Z;P7Y/Z\OW@$T/##+.&X-]WP;&PY(H1:6X MTQUSL0F^@+RZ_;@NM<.Y).NP?^UO">:DDTP+F5*YO2/XF]!XR&D&=B2;+^"L MBC( 4*DBUXV4D7DAB/&P8=0-+3NCG#_ K>M[MJ.]REIK9LI0-$UMJ&Y:&=L! M_;::U6[+WKQ*URO9^92L5F[4T$EX6W3NO9/>99?[3BZ^5>6S5UEW[#38_TZ&'<_(#2N9A(Z8JFD[HKYU/3]'1#9ZT/(.PC=^9P(QC'8FX$,"P/ MY@#C6!:6YW\:SP =C\4P;P,G,D Y Y1C62YD8CY8'CAD MXG0PP>8MCN'/K89Y P:6!S+]V5SCJXU7R.$ZP-;T4(5@(\4K$1LI/M> N.<- M&$GB7FTL#S"P5<-V,(XD"89 +;IK-(Z1V8GAXUX? M;)=$49*X$<#<#J((0V WX@CF #Q@2!29Y^#>\RC8/*>"[3_BQ[\!4$L#!!0 M ( .U&;E67BKL

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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 73 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 74 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 302 344 1 false 63 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://innovativepaymentssolu.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets Sheet http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) Sheet http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement_Parentheticals Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited) Sheet http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3 Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited) Statements 6 false false R7.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://innovativepaymentssolu.com/role/ConsolidatedCashFlow Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS Sheet http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESS ORGANIZATION AND DESCRIPTION OF BUSINESS Notes 8 false false R9.htm 008 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES Sheet http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATES ACCOUNTING POLICIES AND ESTIMATES Notes 9 false false R10.htm 009 - Disclosure - LIQUIDITY MATTERS Sheet http://innovativepaymentssolu.com/role/LIQUIDITYMATTERS LIQUIDITY MATTERS Notes 10 false false R11.htm 010 - Disclosure - INTANGIBLES Sheet http://innovativepaymentssolu.com/role/INTANGIBLES INTANGIBLES Notes 11 false false R12.htm 011 - Disclosure - INVESTMENTS Sheet http://innovativepaymentssolu.com/role/INVESTMENTS INVESTMENTS Notes 12 false false R13.htm 012 - Disclosure - LEASES Sheet http://innovativepaymentssolu.com/role/LEASES LEASES Notes 13 false false R14.htm 013 - Disclosure - FEDERAL RELIEF LOANS Sheet http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANS FEDERAL RELIEF LOANS Notes 14 false false R15.htm 014 - Disclosure - CONVERTIBLE NOTES PAYABLE Notes http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLE CONVERTIBLE NOTES PAYABLE Notes 15 false false R16.htm 015 - Disclosure - DERIVATIVE LIABILITY Sheet http://innovativepaymentssolu.com/role/DERIVATIVELIABILITY DERIVATIVE LIABILITY Notes 16 false false R17.htm 016 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITY STOCKHOLDERS??? EQUITY Notes 17 false false R18.htm 017 - Disclosure - NET LOSS PER SHARE Sheet http://innovativepaymentssolu.com/role/NETLOSSPERSHARE NET LOSS PER SHARE Notes 18 false false R19.htm 018 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONS RELATED PARTY TRANSACTIONS Notes 19 false false R20.htm 019 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://innovativepaymentssolu.com/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 20 false false R21.htm 020 - Disclosure - SUBSEQUENT EVENTS Sheet http://innovativepaymentssolu.com/role/SUBSEQUENTEVENTS SUBSEQUENT EVENTS Notes 21 false false R22.htm 021 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies 22 false false R23.htm 022 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES (Tables) Sheet http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESTables ACCOUNTING POLICIES AND ESTIMATES (Tables) Tables http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATES 23 false false R24.htm 023 - Disclosure - INTANGIBLES (Tables) Sheet http://innovativepaymentssolu.com/role/INTANGIBLESTables INTANGIBLES (Tables) Tables http://innovativepaymentssolu.com/role/INTANGIBLES 24 false false R25.htm 024 - Disclosure - INVESTMENTS (Tables) Sheet http://innovativepaymentssolu.com/role/INVESTMENTSTables INVESTMENTS (Tables) Tables http://innovativepaymentssolu.com/role/INVESTMENTS 25 false false R26.htm 025 - Disclosure - LEASES (Tables) Sheet http://innovativepaymentssolu.com/role/LEASESTables LEASES (Tables) Tables http://innovativepaymentssolu.com/role/LEASES 26 false false R27.htm 026 - Disclosure - CONVERTIBLE NOTES PAYABLE (Tables) Notes http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLETables CONVERTIBLE NOTES PAYABLE (Tables) Tables http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLE 27 false false R28.htm 027 - Disclosure - DERIVATIVE LIABILITY (Tables) Sheet http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYTables DERIVATIVE LIABILITY (Tables) Tables http://innovativepaymentssolu.com/role/DERIVATIVELIABILITY 28 false false R29.htm 028 - Disclosure - STOCKHOLDERS??? EQUITY (Tables) Sheet http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables STOCKHOLDERS??? EQUITY (Tables) Tables http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITY 29 false false R30.htm 029 - Disclosure - NET LOSS PER SHARE (Tables) Sheet http://innovativepaymentssolu.com/role/NETLOSSPERSHARETables NET LOSS PER SHARE (Tables) Tables http://innovativepaymentssolu.com/role/NETLOSSPERSHARE 30 false false R31.htm 030 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details) Sheet http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails ORGANIZATION AND DESCRIPTION OF BUSINESS (Details) Details http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESS 31 false false R32.htm 031 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES (Details) Sheet http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESDetails ACCOUNTING POLICIES AND ESTIMATES (Details) Details http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESTables 32 false false R33.htm 032 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES (Details) - Schedule of estimated useful lives of the assets Sheet http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable ACCOUNTING POLICIES AND ESTIMATES (Details) - Schedule of estimated useful lives of the assets Details http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESTables 33 false false R34.htm 033 - Disclosure - LIQUIDITY MATTERS (Details) Sheet http://innovativepaymentssolu.com/role/LIQUIDITYMATTERSDetails LIQUIDITY MATTERS (Details) Details http://innovativepaymentssolu.com/role/LIQUIDITYMATTERS 34 false false R35.htm 034 - Disclosure - INTANGIBLES (Details) Sheet http://innovativepaymentssolu.com/role/INTANGIBLESDetails INTANGIBLES (Details) Details http://innovativepaymentssolu.com/role/INTANGIBLESTables 35 false false R36.htm 035 - Disclosure - INTANGIBLES (Details) - Schedule of facilitate the functioning of the IPSIPay software Sheet http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable INTANGIBLES (Details) - Schedule of facilitate the functioning of the IPSIPay software Details http://innovativepaymentssolu.com/role/INTANGIBLESTables 36 false false R37.htm 036 - Disclosure - INVESTMENTS (Details) Sheet http://innovativepaymentssolu.com/role/INVESTMENTSDetails INVESTMENTS (Details) Details http://innovativepaymentssolu.com/role/INVESTMENTSTables 37 false false R38.htm 037 - Disclosure - INVESTMENTS (Details) - Schedule of investment Sheet http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable INVESTMENTS (Details) - Schedule of investment Details http://innovativepaymentssolu.com/role/INVESTMENTSTables 38 false false R39.htm 038 - Disclosure - LEASES (Details) Sheet http://innovativepaymentssolu.com/role/LEASESDetails LEASES (Details) Details http://innovativepaymentssolu.com/role/LEASESTables 39 false false R40.htm 039 - Disclosure - LEASES (Details) - Schedule of total lease cost Sheet http://innovativepaymentssolu.com/role/ScheduleoftotalleasecostTable LEASES (Details) - Schedule of total lease cost Details http://innovativepaymentssolu.com/role/LEASESTables 40 false false R41.htm 040 - Disclosure - LEASES (Details) - Schedule of other lease information Sheet http://innovativepaymentssolu.com/role/ScheduleofotherleaseinformationTable LEASES (Details) - Schedule of other lease information Details http://innovativepaymentssolu.com/role/LEASESTables 41 false false R42.htm 041 - Disclosure - LEASES (Details) - Schedule of maturity of operating leases Sheet http://innovativepaymentssolu.com/role/ScheduleofmaturityofoperatingleasesTable LEASES (Details) - Schedule of maturity of operating leases Details http://innovativepaymentssolu.com/role/LEASESTables 42 false false R43.htm 042 - Disclosure - FEDERAL RELIEF LOANS (Details) Sheet http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANSDetails FEDERAL RELIEF LOANS (Details) Details http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANS 43 false false R44.htm 043 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details) Notes http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails CONVERTIBLE NOTES PAYABLE (Details) Details http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLETables 44 false false R45.htm 044 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details) - Schedule of convertible notes payable Notes http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable CONVERTIBLE NOTES PAYABLE (Details) - Schedule of convertible notes payable Details http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLETables 45 false false R46.htm 045 - Disclosure - DERIVATIVE LIABILITY (Details) Sheet http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYDetails DERIVATIVE LIABILITY (Details) Details http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYTables 46 false false R47.htm 046 - Disclosure - DERIVATIVE LIABILITY (Details) - Schedule of assumptions were used in the Black-Scholes valuation model Sheet http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable DERIVATIVE LIABILITY (Details) - Schedule of assumptions were used in the Black-Scholes valuation model Details http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYTables 47 false false R48.htm 047 - Disclosure - DERIVATIVE LIABILITY (Details) - Schedule of movement in derivative liability Sheet http://innovativepaymentssolu.com/role/ScheduleofmovementinderivativeliabilityTable DERIVATIVE LIABILITY (Details) - Schedule of movement in derivative liability Details http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYTables 48 false false R49.htm 048 - Disclosure - STOCKHOLDERS??? EQUITY (Details) Sheet http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails STOCKHOLDERS??? EQUITY (Details) Details http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables 49 false false R50.htm 049 - Disclosure - STOCKHOLDERS??? EQUITY (Details) - Schedule of restricted stock activity Sheet http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable STOCKHOLDERS??? EQUITY (Details) - Schedule of restricted stock activity Details http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables 50 false false R51.htm 050 - Disclosure - STOCKHOLDERS??? EQUITY (Details) - Schedule of restricted stock granted and exercisable Sheet http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable STOCKHOLDERS??? EQUITY (Details) - Schedule of restricted stock granted and exercisable Details http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables 51 false false R52.htm 051 - Disclosure - STOCKHOLDERS??? EQUITY (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model Sheet http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable STOCKHOLDERS??? EQUITY (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model Details http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables 52 false false R53.htm 052 - Disclosure - STOCKHOLDERS??? EQUITY (Details) - Schedule of warrant activity Sheet http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable STOCKHOLDERS??? EQUITY (Details) - Schedule of warrant activity Details http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables 53 false false R54.htm 053 - Disclosure - STOCKHOLDERS??? EQUITY (Details) - Schedule of warrants outstanding and exercisable Sheet http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable STOCKHOLDERS??? EQUITY (Details) - Schedule of warrants outstanding and exercisable Details http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables 54 false false R55.htm 054 - Disclosure - STOCKHOLDERS??? EQUITY (Details) - Schedule of option activity Sheet http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable STOCKHOLDERS??? EQUITY (Details) - Schedule of option activity Details http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables 55 false false R56.htm 055 - Disclosure - STOCKHOLDERS??? EQUITY (Details) - Schedule of options outstanding and exercisable Sheet http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable STOCKHOLDERS??? EQUITY (Details) - Schedule of options outstanding and exercisable Details http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables 56 false false R57.htm 056 - Disclosure - NET LOSS PER SHARE (Details) - Schedule of dilutive shares Sheet http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable NET LOSS PER SHARE (Details) - Schedule of dilutive shares Details http://innovativepaymentssolu.com/role/NETLOSSPERSHARETables 57 false false R58.htm 057 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails RELATED PARTY TRANSACTIONS (Details) Details http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONS 58 false false R59.htm 058 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://innovativepaymentssolu.com/role/SUBSEQUENTEVENTSDetails SUBSEQUENT EVENTS (Details) Details http://innovativepaymentssolu.com/role/SUBSEQUENTEVENTS 59 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 12 fact(s) appearing in ix:hidden were eligible for transformation: dei:Security12bTitle, dei:SecurityExchangeName, dei:TradingSymbol, us-gaap:EarningsPerShareDiluted, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding - f10q0922_innovative.htm 6498, 6499, 6500, 6501, 6502, 6503, 6504, 6505, 6684, 6689, 6690, 6691 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 2 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: qpag:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantsExercisePricePerShare, us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice - f10q0922_innovative.htm 6692, 6693 f10q0922_innovative.htm f10q0922ex31-1_innovative.htm f10q0922ex31-2_innovative.htm f10q0922ex32-1_innovative.htm f10q0922ex32-2_innovative.htm qpag-20220930.xsd qpag-20220930_cal.xml qpag-20220930_def.xml qpag-20220930_lab.xml qpag-20220930_pre.xml http://fasb.org/srt/2022 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 77 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f10q0922_innovative.htm": { "axisCustom": 1, "axisStandard": 15, "contextCount": 302, "dts": { "calculationLink": { "local": [ "qpag-20220930_cal.xml" ] }, "definitionLink": { "local": [ "qpag-20220930_def.xml" ] }, "inline": { "local": [ "f10q0922_innovative.htm" ] }, "labelLink": { "local": [ "qpag-20220930_lab.xml" ] }, "presentationLink": { "local": [ "qpag-20220930_pre.xml" ] }, "schema": { "local": [ "qpag-20220930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd" ] } }, "elementCount": 512, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 165, "http://innovativepaymentssolu.com/20220930": 50, "http://xbrl.sec.gov/dei/2022": 7, "total": 222 }, "keyCustom": 109, "keyStandard": 235, "memberCustom": 39, "memberStandard": 15, "nsprefix": "qpag", "nsuri": "http://innovativepaymentssolu.com/20220930", "report": { "R1": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:LiquidityMatterTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - LIQUIDITY MATTERS", "role": "http://innovativepaymentssolu.com/role/LIQUIDITYMATTERS", "shortName": "LIQUIDITY MATTERS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:LiquidityMatterTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - INTANGIBLES", "role": "http://innovativepaymentssolu.com/role/INTANGIBLES", "shortName": "INTANGIBLES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - INVESTMENTS", "role": "http://innovativepaymentssolu.com/role/INVESTMENTS", "shortName": "INVESTMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - LEASES", "role": "http://innovativepaymentssolu.com/role/LEASES", "shortName": "LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:FederalReliefLoansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - FEDERAL RELIEF LOANS", "role": "http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANS", "shortName": "FEDERAL RELIEF LOANS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:FederalReliefLoansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ConvertibleNotesPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - CONVERTIBLE NOTES PAYABLE", "role": "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLE", "shortName": "CONVERTIBLE NOTES PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ConvertibleNotesPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativesAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - DERIVATIVE LIABILITY", "role": "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITY", "shortName": "DERIVATIVE LIABILITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativesAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "role": "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITY", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - NET LOSS PER SHARE", "role": "http://innovativepaymentssolu.com/role/NETLOSSPERSHARE", "shortName": "NET LOSS PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Condensed Consolidated Balance Sheets", "role": "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://innovativepaymentssolu.com/role/COMMITMENTSANDCONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - SUBSEQUENT EVENTS", "role": "http://innovativepaymentssolu.com/role/SUBSEQUENTEVENTS", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Accounting Policies, by Policy (Policies)", "role": "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ScheduleOfEstimatedUsefulLivesOfAssets", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES (Tables)", "role": "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESTables", "shortName": "ACCOUNTING POLICIES AND ESTIMATES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ScheduleOfEstimatedUsefulLivesOfAssets", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ScheduleOfBeyondFintechIncTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - INTANGIBLES (Tables)", "role": "http://innovativepaymentssolu.com/role/INTANGIBLESTables", "shortName": "INTANGIBLES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ScheduleOfBeyondFintechIncTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - INVESTMENTS (Tables)", "role": "http://innovativepaymentssolu.com/role/INVESTMENTSTables", "shortName": "INVESTMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - LEASES (Tables)", "role": "http://innovativepaymentssolu.com/role/LEASESTables", "shortName": "LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - CONVERTIBLE NOTES PAYABLE (Tables)", "role": "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLETables", "shortName": "CONVERTIBLE NOTES PAYABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - DERIVATIVE LIABILITY (Tables)", "role": "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYTables", "shortName": "DERIVATIVE LIABILITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Tables)", "role": "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables", "shortName": "STOCKHOLDERS\u2019 EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "role": "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c2", "decimals": "0", "lang": null, "name": "us-gaap:PreferredStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - NET LOSS PER SHARE (Tables)", "role": "http://innovativepaymentssolu.com/role/NETLOSSPERSHARETables", "shortName": "NET LOSS PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c88", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ReverseStockSplitDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details)", "role": "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails", "shortName": "ORGANIZATION AND DESCRIPTION OF BUSINESS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c88", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ReverseStockSplitDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "qpag:BeyondFintechIncOwnedPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES (Details)", "role": "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESDetails", "shortName": "ACCOUNTING POLICIES AND ESTIMATES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "qpag:BeyondFintechIncOwnedPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "qpag:ScheduleOfEstimatedUsefulLivesOfAssets", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c96", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES (Details) - Schedule of estimated useful lives of the assets", "role": "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable", "shortName": "ACCOUNTING POLICIES AND ESTIMATES (Details) - Schedule of estimated useful lives of the assets", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "qpag:ScheduleOfEstimatedUsefulLivesOfAssets", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c96", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:NetIncomeLossAttributableNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - LIQUIDITY MATTERS (Details)", "role": "http://innovativepaymentssolu.com/role/LIQUIDITYMATTERSDetails", "shortName": "LIQUIDITY MATTERS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:NetIncomeLossAttributableNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c95", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - INTANGIBLES (Details)", "role": "http://innovativepaymentssolu.com/role/INTANGIBLESDetails", "shortName": "INTANGIBLES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c95", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfBeyondFintechIncTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "qpag:PurchasedTechnology", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - INTANGIBLES (Details) - Schedule of facilitate the functioning of the IPSIPay software", "role": "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable", "shortName": "INTANGIBLES (Details) - Schedule of facilitate the functioning of the IPSIPay software", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfBeyondFintechIncTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "qpag:PurchasedTechnology", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c142", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - INVESTMENTS (Details)", "role": "http://innovativepaymentssolu.com/role/INVESTMENTSDetails", "shortName": "INVESTMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c105", "decimals": null, "lang": "en-US", "name": "qpag:InvestmentDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Investments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - INVESTMENTS (Details) - Schedule of investment", "role": "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable", "shortName": "INVESTMENTS (Details) - Schedule of investment", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Investments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "038 - Disclosure - LEASES (Details)", "role": "http://innovativepaymentssolu.com/role/LEASESDetails", "shortName": "LEASES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "role": "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "039 - Disclosure - LEASES (Details) - Schedule of total lease cost", "role": "http://innovativepaymentssolu.com/role/ScheduleoftotalleasecostTable", "shortName": "LEASES (Details) - Schedule of total lease cost", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "qpag:ScheduleOfOtherLeaseInformation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:OperatingCashFlowsFromOperatingLeases", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040 - Disclosure - LEASES (Details) - Schedule of other lease information", "role": "http://innovativepaymentssolu.com/role/ScheduleofotherleaseinformationTable", "shortName": "LEASES (Details) - Schedule of other lease information", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "qpag:ScheduleOfOtherLeaseInformation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:OperatingCashFlowsFromOperatingLeases", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": null, "groupType": "disclosure", "isDefault": "false", "longName": "041 - Disclosure - LEASES (Details) - Schedule of maturity of operating leases", "role": "http://innovativepaymentssolu.com/role/ScheduleofmaturityofoperatingleasesTable", "shortName": "LEASES (Details) - Schedule of maturity of operating leases", "subGroupType": "details", "uniqueAnchor": null }, "R43": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c114", "decimals": "0", "first": true, "lang": null, "name": "qpag:DisasterLoanAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042 - Disclosure - FEDERAL RELIEF LOANS (Details)", "role": "http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANSDetails", "shortName": "FEDERAL RELIEF LOANS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c114", "decimals": "0", "first": true, "lang": null, "name": "qpag:DisasterLoanAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestExpenseOther", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "043 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details)", "role": "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails", "shortName": "CONVERTIBLE NOTES PAYABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestExpenseOther", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentIncreaseAccruedInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "044 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details) - Schedule of convertible notes payable", "role": "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "shortName": "CONVERTIBLE NOTES PAYABLE (Details) - Schedule of convertible notes payable", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c129", "decimals": "3", "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c141", "decimals": "0", "first": true, "lang": null, "name": "qpag:SharesOfCommonStock", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "045 - Disclosure - DERIVATIVE LIABILITY (Details)", "role": "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYDetails", "shortName": "DERIVATIVE LIABILITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c141", "decimals": "0", "first": true, "lang": null, "name": "qpag:SharesOfCommonStock", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "046 - Disclosure - DERIVATIVE LIABILITY (Details) - Schedule of assumptions were used in the Black-Scholes valuation model", "role": "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable", "shortName": "DERIVATIVE LIABILITY (Details) - Schedule of assumptions were used in the Black-Scholes valuation model", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilitiesCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "047 - Disclosure - DERIVATIVE LIABILITY (Details) - Schedule of movement in derivative liability", "role": "http://innovativepaymentssolu.com/role/ScheduleofmovementinderivativeliabilityTable", "shortName": "DERIVATIVE LIABILITY (Details) - Schedule of movement in derivative liability", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c51", "decimals": "0", "lang": null, "name": "us-gaap:DerivativeLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "048 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details)", "role": "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:CommonStockSharesIssued", "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c3", "decimals": "0", "lang": null, "name": "us-gaap:ExcessStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R5": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals)", "role": "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement_Parentheticals", "shortName": "Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c180", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "049 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of restricted stock activity", "role": "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of restricted stock activity", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c168", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfRestrictedStockGrantedAndExercisableTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:RestrictedStockGrantedShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "050 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of restricted stock granted and exercisable", "role": "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of restricted stock granted and exercisable", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfRestrictedStockGrantedAndExercisableTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:RestrictedStockGrantedShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c205", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "051 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model", "role": "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c205", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c215", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "052 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of warrant activity", "role": "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of warrant activity", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c211", "decimals": "0", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "053 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of warrants outstanding and exercisable", "role": "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of warrants outstanding and exercisable", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "lang": "en-US", "name": "us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c235", "decimals": "0", "first": true, "lang": null, "name": "qpag:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBalance", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "054 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of option activity", "role": "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of option activity", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c231", "decimals": "0", "lang": null, "name": "qpag:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBalance", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfOptionsOutstandingAndExercisableTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "055 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of options outstanding and exercisable", "role": "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of options outstanding and exercisable", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfOptionsOutstandingAndExercisableTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "056 - Disclosure - NET LOSS PER SHARE (Details) - Schedule of dilutive shares", "role": "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable", "shortName": "NET LOSS PER SHARE (Details) - Schedule of dilutive shares", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c262", "decimals": "0", "first": true, "lang": null, "name": "qpag:ShareOfCommonStock", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "057 - Disclosure - RELATED PARTY TRANSACTIONS (Details)", "role": "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails", "shortName": "RELATED PARTY TRANSACTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c262", "decimals": "0", "first": true, "lang": null, "name": "qpag:ShareOfCommonStock", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:AnnualMeetingOfStockholdersDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "058 - Disclosure - SUBSEQUENT EVENTS (Details)", "role": "http://innovativepaymentssolu.com/role/SUBSEQUENTEVENTSDetails", "shortName": "SUBSEQUENT EVENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:AnnualMeetingOfStockholdersDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c47", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Condensed Consolidated Statements of Changes in Stockholders\u2019 Equity (Unaudited)", "role": "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3", "shortName": "Condensed Consolidated Statements of Changes in Stockholders\u2019 Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c54", "decimals": "0", "lang": null, "name": "qpag:StockIssuedDuringPeriodValueFairValueOfWarrantsIssued", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInDerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS", "role": "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESS", "shortName": "ORGANIZATION AND DESCRIPTION OF BUSINESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - ACCOUNTING POLICIES AND ESTIMATES", "role": "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATES", "shortName": "ACCOUNTING POLICIES AND ESTIMATES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_innovative.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 63, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r423" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r424" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r422" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "qpag_ACCOUNTINGPOLICIESANDESTIMATESDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies and Estimates (Textual)" } } }, "localname": "ACCOUNTINGPOLICIESANDESTIMATESDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESDetails" ], "xbrltype": "stringItemType" }, "qpag_ACCOUNTINGPOLICIESANDESTIMATESDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ACCOUNTING POLICIES AND ESTIMATES (Details) [Table]" } } }, "localname": "ACCOUNTINGPOLICIESANDESTIMATESDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESDetails" ], "xbrltype": "stringItemType" }, "qpag_AdditionalAmountOfSoftware": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Additional amount of software.", "label": "Additional Amount Of Software", "terseLabel": "Additional amount of software" } } }, "localname": "AdditionalAmountOfSoftware", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "qpag_AdditionalIrrecvocableRightToAcquireOutstandingCommonStockPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of additional irrecvocable right to acquire percentage.", "label": "Additional Irrecvocable Right To Acquire Outstanding Common Stock Percentage", "terseLabel": "Right to acquire" } } }, "localname": "AdditionalIrrecvocableRightToAcquireOutstandingCommonStockPercentage", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "percentItemType" }, "qpag_AdditionalPenaltyExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of additional penalty expense.", "label": "Additional Penalty Expense", "terseLabel": "Additional penalty expense" } } }, "localname": "AdditionalPenaltyExpense", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "qpag_AgreementFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of agreement fee.", "label": "Agreement Fee", "terseLabel": "Agreement fee" } } }, "localname": "AgreementFee", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "monetaryItemType" }, "qpag_AmortizationOfDebtDiscount": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization Of Debt Discount", "terseLabel": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscount", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "qpag_AmortizationOfRightOfUseAsset": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization of right of use asset.", "label": "Amortization Of Right Of Use Asset", "terseLabel": "Amortization of right of use asset" } } }, "localname": "AmortizationOfRightOfUseAsset", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_AmountOfImmediateExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of immediate expense.", "label": "Amount Of Immediate Expense", "terseLabel": "Amount of immediate expense" } } }, "localname": "AmountOfImmediateExpense", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "monetaryItemType" }, "qpag_AnnualMeetingOfStockholdersDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Annual meeting of stockholders description.", "label": "Annual Meeting Of Stockholders Description", "terseLabel": "Annual meeting of stockholders description" } } }, "localname": "AnnualMeetingOfStockholdersDescription", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "qpag_BellridgeCapitalLPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Bellridge Capital LPMember", "terseLabel": "Bellridge Capital LP., [Member]", "verboseLabel": "Bellridge Capital LP. [Member]" } } }, "localname": "BellridgeCapitalLPMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "domainItemType" }, "qpag_BeyondFintechIncOwnedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of beyond fintech inc owned percentage.", "label": "Beyond Fintech Inc Owned Percentage", "terseLabel": "Beyond fintech inc owned percentage" } } }, "localname": "BeyondFintechIncOwnedPercentage", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESDetails" ], "xbrltype": "percentItemType" }, "qpag_BeyondFintechMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Beyond Fintech Member", "terseLabel": "Beyond Fintech [Member]" } } }, "localname": "BeyondFintechMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "domainItemType" }, "qpag_CONVERTIBLENOTESPAYABLEDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable (Textual)" } } }, "localname": "CONVERTIBLENOTESPAYABLEDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "stringItemType" }, "qpag_CONVERTIBLENOTESPAYABLEDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONVERTIBLE NOTES PAYABLE (Details) [Table]" } } }, "localname": "CONVERTIBLENOTESPAYABLEDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "stringItemType" }, "qpag_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Paid For Amounts Included In The Measurement Of Lease Liabilities Abstract", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities" } } }, "localname": "CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofotherleaseinformationTable" ], "xbrltype": "stringItemType" }, "qpag_CavalryFundILPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cavalry Fund ILPMember", "terseLabel": "Cavalry Fund I LP [Member]" } } }, "localname": "CavalryFundILPMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "domainItemType" }, "qpag_CliffordHenryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Clifford Henry Member", "terseLabel": "Clifford Henry [Member]" } } }, "localname": "CliffordHenryMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "qpag_ConvertibleNotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable [Abstract]" } } }, "localname": "ConvertibleNotesPayableAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_ConvertibleNotesPayableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable Text Block", "terseLabel": "CONVERTIBLE NOTES PAYABLE" } } }, "localname": "ConvertibleNotesPayableTextBlock", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLE" ], "xbrltype": "textBlockItemType" }, "qpag_DERIVATIVELIABILITYDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Liability (Textual)" } } }, "localname": "DERIVATIVELIABILITYDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYDetails" ], "xbrltype": "stringItemType" }, "qpag_DERIVATIVELIABILITYDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DERIVATIVE LIABILITY (Details) [Table]" } } }, "localname": "DERIVATIVELIABILITYDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYDetails" ], "xbrltype": "stringItemType" }, "qpag_DavidRiosMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "David Rios Member", "terseLabel": "David Rios [Member]" } } }, "localname": "DavidRiosMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "qpag_DebtInstrumentAccruedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of debt instrument accrued interest.", "label": "Debt Instrument Accrued Interest", "terseLabel": "Accrued interest and penalty interest" } } }, "localname": "DebtInstrumentAccruedInterest", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "qpag_DebtInstrumentOriginalIssueDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount paid to debt instrument original issue discount.", "label": "Debt Instrument Original Issue Discount", "terseLabel": "Original issue discount" } } }, "localname": "DebtInstrumentOriginalIssueDiscount", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "qpag_DebtInstrumentsConvertibleConversionPrice1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instruments Convertible Conversion Price1", "terseLabel": "Conversion price (in Dollars per share)" } } }, "localname": "DebtInstrumentsConvertibleConversionPrice1", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "perShareItemType" }, "qpag_DebtInstrumentsFaceAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instruments Face Amount", "terseLabel": "Principal" } } }, "localname": "DebtInstrumentsFaceAmount", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "monetaryItemType" }, "qpag_DebtInstrumentsInterestRateStatedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instruments Interest Rate Stated Percentage", "terseLabel": "Interest rate" } } }, "localname": "DebtInstrumentsInterestRateStatedPercentage", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "percentItemType" }, "qpag_DepositForfeited": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of deposit forfeited.", "label": "Deposit Forfeited", "terseLabel": "Deposit forfeited" } } }, "localname": "DepositForfeited", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_DerecognitionOfRightOfUseLeaseOnEarlyTermination": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "De-recognition of right of use lease on early termination.", "label": "Derecognition Of Right Of Use Lease On Early Termination", "terseLabel": "De-recognition of right of use lease on early termination" } } }, "localname": "DerecognitionOfRightOfUseLeaseOnEarlyTermination", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_DerivativeFinancialLiabilityArisingFromConvertibleNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "It represents as a derivative financial liability arising from convertible note.", "label": "Derivative Financial Liability Arising From Convertible Note", "terseLabel": "Derivative financial liability arising from convertible note and warrants" } } }, "localname": "DerivativeFinancialLiabilityArisingFromConvertibleNote", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofmovementinderivativeliabilityTable" ], "xbrltype": "monetaryItemType" }, "qpag_DerivativeLiabilityCredited": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of derivative liability credited.", "label": "Derivative Liability Credited", "terseLabel": "Derivative liability credited" } } }, "localname": "DerivativeLiabilityCredited", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYDetails" ], "xbrltype": "monetaryItemType" }, "qpag_DerivativeLiabilityMovement": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 6.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of derivative liability movements.", "label": "Derivative Liability Movement", "negatedLabel": "Derivative liability movements" } } }, "localname": "DerivativeLiabilityMovement", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "qpag_DescriptionOfRantedOptionsExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of granted options exercisable.", "label": "Description Of Ranted Options Exercisable", "terseLabel": "Description of granted options exercisable" } } }, "localname": "DescriptionOfRantedOptionsExercisable", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "stringItemType" }, "qpag_DisasterLoanAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disaster loan amount", "label": "Disaster Loan Amount", "terseLabel": "Disaster loan amount" } } }, "localname": "DisasterLoanAmount", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANSDetails" ], "xbrltype": "monetaryItemType" }, "qpag_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_EmploymentAgreementDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of employment agreement.", "label": "Employment Agreement Description", "terseLabel": "Employment agreement, description" } } }, "localname": "EmploymentAgreementDescription", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "qpag_EquityMethodInvestmentOwnershipPercentages": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stocks or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment Ownership Percentages", "terseLabel": "Common shares outstanding percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentages", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "percentItemType" }, "qpag_EquityMethodsInvestmentOwnershipPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Methods Investment Ownership Percentage", "terseLabel": "Ownership percentage" } } }, "localname": "EquityMethodsInvestmentOwnershipPercentage", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESDetails" ], "xbrltype": "percentItemType" }, "qpag_ExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price", "terseLabel": "Exercise price (in Dollars per share)" } } }, "localname": "ExercisePrice", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "perShareItemType" }, "qpag_ExercisePrice00345Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price00345 Member", "terseLabel": "Exercise Price 0.0345 [Member]" } } }, "localname": "ExercisePrice00345Member", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice0049Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price0049 Member", "terseLabel": "Grant date Price 0.049 [Member]" } } }, "localname": "ExercisePrice0049Member", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice004Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price004 Member", "terseLabel": "Exercise Price 0.04 [Member]" } } }, "localname": "ExercisePrice004Member", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice0055Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price0055 Member", "terseLabel": "Grant date Price 0.055 [Member]" } } }, "localname": "ExercisePrice0055Member", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice015Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price015 Member", "terseLabel": "Exercise Price 0.15 [Member]" } } }, "localname": "ExercisePrice015Member", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice0187Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price0187 Member", "terseLabel": "Exercise Price 0.1875 [Member]" } } }, "localname": "ExercisePrice0187Member", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price024 Member", "terseLabel": "Exercise Price 0.24 [Member]" } } }, "localname": "ExercisePrice024Member", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice040Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price040 Member", "terseLabel": "Exercise Price 0.40 [Member]" } } }, "localname": "ExercisePrice040Member", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePricePerShareForfeitedCancelledinDollars": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.", "label": "Exercise Price Per Share Forfeited Cancelledin Dollars", "terseLabel": "Exercise price per share, Forfeited/Cancelled" } } }, "localname": "ExercisePricePerShareForfeitedCancelledinDollars", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ExercisePriceRange5Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range5 Member", "terseLabel": "Grant date Price 0.050 [Member]", "verboseLabel": "Exercise Price 0.05 [Member]" } } }, "localname": "ExercisePriceRange5Member", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_FairValueAdjustmentToDerivativeLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Fair Value Adjustment To Derivative Liability", "terseLabel": "Fair value adjustment to derivative liability" } } }, "localname": "FairValueAdjustmentToDerivativeLiability", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofmovementinderivativeliabilityTable" ], "xbrltype": "monetaryItemType" }, "qpag_FairValueAssumptionsExpectedTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Fair Value Assumptions Expected Term1", "terseLabel": "Expected life of derivative liability" } } }, "localname": "FairValueAssumptionsExpectedTerm1", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable" ], "xbrltype": "durationItemType" }, "qpag_FederalReliefLoansAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Federal Relief Loans [Abstract]" } } }, "localname": "FederalReliefLoansAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_FederalReliefLoansNonCurrent": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Federal relief loans portion of non current.", "label": "Federal Relief Loans Non Current", "terseLabel": "Federal relief loans" } } }, "localname": "FederalReliefLoansNonCurrent", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "qpag_FederalReliefLoansTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Federal Relief Loans Text Block", "terseLabel": "FEDERAL RELIEF LOANS" } } }, "localname": "FederalReliefLoansTextBlock", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANS" ], "xbrltype": "textBlockItemType" }, "qpag_FederallyInsuredLimit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of federally insured limit.", "label": "Federally Insured Limit", "terseLabel": "Federally insured limit" } } }, "localname": "FederallyInsuredLimit", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESDetails" ], "xbrltype": "monetaryItemType" }, "qpag_FinancialAndCapitalMarketsAdvice": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of financial and capital markets advice.", "label": "Financial And Capital Markets Advice", "terseLabel": "Financial and capital markets advice" } } }, "localname": "FinancialAndCapitalMarketsAdvice", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "qpag_FintechPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of fintech.", "label": "Fintech Percentage", "terseLabel": "Beyond fintech percentage" } } }, "localname": "FintechPercentage", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INTANGIBLESDetails" ], "xbrltype": "percentItemType" }, "qpag_FrictionlessFinancialTechnologiesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Frictionless Financial Technologies Inc Member", "terseLabel": "Frictionless Financial Technologies, Inc. [Member]" } } }, "localname": "FrictionlessFinancialTechnologiesIncMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "domainItemType" }, "qpag_FrictionlessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Frictionless Member", "terseLabel": "Frictionless [Member]" } } }, "localname": "FrictionlessMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "domainItemType" }, "qpag_FrictionlessTechnologiesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Frictionless Technologies Inc Member", "terseLabel": "Frictionless Financial Technologies, Inc. [Member]", "verboseLabel": "Frictionless Technologies, Inc. [Member]" } } }, "localname": "FrictionlessTechnologiesIncMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails", "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable" ], "xbrltype": "domainItemType" }, "qpag_GainLossOnDebtConversion": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on debt conversion.", "label": "Gain Loss On Debt Conversion", "terseLabel": "Loss on debt conversion" } } }, "localname": "GainLossOnDebtConversion", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "qpag_GrossProceed": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of gross proceeds.", "label": "Gross Proceed", "terseLabel": "Gross proceed (in Dollars)" } } }, "localname": "GrossProceed", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "monetaryItemType" }, "qpag_INTANGIBLESDetailsScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Facilitate The Functioning of The Ipsipay Software [Abstract]" } } }, "localname": "INTANGIBLESDetailsScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareLineItems", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable" ], "xbrltype": "stringItemType" }, "qpag_INTANGIBLESDetailsScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INTANGIBLES (Details) - Schedule of facilitate the functioning of the IPSIPay software [Table]" } } }, "localname": "INTANGIBLESDetailsScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable" ], "xbrltype": "stringItemType" }, "qpag_INTANGIBLESLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangibles [Abstract]" } } }, "localname": "INTANGIBLESLineItems", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INTANGIBLES" ], "xbrltype": "stringItemType" }, "qpag_INTANGIBLESTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INTANGIBLES [Table]" } } }, "localname": "INTANGIBLESTable", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INTANGIBLES" ], "xbrltype": "stringItemType" }, "qpag_INTANGIBLESTablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangibles Table [Abstract]" } } }, "localname": "INTANGIBLESTablesLineItems", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INTANGIBLESTables" ], "xbrltype": "stringItemType" }, "qpag_INTANGIBLESTablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INTANGIBLES (Tables) [Table]" } } }, "localname": "INTANGIBLESTablesTable", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INTANGIBLESTables" ], "xbrltype": "stringItemType" }, "qpag_INVESTMENTSDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment (Textual)" } } }, "localname": "INVESTMENTSDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "stringItemType" }, "qpag_INVESTMENTSDetailsScheduleofinvestmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INVESTMENTS (Details) - Schedule of investment [Line Items]" } } }, "localname": "INVESTMENTSDetailsScheduleofinvestmentLineItems", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable" ], "xbrltype": "stringItemType" }, "qpag_INVESTMENTSDetailsScheduleofinvestmentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INVESTMENTS (Details) - Schedule of investment [Table]" } } }, "localname": "INVESTMENTSDetailsScheduleofinvestmentTable", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable" ], "xbrltype": "stringItemType" }, "qpag_INVESTMENTSDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INVESTMENTS (Details) [Table]" } } }, "localname": "INVESTMENTSDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "stringItemType" }, "qpag_IncreaseDecreaseInInterestAccruals": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of interest accruals.", "label": "Increase Decrease In Interest Accruals", "terseLabel": "Interest accruals" } } }, "localname": "IncreaseDecreaseInInterestAccruals", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_InitialConversionPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of initial conversion price.", "label": "Initial Conversion Price Per Share", "terseLabel": "initial conversion price per share (in Dollars per share)" } } }, "localname": "InitialConversionPricePerShare", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "perShareItemType" }, "qpag_IntrinsicValueOutstandingOptions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Intrinsic Value Outstanding Options", "terseLabel": "Intrinsic value outstanding options" } } }, "localname": "IntrinsicValueOutstandingOptions", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "monetaryItemType" }, "qpag_InvestmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment, description.", "label": "Investment Description", "terseLabel": "Investment, description" } } }, "localname": "InvestmentDescription", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "stringItemType" }, "qpag_InvestmentInDeposits": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of Investment in deposits.", "label": "Investment In Deposits", "negatedLabel": "Deposits paid" } } }, "localname": "InvestmentInDeposits", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_JamesFullerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "James Fuller Member", "terseLabel": "Mr. Fuller [Member]", "verboseLabel": "James Fuller [Member]" } } }, "localname": "JamesFullerMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "qpag_JosephWPatriciaGAbramsFamilyTrustMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Joseph WPatricia GAbrams Family Trust Member", "terseLabel": "Joseph W [Member]" } } }, "localname": "JosephWPatriciaGAbramsFamilyTrustMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "domainItemType" }, "qpag_KiosksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Kiosks Member", "terseLabel": "Kiosks [Member]" } } }, "localname": "KiosksMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "domainItemType" }, "qpag_LEASESDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases (Textual)" } } }, "localname": "LEASESDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/LEASESDetails" ], "xbrltype": "stringItemType" }, "qpag_LEASESDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LEASES (Details) [Table]" } } }, "localname": "LEASESDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/LEASESDetails" ], "xbrltype": "stringItemType" }, "qpag_LIQUIDITYMATTERSDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidity Matters (Textual)" } } }, "localname": "LIQUIDITYMATTERSDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/LIQUIDITYMATTERSDetails" ], "xbrltype": "stringItemType" }, "qpag_LIQUIDITYMATTERSDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIQUIDITY MATTERS (Details) [Table]" } } }, "localname": "LIQUIDITYMATTERSDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/LIQUIDITYMATTERSDetails" ], "xbrltype": "stringItemType" }, "qpag_LiquidityMatterAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidity Matters [Abstract]" } } }, "localname": "LiquidityMatterAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_LiquidityMatterTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for liquidity matters.", "label": "Liquidity Matter Text Block", "terseLabel": "LIQUIDITY MATTERS" } } }, "localname": "LiquidityMatterTextBlock", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/LIQUIDITYMATTERS" ], "xbrltype": "textBlockItemType" }, "qpag_LongtermAssetsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents long term assets policy.", "label": "Longterm Assets Policy Text Block", "terseLabel": "Long-Term Assets" } } }, "localname": "LongtermAssetsPolicyTextBlock", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "qpag_LossOnConversionOfDebtToEquity": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss on conversion of debt to equity.", "label": "Loss On Conversion Of Debt To Equity", "terseLabel": "Loss on conversion of debt to equity" } } }, "localname": "LossOnConversionOfDebtToEquity", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_MadissonCorbettMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Madisson Corbett Member", "terseLabel": "Madisson Corbett [Member]" } } }, "localname": "MadissonCorbettMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "qpag_MercerStreetGlobalOpportunityFundLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mercer Street Global Opportunity Fund LLCMember", "terseLabel": "Mercer Street Global Opportunity Fund, LLC [Member]" } } }, "localname": "MercerStreetGlobalOpportunityFundLLCMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "domainItemType" }, "qpag_MergerAgreementDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Merger Agreement Description.", "label": "Merger Agreement Description", "terseLabel": "Merger agreement, description" } } }, "localname": "MergerAgreementDescription", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "stringItemType" }, "qpag_MinorityInterestsOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Minority Interests Ownership Percentage By Parent", "terseLabel": "Stake owned percentage" } } }, "localname": "MinorityInterestsOwnershipPercentageByParent", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "percentItemType" }, "qpag_MrAndreyNovikovMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mr Andrey Novikov Member", "terseLabel": "Mr. Andrey Novikov [Member]", "verboseLabel": "Andrey Novikov [Member]" } } }, "localname": "MrAndreyNovikovMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails", "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "qpag_MrGastonPereiraMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mr Gaston Pereira Member", "terseLabel": "Mr. Gaston Pereira [Member]" } } }, "localname": "MrGastonPereiraMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "domainItemType" }, "qpag_NetIncomeLossAttributableNoncontrollingInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount paid to net loss.", "label": "Net Income Loss Attributable Noncontrolling Interest", "terseLabel": "Net loss" } } }, "localname": "NetIncomeLossAttributableNoncontrollingInterest", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/LIQUIDITYMATTERSDetails" ], "xbrltype": "monetaryItemType" }, "qpag_ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization and Description of Business (Textual)" } } }, "localname": "ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "stringItemType" }, "qpag_ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ORGANIZATION AND DESCRIPTION OF BUSINESS (Details) [Table]" } } }, "localname": "ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "stringItemType" }, "qpag_ORGANIZATIONANDDESCRIPTIONOFBUSINESSLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ORGANIZATION AND DESCRIPTION OF BUSINESS [Abstract]" } } }, "localname": "ORGANIZATIONANDDESCRIPTIONOFBUSINESSLineItems", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESS" ], "xbrltype": "stringItemType" }, "qpag_ORGANIZATIONANDDESCRIPTIONOFBUSINESSTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ORGANIZATION AND DESCRIPTION OF BUSINESS [Table]" } } }, "localname": "ORGANIZATIONANDDESCRIPTIONOFBUSINESSTable", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESS" ], "xbrltype": "stringItemType" }, "qpag_OperatingCashFlowsFromOperatingLeases": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount paid to operating cash flows from operating leases.", "label": "Operating Cash Flows From Operating Leases", "terseLabel": "Operating cash flows from operating leases" } } }, "localname": "OperatingCashFlowsFromOperatingLeases", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofotherleaseinformationTable" ], "xbrltype": "monetaryItemType" }, "qpag_OptionsExercisableNumberExercisablein": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares options exercisable, number exercisable.", "label": "Options Exercisable Number Exercisablein", "terseLabel": "Options Exercisable, Number Exercisable" } } }, "localname": "OptionsExercisableNumberExercisablein", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "sharesItemType" }, "qpag_OptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "the per share of options exercisable ,weighted average exercise price.", "label": "Options Exercisable Weighted Average Exercise Price", "terseLabel": "Options Exercisable ,Weighted Average Exercise Price" } } }, "localname": "OptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "perShareItemType" }, "qpag_OriginalDiscountsRatePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of Original issue discount rate.", "label": "Original Discounts Rate Percentage", "terseLabel": "Original issue discount rate" } } }, "localname": "OriginalDiscountsRatePercentage", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "percentItemType" }, "qpag_OwnedFrictionlessFinancialTechnologies": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of owned frictionless financial technologies.", "label": "Owned Frictionless Financial Technologies", "terseLabel": "Owned frictionless percentage" } } }, "localname": "OwnedFrictionlessFinancialTechnologies", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INTANGIBLESDetails" ], "xbrltype": "percentItemType" }, "qpag_PenaltyExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of penalty expense.", "label": "Penalty Expense", "terseLabel": "Penalty expense" } } }, "localname": "PenaltyExpense", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "qpag_PenaltyOnConvertibleDebt": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of penalty on convertible debt.", "label": "Penalty On Convertible Debt", "terseLabel": "Penalty on convertible debt" } } }, "localname": "PenaltyOnConvertibleDebt", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_PenaltyOnConvertibleNotes": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Penalty on convertible notes.", "label": "Penalty On Convertible Notes", "terseLabel": "Penalty on convertible notes" } } }, "localname": "PenaltyOnConvertibleNotes", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "qpag_PercentageOfRemainingSharesOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of remaining shares owned.", "label": "Percentage Of Remaining Shares Owned", "terseLabel": "Percentage of remaining shares owned" } } }, "localname": "PercentageOfRemainingSharesOwned", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "percentItemType" }, "qpag_ProceedsFromSharesIssuedForServices": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from shares issued for services.", "label": "Proceeds From Shares Issued For Services", "terseLabel": "Shares issued for services" } } }, "localname": "ProceedsFromSharesIssuedForServices", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_ProceedsFromShortTermNotesAndConvertibleNotes": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount represents value of cash inflow from short term and convrtible notes of entity.", "label": "Proceeds From Short Term Notes And Convertible Notes", "terseLabel": "Proceeds from short term notes and convertible notes" } } }, "localname": "ProceedsFromShortTermNotesAndConvertibleNotes", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_PurchaseOfCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The purchase of common shares.", "label": "Purchase Of Common Shares", "terseLabel": "Purchase of common shares" } } }, "localname": "PurchaseOfCommonShares", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "sharesItemType" }, "qpag_PurchasePriceToAcquireOutstandingCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount paid to purchase price to acquire outstanding common stock.", "label": "Purchase Price To Acquire Outstanding Common Stock", "terseLabel": "Purchase price to acquire outstanding common stock for 1% acquired (in Dollars)" } } }, "localname": "PurchasePriceToAcquireOutstandingCommonStock", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "monetaryItemType" }, "qpag_PurchasedTechnology": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchased Technology", "label": "Purchased Technology", "terseLabel": "Purchased Technology" } } }, "localname": "PurchasedTechnology", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable" ], "xbrltype": "monetaryItemType" }, "qpag_RELATEDPARTYTRANSACTIONSDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Textual)" } } }, "localname": "RELATEDPARTYTRANSACTIONSDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "qpag_RELATEDPARTYTRANSACTIONSDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS (Details) [Table]" } } }, "localname": "RELATEDPARTYTRANSACTIONSDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "qpag_RemainingLeaseTermOperatingLease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The duration remaining lease term \u2013 operating lease.", "label": "Remaining Lease Term Operating Lease", "terseLabel": "Remaining lease term \u2013 operating lease" } } }, "localname": "RemainingLeaseTermOperatingLease", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofotherleaseinformationTable" ], "xbrltype": "durationItemType" }, "qpag_RepayableInstallments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Rapayable installments", "label": "Repayable Installments", "terseLabel": "Repayable installments" } } }, "localname": "RepayableInstallments", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANSDetails" ], "xbrltype": "monetaryItemType" }, "qpag_RestrictedStockGrantedDatePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The share of restricted stock granted, grant date price.", "label": "Restricted Stock Granted Date Price", "terseLabel": "Restricted stock granted, grant date price" } } }, "localname": "RestrictedStockGrantedDatePrice", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable" ], "xbrltype": "perShareItemType" }, "qpag_RestrictedStockGrantedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The share of restricted stock granted, number granted", "label": "Restricted Stock Granted Shares", "terseLabel": "Restricted stock granted, number granted (in Shares)" } } }, "localname": "RestrictedStockGrantedShares", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable" ], "xbrltype": "sharesItemType" }, "qpag_RestrictedStockGrantedWeightedAverageFairValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The share of restricted stock granted, weighted.", "label": "Restricted Stock Granted Weighted Average Fair Value Per Share", "terseLabel": "Restricted stock granted, weighted average fair value per share" } } }, "localname": "RestrictedStockGrantedWeightedAverageFairValuePerShare", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable" ], "xbrltype": "perShareItemType" }, "qpag_RestrictedStockVestedNumbeShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The share of restricted stock vested, number vested.", "label": "Restricted Stock Vested Numbe Shares", "terseLabel": "Restricted stock vested, number vested (in Shares)" } } }, "localname": "RestrictedStockVestedNumbeShares", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable" ], "xbrltype": "sharesItemType" }, "qpag_RestrictedStockVestedWeightedAverageFairValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The share restricted stock vested, weighted average fair value per share.", "label": "Restricted Stock Vested Weighted Average Fair Value Per Share", "terseLabel": "Restricted stock vested, weighted average fair value per share" } } }, "localname": "RestrictedStockVestedWeightedAverageFairValuePerShare", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable" ], "xbrltype": "perShareItemType" }, "qpag_ReverseStockSplitDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Stock Split Description.", "label": "Reverse Stock Split Description", "terseLabel": "Reverse stock split, description" } } }, "localname": "ReverseStockSplitDescription", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "stringItemType" }, "qpag_RichardRosenblumMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Richard Rosenblum Member", "terseLabel": "Richard Rosenblum [Member]", "verboseLabel": "Mr. Rosenblum [Member]" } } }, "localname": "RichardRosenblumMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "domainItemType" }, "qpag_STOCKHOLDERSEQUITYDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Textual)" } } }, "localname": "STOCKHOLDERSEQUITYDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "stringItemType" }, "qpag_STOCKHOLDERSEQUITYDetailsScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model [Line Items]" } } }, "localname": "STOCKHOLDERSEQUITYDetailsScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelLineItems", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "stringItemType" }, "qpag_STOCKHOLDERSEQUITYDetailsScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model [Table]" } } }, "localname": "STOCKHOLDERSEQUITYDetailsScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "stringItemType" }, "qpag_STOCKHOLDERSEQUITYDetailsScheduleofrestrictedstockactivityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of restricted stock activity [Line Items]" } } }, "localname": "STOCKHOLDERSEQUITYDetailsScheduleofrestrictedstockactivityLineItems", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "stringItemType" }, "qpag_STOCKHOLDERSEQUITYDetailsScheduleofrestrictedstockactivityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY (Details) - Schedule of restricted stock activity [Table]" } } }, "localname": "STOCKHOLDERSEQUITYDetailsScheduleofrestrictedstockactivityTable", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "stringItemType" }, "qpag_STOCKHOLDERSEQUITYDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY (Details) [Table]" } } }, "localname": "STOCKHOLDERSEQUITYDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "stringItemType" }, "qpag_SalaryRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of base salary rate.", "label": "Salary Rate", "terseLabel": "Salary rate" } } }, "localname": "SalaryRate", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "qpag_SamadHarakeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Samad Harake Member", "terseLabel": "Samad Harake [Member]" } } }, "localname": "SamadHarakeMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "domainItemType" }, "qpag_ScheduleOfAssumptionsWereUsedInTheBlackScholesValuationModelAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Assumptions Were Used In The Black Scholes Valuation Model Abstract" } } }, "localname": "ScheduleOfAssumptionsWereUsedInTheBlackScholesValuationModelAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_ScheduleOfBeyondFintechIncTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Beyond Fintech Inc Table Text Block", "terseLabel": "Schedule of facilitate the functioning of the IPSIPay software" } } }, "localname": "ScheduleOfBeyondFintechIncTableTextBlock", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INTANGIBLESTables" ], "xbrltype": "textBlockItemType" }, "qpag_ScheduleOfConvertibleNotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Convertible Notes Payable Abstract" } } }, "localname": "ScheduleOfConvertibleNotesPayableAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_ScheduleOfDilutiveSharesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Dilutive Shares Abstract" } } }, "localname": "ScheduleOfDilutiveSharesAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_ScheduleOfEstimatedUsefulLivesOfAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents policy estimated useful lives of assets.", "label": "Schedule Of Estimated Useful Lives Of Assets", "terseLabel": "Schedule of estimated useful lives of the assets" } } }, "localname": "ScheduleOfEstimatedUsefulLivesOfAssets", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESTables" ], "xbrltype": "textBlockItemType" }, "qpag_ScheduleOfEstimatedUsefulLivesOfTheAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Estimated Useful Lives Of The Assets Abstract" } } }, "localname": "ScheduleOfEstimatedUsefulLivesOfTheAssetsAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_ScheduleOfFacilitateTheFunctioningOfTheIpsipaySoftwareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Facilitate The Functioning Of The Ipsipay Software Abstract" } } }, "localname": "ScheduleOfFacilitateTheFunctioningOfTheIpsipaySoftwareAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_ScheduleOfFairValueOfTheWarrantsAndOptionsGrantedAndIssuedBlackScholesValuationModelAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Fair Value Of The Warrants And Options Granted And Issued Black Scholes Valuation Model Abstract" } } }, "localname": "ScheduleOfFairValueOfTheWarrantsAndOptionsGrantedAndIssuedBlackScholesValuationModelAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_ScheduleOfMaturityOfOperatingLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Maturity Of Operating Leases Abstract" } } }, "localname": "ScheduleOfMaturityOfOperatingLeasesAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_ScheduleOfMaturityOfOperatingLeasesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Maturity Of Operating Leases Table Text Block", "terseLabel": "Schedule of maturity of operating leases" } } }, "localname": "ScheduleOfMaturityOfOperatingLeasesTableTextBlock", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "qpag_ScheduleOfOptionActivityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Option Activity Abstract" } } }, "localname": "ScheduleOfOptionActivityAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_ScheduleOfOptionsOutstandingAndExercisableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Options Outstanding And Exercisable Abstract" } } }, "localname": "ScheduleOfOptionsOutstandingAndExercisableAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_ScheduleOfOptionsOutstandingAndExercisableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of options outstanding and exercisable", "label": "Schedule Of Options Outstanding And Exercisable Table Text Block", "terseLabel": "Schedule of options outstanding and exercisable" } } }, "localname": "ScheduleOfOptionsOutstandingAndExercisableTableTextBlock", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables" ], "xbrltype": "textBlockItemType" }, "qpag_ScheduleOfOtherLeaseInformation": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Other Lease Information", "terseLabel": "Schedule of other lease information" } } }, "localname": "ScheduleOfOtherLeaseInformation", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "qpag_ScheduleOfOtherLeaseInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Other Lease Information Abstract" } } }, "localname": "ScheduleOfOtherLeaseInformationAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_ScheduleOfRestrictedStockActivityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Restricted Stock Activity Abstract" } } }, "localname": "ScheduleOfRestrictedStockActivityAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_ScheduleOfRestrictedStockGrantedAndExercisableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Restricted Stock Granted And Exercisable Abstract" } } }, "localname": "ScheduleOfRestrictedStockGrantedAndExercisableAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_ScheduleOfRestrictedStockGrantedAndExercisableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Restricted Stock Granted And Exercisable Table Text Block", "terseLabel": "Schedule of restricted stock granted and exercisable" } } }, "localname": "ScheduleOfRestrictedStockGrantedAndExercisableTableTextBlock", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables" ], "xbrltype": "textBlockItemType" }, "qpag_ScheduleOfTotalLeaseCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Total Lease Cost Abstract" } } }, "localname": "ScheduleOfTotalLeaseCostAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_ScheduleOfWarrantActivityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Warrant Activity Abstract" } } }, "localname": "ScheduleOfWarrantActivityAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_ScheduleOfWarrantsOutstandingAndExercisableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Warrants Outstanding And Exercisable Abstract" } } }, "localname": "ScheduleOfWarrantsOutstandingAndExercisableAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "xbrltype": "stringItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercised or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period", "terseLabel": "Shares Underlying Warrants, Exercised (in Shares)", "verboseLabel": "Shares Underlying options, Exercised (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which other than option holders acquired shares when converting their stock options into shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average exercise price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Exercise Price Per Share", "periodEndLabel": "Exercise price per share, Outstanding at ending", "periodStartLabel": "Exercise price per share, Outstanding at beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisePricePerShare", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisedExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Exercised Exercise Price Per Share", "terseLabel": "Exercise price per share, Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisedExercisePricePerShare", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedForfeitedExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Forfeited Exercise Price Per Share", "terseLabel": "Exercise price per share, Forfeited/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedForfeitedExercisePricePerShare", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantsExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Grants Exercise Price Per Share", "terseLabel": "Exercise price per share, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantsExercisePricePerShare", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Balance", "periodEndLabel": "Shares Underlying options, Outstanding at ending (in Shares)", "periodStartLabel": "Shares Underlying options, Outstanding at beginning (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBalance", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRestrictedSharesVested": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of total restricted shares, vested.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Restricted Shares Vested", "terseLabel": "Total restricted shares, Vested (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRestrictedSharesVested", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of options outstanding, number outstanding.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Option Outstanding", "terseLabel": "Options Outstanding, Number Outstanding" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionOutstanding", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "sharesItemType" }, "qpag_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The per share of weighted average fair market value per share, vested.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Vested Weighted Average Exercise Price", "terseLabel": "Weighted average fair market value per share, Vested" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareIssueExpenses": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share issue expenses.", "label": "Share Issue Expenses", "negatedLabel": "Share issue expenses" } } }, "localname": "ShareIssueExpenses", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_ShareOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares common stock.", "label": "Share Of Common Stock", "terseLabel": "Shares of common stock (in Shares)" } } }, "localname": "ShareOfCommonStock", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "sharesItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicGrantValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Grant Value.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Grant Value", "terseLabel": "Grant value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicGrantValue", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "monetaryItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesForfeitedCancelled": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of total unvested restricted shares, forfeited.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Unvested Restricted Shares Forfeited Cancelled", "negatedLabel": "Total unvested restricted shares, Forfeited/Cancelled (in Shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesForfeitedCancelled", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of total unvested restricted shares, granted", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Unvested Restricted Shares Granted", "terseLabel": "Total unvested restricted shares, Granted and issued (in Shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesGranted", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesVested": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of total unvested restricted shares, vested.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Unvested Restricted Shares Vested", "terseLabel": "Total unvested restricted shares, Vested (in Shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesVested", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareForfeitedCancelled": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of total vested restricted shares, forfeited/cancelled.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Fair Market Value Per Share Forfeited Cancelled", "negatedLabel": "Total vested restricted shares, Forfeited/Cancelled" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareForfeitedCancelled", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of total vested restricted shares, granted", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Fair Market Value Per Share Granted", "terseLabel": "Total vested restricted shares, Granted and issued" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareGranted", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareVested": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of total vested restricted shares, vested.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Fair Market Value Per Share Vested", "terseLabel": "Total vested restricted shares, Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareVested", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term", "terseLabel": "Options Exercisable, Weighted Average Remaining Contractual life in years" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "durationItemType" }, "qpag_SharesOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock.", "label": "Shares Of Common Stock", "terseLabel": "Shares of common stock (in Shares)" } } }, "localname": "SharesOfCommonStock", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYDetails" ], "xbrltype": "sharesItemType" }, "qpag_StockIssueDuringPeriodSharesShareSubscriptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of share subscriptions.", "label": "Stock Issue During Period Shares Share Subscriptions", "terseLabel": "Share subscriptions (in Shares)" } } }, "localname": "StockIssueDuringPeriodSharesShareSubscriptions", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "qpag_StockIssueDuringPeriodValueShareSubscriptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of share subscriptions.", "label": "Stock Issue During Period Value Share Subscriptions", "terseLabel": "Share subscriptions" } } }, "localname": "StockIssueDuringPeriodValueShareSubscriptions", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "qpag_StockIssuedDuringPeriodValueFairValueOfWarrantsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value of warrants issued.", "label": "Stock Issued During Period Value Fair Value Of Warrants Issued", "terseLabel": "Fair value of warrants issued as compensation" } } }, "localname": "StockIssuedDuringPeriodValueFairValueOfWarrantsIssued", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "qpag_StockOptionExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement.", "label": "Stock Option Exercise Price", "terseLabel": "Stock option exercise price (in Dollars per share)" } } }, "localname": "StockOptionExercisePrice", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "perShareItemType" }, "qpag_StockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents stock options.", "label": "Stock Options Member", "terseLabel": "Options [Member]", "verboseLabel": "Stock options [Member]" } } }, "localname": "StockOptionsMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable", "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "domainItemType" }, "qpag_StockPurchaseAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock purchase agreement, description", "label": "Stock Purchase Agreement", "terseLabel": "Stock purchase agreement, description" } } }, "localname": "StockPurchaseAgreement", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "stringItemType" }, "qpag_StockPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents member related to stock purchase agreement.", "label": "Stock Purchase Agreement Member", "terseLabel": "Stock Purchase Agreement [Member]" } } }, "localname": "StockPurchaseAgreementMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "domainItemType" }, "qpag_TotalInstalmentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Instalments Due Abstract", "terseLabel": "Total instalments due:" } } }, "localname": "TotalInstalmentsDueAbstract", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofmaturityofoperatingleasesTable" ], "xbrltype": "stringItemType" }, "qpag_TotalRestrictedSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Restricted Shares Member", "terseLabel": "Total restricted shares [Member]" } } }, "localname": "TotalRestrictedSharesMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "domainItemType" }, "qpag_TotalUnvestedRestrictedSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Unvested Restricted Shares Member", "terseLabel": "Total unvested restricted shares [Member]" } } }, "localname": "TotalUnvestedRestrictedSharesMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "domainItemType" }, "qpag_TotalVestedRestrictedSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Vested Restricted Shares Member", "terseLabel": "Total vested restricted shares [Member]" } } }, "localname": "TotalVestedRestrictedSharesMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "domainItemType" }, "qpag_TotalVestedRestrictedSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of total vested restricted shares.", "label": "Total Vested Restricted Shares Outstanding", "periodEndLabel": "Total vested restricted shares, Outstanding at ending", "periodStartLabel": "Total vested restricted shares, Outstanding at beginning" } } }, "localname": "TotalVestedRestrictedSharesOutstanding", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_TwoThousandEighteenStockIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Thousand Eighteen Stock Incentive Plan Member", "terseLabel": "2018 Stock Incentive Plan [Member]" } } }, "localname": "TwoThousandEighteenStockIncentivePlanMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "domainItemType" }, "qpag_TwoThousandTwentyOnePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Thousand Twenty One Plan Member", "terseLabel": "2021 Stock Incentive Plan [Member]" } } }, "localname": "TwoThousandTwentyOnePlanMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "domainItemType" }, "qpag_TypeOfAgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Type Of Agreement Axis", "terseLabel": "Type of Agreement [Axis]" } } }, "localname": "TypeOfAgreementAxis", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "stringItemType" }, "qpag_TypeOfAgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TypeOfAgreement [Domain]" } } }, "localname": "TypeOfAgreementDomain", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "domainItemType" }, "qpag_UndiscountedMinimumFutureLeasePayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Undiscounted Minimum Future Lease Payments", "terseLabel": "2022" } } }, "localname": "UndiscountedMinimumFutureLeasePayments", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofmaturityofoperatingleasesTable" ], "xbrltype": "monetaryItemType" }, "qpag_UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unvested Restricted Weighted Average Fair Market Value Per Share Member", "terseLabel": "Unvested restricted Weighted average fair market value per share [Member]" } } }, "localname": "UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "domainItemType" }, "qpag_ValueOfGrantDate": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of grant date.", "label": "Value Of Grant Date", "terseLabel": "Value of grant date" } } }, "localname": "ValueOfGrantDate", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "monetaryItemType" }, "qpag_VestedRestrictedWeightedAverageFairMarketValuePerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vested Restricted Weighted Average Fair Market Value Per Share Member", "terseLabel": "Vested restricted Weighted average fair market value per share [Member]" } } }, "localname": "VestedRestrictedWeightedAverageFairMarketValuePerShareMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "domainItemType" }, "qpag_ViviHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vivi Holdings Inc Member", "terseLabel": "Vivi Holdings, Inc. [Member]" } } }, "localname": "ViviHoldingsIncMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails", "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable" ], "xbrltype": "domainItemType" }, "qpag_WarrantsExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares warrants shares.", "label": "Warrants Exercisable", "terseLabel": "Warrant purchase" } } }, "localname": "WarrantsExercisable", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "sharesItemType" }, "qpag_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Member", "terseLabel": "Warrants [Member]" } } }, "localname": "WarrantsMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "domainItemType" }, "qpag_WarrantsOutstandingExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The per share options outstanding, exercise price.", "label": "Warrants Outstanding Exercise Price", "terseLabel": "Warrants Outstanding, Exercise Price", "verboseLabel": "Options Outstanding, Exercise Price" } } }, "localname": "WarrantsOutstandingExercisePrice", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "perShareItemType" }, "qpag_WeightedAverageFairMarketValuePerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Fair Market Value Per Share Member", "terseLabel": "Weighted average fair market value per share [Member]" } } }, "localname": "WeightedAverageFairMarketValuePerShareMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "domainItemType" }, "qpag_WilliamCorbettMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "William Corbett Member", "terseLabel": "William Corbett [Member]" } } }, "localname": "WilliamCorbettMember", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "qpag_commonstockvalue1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount paid to Common stock value.", "label": "commonstockvalue1", "terseLabel": "Common stock, value" } } }, "localname": "commonstockvalue1", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "qpag_terminatesPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Terminates period.", "label": "terminates Period", "terseLabel": "Terminates period" } } }, "localname": "terminatesPeriod", "nsuri": "http://innovativepaymentssolu.com/20220930", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "durationItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "Person with designation of chief executive officer.", "label": "Chief Executive Officer [Member]", "terseLabel": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of investment including named security. Excludes entity that is consolidated.", "label": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "domainItemType" }, "srt_FinancingReceivableNonaccrualToOutstandingPercent": { "auth_ref": [ "r425" ], "lang": { "en-us": { "role": { "documentation": "Percentage of nonaccrual to total financing receivable outstanding.", "label": "Financing Receivable, Nonaccrual to Outstanding, Percent", "terseLabel": "Common stock outstanding percentage" } } }, "localname": "FinancingReceivableNonaccrualToOutstandingPercent", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "percentItemType" }, "srt_MaximumMember": { "auth_ref": [ "r175", "r176", "r177", "r178", "r196", "r208", "r230", "r232", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r406", "r407", "r418", "r419" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r175", "r176", "r177", "r178", "r196", "r208", "r230", "r232", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r406", "r407", "r418", "r419" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r170", "r175", "r176", "r177", "r178", "r196", "r208", "r227", "r230", "r232", "r264", "r265", "r266", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r406", "r407", "r418", "r419" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r170", "r175", "r176", "r177", "r178", "r196", "r208", "r227", "r230", "r232", "r264", "r265", "r266", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r406", "r407", "r418", "r419" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r94", "r99", "r174", "r231" ], "lang": { "en-us": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r154" ], "lang": { "en-us": { "role": { "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.", "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r94", "r99", "r174", "r231", "r358" ], "lang": { "en-us": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r147", "r350" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r27", "r356" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r20", "r356" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in-capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r86", "r87", "r88", "r270", "r271", "r272", "r314" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r67", "r199", "r203", "r204", "r334" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of debt discount" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r67", "r161", "r164" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive shares" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r14", "r82", "r127", "r136", "r142", "r156", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r290", "r298", "r322", "r354", "r356", "r382", "r394" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r6", "r26", "r82", "r156", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r290", "r298", "r322", "r354", "r356" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r82", "r156", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r290", "r298", "r322", "r354" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total Non-Current Assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Noncurrent [Abstract]", "terseLabel": "Non-current assets" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r233", "r234", "r235", "r238", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r255", "r256", "r258", "r259", "r263", "r264", "r265", "r266", "r267" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r5", "r11", "r69" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r70" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r63", "r69", "r75" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "CASH AT END OF PERIOD", "periodStartLabel": "CASH AT BEGINNING OF PERIOD" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r63", "r323" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "NET INCREASE (DECREASE) IN CASH" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r11" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash balance" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/LIQUIDITYMATTERSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price (in Dollars per share)", "verboseLabel": "Exercise price per share (in Dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails", "http://innovativepaymentssolu.com/role/INVESTMENTSDetails", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightExpenseOrRevenueRecognized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of expense or revenue offset related to the warrants or rights.", "label": "Class of Warrant or Right, Expense or Revenue Recognized", "terseLabel": "Warrant expense" } } }, "localname": "ClassOfWarrantOrRightExpenseOrRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Warrant exercisable (in Shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Warrant exercisable (in Shares)" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r171", "r172", "r173", "r179", "r414" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/COMMITMENTSANDCONTINGENCIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r180", "r415" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "Commitments and Contingencies, Policy [Policy Text Block]", "terseLabel": "Contingencies" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r86", "r87", "r314" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock", "verboseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockNoParValue": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Face amount per share of no-par value common stock.", "label": "Common Stock, No Par Value", "terseLabel": "Common stock, per share (in Dollars per share)" } } }, "localname": "CommonStockNoParValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, authorized", "verboseLabel": "Common stock, authorized (in Shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, issued", "verboseLabel": "Common stock, shares issued (in Shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r19", "r220" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r19", "r356" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.0001 par value; 750,000,000 and 500,000,000 shares authorized, 376,901,679 and 367,901,679 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively." } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income, Policy [Policy Text Block]", "terseLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer equipment [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r117", "r392" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Risks and Uncertainties" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r77", "r292" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConversionOfStockAmountConverted1": { "auth_ref": [ "r72", "r73", "r74" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Amount Converted", "terseLabel": "Conversion of convertible debt to equity" } } }, "localname": "ConversionOfStockAmountConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtCurrent": { "auth_ref": [ "r15" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Convertible Debt, Current", "terseLabel": "Convertible debt, net of unamortized discount of $0 and $263,200, respectively" } } }, "localname": "ConvertibleDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtSecuritiesMember": { "auth_ref": [ "r228" ], "lang": { "en-us": { "role": { "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.", "label": "Convertible Debt Securities [Member]", "terseLabel": "Convertible debt [Member]" } } }, "localname": "ConvertibleDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.", "label": "Convertible Debt [Table Text Block]", "terseLabel": "Schedule of convertible notes payable" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r30" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Notes Payable, Current", "terseLabel": "Convertible notes payable" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableMember": { "auth_ref": [ "r15", "r383", "r393", "r413" ], "lang": { "en-us": { "role": { "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable [Member]", "terseLabel": "Total Convertible Notes Payable [Member]" } } }, "localname": "ConvertibleNotesPayableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r53", "r367" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "negatedLabel": "Cost of Goods Sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r195", "r200" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Conversion price (in Dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature": { "auth_ref": [ "r34", "r221", "r222", "r223" ], "lang": { "en-us": { "role": { "documentation": "Description of conversion terms for debt instrument.", "label": "Debt Instrument, Convertible, Terms of Conversion Feature", "terseLabel": "Description of conversion terms" } } }, "localname": "DebtInstrumentConvertibleTermsOfConversionFeature", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r193", "r201", "r202", "r333", "r335", "r336" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Aggregate principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "auth_ref": [ "r81" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.", "label": "Debt Instrument, Increase, Accrued Interest", "terseLabel": "Accrued Interest", "verboseLabel": "Accrued interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANSDetails", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r32", "r194" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest Rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt Instrument, Maturity Date, Description", "terseLabel": "Maturity date" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r197", "r332", "r336" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedLabel": "Unamortized debt discount", "terseLabel": "Convertible debt, net of unamortized discount (in Dollars)" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r67", "r167" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r67", "r125" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r40", "r308", "r309", "r310", "r311" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r38", "r39", "r40", "r321" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative financial liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r38" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "periodEndLabel": "Closing balance", "periodStartLabel": "Opening balance", "terseLabel": "Derivative liability" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet", "http://innovativepaymentssolu.com/role/ScheduleofmovementinderivativeliabilityTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesAndFairValueTextBlock": { "auth_ref": [ "r317", "r320" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.", "label": "Derivatives and Fair Value [Text Block]", "terseLabel": "DERIVATIVE LIABILITY" } } }, "localname": "DerivativesAndFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITY" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r84", "r304", "r305", "r306", "r307", "r312" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative Liabilities" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r50", "r91", "r92", "r93", "r94", "r95", "r100", "r103", "r105", "r106", "r107", "r111", "r112", "r315", "r316", "r389", "r402" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic and diluted loss per share (in Dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r50", "r91", "r92", "r93", "r94", "r95", "r103", "r105", "r106", "r107", "r111", "r112", "r315", "r316", "r389", "r402" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Basic and diluted loss per share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r108", "r109", "r110", "r113" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "NET LOSS PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/NETLOSSPERSHARE" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r44", "r45", "r46", "r86", "r87", "r88", "r90", "r96", "r98", "r114", "r159", "r220", "r224", "r270", "r271", "r272", "r282", "r283", "r314", "r324", "r325", "r326", "r327", "r328", "r329", "r345", "r408", "r409", "r410" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r154" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Acquired percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ExcessStockSharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of excess stock shares of an entity that have been sold or granted to shareholders.", "label": "Excess Stock, Shares Issued", "terseLabel": "Shares of Common Stock (in Shares)" } } }, "localname": "ExcessStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ExcessStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of excess stock held by shareholders.", "label": "Excess Stock, Shares Outstanding", "terseLabel": "Common stock, shares outsatnding (in Shares)" } } }, "localname": "ExcessStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r67", "r205" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "terseLabel": "Fair value of warrants issued" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Schedule of movement in derivative liability" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r163", "r368" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "negatedLabel": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": { "auth_ref": [ "r67" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.", "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges", "terseLabel": "Impairment charges (in Dollars)" } } }, "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r54" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralPartnersOfferingCosts": { "auth_ref": [ "r225" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of offering costs allocated to the general partner.", "label": "General Partners' Offering Costs", "terseLabel": "Additional amount" } } }, "localname": "GeneralPartnersOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r165" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "INTANGIBLES" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INTANGIBLES" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r52", "r82", "r127", "r135", "r138", "r141", "r143", "r156", "r182", "r183", "r184", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r322" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r48", "r127", "r135", "r138", "r141", "r143", "r381", "r387", "r390", "r404" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before Income Taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r83", "r97", "r98", "r126", "r277", "r284", "r285", "r405" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r43", "r275", "r276", "r278", "r279", "r280", "r281" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r71" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r66" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDerivativeLiabilities": { "auth_ref": [ "r66" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).", "label": "Increase (Decrease) in Derivative Liabilities", "terseLabel": "Derivative liability movements" } } }, "localname": "IncreaseDecreaseInDerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in Assets and Liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "auth_ref": [ "r66" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current assets classified as other.", "label": "Increase (Decrease) in Other Current Assets", "negatedLabel": "Other current assets" } } }, "localname": "IncreaseDecreaseInOtherCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "terseLabel": "Operating lease liabilities" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r160", "r162" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndDebtExpense": { "auth_ref": [ "r331" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.", "label": "Interest and Debt Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestAndDebtExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestCostsCapitalized": { "auth_ref": [ "r330" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest capitalized during the period.", "label": "Interest Costs Capitalized", "terseLabel": "Amortization of debt discount" } } }, "localname": "InterestCostsCapitalized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense classified as other.", "label": "Interest Expense, Other", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenseOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r61", "r64", "r71" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentInterestRate": { "auth_ref": [ "r150", "r151" ], "lang": { "en-us": { "role": { "documentation": "Rate of interest on investment.", "label": "Investment Interest Rate", "terseLabel": "Strategic interest" } } }, "localname": "InvestmentInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r155", "r403" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investments" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTableTextBlock": { "auth_ref": [ "r152", "r153", "r157", "r158" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of investment.", "label": "Investment [Table Text Block]", "terseLabel": "Schedule of investment" } } }, "localname": "InvestmentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTextBlock": { "auth_ref": [ "r152", "r153", "r157", "r158" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investment.", "label": "Investment [Text Block]", "terseLabel": "INVESTMENTS" } } }, "localname": "InvestmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_Investments": { "auth_ref": [ "r400" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.", "label": "Investments", "terseLabel": "Investment" } } }, "localname": "Investments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, All Other Investments [Abstract]" } } }, "localname": "InvestmentsAllOtherInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsAndOtherNoncurrentAssets": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments, and noncurrent assets classified as other.", "label": "Investments and Other Noncurrent Assets", "terseLabel": "Investment" } } }, "localname": "InvestmentsAndOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r339", "r341" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "terseLabel": "Lease amount" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/LEASESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Schedule of total lease cost" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r168" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/LEASES" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r29", "r82", "r137", "r156", "r182", "r183", "r184", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r291", "r298", "r299", "r322", "r354", "r355" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r24", "r82", "r156", "r322", "r356", "r386", "r398" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Equity (Deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r7", "r31", "r82", "r156", "r182", "r183", "r184", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r291", "r298", "r299", "r322", "r354", "r355", "r356" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r8", "r9", "r10", "r16", "r17", "r82", "r156", "r182", "r183", "r184", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r291", "r298", "r299", "r322", "r354", "r355" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total Non-Current Liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "terseLabel": "Non-Current Liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r37", "r82", "r156", "r182", "r186", "r187", "r188", "r191", "r192", "r322", "r385", "r397" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Non-controlling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r63" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "NET CASH PROVIDED BY FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r63" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "NET CASH USED IN INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r63", "r65", "r68" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "CASH USED IN OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r3", "r41", "r42", "r46", "r49", "r68", "r82", "r89", "r91", "r92", "r93", "r94", "r97", "r98", "r104", "r127", "r135", "r138", "r141", "r143", "r156", "r182", "r183", "r184", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r316", "r322", "r388", "r401" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net loss attributable to Innovative Payment Solutions, Inc. stockholders" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r41", "r42", "r46", "r97", "r98", "r294", "r301" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedLabel": "Net loss attributable to non-controlling interest" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent accounting pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "NON CASH INVESTING AND FINANCING ACTIVITIES" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r86", "r87", "r88", "r224", "r286" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-controlling shareholders interest" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_OfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.", "label": "Office Equipment [Member]", "terseLabel": "Office equipment [Member]" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total Expense" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r127", "r135", "r138", "r141", "r143" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from Operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r338" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoftotalleasecostTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r4", "r303" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "ORGANIZATION AND DESCRIPTION OF BUSINESS" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESS" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r25", "r356" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIntangibleAssetsNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.", "label": "Other Intangible Assets, Net", "terseLabel": "Total" } } }, "localname": "OtherIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r55" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Investment in intangibles" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r56" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedLabel": "Investment in Frictionless Financial Technologies Inc." } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r55" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Plant and equipment purchased" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r18", "r206" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in Dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, authorized", "verboseLabel": "Preferred stock, authorized (in Shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r18", "r206" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r18", "r356" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of September 30, 2022 and December 31, 2021." } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "terseLabel": "Reclassification of prior year presentation" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r57" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from share issuances" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfDebt": { "auth_ref": [ "r58" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.", "label": "Proceeds from Issuance of Debt", "terseLabel": "Net proceeds" } } }, "localname": "ProceedsFromIssuanceOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r57" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Gross proceeds" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r57" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Pr0oceeds from warrants exercised" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromMinorityShareholders": { "auth_ref": [ "r59" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.", "label": "Proceeds from Noncontrolling Interests", "terseLabel": "Proceeds from minority shareholder contributions" } } }, "localname": "ProceedsFromMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r3", "r41", "r42", "r46", "r62", "r82", "r89", "r97", "r98", "r127", "r135", "r138", "r141", "r143", "r156", "r182", "r183", "r184", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r288", "r293", "r295", "r301", "r302", "r316", "r322", "r390" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss", "totalLabel": "Net Loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow", "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r169" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).", "label": "Property, Plant and Equipment, Estimated Useful Lives", "terseLabel": "Estimated useful lives of property" } } }, "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r12", "r168" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Plant and equipment costs" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r169", "r356", "r391", "r399" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r169", "r416", "r417" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "durationItemType" }, "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.", "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]", "terseLabel": "Accounts Receivable and Allowance for Doubtful Accounts" } } }, "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r229", "r348", "r349" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails", "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails", "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r229", "r348", "r349", "r351" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDescriptionOfTransaction": { "auth_ref": [ "r17", "r337", "r340", "r343", "r344", "r347" ], "lang": { "en-us": { "role": { "documentation": "A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.", "label": "Related Party Transaction, Description of Transaction", "terseLabel": "Related party transactions, description" } } }, "localname": "RelatedPartyTransactionDescriptionOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r229" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r229", "r348", "r351", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails", "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails", "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r346", "r347", "r349", "r352", "r353" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONS" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r60" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "negatedLabel": "Repayment of loans payable" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfShortTermDebt": { "auth_ref": [ "r60" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Repayments of Short-Term Debt", "negatedLabel": "Repayment of convertible notes" } } }, "localname": "RepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockExpense": { "auth_ref": [ "r67" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.", "label": "Restricted Stock or Unit Expense", "terseLabel": "Expense" } } }, "localname": "RestrictedStockExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r21", "r224", "r356", "r396", "r411", "r412" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r86", "r87", "r88", "r90", "r96", "r98", "r159", "r270", "r271", "r272", "r282", "r283", "r314", "r408", "r410" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r78", "r79" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r47", "r82", "r123", "r124", "r134", "r139", "r140", "r144", "r145", "r146", "r156", "r182", "r183", "r184", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r322", "r390" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Net Revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalariesAndWages": { "auth_ref": [ "r51" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold", "terseLabel": "Salary amount" } } }, "localname": "SalariesAndWages", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockDescriptionOfTransaction": { "auth_ref": [ "r289", "r296", "r297" ], "lang": { "en-us": { "role": { "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.", "label": "Sale of Stock, Description of Transaction", "terseLabel": "Description of compensation service" } } }, "localname": "SaleOfStockDescriptionOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of dilutive shares" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/NETLOSSPERSHARETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative liabilities at fair value.", "label": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]", "terseLabel": "Schedule of assumptions were used in the Black-Scholes valuation model" } } }, "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r181" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Schedule of warrant activity" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r237" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of restricted stock activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "terseLabel": "Schedule of warrants outstanding and exercisable" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r237", "r254", "r257" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of option activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebt": { "auth_ref": [ "r16", "r384", "r395" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.", "label": "Secured Debt", "terseLabel": "Senior secured convertible note" } } }, "localname": "SecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SecurityDeposit": { "auth_ref": [ "r13" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.", "label": "Security Deposit", "terseLabel": "Security deposit" } } }, "localname": "SecurityDeposit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r128", "r129", "r130", "r131", "r132", "r133", "r145" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting, Policy [Policy Text Block]", "terseLabel": "Reporting by Segment" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r66" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Vesting term" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "terseLabel": "Shares Underlying Warrants, Forfeited/Cancelled (in Shares)", "verboseLabel": "Shares Underlying options, Forfeited/Cancelled (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average exercise price, Forfeited/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Shares Underlying Warrants, Granted (in Shares)", "verboseLabel": "Shares Underlying options, Granted (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average exercise price, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r247", "r248" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Shares Underlying Warrants, Outstanding at ending (in Shares)", "periodStartLabel": "Shares Underlying Warrants, Outstanding at beginning (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r247", "r248" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted average exercise price, Outstanding at ending", "periodStartLabel": "Weighted average exercise price, Outstanding at beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price", "terseLabel": "Exercise price (in Dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividend rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility of underlying stock" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r266" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "terseLabel": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r241" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Options Outstanding, Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Total restricted shares, Forfeited/Cancelled (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r243" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Total restricted shares, Granted and issued (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r269" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Warrants outstanding an intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r238", "r240" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Total restricted shares, Outstanding at ending (in Shares)", "periodStartLabel": "Total restricted shares, Outstanding at beginning (in Shares)", "terseLabel": "Warrants Outstanding, Number Outstanding", "verboseLabel": "Incentive stock options (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r238", "r240" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted average fair market value per share, Outstanding at ending", "periodStartLabel": "Weighted average fair market value per share, Outstanding at beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r233", "r234", "r235", "r238", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r255", "r256", "r258", "r259", "r263", "r264", "r265", "r266", "r267" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "negatedLabel": "Weighted average fair market value per share, Forfeited/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r243" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average fair market value per share, Granted and issued", "verboseLabel": "Exercise price per share, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r236", "r261", "r262", "r263", "r264", "r267", "r273", "r274" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Payment Arrangement [Policy Text Block]", "terseLabel": "Share-Based Payment Arrangements" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Exercise Price Range [Domain]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r253" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "terseLabel": "Warrants Exercisable, Number Exercisable" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Total unvested restricted shares, Outstanding at ending (in Shares)", "periodStartLabel": "Total unvested restricted shares, Outstanding at beginning (in Shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Options Outstanding, Weighted Average Remaining Contractual life in years" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r241" ], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price", "terseLabel": "Warrants Exercisable ,Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r259" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Warrants Exercisable, Weighted Average Remaining Contractual life in years" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r239" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price", "terseLabel": "Warrants Outstanding, Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Warrants Outstanding, Weighted Average Remaining Contractual life in years" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "terseLabel": "Common stock shares (in Shares)", "verboseLabel": "Issued shares (in Shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/CONVERTIBLENOTESPAYABLEDetails", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtInterestRateIncrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage increase in the stated interest rate on a short-term debt instrument.", "label": "Short-Term Debt, Interest Rate Increase", "terseLabel": "Bearing interest, percentage" } } }, "localname": "ShortTermDebtInterestRateIncrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/FEDERALRELIEFLOANSDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-Term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r76", "r85" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "ACCOUNTING POLICIES AND ESTIMATES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ACCOUNTINGPOLICIESANDESTIMATES" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r36", "r44", "r45", "r46", "r86", "r87", "r88", "r90", "r96", "r98", "r114", "r159", "r220", "r224", "r270", "r271", "r272", "r282", "r283", "r314", "r324", "r325", "r326", "r327", "r328", "r329", "r345", "r408", "r409", "r410" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable", "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r86", "r87", "r88", "r114", "r367" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable", "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r72", "r73", "r74" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock Issued", "terseLabel": "Debt discount on convertible debt" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r35", "r198", "r220", "r221", "r224" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Conversion of debt to equity (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Shares issued for services (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r18", "r19", "r220", "r224" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Number of common stock issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r220", "r224" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "terseLabel": "Restricted stock awards (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r18", "r19", "r220", "r224" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Stock based compensation (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r18", "r19", "r220", "r224", "r244" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "terseLabel": "Warrants exercised (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r36", "r220", "r224" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Conversion of debt to equity" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": { "auth_ref": [ "r36", "r220", "r224" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Stock Issued During Period, Value, Conversion of Units", "terseLabel": "Contribution by minority shareholders" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Shares issued for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r18", "r19", "r220", "r224" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Share issue expenses" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r18", "r19", "r220", "r224" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross", "terseLabel": "Restricted stock awards" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r18", "r19", "r224", "r255" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Stock based compensation" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture", "terseLabel": "Stock based option expense" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r36", "r220", "r224" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Warrants exercised" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionExercisePriceIncrease": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement.", "label": "Stock Option, Exercise Price, Increase", "terseLabel": "Exercise price (in Dollars per share)" } } }, "localname": "StockOptionExercisePriceIncrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]", "terseLabel": "Stock Options [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable" ], "xbrltype": "domainItemType" }, "us-gaap_StockOptionPlanExpense": { "auth_ref": [ "r67" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for option under share-based payment arrangement.", "label": "Stock or Unit Option Plan Expense", "terseLabel": "Option expense" } } }, "localname": "StockOptionPlanExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r19", "r22", "r23", "r82", "r149", "r156", "r322", "r356" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total equity (deficit) attributable to Innovative Payment Solutions, Inc. Stockholders" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Equity (Deficit)" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r45", "r82", "r86", "r87", "r88", "r90", "r96", "r156", "r159", "r224", "r270", "r271", "r272", "r282", "r283", "r286", "r287", "r300", "r314", "r322", "r324", "r325", "r329", "r345", "r409", "r410" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total Equity (deficit)" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r80", "r207", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r224", "r226", "r313" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITY" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r357", "r359" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/SUBSEQUENTEVENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "CASH PAID FOR INTEREST AND TAXES:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalDeferredPurchasePrice": { "auth_ref": [ "r72", "r73", "r74" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A device of credit enhancement where a part of the purchase price for the receivable/ payable is retained to serve as a cash collateral.", "label": "Supplemental Deferred Purchase Price", "terseLabel": "Purchase price (in Dollars)" } } }, "localname": "SupplementalDeferredPurchasePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r115", "r116", "r118", "r119", "r120", "r121", "r122" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantExercisePriceIncrease": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.", "label": "Warrant, Exercise Price, Increase", "terseLabel": "Exercise price (in Dollars per share)" } } }, "localname": "WarrantExercisePriceIncrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/DERIVATIVELIABILITYDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant [Member]", "verboseLabel": "Warrants to purchase shares of common stock [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Warrants term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/INVESTMENTSDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r102", "r107" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted Average Number of Shares Outstanding \u2013 Basic and diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r100", "r107" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted Average Number of Shares Outstanding \u2013 Basic and diluted (in Shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": { "auth_ref": [ "r101" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.", "label": "Weighted Average Number of Shares, Restricted Stock", "terseLabel": "Restricted shares (in Shares)" } } }, "localname": "WeightedAverageNumberOfSharesRestrictedStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://innovativepaymentssolu.com/role/STOCKHOLDERSEQUITYDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2646-109256" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r113": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563" }, "r152": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928" }, "r153": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "321", "URI": "https://asc.fasb.org/topic&trid=75115024" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r157": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "https://asc.fasb.org/topic&trid=2196965" }, "r158": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "325", "URI": "https://asc.fasb.org/topic&trid=2197064" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r165": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org/topic&trid=2144416" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905813&loc=d3e1205-110223" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r173": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r179": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.F)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770" }, "r226": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r274": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r303": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r317": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org/topic&trid=2229140" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "820", "URI": "https://asc.fasb.org/topic&trid=2155941" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123395306&loc=d3e36975-112693" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918703-209980" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r342": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919370-209981" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128295416&loc=SL77919784-209982" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r353": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r359": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r4": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(h))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r420": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r421": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r422": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r423": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r424": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r425": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(2)" }, "r426": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r85": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" } }, "version": "2.1" } ZIP 78 0001213900-22-071662-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-22-071662-xbrl.zip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

9OL+2#RX":T#Y#RK(5 MV*;>D/1N(1CN:ZK,Z'*$"!,,_=MP1'9+.A

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